Jump to a subject
Biochemistry
Biochemistry for MBBS, written in exam-answer format.
Introduction
The cell is the structural and functional unit of life. Metabolic pathways are compartmentalised among its organelles, which allows incompatible reactions to proceed simultaneously and permits independent regulation.
The Organelles and Their Functions
| Organelle | Chief functions |
|---|---|
| Nucleus | DNA replication and transcription; the nucleolus makes ribosomal RNA |
| Mitochondrion | TCA cycle, electron transport, oxidative phosphorylation, β-oxidation, ketogenesis, part of the urea cycle, PDH complex |
| Rough endoplasmic reticulum | Synthesis of secretory and membrane proteins |
| Smooth endoplasmic reticulum | Lipid and steroid synthesis; detoxification (cytochrome P450); calcium store |
| Golgi apparatus | Glycosylation, sulphation, sorting and packaging of proteins |
| Lysosome | Intracellular digestion by about 50 acid hydrolases at pH 5 |
| Peroxisome | Oxidation of very long chain fatty acids, α-oxidation, plasmalogen synthesis, catalase |
| Ribosome | Protein synthesis (80S in eukaryotes) |
| Cytosol | Glycolysis, HMP shunt, fatty acid synthesis, glycogen metabolism |
| Cytoskeleton | Shape, motility and intracellular transport — microfilaments (actin), microtubules (tubulin), intermediate filaments |
Marker Enzymes
A marker enzyme is one confined to a single organelle, used to identify and assess the purity of fractions after subcellular fractionation.
| Organelle | Marker enzyme |
|---|---|
| Mitochondrion | Cytochrome oxidase, succinate dehydrogenase, glutamate dehydrogenase |
| Lysosome | Acid phosphatase, β-glucuronidase |
| Endoplasmic reticulum (microsomes) | Glucose-6-phosphatase, cytochrome P450 |
| Golgi | Galactosyl transferase |
| Peroxisome | Catalase, urate oxidase |
| Cytosol | Lactate dehydrogenase |
| Plasma membrane | Na+/K+-ATPase, 5′-nucleotidase, adenylate cyclase |
| Nucleus | DNA polymerase, RNA polymerase |
Subcellular Fractionation
Tissue homogenised in isotonic sucrose → Differential centrifugation at increasing speed → 600 × g → nuclei → 10,000 × g → mitochondria, lysosomes, peroxisomes → 100,000 × g → microsomes (fragmented ER) → Supernatant → cytosol
- Density gradient centrifugation separates organelles of similar size but different density
- Purity is judged by marker enzyme assay — the practical reason markers matter
Mitochondria in Detail
- Double membrane; the outer is permeable (porins), the inner impermeable and folded into cristae
- Inner membrane — electron transport chain, ATP synthase, carrier proteins; rich in cardiolipin
- Matrix — TCA cycle, β-oxidation, PDH complex, urea cycle enzymes
- Own circular DNA (16.5 kb), its own ribosomes (70S) and tRNAs
- Maternally inherited — sperm mitochondria are degraded after fertilisation
- Regarded as descended from an engulfed bacterium — the endosymbiont theory, supported by the double membrane, circular DNA and 70S ribosomes
Lysosomes
- Single membrane; interior kept at pH 5 by an H+-ATPase
- Contain about 50 acid hydrolases — proteases, lipases, nucleases, glycosidases, sulphatases
- Called "suicide bags"; rupture causes autolysis
- Enzymes are tagged with mannose-6-phosphate in the Golgi for delivery
- Functions — digestion of engulfed material, autophagy, turnover of organelles, bone remodelling by osteoclasts
Compartmentation of Metabolic Pathways
| Pathway | Compartment |
|---|---|
| Glycolysis, HMP shunt, fatty acid synthesis | Cytosol |
| TCA cycle, β-oxidation, etc, ketogenesis | Mitochondrion |
| Gluconeogenesis | Both — starts in mitochondrion, ends in ER |
| Urea cycle | Both — first 2 steps mitochondrial, last 3 cytosolic |
| Haem synthesis | Both |
| Cholesterol and steroid synthesis | Cytosol and smooth ER |
| Protein synthesis | Ribosomes — free or on rough ER |
- Compartmentation permits opposing pathways to run at once — fatty acid synthesis in the cytosol while oxidation proceeds in the mitochondrion — and allows each to be regulated separately
Applied Aspects
- Lysosomal storage diseases — deficiency of a single hydrolase causes accumulation of its substrate: Tay–Sachs, Gaucher, Niemann–Pick, Hurler, Pompe
- I-cell disease — failure to add the mannose-6-phosphate tag, so enzymes are secreted instead of delivered; lysosomes are empty and plasma hydrolase levels are high
- Mitochondrial diseases are maternally inherited and strike high-energy tissues — melas, MERRF, Leber hereditary optic neuropathy
- Zellweger syndrome — absent peroxisomes; very long chain fatty acids accumulate
- Marker enzymes in plasma indicate the site of cell damage — a rise in mitochondrial ast suggests severe hepatocyte necrosis rather than mere membrane leak
Composition
The plasma membrane is a selectively permeable boundary composed of lipid (about 50%), protein (about 45%) and carbohydrate (about 5%).
| Component | Types | Role |
|---|---|---|
| Phospholipids | Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, sphingomyelin | Form the bilayer; amphipathic |
| Cholesterol | — | Modulates fluidity — prevents both excessive rigidity and excessive fluidity |
| Glycolipids | Cerebrosides, gangliosides | Cell recognition; blood group antigens; always on the outer leaflet |
| Integral proteins | Transmembrane | Transporters, channels, receptors, enzymes; removed only by detergents |
| Peripheral proteins | Surface-attached | Structural and signalling; removed by changes in salt or pH |
Fluid Mosaic Model
- Proposed by Singer and Nicolson (1972)
- A lipid bilayer behaving as a two-dimensional fluid, in which proteins float like icebergs in a sea
- Lateral diffusion is rapid; transverse movement (flip-flop) is very slow and needs flippase enzymes
- Asymmetric — phosphatidylcholine and sphingomyelin predominate on the outer leaflet, phosphatidylserine and phosphatidylethanolamine on the inner; all carbohydrate faces outward
CLINICAL PEARL
The asymmetry is functional, not incidental. When phosphatidylserine appears on the outer surface it signals apoptosis, marking the cell for phagocytosis, and it also provides the surface on which the coagulation cascade assembles.
Factors Affecting Membrane Fluidity
| Increases fluidity | Decreases fluidity |
|---|---|
| Unsaturated fatty acids (cis double bonds kink the chain) | Saturated fatty acids |
| Shorter chain length | Longer chains |
| Higher temperature | Lower temperature |
| Cholesterol below the transition temperature | Cholesterol above the transition temperature |
- Cholesterol acts in both directions — it is a fluidity buffer, keeping the membrane within a workable range
Transport Across the Membrane
| Mechanism | Carrier | Energy | Gradient | Examples |
|---|---|---|---|---|
| Simple diffusion | None | None | Down | O2, CO2, steroids, water, urea |
| Facilitated diffusion | Yes | None | Down | GLUT transporters, aquaporins, anion exchanger |
| Primary active transport | Yes | ATP directly | Against | Na+/K+-ATPase, Ca2+-ATPase, H+/K+-ATPase |
| Secondary active transport | Yes | Ion gradient | Against | SGLT-1 and SGLT-2, Na+–amino acid cotransport |
| Ion channels | Channel protein | None | Down | Voltage- and ligand-gated Na+, K+, Ca2+ channels |
| Endocytosis / exocytosis | Vesicles | ATP | — | LDL receptor uptake, phagocytosis, insulin release |
Distinguishing simple from facilitated diffusion
- Facilitated diffusion is saturable, shows substrate specificity, can be competitively inhibited, and follows Michaelis–Menten kinetics
- Simple diffusion is linear with concentration and never saturates
The Sodium–potassium Pump
3 Na+ out, 2 K+ IN per ATP hydrolysed → Creates the Na+ and K+ gradients → Generates the resting membrane potential (electrogenic) → The Na+ gradient powers secondary active transport → Maintains cell volume by countering the Donnan effect
- It consumes 20–30% of resting ATP, and far more in kidney and brain
- Inhibited by digoxin and ouabain — the rise in intracellular sodium reduces Na+/Ca2+ exchange, so calcium accumulates and cardiac contractility increases
Other Membrane Functions
- Selective permeability and maintenance of the internal environment
- Signal transduction — receptors for hormones and neurotransmitters
- Cell recognition and adhesion — glycocalyx, blood group antigens, MHC molecules
- Electrical excitability in nerve and muscle
- Site of many enzymes — adenylate cyclase, alkaline phosphatase
Endocytosis and Exocytosis
| Process | Description | Example |
|---|---|---|
| Phagocytosis | "Cell eating" — large particles | Neutrophils and macrophages engulfing bacteria |
| Pinocytosis | "Cell drinking" — fluid and solutes | Non-specific uptake |
| Receptor-mediated endocytosis | Specific; via clathrin-coated pits | LDL uptake, transferrin, insulin |
| Exocytosis | Vesicle fuses with the membrane and discharges | Insulin secretion, neurotransmitter release |
- Receptor-mediated endocytosis is defective in familial hypercholesterolaemia — the LDL receptor cannot bind or internalise its ligand
Applied Aspects
- Cystic fibrosis — a defective CFTR chloride channel → viscid secretions; the sweat chloride test is diagnostic
- Cholera toxin locks adenylate cyclase on → massive chloride and water secretion. ORS works because SGLT-1 remains intact and glucose drags sodium and water with it
- Hereditary spherocytosis — defective spectrin and ankyrin of the membrane skeleton → loss of the biconcave shape and splenic destruction
- Liposomes, built from the same bilayer principle, are used to deliver amphotericin B and doxorubicin with less toxicity
- Local anaesthetics and general anaesthetics act on membrane channels and lipids
- Membrane fluidity falls with cholesterol loading, which stiffens the red cell in liver disease and produces target cells
Definition
Carbohydrates = polyhydroxy aldehydes or ketones, or compounds that yield these on hydrolysis.
- General formula (CH2O)n for most, though deoxyribose and the amino sugars do not fit it
- They are the chief source of dietary energy, supplying 4 kcal/g and 55–70% of calories in the Indian diet
Classification
| Class | Definition | Examples |
|---|---|---|
| Monosaccharides | Cannot be hydrolysed to simpler sugars | Glucose, fructose, galactose, ribose |
| Disaccharides | Yield 2 monosaccharides | Maltose, lactose, sucrose |
| Oligosaccharides | Yield 3–10 | Raffinose, stachyose |
| Polysaccharides | Yield more than 10 | Starch, glycogen, cellulose, glycosaminoglycans |
Monosaccharides
By number of carbons
| Type | Carbons | Examples | Significance |
|---|---|---|---|
| Triose | 3 | Glyceraldehyde, dihydroxyacetone | Glycolytic intermediates |
| Tetrose | 4 | Erythrose | HMP shunt |
| Pentose | 5 | Ribose, deoxyribose, xylulose, arabinose | Nucleic acids, ATP, NAD, FAD |
| Hexose | 6 | Glucose, fructose, galactose, mannose | The nutritionally important sugars |
| Heptose | 7 | Sedoheptulose | HMP shunt |
By functional group
- Aldoses — carry an aldehyde group at C-1: glucose, galactose, ribose
- Ketoses — carry a ketone group at C-2: fructose, ribulose, sedoheptulose
Disaccharides
| Sugar | Components | Linkage | Reducing? | Source |
|---|---|---|---|---|
| Maltose | Glucose + glucose | α-1,4 | Yes | Starch digestion; malt |
| Lactose | Galactose + glucose | β-1,4 | Yes | Milk — the only sugar of animal origin |
| Sucrose | Glucose + fructose | α-1,2 β | NO | Cane sugar, beet |
| Isomaltose | Glucose + glucose | α-1,6 | Yes | From amylopectin branch points |
| Trehalose | Glucose + glucose | α-1,1 | NO | Fungi, insect haemolymph |
CLINICAL PEARL
Sucrose is non-reducing because both anomeric carbons are involved in the linkage — C-1 of glucose to C-2 of fructose. There is no free aldehyde or ketone group left. This is why a patient with sucrose in the urine gives a negative Benedict test.
Polysaccharides
A. Homopolysaccharides — one kind of monosaccharide
| Polysaccharide | Unit | Linkages | Significance |
|---|---|---|---|
| Starch | Glucose | Amylose — α-1,4 linear (15–20%); amylopectin — α-1,4 with α-1,6 branches | Chief dietary carbohydrate of plants |
| Glycogen | Glucose | α-1,4 with α-1,6 every 8–12 residues | Storage form in animals; more branched than starch |
| Cellulose | Glucose | β-1,4 | Plant cell wall; indigestible by man — dietary fibre |
| Inulin | Fructose | β-2,1 | Used to measure GFR — freely filtered, neither secreted nor reabsorbed |
| Dextrin | Glucose | α-1,4 | Partial hydrolysis product of starch |
| Dextran | Glucose | α-1,6 | Plasma volume expander |
| Chitin | N-acetylglucosamine | β-1,4 | Exoskeleton of insects and crustacea |
B. Heteropolysaccharides — more than one kind of unit
- Glycosaminoglycans — hyaluronic acid, chondroitin sulphate, keratan sulphate, dermatan sulphate, heparan sulphate, heparin
- Each is a repeating amino sugar + uronic acid disaccharide, usually sulphated
- Agar and gum acacia are plant heteropolysaccharides
Derived Carbohydrates
| Type | Example | Significance |
|---|---|---|
| Sugar acids | Gluconic acid, glucuronic acid, ascorbic acid | Glucuronic acid conjugates bilirubin and drugs |
| Sugar alcohols (polyols) | Sorbitol, mannitol, dulcitol, inositol | Diabetic cataract and neuropathy; mannitol as an osmotic diuretic |
| Amino sugars | Glucosamine, galactosamine, N-acetylneuraminic acid (sialic acid) | Glycosaminoglycans and glycoproteins |
| Deoxy sugars | Deoxyribose | DNA |
Applied Aspects
- Lactose intolerance — lactase deficiency, very common in Indian adults; the undigested sugar causes osmotic diarrhoea and flatulence
- Cellulose cannot be digested because man has no β-glucosidase, yet it is nutritionally important as dietary fibre
- Inulin clearance is the gold standard for GFR, though creatinine clearance is used in practice
- Sialic acid on the RBC surface gives the negative charge that keeps cells apart; its loss with ageing marks the cell for splenic removal
- Sugar alcohols are used as sweeteners but cause osmotic diarrhoea in quantity, and sorbitol must be avoided in hereditary fructose intolerance
- Dextran is used as a plasma volume expander, and is also the polysaccharide of dental plaque formed by oral streptococci from sucrose
Introduction
Isomers = compounds with the same molecular formula but a different arrangement of atoms. Carbohydrates show extensive isomerism because they contain several asymmetric (chiral) carbon atoms.
- A chiral carbon carries four different groups
- Number of possible isomers = 2n, where n is the number of chiral carbons
- Glucose has 4 chiral carbons → 24 = 16 isomers; fructose has 3 → 8
Types of Isomerism
| Type | Basis | Example |
|---|---|---|
| Structural (aldose–ketose) | Position of the carbonyl group | Glucose (aldose) and fructose (ketose) |
| Stereoisomerism — D and L | Configuration at the penultimate carbon | D-glucose and L-glucose |
| Optical isomerism | Rotation of plane-polarised light | Dextrorotatory (+) and laevorotatory (−) |
| Epimerism | Differ at one carbon only | Glucose and galactose (C-4); glucose and mannose (C-2) |
| Anomerism | Differ at the anomeric carbon formed on ring closure | α- and β-D-glucose |
D and L Isomerism
- Determined by the –OH on the penultimate (highest-numbered chiral) carbon — C-5 in a hexose
- –OH on the right = D form; on the left = L form, by reference to D- and L-glyceraldehyde
- Almost all naturally occurring sugars are of the D series
- D and L refer to configuration, not to the direction of optical rotation — D-fructose is in fact laevorotatory, which is why it was once called laevulose
Epimers
Epimers = sugars differing in configuration at one specific carbon atom only.
| Pair | Differ at | Enzyme interconverting them |
|---|---|---|
| Glucose and galactose | C-4 | UDP-galactose 4-epimerase |
| Glucose and mannose | C-2 | Phosphomannose isomerase pathway |
| Ribose and arabinose | C-2 | Epimerase |
- The clinical importance is that galactose must be epimerised to glucose before it can be used — failure at any step of this pathway causes galactosaemia
Ring Structure, Anomers and Mutarotation
Open-chain glucose → The C-5 hydroxyl attacks the C-1 aldehyde → Forms an intramolecular hemiacetal → Six-membered pyranose ring (five-membered = furanose) → C-1 becomes a new chiral centre — the anomeric carbon → Two forms: α (–OH below the plane) and β (above)
- The anomeric carbon is C-1 in an aldose and C-2 in a ketose
- β-D-glucose is the more stable and predominates (about 64%) at equilibrium, since all its bulky groups are equatorial
- Haworth projections represent the ring; the chair conformation is the true shape
Mutarotation
Mutarotation = the spontaneous change in optical rotation that occurs when a pure anomer is dissolved in water, as the α and β forms interconvert through the open-chain intermediate until equilibrium is reached.
- α-D-glucose has a specific rotation of +112°, β of +19°; the equilibrium mixture settles at +52.7°
- It proves that the ring opens and closes freely — which is exactly why the anomeric carbon can act as a reducing group
- Accelerated by acid, alkali and the enzyme mutarotase
Biological Significance of Configuration
- Enzymes are absolutely stereospecific — hexokinase phosphorylates D-glucose but not L-glucose
- α versus β determines digestibility: man can hydrolyse the α-1,4 bonds of starch but not the β-1,4 bonds of cellulose — the same monosaccharide, entirely different nutritional fate
- Only β-D-glucose is a substrate for glucose oxidase, which is why strips contain mutarotase
- Blood group antigens differ only in their terminal sugars and linkages
Optical Activity and its Measurement
- A solution of a chiral compound rotates the plane of polarised light
- Dextrorotatory (+ or d) rotates it clockwise; laevorotatory (− or l) anticlockwise
- Measured with a polarimeter; expressed as specific rotation
- Racemic mixture — equal amounts of both, giving no net rotation
- Examples — D-glucose is dextrorotatory (+52.7°), D-fructose is laevorotatory (−92°)
- Invert sugar — hydrolysis of sucrose (+66°) gives an equimolar mixture of glucose and fructose whose net rotation is negative; the sign inverts, hence the name. Honey is largely invert sugar
Applied Aspects
- Galactosaemia arises from failure to convert galactose to glucose — the clinical consequence of an epimerisation pathway defect
- L-sugars are not metabolised and have been explored as non-caloric sweeteners
- Polarimetry was historically used to measure urine glucose, exploiting optical rotation
- Enzymes distinguish stereoisomers absolutely, which is why L-glucose passes through the body unmetabolised while D-glucose is the central fuel of life
- Thalidomide is the classical warning from stereochemistry outside carbohydrate chemistry — one enantiomer sedative, the other teratogenic
- Glucose oxidase strips contain mutarotase, because the enzyme acts only on the β anomer and the sample contains both
- Honey is sweeter than sucrose because it is largely invert sugar, and fructose is the sweetest natural sugar
- Osazone crystals distinguish sugars in the laboratory, but glucose, fructose and mannose give identical crystals since they differ only at carbons involved in the reaction
Definition
Polysaccharides (glycans) = high molecular weight polymers of more than ten monosaccharide units joined by glycosidic bonds.
- They are non-reducing in practical terms, tasteless and mostly insoluble — ideal for storage and structure, since they exert almost no osmotic pressure
Classification
- Homopolysaccharides — one type of monosaccharide
- Heteropolysaccharides — two or more types
Starch
| Component | Proportion | Structure |
|---|---|---|
| Amylose | 15–20% | Unbranched α-1,4 chain; helical; gives a deep blue colour with iodine |
| Amylopectin | 80–85% | α-1,4 chains with α-1,6 branches every 24–30 residues; gives a violet colour with iodine |
- The chief dietary carbohydrate, from cereals, potato and pulses
- Digested by salivary and pancreatic α-amylase, which act only on α-1,4 bonds, yielding maltose, isomaltose and limit dextrins
- α-Amylase cannot cleave α-1,6 bonds — these need isomaltase at the brush border
Glycogen
- The storage polysaccharide of animals; liver 100 g, muscle 400 g
- Similar to amylopectin but more highly branched — a branch every 8–12 residues
- Branching gives many non-reducing ends, so glucose can be added or removed rapidly at many points at once; it also increases solubility
- Gives a red-brown colour with iodine
- Built on a protein primer, glycogenin
Cellulose
- The most abundant organic molecule on earth; the structural polysaccharide of plant cell walls
- Unbranched chains of glucose in β-1,4 linkage
- The β linkage lets the chains lie flat and hydrogen-bond into rigid fibrils — hence its strength
- Man has no β-1,4-glucosidase (cellulase), so it is entirely indigestible; ruminants rely on symbiotic bacteria
- Nutritionally important as insoluble dietary fibre
Comparison of the Three Glucose Polymers
| Feature | Starch | Glycogen | Cellulose |
|---|---|---|---|
| Source | Plants | Animals | Plants |
| Linkage | α-1,4 (+ α-1,6) | α-1,4 (+ α-1,6) | β-1,4 |
| Branching | Every 24–30 residues | Every 8–12 — most branched | None |
| Function | Storage | Storage | Structural |
| Digestible by man | Yes | Yes | NO |
| Iodine colour | Blue to violet | Red-brown | None |
| Solubility | Partly soluble | Soluble | Insoluble |
Other Important Polysaccharides
| Polysaccharide | Unit and linkage | Use |
|---|---|---|
| Inulin | Fructose, β-2,1 | Gold standard for measuring GFR |
| Dextran | Glucose, α-1,6 | Plasma volume expander; also forms dental plaque |
| Dextrin | Glucose, α-1,4 | Partial starch hydrolysis |
| Chitin | N-acetylglucosamine, β-1,4 | Arthropod exoskeleton; surgical sutures |
| Agar | Galactose derivatives | Bacteriological culture medium; laxative |
| Heparin | Glucosamine + iduronic acid, highly sulphated | Anticoagulant |
| Hyaluronic acid | Glucuronic acid + N-acetylglucosamine, unsulphated | Synovial fluid and vitreous humour |
Digestion of Dietary Polysaccharides
Starch in the mouth → Salivary α-amylase (ptyalin) — acts on α-1,4 only → Inactivated by gastric acid → Pancreatic α-amylase in the duodenum → Maltose, isomaltose, maltotriose, limit dextrins → Brush border: maltase, isomaltase, sucrase, lactase → Glucose, galactose, fructose absorbed
- Amylase cannot cleave the α-1,6 branch points, which is why isomaltase is required
- Glucose and galactose are absorbed by SGLT-1 (active, sodium-coupled); fructose by GLUT-5 (facilitated)
Applied Aspects
- Dietary fibre — insoluble (cellulose, hemicellulose, lignin) adds bulk and prevents constipation; soluble (pectin, gum, mucilage) lowers cholesterol and slows glucose absorption
- Glycaemic index depends partly on the amylose:amylopectin ratio — more amylose means slower digestion and a lower index
- Resistant starch escapes digestion and is fermented by colonic bacteria to short-chain fatty acids, which nourish the colonocyte
- Glycogen storage diseases result from defects in the enzymes that build or break these branches — Andersen disease affects the branching enzyme, Cori disease the debranching enzyme
- Heparin remains a mainstay anticoagulant, acting by activating antithrombin III
- Iodine staining distinguishes the polysaccharides — a simple bench test still used to demonstrate starch digestion
- Bacterial dextran on the tooth surface forms the matrix of dental plaque, which is why sucrose is more cariogenic than other sugars
Definition
Reducing sugars = sugars possessing a free (or potentially free) aldehyde or ketone group, which can reduce metal ions such as Cu2+ in alkaline solution.
Which Sugars Reduce
| Reducing | Non-reducing |
|---|---|
| All monosaccharides — glucose, fructose, galactose, mannose, ribose | Sucrose |
| Maltose, lactose, isomaltose | Trehalose |
| — | Starch, glycogen, cellulose (only one free end) |
- Ketoses also reduce, because alkali converts them to aldoses by enolisation — fructose gives a positive Benedict test
- Sucrose does not reduce because both anomeric carbons are engaged in the glycosidic bond
Benedict Test
Sugar + Benedict reagent (copper sulphate, sodium citrate, sodium carbonate) → Heat in a boiling water bath for 2 minutes → Alkali converts the sugar to a strong reducing enediol → Cu2+ (blue) → Cu+ → Red precipitate of cuprous oxide
| Colour | Approximate sugar | Grading |
|---|---|---|
| Blue (no change) | Nil | Negative |
| Green | < 0.5% | Trace / + |
| Yellow | 0.5–1% | ++ |
| Orange | 1–2% | +++ |
| Brick red | > 2% | ++++ |
- Sodium citrate keeps copper in solution, preventing precipitation as hydroxide — the advantage over Fehling reagent
- It is semi-quantitative and non-specific
Other Sugar Tests
| Test | Detects | Principle |
|---|---|---|
| Barfoed test | Monosaccharide vs disaccharide | Acidic copper; only monosaccharides reduce it within 2 minutes |
| Seliwanoff test | Ketoses (fructose) | Rapid cherry-red with resorcinol and HCl |
| Bial test | Pentoses | Green colour with orcinol |
| Osazone formation | Identifies individual sugars | Glucose and fructose give identical needle-shaped crystals; lactose gives powder-puff; maltose gives sunflower |
| Iodine test | Polysaccharides | Starch blue, glycogen red-brown |
Applied Aspects
- Benedict test is not specific for glucose — a positive result in an infant may mean galactosaemia, fructosuria or pentosuria. This is why the glucose oxidase strip, which IS specific, must be used alongside
- A positive Benedict with a negative glucose oxidase strip in a newborn is the classical screening finding in galactosaemia
- False positives — ascorbic acid, salicylates, homogentisic acid, and several antibiotics reduce copper
- Lactosuria is normal in late pregnancy and lactation and must not be mistaken for diabetes
- Urine testing has largely been replaced by blood glucose and HbA1c, since the renal threshold varies between individuals
Definition
Glycosidic bond = the covalent linkage formed between the anomeric carbon of one sugar and a hydroxyl group of another molecule, with the elimination of water.
Formation and Types
Anomeric –OH of sugar 1 + –OH of sugar 2 → Condensation — loss of H2O → glycosidic bond
| Type | Bond to | Examples |
|---|---|---|
| O-glycosidic | Oxygen (the commonest) | All disaccharides and polysaccharides; O-linked glycoproteins (to serine/threonine) |
| N-glycosidic | Nitrogen | Nucleosides and nucleotides; N-linked glycoproteins (to asparagine) |
| S-glycosidic | Sulphur | Some plant glycosides |
- Described by the carbons joined and the anomeric configuration — for example α-1,4 or β-1,4
- Once formed, that anomeric carbon is fixed, and can no longer act as a reducing group or undergo mutarotation
Important Examples
| Compound | Linkage | Enzyme that cleaves it |
|---|---|---|
| Maltose | α-1,4 | Maltase |
| Lactose | β-1,4 | Lactase |
| Sucrose | α-1,2β | Sucrase (invertase) |
| Starch, glycogen | α-1,4 and α-1,6 | α-Amylase; isomaltase for α-1,6 |
| Cellulose | β-1,4 | Cellulase — absent in man |
| Peptidoglycan | β-1,4 | Lysozyme in tears and saliva |
CLINICAL PEARL
The α versus β distinction is nutritionally decisive. Starch and cellulose are both polymers of glucose alone; the only difference is the configuration at the anomeric carbon. Man makes α-glucosidases but no β-1,4-glucosidase — so one is a staple food and the other is fibre.
Properties
- Stable at neutral and alkaline pH, but hydrolysed by acid and heat or by specific glycosidases
- The reducing end of a polysaccharide is the single unengaged anomeric carbon; hence large polysaccharides behave as non-reducing
- Glycosidic bonds are formed using activated donors such as UDP-glucose and UDP-galactose, not by simple condensation in the cell
Applied Aspects
- Disaccharidase deficiencies — lactase deficiency is the commonest, giving osmotic diarrhoea and flatulence; sucrase–isomaltase deficiency is rarer
- Acarbose and voglibose inhibit intestinal α-glucosidases, slowing carbohydrate absorption and blunting the post-prandial glucose rise in diabetes
- Lysozyme hydrolyses the β-1,4 bond of bacterial peptidoglycan — a natural antibacterial in tears, saliva and breast milk
- Cardiac glycosides such as digoxin consist of a steroid joined to sugars by glycosidic bonds; the sugars determine pharmacokinetics
- Glycosylation of proteins through these bonds determines their folding, stability, targeting and half-life — defects cause the congenital disorders of glycosylation
Definition
Dietary fibre = the indigestible portion of plant food, consisting of polysaccharides and lignin that resist digestion by human enzymes but may be fermented by colonic bacteria.
- Formerly called roughage and dismissed as inert; now recognised as nutritionally important
Classification
| Type | Components | Sources | Chief actions |
|---|---|---|---|
| Insoluble | Cellulose, hemicellulose, lignin | Wheat bran, whole grains, vegetables, fruit skins | Increases faecal bulk, shortens transit time, prevents constipation |
| Soluble | Pectin, gums, mucilage, β-glucan, inulin | Oats, barley, pulses, apple, guava, isabgol, guar | Lowers cholesterol and slows glucose absorption |
Physiological Effects
- Increases stool bulk and water content → softer stools, easier passage
- Shortens intestinal transit time → less contact between carcinogens and mucosa
- Binds bile acids → more cholesterol is diverted to bile acid synthesis → plasma cholesterol falls
- Slows gastric emptying and glucose absorption → a flatter post-prandial glucose curve and lower glycaemic index
- Increases satiety and lowers energy density → helps weight control
- Fermented by colonic bacteria to short-chain fatty acids — acetate, propionate and butyrate, which is the preferred fuel of the colonocyte
- Acts as a prebiotic, supporting a favourable gut microbiota
Recommended Intake
- 25–40 g/day in adults, or about 14 g per 1000 kcal
- The traditional Indian diet, rich in whole grains and pulses, is usually adequate; refined flour and polished rice reduce it sharply
Deficiency and Excess
| Low fibre intake | Excessive fibre intake |
|---|---|
| Constipation, haemorrhoids | Flatulence, bloating, abdominal discomfort |
| Diverticulosis | Binds and reduces absorption of iron, calcium and zinc (phytate) |
| Colorectal carcinoma (association) | May precipitate intestinal obstruction |
| Obesity, type 2 diabetes, dyslipidaemia | Reduced energy density in small children |
| Gallstones | Interferes with some drugs |
Applied Aspects
- Isabgol (psyllium husk) is a soluble fibre widely used in India as a bulk laxative and to lower cholesterol
- Fibre must be increased gradually and with adequate water, or it worsens constipation and causes bloating
- Phytate in bran binds iron, calcium and zinc, and can contribute to deficiency in populations already at risk — a genuine concern in Indian diets
- The evidence that fibre prevents colorectal cancer is weaker than once believed; its benefits for constipation, cholesterol and glycaemic control are firmly established
- Low-fibre diets are indicated in acute diverticulitis, inflammatory bowel disease flares and before colonoscopy
Definition
Lysosomes = single-membrane cytoplasmic organelles containing about 50 acid hydrolases that operate at an internal pH of about 5, and which carry out intracellular digestion.
- Discovered by Christian de Duve, who called them "suicide bags"
- The acid pH is maintained by an H+-ATPase proton pump in the membrane
Enzymes and Their Targeting
| Enzyme class | Examples |
|---|---|
| Proteases | Cathepsins |
| Nucleases | DNase, RNase |
| Glycosidases | α-Glucosidase, β-galactosidase, hexosaminidase |
| Lipases and phospholipases | Acid lipase, sphingomyelinase |
| Sulphatases and phosphatases | Acid phosphatase — the marker enzyme |
Enzymes synthesised on the rough endoplasmic reticulum → Pass to the Golgi → Tagged with mannose-6-phosphate → Recognised by the mannose-6-phosphate receptor → Packaged into vesicles → lysosome
- The acid pH is itself protective — if enzymes leak into the cytosol at pH 7.4 they are largely inactive
Types and Functions
| Type | Description |
|---|---|
| Primary lysosome | Newly formed; enzymes not yet used |
| Secondary lysosome | Fused with a vesicle; digestion in progress |
| Phagolysosome | Fused with a phagosome |
| Autophagosome | Digesting the cell's own organelles |
| Residual body | Undigested remnants; accumulate as lipofuscin, the "wear and tear" pigment of ageing |
- Heterophagy — digestion of material taken in from outside
- Autophagy — turnover of the cell's own organelles; important in starvation and in removing damaged mitochondria
- Bone remodelling by osteoclasts, and involution of the uterus after delivery
- Release of thyroid hormone from thyroglobulin
Lysosomal Storage Diseases
| Disease | Enzyme deficient | Accumulates | Key features |
|---|---|---|---|
| Tay–Sachs | Hexosaminidase A | GM2 ganglioside | Cherry-red spot, no hepatosplenomegaly, death by 3 years |
| Gaucher | β-Glucocerebrosidase | Glucocerebroside | Hepatosplenomegaly, bone crises, Gaucher cells; commonest of the group |
| Niemann–Pick | Sphingomyelinase | Sphingomyelin | Hepatosplenomegaly with cherry-red spot |
| Pompe | Acid α-glucosidase | Glycogen | Cardiomegaly and heart failure in infancy |
| Hurler / Hunter | Iduronidase / iduronate sulphatase | Glycosaminoglycans | Coarse facies; corneal clouding in Hurler, clear in Hunter |
| Krabbe | Galactocerebrosidase | Galactocerebroside | Globoid cells, severe neurodegeneration |
I-cell Disease
- Deficiency of the enzyme that adds the mannose-6-phosphate tag
- Enzymes are secreted into plasma instead of being delivered to lysosomes
- Plasma hydrolase levels are high while the lysosome is empty — the diagnostic paradox
Definition
Glycoproteins = proteins covalently linked to carbohydrate chains, usually short and branched, forming less than 40% of the molecule by weight.
- Distinguished from proteoglycans, in which the carbohydrate is a long unbranched glycosaminoglycan and predominates by weight
- Most secreted and membrane proteins are glycosylated
Types of Linkage
| Type | Linked to | Sugar attached | Site of synthesis |
|---|---|---|---|
| N-linked | Asparagine (in Asn-X-Ser/Thr) | N-acetylglucosamine | Endoplasmic reticulum, then Golgi |
| O-linked | Serine or threonine (also hydroxylysine in collagen) | N-acetylgalactosamine | Golgi |
- Dolichol phosphate carries the preassembled oligosaccharide for N-linked glycosylation
- The sugars commonly found are mannose, galactose, N-acetylglucosamine, fucose and sialic acid
- Sialic acid is usually terminal and gives the negative charge
Functions
- Protein folding and stability; protection from proteolysis
- Cell–cell recognition and adhesion — selectins, integrins
- Blood group antigens — A, B and O differ only in their terminal sugar
- Determining plasma half-life — loss of terminal sialic acid exposes galactose, and the asialoglycoprotein receptor of the liver removes the molecule
- Lubrication and protection — mucins of gastric and respiratory mucus
- Receptors and transporters; hormones — TSH, FSH, LH, hCG, erythropoietin
- Targeting — the mannose-6-phosphate tag for lysosomal enzymes
Blood Group Antigens
| Group | Terminal sugar added | Enzyme |
|---|---|---|
| O | None — H substance only | Non-functional transferase |
| A | N-acetylgalactosamine | A transferase |
| B | Galactose | B transferase |
| AB | Both | Both transferases |
- The entire ABO system rests on a single terminal sugar — a striking illustration of how much biological information carbohydrate structure can carry
- Bombay phenotype — absence of the H substance itself, so neither A nor B can be added
Applied Aspects
- Congenital disorders of glycosylation — a growing group causing developmental delay, hepatopathy, coagulopathy and abnormal fat distribution; screened for by transferrin isoform analysis
- Influenza virus neuraminidase cleaves sialic acid to release new virions — the target of oseltamivir and zanamivir
- Tumour markers are largely glycoproteins — CA-125, CA 19-9, CEA, AFP, hCG
- Recombinant erythropoietin must be correctly glycosylated to have a useful half-life, which is why it is made in mammalian rather than bacterial cells
- Selectin-mediated leucocyte rolling depends on glycoprotein recognition; its failure causes leucocyte adhesion deficiency
Definition
Water is the medium of all biological reactions and the most abundant constituent of the body — about 60% of body weight in an adult male, 50–55% in a female, and up to 75% in a newborn.
Structure and Resulting Properties
- A polar molecule with a bent shape; oxygen is electronegative, giving a partial negative charge, and the hydrogens a partial positive
- Each molecule can form four hydrogen bonds
- This hydrogen bonding accounts for nearly every unusual property water has
| Property | Value or feature | Biological importance |
|---|---|---|
| High specific heat | 1 cal/g/°C | Buffers body temperature against metabolic heat |
| High latent heat of vaporisation | 540 cal/g | Sweating is an efficient cooling mechanism |
| High dielectric constant | 80 | Excellent solvent for ionic and polar compounds |
| High surface tension | — | Alveolar stability; countered by surfactant |
| Maximum density at 4 °C | — | Ice floats, insulating water below |
| Slight ionisation | Kw = 10−14 | The basis of pH and of acid–base balance |
Distribution of Body Water
| Compartment | Percentage of body weight | Volume (70 kg adult) |
|---|---|---|
| Total body water | 60% | 42 L |
| Intracellular | 40% (two-thirds of TBW) | 28 L |
| Extracellular | 20% (one-third) | 14 L |
| — Interstitial | 15% | 10.5 L |
| — Plasma | 5% | 3.5 L |
| — Transcellular | 1–2% | CSF, synovial, pleural, gastrointestinal secretions |
- Sodium is the chief extracellular cation; potassium the chief intracellular one
- Measured by dilution techniques — deuterium oxide for total body water, inulin for extracellular fluid, Evans blue for plasma volume
Water Balance
| Intake (mL/day) | Output (mL/day) |
|---|---|
| Drinking — 1200 | Urine — 1500 |
| Food — 1000 | Skin (insensible) — 500 |
| Metabolic water — 300 | Lungs — 400 |
| Total 2500 | Faeces — 100; total 2500 |
- Metabolic (oxidation) water is produced by the respiratory chain — fat yields the most (1.07 mL/g), which is how hibernating animals and the camel survive without drinking
- Obligatory urine volume is about 500 mL, the minimum needed to excrete the daily solute load
Regulation
- Thirst — hypothalamic osmoreceptors respond to a rise in osmolality of as little as 1–2%
- Antidiuretic hormone (vasopressin) — released on a rise in osmolality or a fall in volume; acts on aquaporin-2 in the collecting duct
- Renin–angiotensin–aldosterone system — conserves sodium and therefore water
Definition and Mechanism
A buffer is a solution that resists a change in pH on addition of acid or alkali. It consists of a weak acid and its conjugate base (or a weak base and its conjugate acid).
- Buffering is most effective when pH = pK, where the acid and base forms are present in equal amounts; the useful range is about pK ± 1
- Henderson–hasselbalch equation — pH = pK + log ([conjugate base] / [acid]). For the bicarbonate system, pH = 6.1 + log ([HCO3−] / 0.03 × pCO2)
- Normal ratio is 20 : 1 of bicarbonate to carbonic acid, which gives a pH of 7.4; it is the ratio, not the absolute values, that determines pH — which is why compensation works
Buffer Systems of the Body
| System | Location and share | Features |
|---|---|---|
| Bicarbonate | Extracellular; about 65% of buffering capacity | The most important, despite a pK of 6.1 being far from 7.4, because it is an open system — CO2 is removed by the lungs and bicarbonate regulated by the kidney, so both components are independently adjustable |
| Haemoglobin | Red cells; the major intracellular blood buffer | The imidazole group of histidine has a pK near 7; DEOXYhaemoglobin is a better buffer than oxyhaemoglobin, which is the basis of the isohydric transport of CO2 |
| Phosphate | Intracellular and urinary | PK 6.8, close to physiological pH; the chief urinary buffer, forming titratable acidity |
| Protein | Intracellular and plasma | Histidine, cysteine and terminal groups; a large reservoir intracellularly |
| Ammonia | Renal tubule | NH3 traps H+ as NH4+, which cannot diffuse back; the adaptive mechanism in chronic acidosis |
| Bone | Long term | Carbonate and phosphate exchange — which is why chronic acidosis causes bone demineralisation |
CLINICAL PEARL
The bicarbonate system is the most important buffer in the body despite having the wrong pK for the job. A pK of 6.1 is more than a unit from pH 7.4, which should make it a poor buffer. It works because it is open at both ends — the lungs blow off CO2 and the kidney reclaims or excretes bicarbonate, so the system is continuously regenerated rather than being consumed. A closed buffer of the same pK would be almost useless.
Compensation and the Anion Gap
- Respiratory compensation is rapid (minutes to hours) — ventilation alters pCO2 to correct a metabolic disturbance
- Renal compensation is slow (hours to days) — bicarbonate reabsorption, titratable acid and ammonium excretion correct a respiratory disturbance
- Compensation never fully corrects the pH; overcorrection indicates a second, independent disorder
- Anion gap = Na+ − (Cl− + HCO3−), normally 8 to 16 mmol/L; it represents unmeasured anions, chiefly albumin
- High anion gap metabolic acidosis — ketoacidosis, lactic acidosis, renal failure, and the toxic alcohols and salicylate
- Normal anion gap (hyperchloraemic) acidosis — diarrhoea, renal tubular acidosis, and acetazolamide; here bicarbonate is lost and replaced by chloride
- Correct the gap for albumin, adding about 2.5 mmol/L for every 10 g/L the albumin falls; otherwise a significant acidosis is missed in a hypoalbuminaemic patient
Applied Aspects
- Interpret arterial blood gases in order — pH first (acidaemia or alkalaemia), then pCO2 and bicarbonate to identify the primary disorder, then whether compensation is appropriate, then the anion gap
- Calculate the anion gap in every metabolic acidosis; it separates two entirely different groups of causes and directs the investigation
- Treat the underlying cause rather than the number; giving bicarbonate in diabetic ketoacidosis or lactic acidosis is rarely helpful and may cause paradoxical intracellular acidosis and hypokalaemia
- Remember potassium moves with acid-base; acidosis drives potassium out of cells, so a normal potassium in diabetic ketoacidosis conceals a large total-body deficit that will unmask itself with treatment
- A mixed disorder is common in the sick patient, and the compensation rules are what reveal it — a pCO2 that is not what the bicarbonate predicts means more than one process is present
Definition
Lipids = a heterogeneous group of organic compounds, insoluble in water but soluble in organic solvents such as ether, chloroform and benzene, related either actually or potentially to the fatty acids.
- They are grouped by solubility, not by structure — which is why the class is so chemically varied
Bloor’s Classification
| Class | Definition | Examples |
|---|---|---|
| Simple lipids | Esters of fatty acids with alcohols | Fats and oils (with glycerol); waxes (with a higher alcohol) |
| Compound (complex) lipids | Esters of fatty acids with alcohol, plus an additional group | Phospholipids, glycolipids, lipoproteins, sulpholipids |
| Derived lipids | Products of hydrolysis of the above | Fatty acids, glycerol, steroids, cholesterol, ketone bodies, fat-soluble vitamins |
Simple Lipids
- Triacylglycerol (triglyceride) — three fatty acids esterified to glycerol; the storage form of fat and about 95% of dietary lipid
- Fats are solid at room temperature (mostly saturated); oils are liquid (mostly unsaturated)
- Waxes — esters of fatty acids with long-chain monohydric alcohols; not digestible by man; found in cerumen and sebum
Compound Lipids
| Type | Contains | Examples | Significance |
|---|---|---|---|
| Phospholipids — glycerophospholipids | Glycerol + 2 fatty acids + phosphate + base | Lecithin (choline), cephalin (ethanolamine), phosphatidylserine, phosphatidylinositol, cardiolipin | Membranes; surfactant; IP3/DAG signalling; VDRL antigen |
| Phospholipids — sphingophospholipids | Sphingosine instead of glycerol | Sphingomyelin | Myelin; accumulates in Niemann–Pick disease |
| Glycolipids | Sphingosine + fatty acid + carbohydrate, no phosphate | Cerebrosides, gangliosides, sulphatides | Brain and nerve; blood group antigens; lysosomal storage diseases |
| Lipoproteins | Lipid + apoprotein | Chylomicron, VLDL, LDL, HDL | Transport of lipids in plasma |
Derived Lipids
- Fatty acids — saturated and unsaturated
- Steroids — based on the cyclopentanoperhydrophenanthrene ring: cholesterol, bile acids, steroid hormones, vitamin D
- Ketone bodies — acetoacetate, β-hydroxybutyrate, acetone
- Fat-soluble vitamins — A, D, E, K
- Eicosanoids — prostaglandins, thromboxanes, leukotrienes
Functions of Lipids
| Function | Detail |
|---|---|
| Energy storage | 9 kcal/g — more than twice carbohydrate or protein; stored anhydrous, so far more compact |
| Structural | Phospholipids and cholesterol form all biological membranes |
| Insulation | Subcutaneous fat conserves heat |
| Protection | Cushions kidney, eyeball and other organs |
| Hormones and signalling | Steroid hormones, eicosanoids, IP3 and DAG |
| Vitamin absorption | Carrier for the fat-soluble vitamins A, D, E and K |
| Essential fatty acids | Linoleic and α-linolenic acid |
| Surfactant | Dipalmitoyl phosphatidylcholine prevents alveolar collapse |
Properties Used in the Laboratory
| Property | Meaning | Use |
|---|---|---|
| Saponification | Alkaline hydrolysis of a fat → soap + glycerol | Soap manufacture; the saponification number indicates chain length |
| Iodine number | Grams of iodine absorbed by 100 g of fat | Measures the degree OF unsaturation |
| Acid number | Free fatty acid content | Indicates rancidity |
| Rancidity | Unpleasant odour and taste from oxidative or hydrolytic breakdown | Prevented by antioxidants and airtight storage |
| Hydrogenation | Adding hydrogen to double bonds → solid fat | Vanaspati; produces harmful trans fats |
Amphipathic Lipids and Micelles
- Amphipathic = possessing both a polar (hydrophilic) and a non-polar (hydrophobic) region — phospholipids, cholesterol, bile salts, free fatty acids
- In water they orient with the polar heads outward, forming micelles, bilayers or liposomes
- Micelle formation is essential for fat digestion — bile salts emulsify fat and carry the products to the mucosal surface
- The lipid bilayer of every membrane is the direct consequence of this property
- Liposomes are used as drug delivery vehicles, as in liposomal amphotericin B and doxorubicin
- Neutral lipids such as triglyceride and cholesteryl ester are not amphipathic — they form the core of a lipoprotein, not its surface
Applied Aspects
- Trans fats, produced by partial hydrogenation, raise LDL and lower HDL — the worst combination; now legally restricted in India and many other countries
- Respiratory distress syndrome of the newborn follows deficiency of the phospholipid surfactant
- Lipid storage diseases — Gaucher, Niemann–Pick, Tay–Sachs and Krabbe disease all result from failure to degrade a complex lipid
- Cardiolipin is the antigen used in the VDRL test for syphilis, and antibodies to it explain the biological false positive in lupus
- Essential fatty acid deficiency causes scaly dermatitis and poor wound healing, seen in prolonged fat-free parenteral nutrition
- Steatorrhoea — failure to digest or absorb fat gives bulky, pale, offensive stools that float; caused by pancreatic insufficiency, bile salt deficiency or mucosal disease
Definition
Fatty acids = aliphatic monocarboxylic acids, usually with an even number of carbon atoms in an unbranched chain.
- The even number arises because they are synthesised and degraded two carbons at a time
- Amphipathic — a polar carboxyl head and a non-polar hydrocarbon tail
Classification BY Chain Length
| Type | Carbons | Examples | Note |
|---|---|---|---|
| Short chain | 2–6 | Acetic, butyric, propionic | From colonic bacterial fermentation of fibre; absorbed directly into portal blood |
| Medium chain | 8–12 | Caprylic, capric, lauric | Do not need carnitine or bile salts — hence MCT oil in malabsorption |
| Long chain | 14–20 | Palmitic (16), stearic (18), oleic (18) | The commonest in the diet and in tissues |
| Very long chain | > 20 | Lignoceric, cerotic | Oxidised in peroxisomes; accumulate in Zellweger syndrome |
Classification BY Saturation
| Type | Double bonds | Examples | Sources |
|---|---|---|---|
| Saturated | None | Palmitic (16:0), stearic (18:0), butyric | Ghee, butter, coconut oil, animal fat |
| Monounsaturated | One | Oleic acid (18:1, ω-9) | Olive oil, groundnut oil, mustard oil |
| Polyunsaturated | Two or more | Linoleic (18:2, ω-6), α-linolenic (18:3, ω-3), arachidonic (20:4), EPA, DHA | Sunflower, safflower, soybean, flaxseed, fish oil |
- Nomenclature — 18:2 Δ9,12 means 18 carbons, 2 double bonds, at positions 9 and 12 counting from the carboxyl end
- ω (omega) numbering counts from the methyl end — used nutritionally, because man cannot alter that end
- Naturally occurring unsaturated fatty acids are cis; the cis bond puts a kink in the chain, lowering the melting point and increasing membrane fluidity
Essential Fatty Acids
- Linoleic acid (ω-6) and α-linolenic acid (ω-3) are strictly essential
- Arachidonic acid is semi-essential — it can be made from linoleic acid
- Man lacks desaturases beyond carbon 9, so a double bond cannot be introduced at the ω-3 or ω-6 position
- Functions — eicosanoid precursors, membrane fluidity, retinal and brain development (DHA), lowering plasma cholesterol
- Deficiency — scaly dermatitis, poor wound healing, hair loss, fatty liver, growth retardation
Physical and Chemical Properties
| Property | Determined by |
|---|---|
| Melting point | Rises with chain length; falls with unsaturation. Hence ghee is solid and mustard oil liquid |
| Solubility | Falls with chain length; short-chain acids are water-soluble |
| Salt formation | With alkali → soaps; sodium soaps are hard, potassium soaps soft |
| Hydrogenation | Converts unsaturated to saturated |
| Halogenation | Basis of the iodine number |
| Oxidation | At the double bonds → rancidity and peroxides |
Trans Fatty Acids
- Formed by partial hydrogenation of vegetable oils, as in vanaspati and margarine; also present naturally in small amounts in ruminant fat
- The trans configuration makes the chain straight, so it behaves like a saturated fat
- Raise LDL, lower HDL, raise Lp(a) and triglyceride — a worse profile than saturated fat, which raises LDL but does not lower HDL
- Also promote inflammation and insulin resistance
- Restricted by law in India to 2% of total fat, and banned or limited in many countries
Eicosanoid Precursors
| Series | Precursor | Products | Character |
|---|---|---|---|
| Series 1 | Dihomo-γ-linolenic acid | PGE1 | Anti-inflammatory |
| Series 2 | Arachidonic acid (ω-6) | PGE2, TXA2, LTB4 | Pro-inflammatory, pro-aggregatory |
| Series 3 | EPA (ω-3) | PGE3, TXA3, LTB5 | Much less inflammatory |
- ω-3 and ω-6 compete for the same desaturases and elongases, and for cyclo-oxygenase — which is why the ratio matters more than the absolute intake of either
- This competition is the biochemical basis for the cardiovascular benefit attributed to fish oil
Applied Aspects
- Dietary recommendation — roughly equal parts saturated, monounsaturated and polyunsaturated fat, with an ω-6 : ω-3 ratio of 5:1 to 10:1. The modern Indian diet is often 15–20:1 because of heavy seed-oil use
- Fish oil (EPA and DHA) lowers triglyceride substantially and is used in severe hypertriglyceridaemia
- MCT oil bypasses the carnitine shuttle and needs no bile salts — valuable in fat malabsorption, chylothorax and carnitine deficiency
- DHA supplementation of infant formula supports retinal and neural development, since breast milk supplies it naturally
- Refrigeration and antioxidants delay rancidity — the more unsaturated the oil, the more readily it oxidises, which is why fish oil spoils fastest
- Peroxisomal disorders — Zellweger syndrome and adrenoleucodystrophy result from failure to oxidise very long chain fatty acids
- Rancid fat is harmful as well as unpalatable — the peroxides formed destroy vitamins A and E and generate free radicals
- Coconut oil is unusual among plant oils in being highly saturated, though largely medium-chain, which alters its metabolic handling
- Mustard oil is rich in erucic acid, which has been linked to myocardial lipidosis in animals; the evidence in man is not established
Definition and General Structure
Amino acids = organic compounds containing both an amino (–NH2) and a carboxyl (–COOH) group attached to the same α-carbon, which also bears a hydrogen and a variable side chain (R group).
- 20 standard amino acids are found in proteins
- All except glycine have a chiral α-carbon and therefore show optical isomerism
- All amino acids in human protein are of the L configuration
- Proline is an imino acid — its nitrogen is part of a ring
Classification BY Side Chain Polarity
| Class | Amino acids | Note |
|---|---|---|
| Non-polar, aliphatic | Glycine, alanine, valine, leucine, isoleucine, proline, methionine | Buried in the protein interior |
| Aromatic | Phenylalanine, tyrosine, tryptophan | Absorb at 280 nm — the basis of protein estimation |
| Polar, uncharged | Serine, threonine, cysteine, asparagine, glutamine | Serine and threonine are phosphorylation sites |
| Acidic (negatively charged) | Aspartate, glutamate | Extra –COOH group |
| Basic (positively charged) | Lysine, arginine, histidine | Histidine is the buffer of haemoglobin |
Classification BY Nutritional Requirement
| Essential (10) | Non-essential | Conditionally essential |
|---|---|---|
| Methionine, Arginine, Threonine, Tryptophan, Valine, Isoleucine, Leucine, Phenylalanine, Histidine, Lysine | Alanine, aspartate, asparagine, glutamate, glutamine, glycine, proline, serine | Tyrosine (from phenylalanine), Cysteine (from methionine) |
- Mnemonic — "MATT VILPHLy", or "Any Help In Learning These Little Molecules Proves Truly Valuable"
- Arginine and histidine are essential in growth but adequately synthesised by healthy adults
Classification BY Metabolic Fate
| Class | Amino acids |
|---|---|
| Purely glucogenic | Alanine, glycine, serine, cysteine, aspartate, asparagine, glutamate, glutamine, methionine, valine, histidine, proline, arginine |
| Purely ketogenic | Leucine and lysine only |
| Both | Phenylalanine, tyrosine, tryptophan, isoleucine, threonine |
Properties
Zwitterion and isoelectric pH
- At physiological pH an amino acid exists as a zwitterion — the amino group is protonated (–NH3+) and the carboxyl group is ionised (–COO−)
- It is therefore amphoteric, acting as both acid and base — the basis of the buffering action of proteins
- Isoelectric pH (pI) = the pH at which the molecule carries no net charge and does not move in an electric field
- Solubility is minimum at the pI — used to precipitate proteins, as in casein preparation
Other properties
- Optical activity — all except glycine
- Ultraviolet absorption at 280 nm by the aromatic amino acids
- Ninhydrin reaction — gives a purple colour with all amino acids except proline, which gives yellow
Non-protein Amino Acids and Derivatives
| Compound | Derived from | Role |
|---|---|---|
| GABA | Glutamate | Inhibitory neurotransmitter |
| Serotonin, melatonin | Tryptophan | Neurotransmitter; pineal hormone |
| Histamine | Histidine | Inflammation, gastric acid |
| Dopamine, noradrenaline, adrenaline, melanin, thyroxine | Tyrosine | Neurotransmitters and hormones |
| Nitric oxide, urea, creatine | Arginine | Vasodilator; excretion; energy store |
| Haem, purines, glutathione | Glycine | Oxygen carriage; nucleotides; antioxidant |
| Taurine | Cysteine | Bile salt conjugation |
| Ornithine, citrulline | — | Urea cycle — not found in proteins |
Titration Curve and Buffering
- A simple amino acid such as glycine has two ionisable groups, and therefore two pK values — about 2.3 for –COOH and 9.6 for –NH3+
- The titration curve shows two buffering zones, one around each pK
- PI = the average of the two pK values flanking the zwitterion; for glycine, (2.3 + 9.6) ÷ 2 = 5.97
- Acidic amino acids have a low pI, basic ones a high pI
- Histidine is the only amino acid with a pK near physiological pH (imidazole, pK 6.0) — which is why it is the chief buffering residue of haemoglobin and of proteins generally
- Cysteine and lysine residues are the usual sites of covalent modification and of heavy metal binding
Applied Aspects
- Inborn errors of amino acid metabolism — phenylketonuria, alkaptonuria, maple syrup urine disease, homocystinuria; most are detected on newborn screening by tandem mass spectrometry
- Chromatography and electrophoresis separate amino acids by charge and polarity; the basis of amino acid profiling in metabolic disease
- Protein quality depends on the essential amino acid pattern — lysine is limiting in cereals, methionine in pulses, which is why cereal–pulse combinations complement each other
- D-amino acids occur in bacterial cell walls and some antibiotics; the reason penicillin can target bacteria selectively
Definition
Proteins = polymers of amino acids joined by peptide bonds, folded into a specific three-dimensional shape that determines their function.
The Peptide Bond
–COOH of one amino acid + –NH2 of the next → Loss of water (condensation) → peptide (amide) bond
- Partial double bond character from resonance → it is rigid and planar, and cannot rotate
- Almost always in the trans configuration — except before proline
- Rotation is possible only about the φ (phi) and ψ (psi) bonds either side of the α-carbon; the permitted angles are shown on a Ramachandran plot
- Uncharged but polar; participates in hydrogen bonding
Levels of Organisation
| Level | Definition | Bonds involved |
|---|---|---|
| Primary | The sequence of amino acids, N-terminal to C-terminal | Peptide bonds (covalent); disulphide bonds |
| Secondary | Local regular folding of the backbone | Hydrogen bonds |
| Tertiary | The overall three-dimensional shape of one polypeptide | Hydrophobic interactions (chief), hydrogen, ionic, van der Waals, disulphide |
| Quaternary | Arrangement of two or more subunits | Same non-covalent forces; no peptide bonds between subunits |
Primary structure
- Determined entirely by the gene
- It dictates all higher levels — a protein folds spontaneously into its native shape, as Anfinsen showed
- Insulin was the first protein sequenced (Sanger, 1955)
- A single change can be catastrophic — sickle cell disease is one amino acid substitution
Secondary Structure
| Type | Features | Examples |
|---|---|---|
| α-Helix | Right-handed; 3.6 residues per turn; pitch 5.4 Å; H-bond between C=O of residue n and N–H of n+4; side chains project outward | Keratin, myoglobin, haemoglobin |
| β-Pleated sheet | Extended chains side by side; parallel or antiparallel; H-bonds between strands | Silk fibroin, immunoglobulins, amyloid |
| β-Bend (turn) | Reverses chain direction; often contains glycine and proline | Globular proteins |
| Triple helix | Three left-handed chains wound into a right-handed superhelix | Collagen |
CLINICAL PEARL
Proline is the helix breaker. Its nitrogen is locked in a ring, so it has no N–H to donate a hydrogen bond and its rigid structure kinks the chain. Glycine also destabilises the helix, being too flexible. Both are therefore common at bends.
Tertiary and Quaternary Structure
- Hydrophobic interactions are the chief driving force — non-polar side chains turn inward, away from water, while polar ones face outward
- Disulphide bonds between cysteine residues are the only covalent bonds stabilising tertiary structure; abundant in secreted proteins such as insulin and immunoglobulins
- Chaperones assist folding and prevent aggregation
- Domains — independently folding functional units
- Quaternary structure allows co-operativity and allosteric regulation — haemoglobin (α2β2), lactate dehydrogenase (tetramer), creatine kinase (dimer)
Denaturation
Denaturation = loss of the native three-dimensional structure, and therefore of biological activity, without breaking peptide bonds — the primary structure is preserved.
| Agent | Mechanism |
|---|---|
| Heat | Disrupts hydrogen bonds and hydrophobic interactions |
| Extremes of pH | Alters ionisation, breaking ionic bonds |
| Urea, guanidine hydrochloride | Disrupt hydrogen bonds |
| Organic solvents, detergents (SDS) | Disrupt hydrophobic interactions |
| Heavy metals | Bind sulphydryl groups |
| β-Mercaptoethanol | Reduces disulphide bonds |
| Mechanical — whipping, ultraviolet light | Physical disruption |
- Effects — loss of biological activity, decreased solubility, increased viscosity, greater susceptibility to proteases
- Sometimes reversible (renaturation) if mild, which is itself the proof that primary structure determines conformation
Forces Stabilising Protein Structure
| Bond | Nature | Strength | Between |
|---|---|---|---|
| Peptide | Covalent | Strongest | Backbone amino acids |
| Disulphide | Covalent | Strong | Two cysteine residues |
| Hydrogen | Non-covalent | Weak individually, numerous | C=O and N–H, or polar side chains |
| Ionic (salt bridge) | Non-covalent | Moderate | Oppositely charged side chains |
| Hydrophobic | Non-covalent | The chief force in folding | Non-polar side chains |
| Van der Waals | Non-covalent | Very weak | All closely packed atoms |
- Only the peptide and disulphide bonds are covalent — all higher structure depends on weak forces acting in large numbers, which is exactly why proteins are so easily denatured
Applied Aspects
- Sickle cell disease — Glu→Val at position 6 of the β chain creates a hydrophobic patch, so deoxyhaemoglobin polymerises. A primary structure change causing a quaternary structure disease
- Prion diseases — Creutzfeldt–Jakob disease and kuru; a normal α-helical protein refolds into a β-sheet form that templates the same change in others. Disease from misfolding alone, with no change in sequence
- Amyloidosis and Alzheimer disease — β-sheet aggregates deposited in tissue; stain with Congo red giving apple-green birefringence
- Denaturation in practice — sterilisation by heat, disinfection by alcohol, and the use of egg white or milk as a first-aid antidote in heavy metal poisoning
- Osteogenesis imperfecta — a glycine substitution in collagen disrupts the triple helix, since only glycine is small enough for the interior position
Introduction
Plasma proteins = the proteins present in blood plasma, 6–8 g/dL in total.
| Fraction | Concentration | Site of synthesis |
|---|---|---|
| Albumin | 3.5–5.0 g/dL | Liver |
| Globulins | 2.0–3.5 g/dL | Liver; γ-globulins by plasma cells |
| Fibrinogen | 0.2–0.4 g/dL | Liver |
| A:G ratio | 1.2 : 1 to 2.5 : 1 | — |
- Serum = plasma minus fibrinogen and the other clotting factors
- All plasma proteins except the γ-globulins are made in the liver
Separation BY Electrophoresis
- On cellulose acetate or agarose at pH 8.6, proteins carry a net negative charge and migrate to the anode
- Five bands are resolved: albumin, α1, α2, β, γ
| Band | Chief constituents |
|---|---|
| Albumin | Albumin — moves fastest |
| α1 | α1-antitrypsin, α-fetoprotein, HDL |
| α2 | Haptoglobin, caeruloplasmin, α2-macroglobulin |
| β | Transferrin, LDL, complement C3, haemopexin |
| γ | Immunoglobulins |
Albumin
- The most abundant plasma protein; 585 amino acids, 69 kDa; half-life 20 days
- Contributes 75–80% of the plasma oncotic pressure, because of its high concentration and small size
- Transport — free fatty acids, unconjugated bilirubin, calcium, thyroxine, steroid hormones, and many drugs
- Buffering; a reserve of amino acids
Causes of hypoalbuminaemia
- Reduced synthesis — chronic liver disease, malnutrition (kwashiorkor)
- Increased loss — nephrotic syndrome, protein-losing enteropathy, extensive burns
- Increased catabolism — sepsis, malignancy, trauma
- Dilution — overhydration, pregnancy
- Consequence — oedema and ascites; also altered free drug levels, since less is protein-bound
Important Individual Proteins
| Protein | Function | Clinical significance |
|---|---|---|
| α1-antitrypsin | Inhibits elastase | Deficiency → panacinar emphysema and cirrhosis |
| Haptoglobin | Binds free haemoglobin | Low in intravascular haemolysis |
| Caeruloplasmin | Carries copper; ferroxidase | Low in Wilson disease |
| Transferrin | Carries iron | Raised in iron deficiency; low in chronic disease |
| C-reactive protein | Acute phase, opsonin | Marker of inflammation and infection |
| α-Fetoprotein | Fetal albumin equivalent | Raised in hepatocellular carcinoma and neural tube defects; low in Down syndrome |
| Immunoglobulins | Antibodies | Raised in infection and myeloma (M band) |
Acute Phase Response
| Positive acute phase (↑) | Negative acute phase (↓) |
|---|---|
| C-reactive protein (up to 1000×) | Albumin |
| Fibrinogen | Transferrin |
| Haptoglobin, caeruloplasmin | Prealbumin, retinol-binding protein |
| α1-antitrypsin, ferritin, complement | Transthyretin |
- Driven by IL-6, IL-1 and TNF-α acting on the liver
- The liver reprioritises — making defence proteins at the expense of transport proteins. This is why albumin falls in any acute illness and is a poor marker of nutrition
Characteristic Electrophoretic Patterns
| Condition | Pattern |
|---|---|
| Nephrotic syndrome | ↓↓ Albumin, ↑↑ α2 (macroglobulin retained), ↓ γ |
| Cirrhosis | ↓ Albumin with a diffuse ↑ γ; β–γ bridging; reversed A:G ratio |
| Multiple myeloma | Sharp, discrete M band in the γ region — monoclonal |
| Chronic infection | Diffuse (polyclonal) ↑ γ |
| α1-antitrypsin deficiency | Absent or flat α1 band |
| Acute inflammation | ↑ α1 and α2, ↓ albumin |
CLINICAL PEARL
A sharp band is monoclonal; a broad rise is polyclonal. That single distinction separates myeloma from chronic infection or cirrhosis, and is the main reason serum electrophoresis is still requested.
Applied Aspects
- Serum albumin is a poor marker of acute nutrition — its half-life is 20 days and it falls in any inflammatory state. Prealbumin (2 days) and retinol-binding protein (12 hours) respond faster
- Corrected calcium must be calculated when albumin is low, since about half of plasma calcium is albumin-bound: add 0.8 mg/dL for every 1 g/dL the albumin is below 4
- Drug displacement — in hypoalbuminaemia the free fraction of phenytoin or warfarin rises, causing toxicity at a normal total level
- Bence Jones protein — free light chains in urine in myeloma; they precipitate at 45–60 °C and redissolve on boiling
Definition
Cholesterol = a 27-carbon steroid alcohol, present only in animal tissue, and an essential component of every cell membrane.
Structure
- Based on the cyclopentanoperhydrophenanthrene ring — three six-membered rings (A, B, C) and one five-membered ring (D)
- Hydroxyl group at C-3 — the only polar part, making it amphipathic
- Double bond between C-5 and C-6
- Eight-carbon side chain at C-17
- Methyl groups at C-10 and C-13
- About 70% circulates esterified to a fatty acid at C-3, which makes it entirely non-polar
Functions
| Function | Detail |
|---|---|
| Membrane structure | Modulates fluidity — prevents both excessive rigidity and excessive fluidity; a major constituent of myelin |
| Bile acids | The largest single use; via 7α-hydroxylase |
| Steroid hormones | Cortisol, aldosterone, testosterone, oestrogen, progesterone |
| Vitamin D | Via 7-dehydrocholesterol in skin |
| Lipid rafts | Cell signalling platforms |
Sources and Normal Values
- Endogenous synthesis about 1 g/day — chiefly liver; diet supplies 300–500 mg
- HMG-CoA reductase is the rate-limiting enzyme, inhibited by cholesterol itself and by statins
- Desirable total cholesterol < 200 mg/dL; LDL < 100; HDL > 40
- Cholesterol cannot be degraded for energy — man cannot break the ring; it leaves the body only in bile, as bile acids or free sterol
Reactions Used in the Laboratory
- Liebermann–Burchard reaction — green colour with acetic anhydride and concentrated sulphuric acid; the classical colorimetric test
- Salkowski test — red colour with concentrated sulphuric acid
- Enzymatic method (cholesterol oxidase) is used in modern laboratories
Applied Aspects
- Atherosclerosis — oxidised LDL is taken up by macrophage scavenger receptors, which are not down-regulated, forming foam cells
- Familial hypercholesterolaemia — LDL receptor defect; autosomal dominant; tendon xanthomas, corneal arcus, premature coronary disease
- Gallstones — form when bile is supersaturated with cholesterol relative to bile salts and lecithin
- Statins lower LDL both by inhibiting synthesis and by up-regulating LDL receptors; the second effect is the more important
- Smith–Lemli–Opitz syndrome — a defect in the last step of cholesterol synthesis causing severe malformation, showing that cholesterol is essential for normal development
Definition
Peptide bond = the covalent amide linkage formed between the α-carboxyl group of one amino acid and the α-amino group of the next, with the elimination of a molecule of water.
Formation
R1–CH(NH2)–COOH + H2N–CH(R2)–COOH → Condensation — loss of H2O → R1–CH(NH2)–CO–NH–CH(R2)–COOH → dipeptide
- In the cell it is formed on the ribosome by peptidyl transferase, which is a ribozyme
- It is thermodynamically unfavourable and requires energy — 4 high-energy bonds per peptide bond
Characteristics
| Property | Explanation |
|---|---|
| Partial double bond character | Resonance between the C=O and C–N bonds; the C–N bond is shorter than a normal single bond |
| Rigid and planar | No free rotation about the C–N bond; six atoms lie in one plane |
| Trans configuration | The two α-carbons lie on opposite sides — less steric hindrance. Except before proline, where cis also occurs |
| Uncharged but polar | Participates in hydrogen bonding — the basis of secondary structure |
| Strong and stable | Resists spontaneous hydrolysis; needs enzymes, strong acid or prolonged heat |
| Rotation permitted at φ and ψ | The bonds either side of the α-carbon; permitted angles shown on the Ramachandran plot |
Significance
- The rigidity and planarity restrict the shapes a chain can adopt, which is precisely what makes reproducible folding possible
- Its hydrogen bonding capacity generates the α-helix and β-pleated sheet
- It is not broken by denaturation — which is why primary structure survives when a protein is denatured
Cleavage of Peptide Bonds
| Method | Agent | Specificity |
|---|---|---|
| Enzymatic — endopeptidase | Trypsin | C-side of lysine and arginine |
| — | Chymotrypsin | C-side of aromatic amino acids |
| — | Pepsin | N-side of aromatic amino acids |
| Enzymatic — exopeptidase | Carboxypeptidase; aminopeptidase | From the C- or N-terminal end |
| Chemical | Cyanogen bromide | C-side of methionine |
| — | 6 N HCl at 110 °C for 24 h | Complete hydrolysis; destroys tryptophan |
Applied Aspects
- Biuret reaction detects two or more peptide bonds — a violet colour with copper in alkali; the standard method of protein estimation. Free amino acids and dipeptides give no colour
- Protein sequencing uses specific cleavage with overlapping fragments; Edman degradation removes one residue at a time from the N-terminus
- ACE inhibitors and protease inhibitors act by blocking peptide bond cleavage — the basis of captopril in hypertension and of the antiretroviral protease inhibitors
- Penicillin inhibits bacterial transpeptidase, preventing cross-linking of peptidoglycan — peptide bond chemistry exploited for selective toxicity
Definition and Structure
Haemoglobin = the oxygen-carrying conjugated protein of the red blood cell, consisting of globin (protein) and four haem (prosthetic) groups.
- Molecular weight 64,500 Da; a tetramer of four polypeptide chains, each with one haem
- Normal concentration 13–17 g/dL (male), 12–15 g/dL (female)
- 1 g of haemoglobin carries 1.34 mL of oxygen
Haem
- Protoporphyrin IX + ferrous iron (Fe2+)
- Iron is held by four bonds to pyrrole nitrogens, a fifth to the proximal histidine (F8) of globin, and the sixth is free to bind oxygen
- Iron must remain in the Fe2+ state — oxidation to Fe3+ gives methaemoglobin, which cannot carry oxygen
- Oxygen binding is oxygenation, not oxidation — the iron stays ferrous
Types of Human Haemoglobin
| Type | Chains | When | Normal proportion in adult |
|---|---|---|---|
| HbA | α2β2 | Adult | 96–98% |
| HbA2 | α2δ2 | Adult | 2–3% — raised in β-thalassaemia trait |
| HbF | α2γ2 | Fetal | < 1% |
| Gower, Portland | ζ and ε chains | Embryonic | Absent |
- HbF binds 2,3-BPG poorly, because its γ chains lack the necessary histidine residues → higher oxygen affinity, allowing the fetus to take oxygen from maternal blood
Oxygen Binding and the Dissociation Curve
- Sigmoid curve, reflecting co-operative binding — binding of the first oxygen increases the affinity of the remaining sites
- T (tense, low affinity) and R (relaxed, high affinity) states
- P50 = 27 mmHg — the partial pressure at which haemoglobin is half saturated
- Denaturation abolishes biological activity while leaving the peptide bonds intact, which is why a denatured protein still gives every colour reaction of protein but no longer works
- Most denaturation is irreversible in practice, though small proteins such as ribonuclease can refold spontaneously — the observation that established that the primary sequence determines the final shape
- Heat, extremes of pH, organic solvents, urea, heavy metals and mechanical agitation all denature protein, and each is used deliberately somewhere in the laboratory or the clinic
- Cooking, sterilisation and disinfection all depend on denaturation, as does the coagulation of albumin in the heat test for proteinuria
Definition
Collagen = the most abundant protein in the human body, forming 25–30% of total body protein; the chief structural protein of the extracellular matrix.
Structure
- Triple helix — three left-handed polypeptide (α) chains wound into a right-handed superhelix
- Repeating sequence (Gly–X–Y)n, where X is often proline and Y often hydroxyproline
- Glycine occupies every third position — it is the only amino acid small enough to fit the crowded interior of the helix
- Rich in proline and hydroxyproline; contains hydroxylysine; lacks tryptophan and cysteine
- Held together by hydrogen bonds involving hydroxyproline
Types
| Type | Location |
|---|---|
| Type I | Skin, bone, tendon, cornea — the commonest (90%) |
| Type II | Cartilage, vitreous humour |
| Type III | Reticulin — blood vessels, fetal skin, granulation tissue |
| Type IV | Basement membrane — does not form fibrils |
| Type VII | Anchoring fibrils of skin |
Biosynthesis
Preprocollagen → signal peptide removed → hydroxylation of proline and lysine — needs vitamin C, Fe2+, α-ketoglutarate, O2 → glycosylation of hydroxylysine → Triple helix forms → procollagen, secreted → Procollagen peptidase removes the terminal extensions → tropocollagen → Self-assembly into fibrils → lysyl oxidase (needs copper) forms cross-links → mature collagen
- Two vitamin and mineral dependencies matter clinically — vitamin C for hydroxylation and copper for cross-linking
Disorders of Collagen
| Disorder | Defect | Features |
|---|---|---|
| Scurvy | Vitamin C deficiency → no hydroxylation | Bleeding gums, perifollicular haemorrhage, poor wound healing, old scars breaking down |
| Osteogenesis imperfecta | Type I collagen — usually a glycine substitution | Brittle bones, blue sclerae, deafness, dentinogenesis imperfecta |
| Ehlers–Danlos syndrome | Various — types I, III, V; lysyl hydroxylase or procollagen peptidase | Hyperextensible skin, hypermobile joints, vascular rupture |
| Menkes disease | Copper transport defect → lysyl oxidase fails | Kinky hair, arterial tortuosity, neurodegeneration |
| Alport syndrome | Type IV collagen | Haematuria, renal failure, sensorineural deafness |
| Goodpasture syndrome | Antibodies to type IV collagen | Glomerulonephritis with pulmonary haemorrhage |
Applied Aspects
- Urinary hydroxyproline is a marker of collagen turnover — raised in Paget disease, hyperparathyroidism and bone metastases
- Elastin is the complementary protein — rich in glycine and proline but not hydroxylated, cross-linked by desmosine, and confers recoil rather than tensile strength
- Gelatin is denatured collagen — a poor-quality dietary protein, lacking tryptophan entirely
- Collagen provides tensile strength, which is why its disorders present with fragility — of bone, skin, vessels or basement membrane, depending on the type affected
Definition
Immunoglobulins (antibodies) = glycoproteins produced by plasma cells that recognise and bind specific antigens.
Basic Structure
- Y-shaped; four polypeptide chains — two identical heavy and two identical light chains
- Held by interchain disulphide bonds
- Light chains — two types, kappa (κ) and lambda (λ); a given molecule has one or the other, never both
- Heavy chains determine the class — γ, α, μ, δ, ε for IgG, IgA, IgM, IgD, IgE
- Variable region — antigen binding; constant region — effector functions
- Hinge region gives flexibility; rich in proline
Enzymatic fragments
| Enzyme | Fragments produced | Properties |
|---|---|---|
| Papain | 2 Fab + 1 Fc | Each Fab is monovalent — binds but cannot precipitate |
| Pepsin | 1 F(ab′)2 + fragments | Bivalent — still precipitates antigen; Fc destroyed |
Classes and Their Properties
| Class | Structure | Proportion | Chief features |
|---|---|---|---|
| IgG | Monomer | 75–80% | The only one crossing the placenta; fixes complement; secondary response; longest half-life (23 days) |
| IgA | Monomer in serum; dimer with secretory piece in secretions | 10–15% | Chief antibody of mucosal secretions — milk, saliva, tears, gut |
| IgM | Pentamer | 5–10% | Largest; first in the primary response; best complement fixer; natural blood group antibodies |
| IgD | Monomer | < 1% | B cell surface receptor |
| IgE | Monomer | Least (0.004%) | Allergy and parasitic infection; binds mast cells and basophils |
CLINICAL PEARL
Mnemonics — IgG Goes across the placenta; IgA in secretions (sAliva); IgM is Massive and first; IgE for Exposure and allergy.
Functions
- Neutralisation of toxins and viruses
- Opsonisation — coating organisms for phagocytosis
- Complement activation — classical pathway; IgM > IgG
- Agglutination and precipitation
- Antibody-dependent cell-mediated cytotoxicity
- Passive immunity to the newborn — IgG across the placenta, IgA in breast milk
Applied Aspects
- Multiple myeloma — a monoclonal plasma cell tumour producing a sharp M band on electrophoresis; free light chains appear in urine as Bence Jones protein
- Raised IgM alone in the newborn indicates intrauterine infection, since IgM cannot cross the placenta and must be the infant's own
- Rh incompatibility — maternal IgG crosses the placenta and causes haemolytic disease; prevented by anti-D immunoglobulin
- Monoclonal antibodies are now major drugs — rituximab, trastuzumab, infliximab, adalimumab
- Selective IgA deficiency is the commonest primary immunodeficiency; recurrent mucosal infection and a risk of anaphylaxis on transfusion
Definition
Electrophoresis = the movement of charged particles in an electric field, used to separate proteins and nucleic acids according to their charge, size and shape.
Principle
- At a pH above the isoelectric point, a protein carries a net negative charge and migrates to the anode
- Serum electrophoresis is run at pH 8.6, where all serum proteins are negatively charged
- Rate of migration depends on net charge, molecular size and shape, the strength of the field, and the supporting medium
- Albumin moves fastest — it is the most negatively charged and relatively small
Supporting Media and Their Uses
| Medium | Separates by | Chief use |
|---|---|---|
| Cellulose acetate / agarose | Charge | Routine serum protein electrophoresis |
| SDS-page | Molecular size only — SDS masks the native charge | Determining molecular weight; Western blotting |
| Isoelectric focusing | Isoelectric point | Separating isoenzymes and haemoglobin variants; very high resolution |
| Two-dimensional | PI, then size | Proteomics |
| Agarose gel | Size | DNA and RNA |
| Capillary electrophoresis | Charge and size | Automated; increasingly replacing gels |
The Normal Serum Pattern
| Band | Percentage | Chief proteins |
|---|---|---|
| Albumin | 55–65% | Albumin |
| α1 | 2–4% | α1-antitrypsin |
| α2 | 6–12% | Haptoglobin, caeruloplasmin |
| β | 8–12% | Transferrin, C3 |
| γ | 12–22% | Immunoglobulins |
Diagnostic Patterns
| Condition | Characteristic finding |
|---|---|
| Multiple myeloma | Sharp M band in the γ region — monoclonal |
| Chronic infection or inflammation | Broad polyclonal ↑ γ |
| Cirrhosis | ↓ Albumin with β–γ bridging |
| Nephrotic syndrome | ↓↓ Albumin, ↑↑ α2, ↓ γ |
| α1-antitrypsin deficiency | Flat or absent α1 band |
| Agammaglobulinaemia | Absent γ band |
Related Techniques and Applied Aspects
- Immunofixation identifies the exact heavy and light chain type of an M band — essential in diagnosing myeloma
- Haemoglobin electrophoresis at alkaline pH separates HbA, HbF, HbS and HbC; the standard test for the haemoglobinopathies, which matter greatly in India
- Western blot uses SDS-page followed by antibody detection — the confirmatory test for HIV
- Isoenzyme separation — LDH and CK isoenzymes, used to localise tissue damage
- DNA electrophoresis underlies PCR analysis, Southern blotting and DNA fingerprinting
Classification BY Composition
| Class | Definition | Examples |
|---|---|---|
| Simple proteins | Yield only amino acids on hydrolysis | Albumins (water-soluble), globulins (salt-soluble), glutelins and prolamines (plant), histones and protamines (basic, DNA-binding), scleroproteins (keratin, collagen, elastin) |
| Conjugated proteins | Yield amino acids plus a non-protein prosthetic group | Glycoproteins (carbohydrate — immunoglobulins, mucins); lipoproteins (lipid); phosphoproteins (casein); chromoproteins (haem — haemoglobin, cytochromes); metalloproteins (ceruloplasmin, ferritin); nucleoproteins |
| Derived proteins | Products of partial denaturation or hydrolysis | Proteans, metaproteins, proteoses, peptones, peptides |
Classification BY Shape and BY Function
| Basis | Type | Features and examples |
|---|---|---|
| Shape | Fibrous | Long parallel chains, insoluble in water, structural, resistant to digestion — keratin, collagen, elastin, fibrin, myosin |
| Shape | Globular | Compactly folded, soluble, functionally active — enzymes, haemoglobin, albumin, immunoglobulins, hormones |
| Function | Structural | Collagen, keratin, elastin |
| Function | Catalytic | All enzymes |
| Function | Transport | Haemoglobin, albumin, transferrin, lipoproteins |
| Function | Contractile | Actin, myosin, tubulin |
| Function | Defence | Immunoglobulins, complement, fibrinogen |
| Function | Regulatory and hormonal | Insulin, growth hormone, transcription factors |
| Function | Storage | Ferritin, casein, ovalbumin |
CLINICAL PEARL
Fibrous and globular proteins differ in solubility because they differ in what they hide. A globular protein folds so that hydrophobic side chains are buried in the interior and polar groups face the water — hence solubility and a defined active site. A fibrous protein instead packs extended chains against one another, leaving hydrophobic surfaces exposed and cross-linked, which gives tensile strength and insolubility. Structure follows directly from function.
Precipitation Reactions
- Proteins are held in solution by their hydration shell and by their surface charge; removing either causes precipitation
- At the isoelectric pH the net charge is zero, so repulsion between molecules is minimal and the protein is least soluble and most easily precipitated — the basis of isoelectric precipitation, as in the clotting of milk casein by acid
- Salting out — high concentrations of neutral salts (ammonium sulphate, sodium chloride) compete for water and remove the hydration shell; globulins precipitate at half saturation and albumins at full saturation, which is used to separate them
- Salting IN — low salt concentrations increase solubility, which is why globulins dissolve in dilute salt but not in pure water
- Organic solvents (alcohol, acetone) lower the dielectric constant and dehydrate the protein
- Heavy metal ions (Hg2+, Pb2+, Ag+) bind negatively charged groups above the isoelectric point — the basis of using egg white or milk as a first-aid antidote in heavy metal poisoning
- Alkaloidal reagents (tungstic, trichloroacetic, picric and sulphosalicylic acid) precipitate protein below the isoelectric point; used for deproteinising blood before analysis and for detecting urinary protein
- Heat with dilute acid — the basis of the heat coagulation test for proteinuria
Applied Aspects
- Serum protein electrophoresis separates albumin from the globulin fractions, and the pattern is diagnostic — a monoclonal band in myeloma, a diffuse polyclonal rise in chronic infection and liver disease, and a reduced gamma region in hypogammaglobulinaemia
- The albumin to globulin ratio is normally about 1.2 to 2, and its reversal is a useful and cheap indicator of chronic liver disease or myeloma
- Give milk or egg white in acute heavy metal poisoning as an immediate measure while arranging chelation; the protein binds the metal in the gut
- Denaturation destroys function but not the peptide bonds, which is why a boiled enzyme is inactive yet still gives all the colour reactions of protein
- Bence Jones protein precipitates on heating to 40–60°C and redissolves on boiling — an unusual behaviour that was the original basis of its detection in myeloma
Definition
Enzymes = biological catalysts, almost all proteins, that accelerate the rate of a biochemical reaction without being consumed or altering the equilibrium.
- Exception — ribozymes are catalytic RNA molecules (peptidyl transferase of the ribosome)
- Accelerate reactions 103 to 1017 fold
- Highly specific and can be regulated — the two features that distinguish them from chemical catalysts
Terminology
| Term | Meaning |
|---|---|
| Apoenzyme | The protein part alone — catalytically inactive |
| Cofactor | The non-protein part |
| Coenzyme | An organic cofactor, loosely bound; usually a vitamin derivative |
| Prosthetic group | A cofactor tightly (covalently) bound — haem, biotin, FAD |
| Holoenzyme | Apoenzyme + cofactor — the active enzyme |
| Active site | The cleft where substrate binds and catalysis occurs |
| Isoenzymes | Different molecular forms catalysing the same reaction |
Iubmb Classification — Six Classes
| Class | Name | Reaction catalysed | Example |
|---|---|---|---|
| 1 | Oxidoreductases | Oxidation–reduction; transfer of H or electrons | Lactate dehydrogenase, cytochrome oxidase |
| 2 | Transferases | Transfer of a group other than hydrogen | Transaminases (ALT, ast), hexokinase |
| 3 | Hydrolases | Cleavage of a bond by adding water | Pepsin, trypsin, lipase, alkaline phosphatase |
| 4 | Lyases | Cleavage without water or oxidation; often forms a double bond | Aldolase, fumarase, carbonic anhydrase |
| 5 | Isomerases | Intramolecular rearrangement | Phosphohexose isomerase, epimerase, mutase |
| 6 | Ligases (synthetases) | Joining of two molecules, using ATP | Pyruvate carboxylase, DNA ligase, glutamine synthetase |
- Mnemonic — "Over The Hill Like I Live"
- Each enzyme has a four-digit EC number; for example hexokinase is EC 2.7.1.1
Mechanism of Enzyme Action
E + S → Enzyme–substrate (ES) complex → Transition state stabilised → E + P
How the rate is increased
- Lowering the activation energy — the fundamental mechanism. The enzyme provides an alternative path with a lower energy barrier
- Proximity and orientation — substrates are held close together in the correct alignment
- Strain and distortion of the substrate bond
- Acid–base catalysis — by histidine, aspartate, glutamate residues
- Covalent catalysis — a transient covalent bond with the enzyme, as in chymotrypsin
CLINICAL PEARL
Note: an enzyme does not alter the equilibrium constant or the ΔG of a reaction. It accelerates the forward and reverse reactions equally, so equilibrium is reached faster but is unchanged.
Theories of Enzyme–substrate Binding
| Theory | Proposed by | Concept |
|---|---|---|
| Lock and key | Emil Fischer (1894) | Active site is rigid and exactly complementary to the substrate. Explains specificity but not all observations |
| Induced fit | Koshland (1958) | Active site is flexible; the substrate induces a conformational change that brings catalytic groups into position. The accepted model |
Enzyme Specificity
| Type | Meaning | Example |
|---|---|---|
| Absolute | Acts on one substrate only | Urease (urea), lactase |
| Group (relative) | Acts on a particular bond or group | Trypsin — peptide bonds of lysine and arginine |
| Bond | Acts on a bond type regardless of the rest of the molecule | Lipase, glycosidase |
| Stereospecificity | Acts on one optical or geometric isomer only | L-amino acid oxidase; D-glucose but not L-glucose |
Factors Affecting Enzyme Activity
- Substrate concentration — hyperbolic curve; plateaus at Vmax
- Enzyme concentration — linear relation, the basis of enzyme assays
- Temperature — optimum 37 °C in man; activity doubles for every 10 °C rise (Q10 = 2) until denaturation above 50–60 °C
- PH — each enzyme has an optimum: pepsin 1–2, salivary amylase 6.8, trypsin 8, alkaline phosphatase 9–10
- Product concentration — accumulation slows the reaction
- Activators and inhibitors
Applied Aspects
- Enzymes are named by adding "-ase" to the substrate (urease) or the reaction (dehydrogenase); older trivial names persist — pepsin, trypsin, ptyalin
- Fever raises enzyme activity, contributing to the increased metabolic rate; hypothermia lowers it, which is why it protects the brain during cardiac surgery
- Acidosis and alkalosis shift enzymes away from their optimum pH and impair metabolism
- Inborn errors of metabolism are almost all single enzyme defects — phenylketonuria, galactosaemia, glycogen storage diseases
- Many drugs act as enzyme inhibitors — aspirin on cyclo-oxygenase, statins on HMG-CoA reductase, allopurinol on xanthine oxidase
Effect of Substrate Concentration
- At low [S] the reaction is first order — rate is proportional to [S]
- At high [S] it becomes zero order — rate is independent of [S], because all active sites are saturated
- The curve is a rectangular hyperbola
Michaelis–menten Equation
V = (Vmax × [S]) ÷ (Km + [S])
| Term | Meaning |
|---|---|
| V | Initial velocity at a given [S] |
| Vmax | Maximum velocity when the enzyme is fully saturated |
| Km | The substrate concentration at which v = ½ Vmax |
Assumptions
- Only the initial velocity is measured, so the reverse reaction is negligible
- A steady state exists — ES is formed and broken down at equal rates
- [S] is far greater than [E]
Significance of KM
- Km is a measure of the affinity of the enzyme for its substrate
- Low Km = high affinity (saturated at low substrate)
- High Km = low affinity
- It is a constant for a given enzyme and substrate, independent of enzyme concentration
- Units are those of concentration (mol/L)
- Helps identify which isoenzyme is present, and predicts behaviour at physiological substrate levels
| Enzyme | Km for glucose | Consequence |
|---|---|---|
| Hexokinase | 0.05 mM (low) | Works at all blood glucose levels; present in all tissues; inhibited by G6P |
| Glucokinase | 10 mM (high) | Works only when glucose is high, as after a meal; liver and pancreatic β cell; not inhibited by G6P; induced by insulin |
CLINICAL PEARL
This Km difference is physiologically decisive: the liver takes up glucose only when the portal level is high, so the brain, whose hexokinase has a low Km, is never deprived.
Lineweaver–burk Plot
The double reciprocal plot — 1/v against 1/[S] — converts the hyperbola into a straight line.1/v = (Km/Vmax) × 1/[S] + 1/Vmax
| Feature | Value |
|---|---|
| Y-intercept | 1/Vmax |
| X-intercept | −1/Km |
| Slope | Km/Vmax |
- Advantage — gives accurate values of Km and Vmax without needing very high substrate concentrations, and distinguishes types of inhibition at a glance
- Other plots — Eadie–Hofstee, Hanes–Woolf
Allosteric Enzymes Do Not Obey Michaelis–menten
- They give a sigmoid curve, not hyperbolic
- Because of co-operativity between subunits — binding at one site alters affinity at the others
- The measure used is K0.5 or S0.5, not Km
- Examples — phosphofructokinase-1, aspartate transcarbamoylase; haemoglobin behaves the same way though it is not an enzyme
Enzyme Units
| Unit | Definition |
|---|---|
| International Unit (IU) | Amount of enzyme converting 1 µmol of substrate per minute under defined conditions |
| Katal | SI unit — 1 mol of substrate per second |
| Specific activity | Units per mg of protein — a measure of purity |
| Turnover number (kcat) | Molecules of substrate converted per molecule of enzyme per second; carbonic anhydrase is the fastest known |
Measurement of Enzyme Activity
- Enzymes are measured by their activity, not their mass — they are present in far too small an amount to weigh
- Conditions must be standardised — optimum pH, 37 °C, saturating substrate, so that the rate depends on enzyme concentration alone
- Zero-order conditions are used deliberately: with substrate in excess, velocity is proportional to the amount of enzyme
- Only the initial velocity is measured, before product accumulates
- Coupled assays are used when the product is not directly measurable — the reaction is linked to one that changes NADH absorbance at 340 nm
Applied Aspects
- Glucokinase mutations cause MODY-2 (maturity onset diabetes of the young) — a raised Km resets the glucose sensor of the β cell to a higher threshold
- Alcohol dehydrogenase has a low Km and is saturated at low blood alcohol → alcohol is cleared by zero-order kinetics, at a constant rate irrespective of concentration
- Phenytoin, aspirin and ethanol all show zero-order elimination at therapeutic doses → small dose increases cause large rises in plasma level and toxicity
- Knowing Km guides the design of competitive inhibitors as drugs
- Enzyme deficiency states may be due to a raised Km rather than an absent enzyme — some respond to large doses of the vitamin coenzyme, as in vitamin-responsive homocystinuria
Definition and Classification
Enzyme inhibitor = a substance that decreases the rate of an enzyme-catalysed reaction.
- Reversible — binds non-covalently; can be removed by dialysis
- Irreversible — binds covalently; the enzyme is permanently inactivated
Competitive Inhibition
- The inhibitor is structurally similar to the substrate
- It competes for the same active site
- The effect can be overcome by increasing substrate concentration
| Parameter | Effect |
|---|---|
| Km | Increased (apparent affinity falls) |
| Vmax | Unchanged |
| Lineweaver–Burk | Lines meet on the Y-axis (same 1/Vmax) |
Examples
- Malonate inhibits succinate dehydrogenase — the classical example
- Methanol poisoning treated with ethanol — ethanol competes for alcohol dehydrogenase and prevents formation of toxic formaldehyde and formate
- Sulphonamides compete with PABA for bacterial dihydropteroate synthase
- Statins compete with HMG-CoA for HMG-CoA reductase
- Allopurinol competes with hypoxanthine for xanthine oxidase
- Methotrexate competes with folate for dihydrofolate reductase
Non-competitive Inhibition
- The inhibitor binds at a site other than the active site (allosteric)
- It binds equally to E and ES
- Not overcome by increasing substrate
| Parameter | Effect |
|---|---|
| Km | Unchanged |
| Vmax | Decreased |
| Lineweaver–Burk | Lines meet on the X-axis (same −1/Km) |
- Examples — heavy metals (lead, mercury, silver) binding sulphydryl groups; cyanide on cytochrome oxidase; fluoride on enolase
Uncompetitive Inhibition
- The inhibitor binds only to the ES complex, never to free enzyme
- Both Km and Vmax are decreased, in the same proportion
- Lineweaver–Burk gives parallel lines
- Example — lithium on inositol monophosphatase
Comparison Table
| Feature | Competitive | Non-competitive | Uncompetitive |
|---|---|---|---|
| Binds to | Active site of free E | Allosteric site of E and ES | ES only |
| Resembles substrate | Yes | No | No |
| Km | ↑ | Unchanged | ↓ |
| Vmax | Unchanged | ↓ | ↓ |
| Overcome by ↑ [S] | Yes | No | No |
| L–B lines meet | On Y-axis | On X-axis | Parallel |
Irreversible and Suicide Inhibition
- Irreversible — covalent modification of the active site
- Organophosphates phosphorylate the serine of acetylcholinesterase
- Aspirin irreversibly acetylates cyclo-oxygenase
- Penicillin irreversibly inhibits bacterial transpeptidase
- Iodoacetate inhibits glyceraldehyde-3-phosphate dehydrogenase
Suicide (mechanism-based) inhibition
- The inhibitor is a substrate analogue that the enzyme itself converts into a reactive species, which then destroys the enzyme
- Examples — allopurinol on xanthine oxidase (also competitive), 5-fluorouracil on thymidylate synthase, α-methyldopa
- Advantage — very high specificity, since only the target enzyme activates it
Applied Aspects
- Antimetabolites in cancer therapy — methotrexate, 5-fluorouracil, 6-mercaptopurine all work as enzyme inhibitors
- Ethanol as an antidote in methanol and ethylene glycol poisoning is the classic clinical use of competitive inhibition; fomepizole is the modern alternative
- Heavy metal poisoning treated with chelating agents — BAL, EDTA, penicillamine — which remove the metal from the sulphydryl groups
- Feedback inhibition by the end product is usually allosteric and is the commonest physiological form of regulation
WHY Regulation Is Needed
Metabolic pathways must respond to changing demand. Regulation acts at the rate-limiting (committed) step, which is usually an irreversible reaction catalysed by an allosteric enzyme.
Mechanisms — Overview
| Mechanism | Speed | Changes |
|---|---|---|
| Allosteric regulation | Seconds | Activity of existing enzyme |
| Covalent modification | Seconds to minutes | Activity of existing enzyme |
| Proteolytic activation of zymogens | Minutes | Irreversible activation |
| Induction and repression | Hours to days | Amount of enzyme |
| Compartmentation | — | Access to substrate |
| Isoenzymes | — | Tissue-appropriate kinetics |
Allosteric Regulation
- The regulator binds at a site distinct from the active site (Greek allos = other)
- Positive modulator → increases activity; negative modulator → decreases it
- Allosteric enzymes are oligomeric and show sigmoid kinetics
- Feedback (end-product) inhibition is the commonest form — the final product of a pathway inhibits the first committed enzyme
| Enzyme | Activator | Inhibitor |
|---|---|---|
| Phosphofructokinase-1 | Amp, ADP, fructose-2,6-bisphosphate | ATP, citrate, H+ |
| Isocitrate dehydrogenase | ADP, Ca2+ | ATP, NADH |
| Acetyl-CoA carboxylase | Citrate | Palmitoyl-CoA |
| Pyruvate carboxylase | Acetyl-CoA | ADP |
| HMG-CoA reductase | — | Cholesterol |
| Ala synthase | — | Haem |
Covalent Modification
- The commonest is phosphorylation and dephosphorylation
- Protein kinases phosphorylate (using ATP) at serine, threonine or tyrosine; phosphatases remove it
- Ultimately controlled by hormones through second messengers
Glucagon / adrenaline → ↑ cAMP → Protein kinase A → Phosphorylates target enzymes → Glycogen phosphorylase activated; glycogen synthase inactivated
| Enzyme | Phosphorylated form |
|---|---|
| Glycogen phosphorylase | Active |
| Glycogen synthase | Inactive |
| Pyruvate dehydrogenase | Inactive |
| Hormone-sensitive lipase | Active |
| Acetyl-CoA carboxylase | Inactive |
| HMG-CoA reductase | Inactive |
CLINICAL PEARL
The pattern is consistent: phosphorylation (the fasting, glucagon-driven state) switches ON the pathways that release fuel and switches off those that store it. Insulin, by promoting dephosphorylation, does the reverse.
Zymogens (proenzymes)
- Inactive precursors activated by irreversible proteolytic cleavage
- Purpose — prevents the enzyme digesting the cell that makes it, and allows a rapid, amplifying response
| Zymogen | Active enzyme | Activated by |
|---|---|---|
| Trypsinogen | Trypsin | Enterokinase, then trypsin itself |
| Chymotrypsinogen | Chymotrypsin | Trypsin |
| Pepsinogen | Pepsin | HCl, then pepsin (autocatalysis) |
| Prothrombin | Thrombin | Prothrombin activator |
| Procarboxypeptidase | Carboxypeptidase | Trypsin |
| Plasminogen | Plasmin | TPA, urokinase, streptokinase |
Induction and Repression
- Alters the amount of enzyme by changing the rate of transcription; slow but long lasting
- Inducible enzymes — glucokinase, HMG-CoA reductase, ala synthase, the urea cycle enzymes, cytochrome P450
- Insulin induces glucokinase and the lipogenic enzymes; glucagon and cortisol induce the gluconeogenic enzymes
- Constitutive enzymes are produced at a constant rate regardless of demand
Applied Aspects
- Acute pancreatitis — premature intrapancreatic activation of trypsinogen → autodigestion; the whole point of the zymogen system is to prevent this
- Enzyme induction by drugs — rifampicin, phenytoin, carbamazepine and alcohol induce cytochrome P450 → failure of oral contraceptives and warfarin
- Enzyme inhibition by drugs — cimetidine, erythromycin, ketoconazole inhibit P450 → toxicity of co-administered drugs
- α1-antitrypsin deficiency — loss of a natural protease inhibitor → unopposed elastase → emphysema and liver disease
- Phenobarbitone induces UDP-glucuronyl transferase — formerly used to treat neonatal jaundice by increasing bilirubin conjugation
Principle
Diagnostic enzymology = measurement of enzyme activity in plasma to detect and monitor tissue damage.Enzymes appear in plasma when cells are damaged, when their turnover increases, or when their excretion is obstructed.
| Group | Meaning | Example |
|---|---|---|
| Plasma-specific (functional) | Act in plasma; synthesised by the liver | Clotting factors, lipoprotein lipase, pseudocholinesterase |
| Non-plasma-specific | Have no function in plasma; leak from tissue | All the diagnostic enzymes |
| Secretory | Normally secreted into a duct | Amylase, lipase, alkaline phosphatase |
Cardiac Markers
| Marker | Rises | Peaks | Returns to normal | Comment |
|---|---|---|---|---|
| Myoglobin | 1–3 h | 6–9 h | 24 h | Earliest but non-specific |
| CK-MB | 4–6 h | 24 h | 48–72 h | Best for detecting RE-infarction, as it normalises quickly |
| Troponin I and T | 4–6 h | 24–48 h | 7–10 days | Most sensitive and specific; the gold standard |
| Ast | 12 h | 24–48 h | 3–5 days | Non-specific |
| LDH | 12–24 h | 48–72 h | 8–14 days | Useful in late presentation |
- Troponin has replaced all others for diagnosis; the others retain value only for timing
Liver Enzymes
| Enzyme | Chief significance |
|---|---|
| ALT (SGPT) | More specific for liver; markedly raised in viral hepatitis (> 10×) |
| Ast (SGOT) | Liver, heart, muscle. ast:ALT > 2 suggests alcoholic liver disease |
| Alkaline phosphatase | Markedly raised in obstructive jaundice and bone disease (Paget, rickets, metastases) |
| GGT | Most sensitive index of alcohol intake; rises with ALP in cholestasis, confirming a hepatic rather than bony source |
| 5′-nucleotidase | Confirms that a raised ALP is of hepatobiliary origin |
Other Diagnostic Enzymes
| Enzyme | Raised in |
|---|---|
| Amylase and lipase | Acute pancreatitis; lipase is more specific and stays up longer |
| Creatine kinase (CK-MM) | Duchenne muscular dystrophy (very high), rhabdomyolysis, myositis |
| Acid phosphatase | Carcinoma prostate (now superseded by PSA) |
| Pseudocholinesterase | Decreased in liver disease and organophosphate poisoning |
| Aldolase | Muscle disease |
| ACE | Sarcoidosis |
Isoenzymes and Their Diagnostic Value
Isoenzymes = physically distinct forms of an enzyme catalysing the same reaction, but differing in structure, kinetics and electrophoretic mobility.
Lactate dehydrogenase — 5 isoenzymes
- A tetramer of H (heart) and M (muscle) subunits
- LDH-1 (H4) — heart and RBC
- LDH-2 (H3M) — reticuloendothelial system; normally the highest in serum
- LDH-3 — lung; LDH-4 — kidney, placenta
- LDH-5 (M4) — liver and skeletal muscle
- "Flipped pattern" LDH-1 > LDH-2 indicates myocardial infarction
Creatine kinase — 3 isoenzymes
- CK-MM — skeletal muscle; CK-MB — heart; CK-BB — brain
Factors to Consider Before Interpreting a Raised Enzyme
- Tissue specificity — how confined is the enzyme to one organ?
- Timing — when did the injury occur relative to the sample?
- Magnitude — a rise of 10× means something different from 1.5×
- Half-life — determines how long the abnormality persists
- Route of clearance — renal or hepatic failure may raise levels without tissue damage
- Physiological causes — ALP rises in growing children, in pregnancy, and after a fatty meal (intestinal isoenzyme)
- Artefacts — haemolysis of the sample falsely raises LDH, ast and potassium
Applied Aspects
- Enzymes are used therapeutically too — streptokinase and urokinase as thrombolytics, asparaginase in leukaemia, pancreatin in pancreatic insufficiency
- Enzymes as laboratory reagents — glucose oxidase for blood glucose, urease for urea, and horseradish peroxidase in ELISA
- Timing matters — a normal troponin within 4 hours of chest pain does not exclude infarction; the test must be repeated
- The pattern of enzymes is more informative than any single value — ALT with ALP, or ast with ALT, localises the disease far better than either alone
- Serial measurement beats a single reading — a falling trend indicates recovery, a rising one continuing damage
- Normal enzymes do not exclude disease — in established cirrhosis the transaminases may be normal because little viable liver remains
Definition
Coenzymes = small, heat-stable, non-protein organic molecules that are essential for the activity of certain enzymes, acting as carriers of atoms, groups or electrons.
- Most coenzymes are derived from water-soluble B-complex vitamins — the reason these vitamins are required in the diet
- They are loosely bound; a tightly (covalently) bound cofactor is a prosthetic group
- Coenzymes are regenerated, so they act catalytically and are needed only in small amounts
Coenzymes Derived from Vitamins
| Vitamin | Coenzyme | Function | Deficiency |
|---|---|---|---|
| B1 Thiamine | Thiamine pyrophosphate (TPP) | Oxidative decarboxylation; transketolase | Beri-beri, Wernicke encephalopathy |
| B2 Riboflavin | FMN, FAD | Hydrogen transfer (2H) | Angular stomatitis, glossitis |
| B3 Niacin | NAD+, NADP+ | Hydrogen transfer (2 electrons + H+) | Pellagra |
| B5 Pantothenate | Coenzyme A | Acyl group transfer | Burning feet syndrome |
| B6 Pyridoxine | Pyridoxal phosphate (PLP) | Transamination, decarboxylation, ala synthase | Peripheral neuropathy, sideroblastic anaemia, convulsions |
| B7 Biotin | Biocytin | CO2 fixation (carboxylation) | Dermatitis; caused by raw egg white (avidin) |
| B9 Folate | Tetrahydrofolate | One-carbon transfer | Megaloblastic anaemia, neural tube defect |
| B12 Cobalamin | Methylcobalamin, deoxyadenosylcobalamin | Methyl transfer; methylmalonyl-CoA mutase | Megaloblastic anaemia, subacute combined degeneration |
Non-vitamin Coenzymes
- ATP — phosphate and energy transfer
- S-adenosylmethionine (SAM) — the chief methyl donor
- UDP-glucose — glycosyl transfer
- Lipoic acid — acyl transfer in the PDH complex
- Coenzyme Q — electron transfer in the respiratory chain
Applied Aspects
- Isoniazid antagonises pyridoxine → peripheral neuropathy; hence pyridoxine is given prophylactically with antitubercular treatment
- Methotrexate blocks dihydrofolate reductase → folate coenzymes cannot be regenerated; rescued with folinic acid
- Thiamine must be given before glucose in a malnourished or alcoholic patient — a glucose load without thiamine can precipitate Wernicke encephalopathy
- Multiple carboxylase deficiency responds to large doses of biotin
Definition
Isoenzymes (isozymes) = multiple molecular forms of the same enzyme that catalyse the same reaction but differ in amino acid sequence, physical and kinetic properties, and tissue distribution.
- They arise from different genes, different alleles, or different combinations of subunits
- Separated by electrophoresis, differing in charge and mobility
Lactate Dehydrogenase
- A tetramer of two kinds of subunit — H (heart) and M (muscle) → 5 isoenzymes
| Isoenzyme | Subunits | Chief source | Note |
|---|---|---|---|
| LDH-1 | H4 | Heart, RBC, kidney | Rises in myocardial infarction and haemolysis |
| LDH-2 | H3M | Reticuloendothelial system | Normally the highest in serum |
| LDH-3 | H2M2 | Lung | Pulmonary embolism |
| LDH-4 | HM3 | Kidney, placenta | — |
| LDH-5 | M4 | Liver, skeletal muscle | Rises in hepatitis and muscle injury |
CLINICAL PEARL
Flipped pattern — when LDH-1 exceeds LDH-2, suspect myocardial infarction (or haemolysis, or megaloblastic anaemia). Normally LDH-2 is the highest.
Creatine Kinase
| Isoenzyme | Subunits | Source | Clinical use |
|---|---|---|---|
| CK-1 (BB) | BB | Brain | Rarely used |
| CK-2 (MB) | MB | Cardiac muscle | Myocardial infarction; best marker of RE-infarction |
| CK-3 (MM) | MM | Skeletal muscle | Muscular dystrophy, rhabdomyolysis |
Other Important Isoenzymes
- Alkaline phosphatase — liver, bone, intestinal and placental forms; the bone form rises in Paget disease and rickets, the placental form in pregnancy
- Hexokinase and glucokinase — the classic example of isoenzymes with different Km, allowing liver and brain to handle glucose differently
- Amylase — salivary (S) and pancreatic (P) types, distinguishing mumps from pancreatitis
Applied Aspects
- Isoenzyme analysis localises the damaged tissue when the total enzyme is raised but its source is uncertain — the chief diagnostic value
- Macro-enzymes — enzyme bound to immunoglobulin; gives a persistently raised value with no disease, and can cause needless investigation
- Troponin has largely replaced CK-MB and LDH isoenzymes in cardiac diagnosis, but the principle remains examinable and is still used in other tissues
Definition
Allosteric enzymes = regulatory enzymes whose activity is altered by the non-covalent binding of a modulator at a site other than the active site.
- Usually the rate-limiting enzyme of a pathway, catalysing the first committed and irreversible step
Characteristics
- Oligomeric — several subunits, each with an active site and a regulatory (allosteric) site
- Sigmoid (S-shaped) kinetics, not the hyperbola of Michaelis–Menten
- Show co-operativity — binding at one site changes the affinity of the others
- The measure of affinity is K0.5, not Km
- Sensitive to small changes in modulator concentration — the sigmoid shape means a small rise produces a large change in rate
- Modulators may be homotropic (the substrate itself) or heterotropic (a different molecule)
Models of Allosteric Behaviour
| Model | Proposed by | Concept |
|---|---|---|
| Concerted (symmetry) | Monod, Wyman, Changeux | All subunits switch together between a T (tense, low affinity) and R (relaxed, high affinity) state |
| Sequential | Koshland | Subunits change one at a time, each influencing the next |
Important Examples
| Enzyme | Pathway | Positive modulator | Negative modulator |
|---|---|---|---|
| Phosphofructokinase-1 | Glycolysis | Amp, fructose-2,6-bisphosphate | ATP, citrate |
| Aspartate transcarbamoylase | Pyrimidine synthesis | ATP | CTP (feedback) |
| Isocitrate dehydrogenase | TCA cycle | ADP | ATP, NADH |
| HMG-CoA reductase | Cholesterol synthesis | — | Cholesterol |
| Carbamoyl phosphate synthetase I | Urea cycle | N-acetylglutamate | — |
| Acetyl-CoA carboxylase | Fatty acid synthesis | Citrate | Palmitoyl-CoA |
Feedback Inhibition
A → Enzyme 1 (allosteric, rate-limiting) → B → C → End product D → D inhibits Enzyme 1
- Also called end-product or retro-inhibition
- Prevents wasteful overproduction — the commonest physiological control of a pathway
- Acts on the first committed step, so no intermediates accumulate
Applied Aspects
- Haemoglobin is the classic allosteric protein — sigmoid oxygen curve, T and R states, with 2,3-BPG, H+ and CO2 as negative modulators. It is not an enzyme but obeys the same principles
- Allosteric drugs — benzodiazepines act at an allosteric site on the GABAA receptor
- Loss of feedback inhibition underlies some metabolic disease — in acute intermittent porphyria, reduced haem fails to inhibit ala synthase, so precursors accumulate
Definition
Zymogens (proenzymes) = inactive precursors of enzymes, activated by irreversible proteolytic cleavage of one or more peptide bonds.
WHY the Body Uses Zymogens
- Protects the synthesising cell from being digested by its own enzyme
- Allows the enzyme to be stored safely and released in bulk when needed
- Permits activation at the correct site — the gut lumen, not the pancreas
- Gives a rapid, amplifying cascade, as in coagulation and complement
- Activation is irreversible, so control must be exerted by separate inhibitors
Important Examples
| Zymogen | Active enzyme | Activator | Site |
|---|---|---|---|
| Pepsinogen | Pepsin | HCl, then pepsin itself (autocatalysis) | Stomach |
| Trypsinogen | Trypsin | Enterokinase (enteropeptidase), then trypsin | Duodenum |
| Chymotrypsinogen | Chymotrypsin | Trypsin | Duodenum |
| Procarboxypeptidase | Carboxypeptidase | Trypsin | Duodenum |
| Proelastase | Elastase | Trypsin | Duodenum |
| Prothrombin | Thrombin | Prothrombin activator (Xa, Va, Ca2+) | Blood |
| Fibrinogen | Fibrin | Thrombin | Blood |
| Plasminogen | Plasmin | TPA, urokinase, streptokinase | Clot |
| Procollagenase | Collagenase | Proteases | Connective tissue |
CLINICAL PEARL
Trypsin is the master activator of the pancreatic zymogens — it activates chymotrypsinogen, procarboxypeptidase, proelastase and more trypsinogen. Block trypsin and the whole cascade fails.
Protective Mechanisms Against Premature Activation
- Pancreatic secretory trypsin inhibitor (SPINK1) within the acinar cell
- Zymogens stored in membrane-bound granules, separate from lysosomal enzymes
- Enterokinase is confined to the duodenal mucosa, not the pancreas
- The low intracellular calcium of the acinar cell disfavours activation
Applied Aspects
- Acute pancreatitis — the protective mechanisms fail and trypsinogen is activated within the pancreas → autodigestion. Commonest causes are gallstones and alcohol
- Hereditary pancreatitis — a mutation in trypsinogen (PRSS1) makes it resistant to inactivation, or a SPINK1 mutation removes the inhibitor
- α1-antitrypsin is the natural inhibitor of elastase; its deficiency causes panacinar emphysema and cirrhosis
- Thrombolytic therapy exploits the zymogen principle — streptokinase and tPA convert plasminogen to plasmin within the clot
Definition
Michaelis constant (Km) = the substrate concentration at which the reaction velocity is half of Vmax.
- Units are those of concentration (mol/L or mmol/L)
- Derived from the Michaelis–Menten equation: v = Vmax[S] / (Km + [S])
Significance
- Km is inversely related to the affinity of the enzyme for its substrate
– Low Km → high affinity
– High Km → low affinity
- It is a constant for a given enzyme–substrate pair under stated conditions, and is independent of enzyme concentration — unlike Vmax
- When a single enzyme acts on several substrates, the one with the lowest Km is the preferred (physiological) substrate
- It indicates whether an enzyme is operating near saturation at physiological substrate levels
- It is used to identify isoenzymes and to detect inhibitors
Physiological Illustration — Hexokinase VS Glucokinase
| Feature | Hexokinase | Glucokinase |
|---|---|---|
| Km | 0.05 mM (low) | 10 mM (high) |
| Affinity | High | Low |
| Tissue | All tissues, including brain and RBC | Liver and pancreatic β cell |
| Inhibited by G6P | Yes | No |
| Induced by insulin | No | Yes |
| Role | Ensures a constant supply to vital tissues | Removes excess glucose after a meal; acts as the glucose sensor |
CLINICAL PEARL
The consequence: the brain, with its low-Km hexokinase, takes glucose at all times; the liver, with its high-Km glucokinase, takes it only when there is plenty. The brain is therefore never starved by the liver.
Effect of Inhibitors on KM
| Inhibition | Km | Vmax |
|---|---|---|
| Competitive | ↑ | Unchanged |
| Non-competitive | Unchanged | ↓ |
| Uncompetitive | ↓ | ↓ |
Applied Aspects
- MODY-2 — a glucokinase mutation raises its Km so the β cell senses glucose at a higher threshold → mild stable hyperglycaemia
- Alcohol dehydrogenase has a low Km and is saturated at low blood alcohol → ethanol is eliminated at a constant rate (zero order)
- Drug design — a competitive inhibitor is effective only if its affinity exceeds that of the natural substrate
Definition
Competitive inhibition = inhibition in which a substance structurally similar to the substrate competes with it for the active site of the enzyme.
Characteristics
- The inhibitor resembles the substrate (a substrate analogue)
- It binds reversibly to the free enzyme only
- Km is increased; Vmax is unchanged
- Reversed by increasing substrate concentration — the defining feature
- On the Lineweaver–Burk plot the lines meet on the Y-axis
Classical Example
Succinate → fumarate (succinate dehydrogenase) → malonate resembles succinate → Binds the active site → Reaction blocked → Relieved by adding more succinate
Medically Important Examples
| Inhibitor | Enzyme inhibited | Use |
|---|---|---|
| Ethanol | Alcohol dehydrogenase | Antidote in methanol and ethylene glycol poisoning |
| Sulphonamides | Dihydropteroate synthase (competes with PABA) | Antibacterial |
| Methotrexate | Dihydrofolate reductase | Cancer, rheumatoid arthritis, psoriasis |
| Allopurinol | Xanthine oxidase | Gout |
| Statins | HMG-CoA reductase | Hyperlipidaemia |
| Neostigmine, physostigmine | Acetylcholinesterase | Myasthenia gravis, glaucoma |
| Captopril | Angiotensin converting enzyme | Hypertension |
| Dicoumarol | Vitamin K epoxide reductase | Anticoagulant |
Methanol Poisoning — the Principle in Practice
Methanol → Alcohol dehydrogenase → Formaldehyde → formic acid → Severe metabolic acidosis + blindness
- Ethanol has a much higher affinity for alcohol dehydrogenase than methanol does
- Giving ethanol therefore saturates the enzyme, so methanol is excreted unchanged by the kidney and lung
- Fomepizole is the modern alternative, a direct inhibitor of the same enzyme
- Sodium bicarbonate corrects the acidosis; dialysis removes the methanol
Applied Aspects
- Antimetabolites in cancer chemotherapy are almost all competitive inhibitors of enzymes of nucleotide synthesis
- Substrate analogues are the basis of rational drug design — the structure of the natural substrate is the starting point
- Competitive inhibition can be overcome, which is both an advantage (reversible, safer) and a limitation (higher doses may be needed)
Definition
Enzyme specificity = the ability of an enzyme to select and act on one substrate, or one type of bond, in preference to all others.
- It is the property that distinguishes enzymes from chemical catalysts, and arises from the three-dimensional structure of the active site
Types of Specificity
| Type | Meaning | Example |
|---|---|---|
| Absolute (substrate) | Acts on one substrate only | Urease → urea only; lactase → lactose only |
| Group specificity | Acts on a group of related substrates sharing a chemical group | Trypsin — peptide bonds on the carboxyl side of lysine and arginine; chymotrypsin — aromatic amino acids |
| Bond specificity | Acts on a type of bond, whatever the surrounding structure | Lipase → ester bonds; α-amylase → α-1,4 glycosidic bonds |
| Stereospecificity | Acts on one optical or geometric isomer only | L-amino acid oxidase; hexokinase acts on D-glucose but not L-glucose; fumarase acts on the trans isomer only |
Basis of Specificity
- The active site is a three-dimensional cleft whose shape, charge distribution and hydrophobicity complement the substrate
- Lock and key (Fischer) — rigid complementarity
- Induced fit (Koshland) — the site moulds itself around the substrate; the accepted model
- Three-point attachment explains stereospecificity — only one enantiomer can contact all three binding points simultaneously
Advantages of Specificity
- Prevents unwanted side reactions in a cell containing thousands of compounds
- Allows precise regulation of individual pathways
- Makes enzymes valuable as laboratory reagents — glucose oxidase measures glucose without interference from other sugars
- Provides the basis for selective drug action
Applied Aspects
- Glucose oxidase strips for blood glucose depend on absolute specificity; older copper-reduction methods (Benedict) detect any reducing sugar and are therefore positive in galactosaemia and pentosuria too
- Stereospecificity in pharmacology — drug enantiomers may differ entirely in effect; the tragedy of thalidomide is the classical example
- Enzyme replacement therapy works only because the administered enzyme is specific for the accumulated substrate, as in Gaucher disease
- Loss of specificity does not occur — but a mutation altering the active site abolishes activity, which is how most inborn errors arise
- Broad-specificity enzymes have their uses — cytochrome P450 acts on a huge range of drugs, which is why so many drug interactions occur at this site
Definition
Glycolysis (Embden–Meyerhof pathway) = the sequence of reactions converting one molecule of glucose to two molecules of pyruvate, with the net production of ATP.
| Feature | Detail |
|---|---|
| Site | Cytoplasm of all cells |
| Occurs in | Every tissue; the only pathway for energy in RBC, cornea and lens, which have no mitochondria |
| Oxygen | Proceeds with or without oxygen |
| End product | Pyruvate (aerobic) or lactate (anaerobic) |
Reactions
A. Energy investment phase (2 ATP used)
Glucose → Hexokinase / glucokinase — ATP used, irreversible → Glucose-6-phosphate → Phosphohexose isomerase → Fructose-6-phosphate → phosphofructokinase-1 — ATP used, rate-limiting, irreversible → Fructose-1,6-bisphosphate → Aldolase → Glyceraldehyde-3-phosphate + DHAP
- DHAP is converted to G3P by triose phosphate isomerase, so all six carbons continue — hence everything after this point is × 2
B. Energy generation phase (4 ATP made)
Glyceraldehyde-3-phosphate → G3P dehydrogenase — NADH produced; inhibited by iodoacetate → 1,3-bisphosphoglycerate → Phosphoglycerate kinase — ATP made (substrate-level) → 3-phosphoglycerate → Phosphoglycerate mutase → 2-phosphoglycerate → Enolase — inhibited by fluoride → Phosphoenolpyruvate → pyruvate kinase — ATP made, irreversible → pyruvate
The Three Irreversible Steps
| Enzyme | Reaction | Why it matters |
|---|---|---|
| Hexokinase / glucokinase | Glucose → G6P | Traps glucose in the cell; the phosphorylated sugar cannot leave |
| Phosphofructokinase-1 | F6P → F1,6BP | Rate-limiting and the chief control point |
| Pyruvate kinase | PEP → pyruvate | Final committed step |
- These three are bypassed by separate enzymes in gluconeogenesis
Energetics
| Condition | ATP used | ATP made | Net |
|---|---|---|---|
| Anaerobic | 2 | 4 (substrate level) | 2 ATP |
| Aerobic (malate–aspartate shuttle) | 2 | 4 + 2 NADH (× 2.5) = 9 | 7 ATP |
| Aerobic (glycerophosphate shuttle) | 2 | 4 + 2 FADH2 (× 1.5) = 7 | 5 ATP |
| From glycogen | 1 (G1P is already phosphorylated) | 4 | 3 ATP (anaerobic) |
CLINICAL PEARL
Note on values: modern texts use NADH = 2.5 ATP and FADH2 = 1.5 ATP. Older books use 3 and 2, giving 8 ATP aerobically. Quote the modern figures and mention the older ones.
- Substrate-level phosphorylation occurs at two steps — phosphoglycerate kinase and pyruvate kinase. These need no oxygen, which is why RBC survive
Regulation
| Enzyme | Activated by | Inhibited by |
|---|---|---|
| Phosphofructokinase-1 | Amp, ADP, fructose-2,6-bisphosphate | ATP, citrate, H+ (low pH) |
| Hexokinase | — | Glucose-6-phosphate |
| Glucokinase | Insulin (induction) | Glucagon (repression); not inhibited by G6P |
| Pyruvate kinase | Fructose-1,6-bisphosphate, insulin | ATP, alanine, glucagon (phosphorylation) |
- Fructose-2,6-bisphosphate is the most important physiological activator of PFK-1. It is made by PFK-2, which insulin activates and glucagon inactivates — the link between hormone and pathway
- Citrate inhibits PFK-1 — when the TCA cycle is well supplied, glycolysis slows
Fate of Pyruvate
| Condition | Fate | Enzyme |
|---|---|---|
| Aerobic | → Acetyl-CoA → TCA cycle | Pyruvate dehydrogenase complex |
| Anaerobic | → Lactate | Lactate dehydrogenase |
| Fasting | → Oxaloacetate → glucose | Pyruvate carboxylase |
| Transamination | → Alanine | ALT |
- The purpose of forming lactate is to regenerate NAD+, without which glycolysis would stop at the G3P dehydrogenase step
Significance
- The only source of ATP for RBC, cornea, lens and renal medulla
- Provides rapid ATP in exercising muscle when oxygen is limiting
- Provides intermediates — DHAP for glycerol-3-phosphate (triglyceride synthesis), 3-phosphoglycerate for serine
- Supplies 2,3-BPG in the RBC through the Rapoport–Luebering shunt
- It is the common pathway for all dietary hexoses — fructose and galactose enter it
Applied Aspects
- Pyruvate kinase deficiency — the second commonest cause of hereditary non-spherocytic haemolytic anaemia; the RBC cannot make enough ATP for its Na+–K+ pump
- Fluoride inhibits enolase — hence sodium fluoride is added to blood collection tubes for glucose estimation, to stop glycolysis in the sample
- Arsenic poisoning — arsenate substitutes for phosphate at the G3P dehydrogenase step, so glycolysis continues but no ATP is formed
- Warburg effect — tumour cells use aerobic glycolysis even with adequate oxygen; the basis of FDG-pet scanning
- Lactic acidosis — from tissue hypoxia, shock, or metformin overdose
- Hexokinase deficiency — a rare haemolytic anaemia; unlike pyruvate kinase deficiency, 2,3-BPG is low, so the anaemia is poorly tolerated
- Cancer chemotherapy increasingly targets glycolytic enzymes, exploiting the tumour cell's dependence on this pathway
Definition
Tricarboxylic acid (Krebs, citric acid) cycle = the final common oxidative pathway in which the acetyl group of acetyl-CoA is completely oxidised to CO2 and water, with the generation of reducing equivalents.
| Feature | Detail |
|---|---|
| Site | Mitochondrial matrix — except succinate dehydrogenase, which is in the inner membrane |
| Oxygen | Strictly aerobic — it stops without O2, because NADH cannot be reoxidised |
| Absent in | RBC (no mitochondria) |
| Nature | Amphibolic — both catabolic and anabolic |
Reactions
Acetyl-CoA (2C) + Oxaloacetate (4C) → Citrate synthase → Citrate (6C) → Aconitase → Isocitrate → isocitrate dehydrogenase — NADH + CO2; rate-limiting → α-Ketoglutarate (5C) → α-KG dehydrogenase — NADH + CO2 → Succinyl-CoA (4C) → Succinate thiokinase — GTP (substrate-level) → Succinate → Succinate dehydrogenase — FADH2 → Fumarate → Fumarase → Malate → Malate dehydrogenase — NADH → Oxaloacetate regenerated
Energetics
| Product | Number | ATP each | Total |
|---|---|---|---|
| NADH | 3 | 2.5 | 7.5 |
| FADH2 | 1 | 1.5 | 1.5 |
| GTP | 1 | 1 | 1 |
| Total per acetyl-CoA | — | — | 10 ATP |
- 2 CO2 are released per turn — at the isocitrate dehydrogenase and α-KG dehydrogenase steps
- The carbons released are not those of the entering acetyl group; they come from oxaloacetate
- Complete oxidation of one glucose = 32 ATP (glycolysis 7 + 2 PDH × 2.5 = 5 + TCA 2 × 10 = 20). Older texts give 38
Regulation
| Enzyme | Activated by | Inhibited by |
|---|---|---|
| Citrate synthase | ADP | ATP, NADH, succinyl-CoA, citrate |
| Isocitrate dehydrogenase | ADP, Ca2+ | ATP, NADH |
| α-KG dehydrogenase | Ca2+ | NADH, succinyl-CoA, ATP |
- The cycle is governed chiefly by the availability of NAD+ and ADP — that is, by the energy demand of the cell (respiratory control)
- Ca2+ stimulates three enzymes — linking muscle contraction directly to increased ATP production
Amphibolic Role
Catabolic — the final common pathway
- Oxidises acetyl-CoA derived from carbohydrate, fat and protein
Anabolic — intermediates are drawn off
| Intermediate | Used to synthesise |
|---|---|
| Citrate | Fatty acids and cholesterol (exported to cytosol) |
| α-Ketoglutarate | Glutamate, glutamine, proline |
| Succinyl-CoA | Haem (with glycine) |
| Oxaloacetate | Aspartate, pyrimidines, glucose (gluconeogenesis) |
| Malate | Gluconeogenesis |
Anaplerotic Reactions
Anaplerotic ("filling up") reactions = reactions that replenish TCA intermediates withdrawn for biosynthesis. Without them the cycle would grind to a halt.
| Reaction | Enzyme | Significance |
|---|---|---|
| Pyruvate + CO2 → Oxaloacetate | Pyruvate carboxylase (biotin, ATP) | The most important; activated by acetyl-CoA |
| Glutamate → α-Ketoglutarate | Glutamate dehydrogenase / transaminase | Links protein catabolism |
| Aspartate → Oxaloacetate | Transaminase | Links protein catabolism |
| Propionyl-CoA → Succinyl-CoA | Propionyl-CoA carboxylase (biotin, B12) | From odd-chain fatty acids |
CLINICAL PEARL
Acetyl-CoA activates pyruvate carboxylase. When acetyl-CoA accumulates in starvation, oxaloacetate is made to keep the cycle running — and diverted to gluconeogenesis. This single control links fat breakdown to glucose production.
Inhibitors
| Inhibitor | Enzyme blocked |
|---|---|
| Fluoroacetate (rat poison) | Aconitase (as fluorocitrate) |
| Malonate | Succinate dehydrogenase (competitive) |
| Arsenite | α-KG dehydrogenase (binds lipoic acid) |
Applied Aspects
- Fatty acids cannot be converted to glucose — the two carbons entering as acetyl-CoA are lost as CO2, so there is no net gain of oxaloacetate
- Thiamine deficiency blocks the TPP-dependent α-KG dehydrogenase → accumulation of pyruvate and lactate → the neurological and cardiac features of beri-beri
- In starvation and diabetes oxaloacetate is drained into gluconeogenesis, so acetyl-CoA cannot enter the cycle and is diverted to ketone bodies — "fat burns in the flame of carbohydrate"
- Succinate dehydrogenase mutations cause phaeochromocytoma and paraganglioma
- Fluoroacetate poisoning — converted to fluorocitrate, which blocks aconitase; citrate accumulates and the cycle stops
- Isocitrate dehydrogenase (IDH) mutations occur in gliomas and acute myeloid leukaemia and are now therapeutic targets
- The cycle cannot run without oxygen even though it uses none directly — because NADH must be reoxidised by the respiratory chain
Definition
Gluconeogenesis = the synthesis of glucose from non-carbohydrate precursors.
| Feature | Detail |
|---|---|
| Site | Liver (90%) and kidney cortex (10%); the renal share rises to 40% in prolonged starvation |
| Cell location | Mainly cytosol; first step in mitochondria, last in the endoplasmic reticulum |
| When active | Fasting, starvation, prolonged exercise, diabetes |
| Cost | 6 high-energy bonds (4 ATP + 2 GTP) per glucose |
Substrates
| Substrate | Source | Enters as |
|---|---|---|
| Lactate | Muscle and RBC (Cori cycle) | Pyruvate |
| Glucogenic amino acids | Muscle protein breakdown; alanine is the chief one | Pyruvate or TCA intermediates |
| Glycerol | Triglyceride breakdown in adipose tissue | DHAP |
| Propionate | Odd-chain fatty acids | Succinyl-CoA |
CLINICAL PEARL
Fatty acids (even-chain) cannot make glucose. Acetyl-CoA cannot be converted to pyruvate, because the pyruvate dehydrogenase reaction is irreversible. Only glycerol from the triglyceride can.
The Four Key Enzymes — Bypassing Glycolysis
| Glycolytic step (irreversible) | Gluconeogenic bypass | Notes |
|---|---|---|
| Pyruvate kinase (PEP → pyruvate) | 1. Pyruvate carboxylase (pyruvate → OAA)2. PEPCK (OAA → PEP) | Carboxylase is mitochondrial, needs biotin and ATP, activated by acetyl-CoA. PEPCK uses GTP |
| Phosphofructokinase-1 | 3. Fructose-1,6-bisphosphatase | Cytosolic; inhibited by amp and fructose-2,6-bisphosphate |
| Hexokinase / glucokinase | 4. Glucose-6-phosphatase | In the endoplasmic reticulum of liver and kidney only — which is why muscle cannot release free glucose |
The Oxaloacetate Shuttle
Pyruvate enters mitochondrion → Pyruvate carboxylase → Oxaloacetate → OAA cannot cross the inner mitochondrial membrane → Reduced to malate (malate dehydrogenase) → Malate crosses into the cytosol → Re-oxidised to OAA → PEPCK → PEP
- This shuttle also carries NADH into the cytosol, which is needed at the G3P dehydrogenase step of gluconeogenesis
- When lactate is the substrate, NADH is generated in the cytosol already, so aspartate may be used instead of malate
Regulation
| Regulator | Gluconeogenesis | Glycolysis |
|---|---|---|
| Glucagon (fasting) | ↑↑ | ↓ |
| Insulin (fed) | ↓ | ↑ |
| Cortisol | ↑ (induces PEPCK) | ↓ |
| Acetyl-CoA | ↑ (activates pyruvate carboxylase) | ↓ (inhibits PDH) |
| Fructose-2,6-bisphosphate | ↓ | ↑ |
| Amp | ↓ | ↑ |
| ATP, citrate | ↑ | ↓ |
Fructose-2,6-bisphosphate — the master switch
Glucagon → ↑ cAMP → protein kinase A → Phosphorylates the bifunctional enzyme PFK-2 / FBPase-2 → Kinase activity off, phosphatase ON → ↓ Fructose-2,6-bisphosphate → ↓ PFK-1 and ↑ fructose-1,6-bisphosphatase → glycolysis off, gluconeogenesis ON
- This reciprocal control prevents a futile cycle in which glucose would be simultaneously made and broken down, wasting ATP as heat
Significance
- Maintains blood glucose during fasting, once liver glycogen is exhausted after about 18–24 hours
- Supplies the brain (120 g glucose/day) and the RBC, which are obligate glucose users
- Clears lactate produced by muscle and RBC (Cori cycle), preventing acidosis
- Clears glycerol from fat breakdown and propionate
Comparison with Glycolysis
| Feature | Glycolysis | Gluconeogenesis |
|---|---|---|
| Direction | Glucose → pyruvate | Pyruvate → glucose |
| Site | Cytosol, all cells | Liver and kidney only |
| Energy | Yields 2 ATP | Consumes 6 ATP |
| Active in | Fed state | Fasting |
| Hormone | Insulin | Glucagon, cortisol |
| Key enzymes | Hexokinase, PFK-1, pyruvate kinase | Pyruvate carboxylase, PEPCK, F-1,6-BPase, G-6-Pase |
- The two are reciprocally regulated so that they never run at full speed together — that would be a futile cycle, wasting ATP as heat
Applied Aspects
- Von Gierke disease (type I glycogen storage disease) — glucose-6-phosphatase deficiency → neither glycogenolysis nor gluconeogenesis can release glucose → severe fasting hypoglycaemia, lactic acidosis, hyperuricaemia, hepatomegaly
- Alcohol causes hypoglycaemia — its oxidation raises the NADH:NAD+ ratio, driving pyruvate to lactate and oxaloacetate to malate, so both gluconeogenic substrates are depleted. Dangerous in a fasting drinker
- Metformin reduces hepatic gluconeogenesis — its chief action in type 2 diabetes
- Biotin deficiency impairs pyruvate carboxylase and hence gluconeogenesis
- Cortisol excess (Cushing) → excess gluconeogenesis → steroid diabetes
- Hereditary fructose intolerance — aldolase B deficiency; fructose-1-phosphate accumulates and inhibits gluconeogenesis → severe hypoglycaemia after fructose
Normal Values
| State | Plasma glucose |
|---|---|
| Fasting | 70–100 mg/dL |
| 2 hours post-prandial | < 140 mg/dL |
| Random | 80–140 mg/dL |
| Renal threshold | 180 mg/dL |
| Hypoglycaemia | < 70 mg/dL; symptoms below 55 |
- Blood glucose is held within narrow limits because the brain and RBC depend on it absolutely
Sources and Fates of Blood Glucose
| Sources (raise glucose) | Fates (lower glucose) |
|---|---|
| Dietary carbohydrate | Oxidation by tissues (glycolysis → TCA) |
| Glycogenolysis (liver) | Glycogenesis (liver, muscle) |
| Gluconeogenesis (liver, kidney) | Lipogenesis — conversion to fat |
| — | HMP shunt — NADPH and ribose |
| — | Excretion in urine above the renal threshold |
Hormonal Regulation
A. Insulin — the only hypoglycaemic hormone
- Secreted by β cells in response to a rise in blood glucose
- ↑ Glucose uptake by GLUT-4 in muscle and adipose tissue
- ↑ Glycogenesis; ↓ glycogenolysis
- ↓ Gluconeogenesis (represses PEPCK)
- ↑ Glycolysis (induces glucokinase, PFK, pyruvate kinase)
- ↑ Lipogenesis; ↓ lipolysis and ketogenesis
B. The counter-regulatory hormones
| Hormone | Chief action | Speed |
|---|---|---|
| Glucagon | ↑ Hepatic glycogenolysis and gluconeogenesis; the first line of defence | Minutes |
| Adrenaline | ↑ Glycogenolysis in liver and muscle; ↓ insulin release (α2) | Seconds |
| Cortisol | ↑ Gluconeogenesis (induces PEPCK); ↓ peripheral uptake; ↑ proteolysis | Hours |
| Growth hormone | ↓ Peripheral glucose uptake; ↑ lipolysis | Hours |
| Thyroxine | ↑ Absorption and glycogenolysis | Days |
CLINICAL PEARL
Note the asymmetry: only one hormone lowers blood glucose, but four raise it. Hypoglycaemia kills within minutes; hyperglycaemia takes years. The body defends accordingly.
Response in the Fed State
Meal → ↑ Blood glucose → ↑ Insulin, ↓ glucagon → Liver: ↑ glycogenesis, ↑ glycolysis, ↑ lipogenesis → Muscle: ↑ GLUT-4 → ↑ uptake and glycogen → Adipose: ↑ uptake, ↑ triglyceride synthesis → Blood glucose returns to normal in 2 hours
Response in Fasting and Starvation
| Phase | Time | Chief source of glucose |
|---|---|---|
| Fed | 0–4 h | Dietary |
| Post-absorptive | 4–16 h | Hepatic glycogenolysis |
| Early fasting | 16–48 h | Glycogen exhausted → gluconeogenesis |
| Prolonged starvation | > 48 h – weeks | Gluconeogenesis (from muscle protein) + ketone bodies spare glucose |
- Liver glycogen (about 100 g) lasts only 18–24 hours
- Muscle glycogen cannot raise blood glucose — muscle lacks glucose-6-phosphatase; it can only be used locally, or exported as lactate for the Cori cycle
- In prolonged starvation the brain adapts to use ketone bodies, which spares protein and prolongs survival
Glucose Tolerance Test
- 75 g oral glucose after an overnight fast; samples at 0 and 2 hours
- Normal — fasting < 100, 2 h < 140 mg/dL
- Impaired glucose tolerance — 2 h between 140 and 199
- Diabetes — fasting ≥ 126 or 2 h ≥ 200 mg/dL
- Lag storage curve — a high peak with rapid fall; seen after gastrectomy and in hyperthyroidism
Applied Aspects
- Diabetes mellitus — insulin deficiency or resistance → the cells are "starving in the midst of plenty"; unrestrained gluconeogenesis and lipolysis
- Hypoglycaemia — commonest cause is insulin or sulfonylurea therapy. Also insulinoma, alcohol, Addison disease, liver failure
- Whipple triad confirms true hypoglycaemia — symptoms, a low measured glucose, and relief on giving glucose
- HbA1c reflects the average glucose over 8–12 weeks — the standard measure of long-term control
- Dawn phenomenon — early-morning hyperglycaemia from the nocturnal surge of growth hormone and cortisol
- Somogyi effect — nocturnal hypoglycaemia provokes a counter-regulatory surge and rebound morning hyperglycaemia; treated by reducing, not increasing, the evening insulin
- Glycosuria appears above the renal threshold of 180 mg/dL; in pregnancy the threshold falls, giving benign glycosuria
Definition and Importance
The pyruvate dehydrogenase (PDH) complex catalyses the oxidative decarboxylation of pyruvate to acetyl-CoA.
Pyruvate + CoA-SH + NAD+ → Acetyl-CoA + CO2 + NADH + H+
- Site — mitochondrial matrix
- It is irreversible — the single most important consequence being that fatty acids can never be converted to glucose
- It is the gateway linking glycolysis to the TCA cycle
Components
| Enzyme | Abbreviation | Coenzyme | Vitamin |
|---|---|---|---|
| Pyruvate dehydrogenase | E1 | Thiamine pyrophosphate (TPP) | B1 |
| Dihydrolipoyl transacetylase | E2 | Lipoamide and Coenzyme A | — and B5 |
| Dihydrolipoyl dehydrogenase | E3 | FAD and NAD+ | B2 and B3 |
CLINICAL PEARL
Five coenzymes, four vitamins. Mnemonic for the coenzymes: "Tender Loving Care For Nancy" — TPP, Lipoamide, CoA, FAD, NAD+. Note that TPP, lipoamide and FAD are prosthetic groups (bound), while CoA and NAD+ are freely diffusible.
Steps
Decarboxylation — pyruvate + TPP → hydroxyethyl-TPP + CO2 → Oxidation — transferred to lipoamide as acetyl group → Transfer — acetyl group to CoA → acetyl-CoA → Reoxidation — reduced lipoamide → FAD → FADH2 → NAD+ → NADH
Regulation
A. Covalent modification — the chief mechanism
| Enzyme | Effect | Stimulated by |
|---|---|---|
| PDH kinase | Phosphorylates → PDH inactive | ATP, NADH, acetyl-CoA (all signs of plenty) |
| PDH phosphatase | Dephosphorylates → PDH active | Ca2+, insulin, Mg2+ |
B. Product inhibition
- Acetyl-CoA and NADH inhibit the complex directly
- This is why β-oxidation of fatty acids switches off PDH — it floods the cell with acetyl-CoA and NADH, sparing glucose
Metabolic Significance
- Commits carbohydrate carbon irreversibly to oxidation or fat synthesis
- Its irreversibility is why acetyl-CoA is not glucogenic
- Ca2+ activation couples muscle contraction to fuel oxidation
- In the fed state insulin activates it → glucose is oxidised or converted to fat
- In fasting it is switched off → pyruvate is diverted to gluconeogenesis instead of being wasted
Related Complexes
- α-Ketoglutarate dehydrogenase of the TCA cycle and the branched-chain α-keto acid dehydrogenase use the same five coenzymes and the same mechanism
- Hence thiamine deficiency affects all three, and arsenite inhibits all three by binding lipoamide
Energetics and Position in Metabolism
| Point | Detail |
|---|---|
| Yield | 1 NADH = 2.5 ATP per pyruvate; 5 ATP per glucose |
| Carbon balance | 3C pyruvate → 2C acetyl group + 1 CO2 |
| ΔG | Strongly negative → irreversible |
| Links | Glycolysis (cytosol) to the TCA cycle (mitochondrion) |
| Entry of pyruvate | Via the mitochondrial pyruvate carrier |
- It is the only route by which carbohydrate carbon can enter the TCA cycle
- Because it is irreversible, carbohydrate can make fat but fat cannot make carbohydrate — one of the most consequential facts in metabolism
Fate of Acetyl-coa
| Fate | Pathway | When |
|---|---|---|
| Complete oxidation | TCA cycle → CO2 + ATP | Energy is needed |
| Fatty acid synthesis | Via citrate shuttle to the cytosol | Fed state, energy surplus |
| Cholesterol synthesis | HMG-CoA reductase pathway | Fed state |
| Ketone bodies | HMG-CoA synthase pathway in liver mitochondria | Starvation, uncontrolled diabetes |
| Acetylcholine | With choline, in nerve terminals | Always |
| Acetylation reactions | Drug metabolism, histone acetylation | Always |
- Acetyl-CoA is the central junction of metabolism — every major fuel converges on it, and several biosynthetic routes leave from it
Applied Aspects
- Thiamine deficiency → PDH cannot function → pyruvate and lactate accumulate → lactic acidosis, and the brain is deprived of acetyl-CoA. This underlies Wernicke encephalopathy and beri-beri
- Give thiamine before glucose in an alcoholic or malnourished patient — a glucose load consumes the last thiamine and can precipitate Wernicke encephalopathy
- PDH deficiency (inherited) — congenital lactic acidosis with neurological damage; treated with a ketogenic diet, which bypasses the block
- Arsenic poisoning — arsenite binds the sulphydryl groups of lipoamide → inhibits PDH; treated with BAL (dimercaprol)
- Dichloroacetate inhibits PDH kinase, keeping the complex active; used experimentally in congenital lactic acidosis
- Leigh syndrome — a mitochondrial encephalopathy in which PDH deficiency is one recognised cause
Definition
Cori cycle (lactic acid cycle) = the cycle in which lactate produced by anaerobic glycolysis in muscle and RBC is carried to the liver, converted back to glucose, and returned to those tissues.
The Cycle
Muscle / RBC: glucose → 2 lactate (2 ATP gained) → Lactate enters blood → liver → Lactate → pyruvate → gluconeogenesis (6 ATP spent) → Glucose released into blood → Returns to muscle and RBC
Energetics
| Tissue | ATP change | Comment |
|---|---|---|
| Muscle / RBC | +2 ATP gained | Rapid, oxygen independent |
| Liver | −6 ATP spent | Uses ATP from fatty acid oxidation |
| Net for the body | −4 ATP | A deliberate, useful loss |
CLINICAL PEARL
The cycle costs the body energy, and that is the point. It shifts the metabolic burden from muscle, which needs ATP urgently, to the liver, which has plenty from fat oxidation. It also clears lactate that would otherwise cause acidosis.
Significance
- Prevents lactic acidosis by removing lactate from the blood
- Allows muscle to continue working anaerobically during intense exercise
- Salvages carbon that would otherwise be lost
- Supplies glucose to RBC, which produce lactate continuously since they have no mitochondria
- Accounts for a significant part of the oxygen debt after exercise
The Glucose–alanine Cycle (compare)
Muscle: pyruvate + amino group → alanine (transamination) → Alanine to liver → Liver: alanine → pyruvate + NH3 → Pyruvate → glucose; NH3 → urea → Glucose returns to muscle
- Carries both carbon and nitrogen to the liver, whereas the Cori cycle carries carbon only
- Prominent in starvation, when muscle protein is being broken down
Applied Aspects
- Lactic acidosis results when lactate production exceeds hepatic clearance — in shock, hypoxia, sepsis, and in liver failure, where the cycle itself fails
- Metformin inhibits hepatic gluconeogenesis and so impairs lactate clearance → contraindicated in renal and hepatic failure
- Serum lactate is a marker of tissue hypoperfusion and is used to gauge the severity of shock and the response to resuscitation
- The cycle is named after Carl and Gerty Cori, who received the Nobel Prize in 1947
- In prolonged starvation the glucose–alanine cycle predominates, because muscle protein rather than glycogen is being consumed
Definition
Rapoport–Luebering shunt = a bypass of the phosphoglycerate kinase step of glycolysis, occurring in the red blood cell, which generates 2,3-bisphosphoglycerate (2,3-BPG).
The Pathway
1,3-bisphosphoglycerate → Bisphosphoglycerate mutase → 2,3-bisphosphoglycerate → 2,3-BPG phosphatase → 3-phosphoglycerate → Rejoins glycolysis
- The ATP normally made at the phosphoglycerate kinase step is sacrificed — the shunt yields no ATP
- About 15–25% of glycolytic flux in the RBC takes this route
- RBC 2,3-BPG concentration is high — roughly equimolar with haemoglobin (about 5 mmol/L)
Function of 2,3-BPG
- Binds to the central cavity of deoxyhaemoglobin, between the two β chains
- Stabilises the T (tense, low affinity) state
- Shifts the oxygen dissociation curve to the right → ↑ P50 → oxygen is unloaded more readily to the tissues
- Without 2,3-BPG, haemoglobin would bind oxygen so tightly that little would be released
Conditions Altering 2,3-BPG
| ↑ 2,3-BPG (curve shifts right) | ↓ 2,3-BPG (curve shifts left) |
|---|---|
| High altitude | Stored (banked) blood |
| Chronic anaemia | Acidosis |
| Chronic hypoxia, COPD, cyanotic heart disease | Hypophosphataemia |
| Alkalosis | Hexokinase deficiency |
| Pyruvate kinase deficiency | Septic shock |
| Thyroxine, growth hormone, androgens | — |
CLINICAL PEARL
HbF binds 2,3-BPG poorly, because its γ chains lack the histidine residues needed. This is why fetal haemoglobin has a higher oxygen affinity and can extract oxygen from maternal blood.
Applied Aspects
- Stored blood loses 2,3-BPG within 1–2 weeks → the transfused cells hold oxygen tightly and release it poorly. Levels recover in 12–24 hours in the recipient. This matters in massive transfusion
- CPD-A anticoagulant contains adenine and dextrose partly to preserve 2,3-BPG and ATP
- Pyruvate kinase deficiency — the block is after the shunt, so 2,3-BPG accumulates → better tissue oxygenation → the anaemia is better tolerated than its severity suggests
- Adaptation to altitude — a rise in 2,3-BPG within hours is one of the earliest compensations
Definition
Substrate-level phosphorylation = the formation of ATP (or GTP) by the direct transfer of a high-energy phosphate group from a substrate to ADP, without involving the electron transport chain.
- Contrast with oxidative phosphorylation, which requires the respiratory chain and oxygen
The Reactions
| Reaction | Enzyme | Pathway | Product |
|---|---|---|---|
| 1,3-BPG → 3-phosphoglycerate | Phosphoglycerate kinase | Glycolysis | ATP |
| PEP → pyruvate | Pyruvate kinase | Glycolysis | ATP |
| Succinyl-CoA → succinate | Succinate thiokinase | TCA cycle | GTP |
| Creatine phosphate + ADP | Creatine kinase | Muscle | ATP |
Comparison with Oxidative Phosphorylation
| Feature | Substrate-level | Oxidative |
|---|---|---|
| Oxygen required | NO | Yes |
| Site | Cytosol and mitochondrial matrix | Inner mitochondrial membrane |
| Mechanism | Direct phosphate transfer | Chemiosmotic — proton gradient |
| Yield | Small (4 ATP per glucose) | Large (about 28 ATP per glucose) |
| Uncouplers | Not affected | Abolished |
| Occurs in RBC | Yes — the only source | No |
Significance
- The sole source of ATP for tissues without mitochondria — RBC, cornea, lens
- Provides rapid ATP in exercising muscle when oxygen delivery lags behind demand
- Sustains cells during hypoxia and ischaemia, buying time before irreversible injury
- Continues when the respiratory chain is poisoned — the reason a cyanide-poisoned patient does not die instantly
Applied Aspects
- Iodoacetate blocks glyceraldehyde-3-phosphate dehydrogenase → abolishes both substrate-level phosphorylations of glycolysis
- Arsenate substitutes for inorganic phosphate at the same step, forming an unstable arseno-compound → glycolysis proceeds but yields no ATP. This is "uncoupling at substrate level"
- Fluoride inhibits enolase → blocks the pyruvate kinase step; used to preserve glucose in blood samples
- Creatine phosphate is the immediate ATP buffer of muscle, supplying energy for the first 5–8 seconds of maximal effort
Definition
Anaplerotic reactions ("filling up" reactions) = reactions that replenish the intermediates of the TCA cycle that have been withdrawn for biosynthesis.
WHY They Are Needed
- The TCA cycle is amphibolic — its intermediates are constantly drawn off:
– Citrate → fatty acids and cholesterol
– α-Ketoglutarate → glutamate
– Succinyl-CoA → haem
– Oxaloacetate → aspartate and glucose
- Since the intermediates act catalytically, even a small loss would halt the cycle unless replaced
The Reactions
| Reaction | Enzyme | Requirements | Importance |
|---|---|---|---|
| Pyruvate + CO2 → Oxaloacetate | Pyruvate carboxylase | Biotin, ATP; activated by acetyl-CoA | The most important |
| Glutamate → α-Ketoglutarate | Glutamate dehydrogenase; transaminases | NAD(P)+ | Links amino acid catabolism |
| Aspartate → Oxaloacetate | Ast (transaminase) | Pyridoxal phosphate | Common |
| Propionyl-CoA → Succinyl-CoA | Propionyl-CoA carboxylase, then mutase | Biotin and vitamin B12 | From odd-chain fatty acids and some amino acids |
| Glutamine → Glutamate → α-KG | Glutaminase | — | Important in kidney |
Pyruvate Carboxylase — the Key Regulator
Fasting → ↑ fatty acid oxidation → ↑ Acetyl-CoA → Activates pyruvate carboxylase → ↑ Oxaloacetate → If energy is needed → runs the TCA cycle → If glucose is needed → diverted to gluconeogenesis
- Note the logic — the very molecule that signals abundant fat oxidation is the one that ensures enough oxaloacetate is available
- Acetyl-CoA therefore cannot make glucose itself, but it drives the machinery that does
Applied Aspects
- In starvation and uncontrolled diabetes, oxaloacetate is drained into gluconeogenesis. Acetyl-CoA from fat cannot then enter the cycle and is diverted to ketone bodies. Hence the saying "fat burns in the flame of carbohydrate"
- Biotin deficiency impairs pyruvate carboxylase → hypoglycaemia and lactic acidosis; caused by prolonged raw egg white ingestion (avidin)
- Vitamin B12 deficiency blocks methylmalonyl-CoA mutase → methylmalonic acid accumulates — a sensitive early marker of deficiency, and the cause of the neurological damage
- Pyruvate carboxylase deficiency — lactic acidosis, hypoglycaemia and severe neurological impairment
Definition
Glycogen storage diseases (glycogenoses) = inherited disorders of enzymes of glycogen synthesis or breakdown, causing abnormal quantity or structure of glycogen in tissues.
- All are autosomal recessive except type VIII (X-linked)
- The liver types cause hypoglycaemia and hepatomegaly; the muscle types cause exercise intolerance and cramps
The Important Types
| Type | Name | Enzyme deficient | Chief features |
|---|---|---|---|
| I | Von Gierke | Glucose-6-phosphatase | Severe fasting hypoglycaemia, hepatomegaly, lactic acidosis, hyperuricaemia, hyperlipidaemia, doll-like face |
| II | Pompe | Lysosomal α-1,4-glucosidase (acid maltase) | Cardiomegaly and heart failure, hypotonia, death in infancy. The only lysosomal one |
| III | Cori / Forbes | Debranching enzyme | Milder Von Gierke; abnormal glycogen with short outer branches |
| IV | Andersen | Branching enzyme | Cirrhosis and liver failure; long unbranched chains |
| V | McArdle | Muscle phosphorylase | Exercise intolerance, cramps, myoglobinuria; NO rise in blood lactate on exercise; second-wind phenomenon |
| VI | Hers | Liver phosphorylase | Mild hepatomegaly, mild hypoglycaemia |
WHY Type I Is So Severe
Glucose-6-phosphatase absent → Neither glycogenolysis nor gluconeogenesis can release free glucose → Severe fasting hypoglycaemia → G6P accumulates → diverted to glycolysis → lactic acidosis → and to the HMP shunt → ribose → hyperuricaemia → and to lipogenesis → hyperlipidaemia
- It is the only enzyme common to the final step of both pathways — hence the severity
Diagnosis
- Blood glucose, lactate, uric acid and lipids during fasting
- Glucagon stimulation test — no rise in blood glucose in types I, III and VI
- Ischaemic exercise test — no rise in venous lactate in McArdle disease; the classical bedside test
- Enzyme assay on liver or muscle biopsy; genetic testing
Applied Aspects
- Treatment of the liver forms — frequent small feeds, uncooked cornstarch overnight as a slow-release glucose source, avoiding fasting
- McArdle disease — moderate exercise with the "second wind" as fatty acids take over; avoid intense exertion, which risks rhabdomyolysis and renal failure
- Pompe disease is treated with enzyme replacement therapy (alglucosidase alfa) — one of the few glycogenoses with a specific treatment
- These conditions illustrate that a single enzyme defect can be traced logically to every clinical feature
Definition
Lactic acidosis = metabolic acidosis with a raised anion gap caused by accumulation of lactic acid, with blood lactate above 5 mmol/L and pH below 7.35.
- Normal blood lactate is 0.5–2 mmol/L
Biochemical Basis
Tissue hypoxia or a metabolic block → Pyruvate cannot enter the TCA cycle → NADH accumulates — cannot be reoxidised → Lactate dehydrogenase: pyruvate + NADH → lactate + NAD+ → Regenerates NAD+ so glycolysis can continue → Lactate accumulates
- Lactate formation is therefore protective in the short term — it allows glycolysis and hence ATP production to continue without oxygen
Classification
| Type | Mechanism | Causes |
|---|---|---|
| Type A | Tissue hypoxia — the common form | Shock (any kind), severe anaemia, cardiac arrest, severe hypoxaemia, carbon monoxide poisoning |
| Type B | No hypoxia — impaired metabolism | B1 — diabetes, liver failure, sepsis, malignancyB2 — metformin, ethanol, methanol, salicylate, antiretrovirals, cyanideB3 — inborn errors: PDH deficiency, pyruvate carboxylase deficiency, Von Gierke disease, mitochondrial disease |
Contribution of Specific Blocks
| Defect | Why lactate rises |
|---|---|
| Thiamine deficiency | PDH and α-KG dehydrogenase need TPP → pyruvate accumulates |
| Alcohol | ↑ NADH:NAD+ ratio drives pyruvate to lactate |
| Metformin | Inhibits hepatic gluconeogenesis → lactate is not cleared |
| Cyanide, CO | Block the respiratory chain → NADH cannot be reoxidised |
| Liver failure | The Cori cycle fails — lactate cannot be converted back to glucose |
Clinical Features and Diagnosis
- Kussmaul breathing (deep sighing respiration), tachycardia, hypotension, confusion
- Raised anion gap = Na+ − (Cl− + HCO3−); normal 8–16 mEq/L
- Arterial blood gas — low pH, low bicarbonate, compensatory low PCO2
- Blood lactate is the confirmatory test
Applied Aspects
- Treat the cause, not the number — restore tissue perfusion and oxygenation; bicarbonate is reserved for severe acidosis and is controversial
- Metformin is contraindicated in renal impairment, and withheld before contrast studies and surgery
- Lactate clearance is used to judge the adequacy of resuscitation in sepsis and shock — a falling lactate is a good prognostic sign
- D-lactic acidosis — a rare form from bacterial fermentation in short bowel syndrome; not detected by the standard L-lactate assay
Definition
Glucose transporters (GLUT) = a family of membrane proteins that carry glucose across cell membranes by facilitated diffusion — down its concentration gradient, without ATP.
- Distinct from the SGLT family, which perform secondary active transport coupled to sodium
The Glut Family
| Transporter | Site | Km | Special feature |
|---|---|---|---|
| GLUT-1 | Brain, RBC, placenta, blood–brain barrier | Low (1 mM) | Basal uptake; ensures a constant supply to the brain |
| GLUT-2 | Liver, pancreatic β cell, kidney, intestine | High (15–20 mM) | Bidirectional; acts as the glucose sensor of the β cell with glucokinase |
| GLUT-3 | Neurones, placenta | Very low (1 mM) | Highest affinity — neurones get priority |
| GLUT-4 | Skeletal muscle, cardiac muscle, adipose tissue | Low (5 mM) | The insulin-dependent one |
| GLUT-5 | Intestine, testis | — | Fructose transporter, not glucose |
Glut-4 and Insulin Action
Insulin binds its receptor → Tyrosine kinase → IRS-1 → PI3-kinase → GLUT-4 vesicles translocate to the cell membrane → ↑ Number of transporters on the surface → ↑ Glucose uptake into muscle and fat
- Insulin increases uptake 10–40 fold in these tissues
- Exercise also recruits GLUT-4, independently of insulin, through AMPK — the biochemical reason exercise lowers blood glucose in diabetes
CLINICAL PEARL
Brain, liver, RBC and kidney take up glucose without insulin. This is why the brain is spared in diabetes but is the first organ to suffer in hypoglycaemia, and why insulin deficiency causes hyperglycaemia while the brain still functions.
SGLT — Active Transport
| Transporter | Site | Function |
|---|---|---|
| SGLT-1 | Intestinal mucosa, renal PCT (S3) | Absorbs glucose against its gradient, coupled to Na+. The basis of oral rehydration solution |
| SGLT-2 | Renal PCT (S1, S2) | Reabsorbs 90% of filtered glucose |
Applied Aspects
- SGLT-2 inhibitors (dapagliflozin, empagliflozin) deliberately block renal glucose reabsorption → glycosuria → lower blood glucose independently of insulin; they also reduce cardiovascular and renal events
- ORS works because SGLT-1 remains intact in cholera — glucose must be present for sodium and therefore water to be absorbed. A purely saline solution would not work
- GLUT-1 deficiency syndrome — impaired glucose transport across the blood–brain barrier → infantile seizures and developmental delay; treated with a ketogenic diet, since ketones use a different transporter
- GLUT-4 dysfunction is central to the insulin resistance of type 2 diabetes and obesity
- Fanconi–Bickel syndrome — GLUT-2 defect → hepatomegaly with a renal tubular defect
- Fructose malabsorption follows a GLUT-5 defect → osmotic diarrhoea and bloating after fruit or sweetened drinks
Introduction
Glycogen = the storage polysaccharide of animals; a highly branched polymer of glucose with α-1,4 linkages in the chains and α-1,6 linkages at the branch points, one every 8–12 residues.
| Site | Amount | Purpose |
|---|---|---|
| Liver | 100 g (6–8% of wet weight) | Maintains blood glucose for the whole body |
| Muscle | 400 g (1–2%) | Local energy only — muscle lacks glucose-6-phosphatase |
- Branching gives many non-reducing ends, so synthesis and breakdown can proceed rapidly at many points at once, and increases solubility
Glycogenesis (synthesis)
Glucose → Hexokinase / glucokinase → Glucose-6-phosphate → Phosphoglucomutase → Glucose-1-phosphate → UDP-glucose pyrophosphorylase + UTP → UDP-glucose (the active donor) → glycogen synthase — adds α-1,4 — rate-limiting → Branching enzyme — transfers a block of 6–8 residues to make an α-1,6 branch
- Glycogenin is the primer — a protein that autoglucosylates itself to start the chain; glycogen synthase cannot begin from nothing
- 2 high-energy bonds are used per glucose added (one ATP, one UTP)
- The branching enzyme is amylo-(1,4→1,6)-transglucosidase
Glycogenolysis (breakdown)
Glycogen → glycogen phosphorylase — needs pyridoxal phosphate; rate-limiting → Cleaves α-1,4 bonds by phosphorolysis, stopping 4 residues from a branch → limit dextrin → debranching enzyme — two activities in one protein → Glucose-1-phosphate (about 90%) + free glucose (about 10%) → G1P → G6P → glucose (liver) or glycolysis (muscle)
- Debranching enzyme has two activities — a 4:4 transferase that moves three residues, and an α-1,6-glucosidase that releases the branch point as free glucose
- Phosphorolysis, not hydrolysis — the product is already phosphorylated, saving one ATP
- Only the liver can release free glucose into the blood, because only it (and the kidney) has glucose-6-phosphatase
Regulation
A. Hormonal — covalent modification
Glucagon (liver) / Adrenaline (liver and muscle) → ↑ cAMP → Protein kinase A → Phosphorylates phosphorylase kinase → Which phosphorylates glycogen phosphorylase → phosphorylase active (a form) and synthase inactive → glycogen broken down
| Enzyme | Phosphorylated | Dephosphorylated |
|---|---|---|
| Glycogen phosphorylase | Active (a) | Inactive (b) |
| Glycogen synthase | Inactive (b) | Active (a) |
- One signal switches both enzymes in opposite directions — the cell can never synthesise and degrade glycogen at the same time
- Insulin activates protein phosphatase-1, which dephosphorylates both and so promotes storage
- The cascade gives enormous amplification — a few hormone molecules mobilise millions of glucose units
B. Allosteric
| Regulator | Tissue | Effect |
|---|---|---|
| Amp | Muscle | Activates phosphorylase b directly |
| ATP, glucose-6-phosphate | Muscle | Inhibit phosphorylase; activate synthase |
| Ca2+ | Muscle | Activates phosphorylase kinase through calmodulin — links contraction to fuel supply |
| Glucose | Liver | Binds phosphorylase a and promotes its inactivation — the liver stops breaking down glycogen when blood glucose is adequate |
Differences Between Liver and Muscle Glycogen
| Feature | Liver | Muscle |
|---|---|---|
| Amount | 100 g (higher concentration) | 400 g (larger total mass) |
| Purpose | Blood glucose homeostasis | Own energy during contraction |
| Glucose-6-phosphatase | Present | Absent |
| Releases free glucose | Yes | NO |
| Glucagon receptor | Present | Absent — muscle responds only to adrenaline |
| Ca2+ regulation | Minor | Important |
| Depleted by | Fasting (18–24 h) | Exercise |
CLINICAL PEARL
Muscle glycogen cannot raise blood glucose. The best it can do is release lactate, which the liver converts back to glucose through the Cori cycle. This is a favourite examination point.
Energetics and Efficiency
| Point | Detail |
|---|---|
| Cost of storage | 2 high-energy bonds per glucose added (ATP + UTP) |
| Recovery on breakdown | 90% released as glucose-1-phosphate, already phosphorylated |
| Net saving | Glycogen-derived glucose yields 3 ATP anaerobically instead of 2 |
| Why not store glucose itself? | Free glucose at the same energy content would create an impossible osmotic load; the polymer is osmotically inert |
| Why branched? | Many non-reducing ends allow rapid mobilisation; also more soluble |
- Glycogen is a compromise — less energy-dense than fat, but it can be mobilised within seconds and used without oxygen
- Fat cannot replace it for sudden demand or for anaerobic work
Applied Aspects
- Glycogen storage diseases — Von Gierke (glucose-6-phosphatase), Pompe (lysosomal α-glucosidase), Cori (debranching), Andersen (branching), McArdle (muscle phosphorylase), Hers (liver phosphorylase)
- Carbohydrate loading before endurance events raises muscle glycogen and delays fatigue — a direct application of this pathway
- Liver glycogen lasts only 18–24 hours of fasting; thereafter gluconeogenesis takes over
- Vitamin B6 deficiency impairs phosphorylase — glycogen phosphorylase holds the largest single store of pyridoxal phosphate in the body
- Adrenaline raises blood glucose in seconds, which is why it is part of the fight-or-flight response and why hypoglycaemia causes tremor and palpitations
Definition
Hexose monophosphate shunt (pentose phosphate pathway, Warburg–Dickens pathway) = an alternative route of glucose-6-phosphate oxidation that generates NADPH and ribose-5-phosphate.
| Feature | Detail |
|---|---|
| Site (cell) | Cytosol |
| Site (tissue) | Liver, adipose tissue, adrenal cortex, gonads, RBC, lactating mammary gland |
| Oxygen | Not required |
| ATP | No ATP produced or consumed |
| Share of glucose | About 10%, but far more in the above tissues |
- The tissues listed all have either active lipid synthesis or a high oxidative stress load — which is exactly what NADPH is needed for
The Two Phases
A. Oxidative (irreversible) phase
Glucose-6-phosphate → glucose-6-phosphate dehydrogenase (G6PD) — rate-limiting; NADPH produced → 6-Phosphogluconolactone → Lactonase → 6-Phosphogluconate → 6-Phosphogluconate dehydrogenase — NADPH + CO2 → ribulose-5-phosphate
- 2 NADPH are produced per glucose-6-phosphate
- G6PD is regulated by the NADP+:NADPH ratio — NADPH inhibits it, so the pathway runs only when NADPH is being consumed
B. Non-oxidative (reversible) phase
- Ribulose-5-phosphate is converted to ribose-5-phosphate (isomerase) or xylulose-5-phosphate (epimerase)
- Transketolase transfers 2-carbon units; requires thiamine pyrophosphate
- Transaldolase transfers 3-carbon units; no coenzyme
- These interconvert sugars of 3, 4, 5, 6 and 7 carbons, ultimately yielding fructose-6-phosphate and glyceraldehyde-3-phosphate, which rejoin glycolysis
- Because it is reversible, the cell can make ribose without making NADPH, or the reverse, according to need
Functions of Nadph
| Function | Where | Significance |
|---|---|---|
| Reductive biosynthesis | Liver, adipose tissue, lactating breast | Fatty acid and cholesterol synthesis |
| Steroid hormone synthesis | Adrenal cortex, gonads | Hydroxylation reactions |
| Glutathione reduction | RBC and all cells | Glutathione reductase → protects against oxidative damage |
| Respiratory burst | Neutrophils, macrophages | NADPH oxidase makes superoxide to kill bacteria |
| Cytochrome P450 | Liver microsomes | Drug metabolism, detoxification |
| Nitric oxide synthase | Endothelium | Vasodilatation |
| Methaemoglobin reduction | RBC | Via methaemoglobin reductase |
CLINICAL PEARL
NADPH and NADH are not interchangeable. NADH is made in catabolism and used to make ATP; NADPH is made in the HMP shunt and used for reductive synthesis and antioxidant defence. The single extra phosphate lets enzymes tell them apart.
Functions of Ribose-5-phosphate
- Synthesis of nucleotides — ATP, GTP, NAD, FAD, CoA
- Synthesis of DNA and RNA (as deoxyribose, via ribonucleotide reductase)
- Essential in rapidly dividing tissues — bone marrow, gut mucosa, tumours
Significance in the Red Blood Cell
RBC constantly exposed to oxygen → free radicals → Glutathione peroxidase destroys H2O2, becoming GSSG → Glutathione reductase needs NADPH to regenerate GSH → NADPH comes only from the HMP shunt in the RBC → Without it: haemoglobin and membrane proteins oxidised → Heinz bodies → haemolysis
- The RBC has no other source of NADPH, having no mitochondria and no malic enzyme activity of consequence — which is why G6PD deficiency shows itself there first
Regulation and Interaction with Other Pathways
| Cellular need | Pathway response |
|---|---|
| NADPH only (adipose tissue) | Oxidative phase runs; pentoses recycled to fructose-6-phosphate and returned to glycolysis |
| Ribose only (dividing cells) | Non-oxidative phase runs in reverse from glycolytic intermediates — no NADPH made |
| Both (most tissues) | Oxidative phase alone suffices |
| NADPH and ATP | Pentoses converted to pyruvate through glycolysis |
- The reversibility of the non-oxidative phase is what makes this flexibility possible — the cell is never forced to make one product to obtain the other
- G6PD is the control point, governed by the NADP+:NADPH ratio rather than by hormones
- Insulin induces G6PD in the fed state, linking the shunt to lipogenesis
Applied Aspects
- G6PD deficiency — the commonest enzymopathy in the world, affecting about 400 million people; X-linked; acute haemolysis on exposure to oxidant drugs, fava beans or infection
- Chronic granulomatous disease — defective NADPH oxidase → neutrophils engulf but cannot kill catalase-positive organisms → recurrent abscesses. Diagnosed by the NBT or DHR test
- Thiamine deficiency impairs transketolase — the basis of the erythrocyte transketolase activity test for thiamine status
- Wernicke–Korsakoff syndrome is associated with a transketolase variant of low thiamine affinity in some patients
- Tumours up-regulate the HMP shunt for both NADPH and ribose — a target for anticancer drugs
- Adrenal cortex and gonads have very high shunt activity — steroid hydroxylations consume NADPH heavily
- The lactating mammary gland runs the pathway hard to supply NADPH for milk fat synthesis
- Ribose-5-phosphate for nucleotide synthesis makes the pathway essential in bone marrow and any regenerating tissue
- Sepsis and chronic infection deplete NADPH through the respiratory burst, which can unmask borderline G6PD deficiency
Definition
Diabetes mellitus = a group of metabolic disorders characterised by chronic hyperglycaemia resulting from defects in insulin secretion, insulin action, or both.
Classification
| Type | Mechanism | Features |
|---|---|---|
| Type 1 | Autoimmune destruction of β cells → absolute insulin deficiency | Young, lean, ketosis-prone, needs insulin; anti-GAD and islet cell antibodies; HLA-DR3/DR4 |
| Type 2 | Insulin resistance with relative deficiency | Older, obese, strong family history, ketosis-resistant; 90–95% of cases |
| Gestational | Insulin resistance of pregnancy | Onset in pregnancy; risk of macrosomia; later type 2 risk |
| MODY | Single gene defect, autosomal dominant | MODY-2 is a glucokinase mutation; young, non-obese, no antibodies |
| Secondary | Other disease or drugs | Pancreatitis, Cushing, acromegaly, phaeochromocytoma, steroids, thiazides |
Diagnostic Criteria
| Test | Normal | Prediabetes | Diabetes |
|---|---|---|---|
| Fasting plasma glucose | < 100 mg/dL | 100–125 (impaired fasting glucose) | ≥ 126 mg/dL |
| 2-h plasma glucose (75 g OGTT) | < 140 mg/dL | 140–199 (impaired glucose tolerance) | ≥ 200 mg/dL |
| HbA1c | < 5.7% | 5.7–6.4% | ≥ 6.5% |
| Random glucose | — | — | ≥ 200 mg/dL with classical symptoms |
- A result must be confirmed on a second occasion unless the patient has unequivocal hyperglycaemia with symptoms
Metabolic Changes — the Consequences of Insulin Lack
| Metabolism | Change | Result |
|---|---|---|
| Carbohydrate | ↓ Uptake (GLUT-4), ↓ glycogenesis, ↑↑ gluconeogenesis, ↑ glycogenolysis | Hyperglycaemia |
| Lipid | ↑↑ Lipolysis (hormone-sensitive lipase unopposed), ↓ lipogenesis, ↓ lipoprotein lipase | ↑ Free fatty acids, ketosis, hypertriglyceridaemia, fatty liver |
| Protein | ↑ Proteolysis, ↓ synthesis | Muscle wasting, weight loss, negative nitrogen balance |
| Electrolyte | Osmotic diuresis | Dehydration, loss of Na, K, phosphate |
The classical symptoms explained
Hyperglycaemia exceeds the renal threshold of 180 mg/dL → glycosuria → osmotic diuresis → polyuria → dehydration → polydipsia (thirst) → Cells cannot use glucose → polyphagia with weight loss → The cell is "starving in the midst of plenty"
Biochemical Basis of Complications
| Mechanism | Process | Consequence |
|---|---|---|
| Non-enzymatic glycation | Glucose attaches to proteins without an enzyme → advanced glycation end-products (AGEs) | Cross-linked collagen, thickened basement membrane, HbA1c |
| Polyol (sorbitol) pathway | Aldose reductase converts glucose → sorbitol (NADPH used); sorbitol is trapped inside the cell | Osmotic damage → cataract, retinopathy, neuropathy; NADPH depletion worsens oxidative stress |
| Protein kinase C activation | From diacylglycerol | Altered vascular permeability and blood flow |
| Hexosamine pathway | Excess fructose-6-phosphate diverted | Altered gene expression |
| Oxidative stress | Free radical overproduction | Endothelial damage — the common final path |
- The polyol pathway explains why the lens, retina, nerve and kidney suffer most — these tissues take up glucose independently of insulin, so intracellular glucose rises with blood glucose
Complications
| Acute | Chronic — microvascular | Chronic — macrovascular |
|---|---|---|
| Diabetic ketoacidosis (type 1) | Retinopathy — commonest cause of blindness in working age | Coronary artery disease |
| Hyperosmolar hyperglycaemic state (type 2) | Nephropathy — microalbuminuria then proteinuria | Stroke |
| Hypoglycaemia (from treatment) | Neuropathy — glove and stocking; autonomic | Peripheral vascular disease, diabetic foot |
| Lactic acidosis | — | Increased infection risk |
Laboratory Monitoring
| Test | Reflects | Frequency |
|---|---|---|
| Fasting and post-prandial glucose | Current control | As needed |
| HbA1c | Average glucose over 8–12 weeks | Every 3–6 months |
| Urine albumin:creatinine ratio | Early nephropathy | Annually |
| Lipid profile | Cardiovascular risk | Annually |
| Serum creatinine and eGFR | Renal function | Annually |
| Fundus examination | Retinopathy | Annually from diagnosis in type 2 |
| Foot examination | Neuropathy and vascular disease | Annually |
- Microalbuminuria (30–300 mg/g) is the earliest sign of nephropathy and is reversible — the reason for annual screening
Applied Aspects
- India has one of the largest diabetic populations in the world, with onset a decade earlier and at a lower BMI than in Western populations — the "thin-fat" Indian phenotype with central obesity
- Tight glycaemic control reduces microvascular complications convincingly (DCCT, UKPDS); the effect on macrovascular disease is smaller and needs blood pressure and lipid control too
- Metformin reduces hepatic gluconeogenesis through AMPK — first-line in type 2
- SGLT-2 inhibitors promote glycosuria independently of insulin and reduce cardiovascular and renal events
- Screening for complications — annual fundus examination, urine albumin:creatinine ratio, and foot examination, from diagnosis in type 2
- Type 1 screening starts 5 years after diagnosis, since the onset is abrupt and datable, unlike type 2 where hyperglycaemia may have existed for years
Introduction
- Fructose and galactose are the other two dietary monosaccharides, from sucrose and lactose respectively
- Both must be converted to intermediates of glycolysis before they can be used
- The liver handles almost all of both
Fructose Metabolism
Fructose (from sucrose, honey, fruit) → fructokinase (liver) — ATP used → Fructose-1-phosphate → aldolase B → DHAP + Glyceraldehyde → Glyceraldehyde → (triokinase) → glyceraldehyde-3-phosphate → Both enter glycolysis below the PFK-1 step
- Fructose bypasses phosphofructokinase-1 — the rate-limiting and regulated step of glycolysis
- Therefore fructose metabolism is unregulated — it floods the pathway, producing acetyl-CoA and glycerol-3-phosphate and driving lipogenesis
- In muscle, hexokinase phosphorylates fructose to fructose-6-phosphate directly, but its affinity for fructose is low
Disorders of fructose metabolism
| Disorder | Enzyme | Features | Severity |
|---|---|---|---|
| Essential fructosuria | Fructokinase | Fructose in blood and urine; reducing substance in urine | Benign — needs no treatment |
| Hereditary fructose intolerance | Aldolase B | Fructose-1-phosphate accumulates → traps phosphate → inhibits glycogenolysis and gluconeogenesis → severe hypoglycaemia, vomiting, liver failure | Severe — can be fatal |
| Fructose-1,6-bisphosphatase deficiency | FBPase | Fasting hypoglycaemia with lactic acidosis | Serious |
- Hereditary fructose intolerance presents at weaning, when fruit and sucrose are introduced. Children develop a strong aversion to sweet food and are notably free of dental caries
- Treatment — complete exclusion of fructose, sucrose and sorbitol. Intravenous fructose or sorbitol can be fatal
Galactose Metabolism
Lactose → (lactase) → glucose + galactose → galactokinase — ATP used → Galactose-1-phosphate → galactose-1-phosphate uridyl transferase (GALT) + UDP-glucose → UDP-galactose + glucose-1-phosphate → UDP-galactose-4-epimerase → UDP-glucose → glycogen or glycolysis
- The epimerase reaction is reversible, so galactose can be made from glucose — which is why galactose is not an essential nutrient, and why lactation continues on a galactose-free diet
- UDP-galactose is needed for lactose, glycolipids, glycoproteins and glycosaminoglycans
Disorders of galactose metabolism
| Disorder | Enzyme | Accumulates | Features |
|---|---|---|---|
| Classical galactosaemia | GALT | Galactose-1-phosphate and galactitol | Vomiting, diarrhoea, failure to thrive, hepatomegaly, jaundice, cataract, mental retardation; E. Coli sepsis |
| Galactokinase deficiency | Galactokinase | Galactitol only | Cataract only — no liver or brain damage |
| Epimerase deficiency | Epimerase | UDP-galactose | Benign or severe variants |
CLINICAL PEARL
Why cataract in both: galactose is reduced by aldose reductase to galactitol, which cannot leave the lens and draws in water osmotically. The liver and brain damage of classical galactosaemia is caused by galactose-1-phosphate, which accumulates only when GALT is deficient — hence galactokinase deficiency spares them.
Diagnosis and Management of Galactosaemia
- Reducing substance in urine that is not glucose — Benedict test positive but glucose oxidase strip negative. A classical examination point
- Confirmed by RBC GALT assay; included in newborn screening in many countries
- Treatment — lifelong exclusion of galactose and lactose; soya-based formula
- Early treatment prevents the acute illness and cataract, but long-term learning difficulties and ovarian failure may still occur
Comparison of the Two Sugars
| Feature | Fructose | Galactose |
|---|---|---|
| Dietary source | Sucrose, fruit, honey | Lactose |
| First enzyme | Fructokinase | Galactokinase |
| Key enzyme | Aldolase B | GALT |
| Enters glycolysis at | Below PFK-1 | Glucose-1-phosphate |
| Benign disorder | Essential fructosuria | Galactokinase deficiency (cataract only) |
| Severe disorder | Hereditary fructose intolerance | Classical galactosaemia |
| Essential nutrient? | No | No — made from glucose |
Other Fates of Glucose — the Polyol Pathway
Glucose → aldose reductase (NADPH used) → sorbitol → Sorbitol dehydrogenase (NAD+) → fructose
- Sorbitol cannot cross cell membranes — it is trapped where it is made
- Tissues with aldose reductase but little sorbitol dehydrogenase — lens, retina, nerve, kidney, RBC — accumulate it
- These tissues take up glucose independently of insulin, so intracellular glucose follows blood glucose
- Result — osmotic swelling and NADPH depletion, giving cataract, retinopathy and neuropathy in diabetes
- Physiologically the pathway supplies fructose to seminal vesicles, the chief energy source of spermatozoa
Applied Aspects
- High fructose corn syrup in soft drinks and processed food is implicated in obesity, non-alcoholic fatty liver disease and hypertriglyceridaemia, precisely because fructose bypasses the regulated step of glycolysis
- Fructose also raises uric acid — its phosphorylation consumes ATP rapidly, and the amp formed is degraded to urate. A dietary contributor to gout
- Sorbitol in "sugar-free" products is converted to fructose and is dangerous in hereditary fructose intolerance
- Lactose intolerance is different from galactosaemia — it is deficiency of the intestinal enzyme lactase, causing bloating and osmotic diarrhoea, and is extremely common in Indian and East Asian adults
- Aldose reductase inhibitors (epalrestat) have been tried for diabetic neuropathy with modest benefit
- Galactose is used in liver function testing historically, since its clearance depends on hepatic capacity
- Fructose was once promoted as a diabetic sweetener because it needs no insulin; this is now discouraged given its lipogenic effect
- Whole fruit is not the problem — the fructose load is modest and comes with fibre; concentrated sweeteners and soft drinks are
Structure and Synthesis
Insulin = a polypeptide hormone of 51 amino acids in two chains — A chain (21) and B chain (30) — joined by two interchain disulphide bonds, with one intrachain bond in the A chain.
Preproinsulin (signal peptide + B + C + A) → Signal peptide removed in the endoplasmic reticulum → proinsulin → Cleaved in secretory granules by prohormone convertases → insulin + C-peptide, secreted in equimolar amounts
- Synthesised by β cells of the islets of Langerhans
- Stored as a zinc-containing hexamer
- C-peptide has no hormonal action but is clinically valuable — it has a longer half-life and is not present in injected insulin
- Insulin was the first protein to be sequenced (Sanger, 1955) and the first made by recombinant DNA technology (1982)
Regulation of Secretion
Glucose enters the β cell via GLUT-2 → Phosphorylated by glucokinase — the glucose sensor → Metabolism → ↑ ATP:ADP ratio → ATP-sensitive K+ channel closes → Depolarisation → Voltage-gated Ca2+ channels open → ↑ Intracellular Ca2+ → exocytosis of insulin
| Stimulate secretion | Inhibit secretion |
|---|---|
| Glucose — the chief stimulus | Hypoglycaemia |
| Amino acids (arginine, leucine), fatty acids | Somatostatin |
| Incretins — GLP-1 and GIP | Adrenaline (α2 effect) |
| Sulfonylureas (close the K+ channel) | Diazoxide (opens the K+ channel) |
| Vagal stimulation, β-adrenergic agonists | Chronic hyperglycaemia (glucotoxicity) |
| Glucagon, GH, cortisol (indirectly) | Thiazides, phenytoin |
- Oral glucose releases more insulin than intravenous glucose at the same blood level — the incretin effect, the basis of GLP-1 agonists and DPP-4 inhibitors
- Secretion is biphasic — a rapid first phase from stored granules, then a sustained second phase. Loss of the first phase is the earliest defect in type 2 diabetes
Mechanism of Action
Insulin binds the insulin receptor — a tetrameric (α2β2) tyrosine kinase → β subunits autophosphorylate → Phosphorylate insulin receptor substrates (IRS-1, IRS-2) → Two arms → PI3-kinase → Akt → GLUT-4 translocation, glycogen synthesis, protein synthesis → map kinase → growth and gene expression
Metabolic Actions
| Metabolism | Action |
|---|---|
| Carbohydrate | ↑ Glucose uptake (GLUT-4) in muscle and fat; ↑ glycolysis (glucokinase, PFK, pyruvate kinase); ↑ glycogenesis; ↓ gluconeogenesis and glycogenolysis |
| Lipid | ↑ Lipogenesis (acetyl-CoA carboxylase); ↓ lipolysis (inhibits hormone-sensitive lipase); ↑ lipoprotein lipase; ↓ ketogenesis |
| Protein | ↑ Amino acid uptake; ↑ protein synthesis; ↓ proteolysis — an anabolic hormone |
| Electrolyte | Drives K+ into cells — used to treat hyperkalaemia |
| Growth | Promotes cell growth and DNA synthesis |
- Insulin is the anabolic hormone — it promotes storage of all three fuels and opposes their release. Every action follows from that principle
Insulin Resistance
- Defined as a subnormal response to a normal or raised insulin concentration
- Mechanisms — post-receptor defects in IRS-1 phosphorylation, reduced GLUT-4 translocation, lipotoxicity from free fatty acids, inflammatory cytokines (TNF-α, IL-6) from adipose tissue
- Causes — obesity (especially central), physical inactivity, pregnancy, stress, steroids, acromegaly, Cushing syndrome, polycystic ovary syndrome
- Acanthosis nigricans is the clinical marker — velvety hyperpigmentation of the neck and axillae
Insulin Preparations and Degradation
| Type | Onset | Peak | Duration | Example |
|---|---|---|---|---|
| Rapid-acting analogue | 10–15 min | 1 h | 3–5 h | Lispro, aspart, glulisine |
| Short-acting (regular) | 30 min | 2–3 h | 6–8 h | Human regular insulin |
| Intermediate | 1–2 h | 6–10 h | 12–18 h | NPH (isophane) |
| Long-acting analogue | 1–2 h | Peakless | 20–24 h+ | Glargine, detemir, degludec |
- Analogues differ from human insulin by a few amino acids, altering the tendency to form hexamers — rapid analogues dissociate faster, long-acting ones precipitate at tissue pH
- Insulin is degraded by insulinase (insulin-degrading enzyme) in liver and kidney; plasma half-life is only 5–6 minutes
- About 50% is removed on the first pass through the liver, which is why peripheral levels are lower than portal ones
- Renal failure prolongs insulin action → the dose must be reduced, a common cause of hypoglycaemia in diabetic nephropathy
Applied Aspects
- C-peptide distinguishes endogenous from exogenous insulin — high in insulinoma, low or absent in factitious hypoglycaemia from injected insulin. A key forensic and clinical test
- C-peptide also assesses residual β-cell function — absent in established type 1, present in type 2
- Sulfonylureas close the KATP channel, mimicking the effect of ATP; they therefore work only if β cells remain
- Neonatal diabetes from KATP channel mutations responds to oral sulfonylureas rather than insulin — a striking example of mechanism guiding therapy
- Insulin with glucose is standard emergency treatment for hyperkalaemia, exploiting its effect on potassium rather than glucose
- Insulin autoantibodies and receptor antibodies cause rare syndromes of extreme resistance or spontaneous hypoglycaemia
- Lipohypertrophy at injection sites impairs absorption; rotating sites is essential and often neglected
- The insulin receptor belongs to the same family as the IGF-1 receptor, which is why very high insulin levels have growth-promoting effects — as in acanthosis nigricans
- Insulin cannot be given orally — it is a protein and would be digested; inhaled and oral formulations remain limited
- Hypoglycaemia is the limiting factor in insulin therapy and the commonest serious adverse effect of diabetes treatment
- Insulin remains on the WHO essential medicines list, yet access and cost are still major barriers in much of the world
Definition
Glucose-6-phosphate dehydrogenase (G6PD) deficiency = an X-linked recessive disorder of the rate-limiting enzyme of the HMP shunt, causing episodic haemolysis on oxidative stress.
- The commonest enzymopathy in the world — about 400 million people; common in Africa, the Mediterranean, the Middle East and parts of India
- Affects males; females are usually carriers, though lyonisation can make some symptomatic
Biochemical Basis
G6PD deficient → ↓ NADPH (the RBC has no other source) → Glutathione reductase cannot regenerate GSH → Oxidative stress unopposed → Haemoglobin oxidised and denatured → HEINZ bodies precipitate on the membrane → Removed by splenic macrophages → bite cells → intravascular and extravascular haemolysis
Precipitating Factors
| Category | Examples |
|---|---|
| Drugs | Primaquine, chloroquine, dapsone, sulphonamides, nitrofurantoin, ciprofloxacin, aspirin (high dose) |
| Food | Fava beans (favism) — contains divicine and isouramil |
| Infection | Any acute infection — the commonest trigger in practice |
| Chemicals | Naphthalene (mothballs), henna |
| Metabolic | Diabetic ketoacidosis, severe illness |
Clinical Variants
| Variant | Population | Severity |
|---|---|---|
| G6PD B | Normal | — |
| G6PD A− | African | Mild — only older RBC affected, so haemolysis is self-limiting |
| G6PD Mediterranean | Mediterranean, Middle East, Indian | Severe — all RBC affected; favism occurs |
| Chronic non-spherocytic | Rare | Continuous haemolysis |
Clinical and Laboratory Features
- Acute haemolytic crisis 1–3 days after exposure — pallor, jaundice, dark urine (haemoglobinuria), back pain, fever
- Neonatal jaundice — may be severe enough to cause kernicterus
- Blood film — bite cells, blister cells, Heinz bodies (supravital stain), polychromasia, reticulocytosis
- ↑ Indirect bilirubin, ↑ LDH, ↓ haptoglobin
- Enzyme assay must be delayed until 2–3 months after a crisis — young reticulocytes have higher enzyme levels and can give a falsely normal result
Applied Aspects
- Management is prevention — a written list of drugs and foods to avoid; treat infection promptly; transfusion only in severe crisis
- Screen before prescribing primaquine or dapsone, particularly in malaria-endemic areas
- Confers protection against falciparum malaria — the reason the gene is so common; another example of balanced polymorphism, like sickle cell trait
- Methylene blue is contraindicated for methaemoglobinaemia in these patients, since its action itself requires NADPH
Definition
Glycated haemoglobin (HbA1c) = haemoglobin to which glucose has become attached non-enzymatically and irreversibly, expressed as a percentage of total haemoglobin.
Formation
Glucose + N-terminal valine of the β chain → Non-enzymatic, concentration-dependent → Unstable Schiff base (aldimine) — reversible → Amadori rearrangement → Stable ketoamine — HbA1c — irreversible
- Because it is irreversible, HbA1c accumulates over the lifespan of the red cell (120 days)
- It therefore reflects the average blood glucose over the preceding 8–12 weeks
- The most recent month contributes about 50% of the value
Interpretation
| HbA1c | Interpretation | Estimated average glucose |
|---|---|---|
| < 5.7% | Normal | < 117 mg/dL |
| 5.7–6.4% | Prediabetes | 117–137 |
| ≥ 6.5% | Diabetes | ≥ 140 |
| < 7% | Target for most diabetics | < 154 |
| > 8% | Poor control — action needed | > 183 |
- Rough conversion — average glucose (mg/dL) = (28.7 × HbA1c) − 46.7
- Now also reported in IFCC units (mmol/mol)
Advantages
- No fasting required; can be taken at any time
- Less day-to-day variation than blood glucose
- Unaffected by acute stress, illness or a recent meal
- Correlates with the risk of complications — the DCCT and UKPDS trials established this
- Sample is stable
Conditions Giving a Misleading Result
| Falsely low | Falsely high |
|---|---|
| Any cause of shortened RBC survival | Iron deficiency anaemia |
| Haemolytic anaemia | Vitamin B12 and folate deficiency |
| Recent blood transfusion or acute blood loss | Splenectomy (longer RBC survival) |
| Pregnancy (later stages) | Chronic kidney disease, alcoholism |
| Erythropoietin therapy | Hyperbilirubinaemia, high triglyceride |
| Haemoglobinopathies — may interfere either way, depending on the assay | — |
CLINICAL PEARL
The principle is simple: anything that shortens red cell survival gives a falsely low value, and anything that lengthens it gives a falsely high one. Deduce the answer rather than memorising the list.
Applied Aspects
- HbA1c should be checked every 3 months until stable, then 6-monthly — testing sooner is pointless, since the value cannot have changed
- It cannot detect hypoglycaemia or glycaemic variability — a patient swinging between highs and lows may have a deceptively good value. Self-monitoring or continuous glucose monitoring is needed as well
- Fructosamine (glycated albumin) reflects the previous 2–3 weeks and is used when HbA1c is unreliable — in haemolysis, pregnancy or haemoglobinopathy
- HbA1c targets should be individualised — tighter in the young and newly diagnosed, more relaxed in the elderly or those with hypoglycaemia unawareness
Definition
Metabolic syndrome (syndrome X, insulin resistance syndrome) = a cluster of metabolic abnormalities centred on insulin resistance and central obesity, conferring an increased risk of type 2 diabetes and cardiovascular disease.
Diagnostic Criteria
- Any three of the following five (harmonised IDF/AHA definition):
| Component | Cut-off |
|---|---|
| Central obesity (waist circumference) | ≥ 90 cm men, ≥ 80 cm women for South Asians — lower than the European cut-offs |
| Triglyceride | ≥ 150 mg/dL |
| HDL cholesterol | < 40 mg/dL (men), < 50 mg/dL (women) |
| Blood pressure | ≥ 130/85 mmHg |
| Fasting plasma glucose | ≥ 100 mg/dL |
- The South Asian waist cut-offs are lower because Indians develop metabolic disease at a lower BMI, with more visceral fat for the same weight — the "thin-fat" phenotype
Biochemical Basis
Central (visceral) obesity → Visceral fat is lipolytically active and drains into the portal vein → ↑ Free fatty acids to the liver → Three consequences → ↑ Gluconeogenesis → hyperglycaemia → ↑ VLDL → high triglyceride, low HDL, small dense LDL → Hepatic and muscle insulin resistance (lipotoxicity)
- Adipose tissue also secretes adipokines — ↑ TNF-α, IL-6, leptin, resistin and PAI-1; ↓ adiponectin
- The result is a chronic low-grade inflammatory and prothrombotic state
Associated Conditions
- Type 2 diabetes — a five-fold increased risk
- Cardiovascular disease — roughly twice the risk
- Non-alcoholic fatty liver disease — the hepatic manifestation
- Polycystic ovary syndrome
- Obstructive sleep apnoea, hyperuricaemia and gout
- Certain cancers — colon, breast, endometrium
Management
| Priority | Measure |
|---|---|
| First line — lifestyle | Weight loss of 5–10% improves every component; 150 minutes of moderate exercise weekly; dietary change |
| Dyslipidaemia | Statin; fibrate if triglyceride is very high |
| Blood pressure | ACE inhibitor or ARB — also renoprotective |
| Glucose | Metformin |
| Other | Stop smoking; treat sleep apnoea |
- No single drug treats the syndrome — each component is treated separately, but weight loss addresses all of them at once
Applied Aspects
- Waist circumference is a better predictor than BMI in Indians — a normal BMI does not exclude the syndrome
- The concept is useful clinically but contested — some argue it adds little beyond treating each risk factor individually
- Childhood obesity is producing the syndrome in adolescents, which was almost unknown a generation ago
- Adiponectin is the one adipokine that falls with obesity — it is insulin-sensitising and anti-inflammatory, so its loss compounds the problem
Definition
Glycosuria = the presence of detectable glucose in the urine.
- Normally the urine contains less than 25 mg/dL, which routine tests do not detect
Renal Handling of Glucose
Glucose freely filtered at the glomerulus → Reabsorbed in the proximal convoluted tubule by SGLT-2 (90%) and SGLT-1 (10%) → Transport is saturable → Above the transport maximum (Tm) of about 350 mg/min → Glucose appears in urine
- Renal threshold = 180 mg/dL — the blood level at which glucose first appears in urine
- Splay — glycosuria begins a little below the calculated threshold because nephrons differ in their individual capacity
Classification of Causes
| Type | Blood glucose | Causes |
|---|---|---|
| Hyperglycaemic glycosuria | Raised | Diabetes mellitus; also Cushing, acromegaly, phaeochromocytoma, thyrotoxicosis, severe stress, steroids |
| Renal glycosuria | Normal | Lowered renal threshold — familial renal glycosuria (SGLT-2 mutation), pregnancy, Fanconi syndrome, chronic kidney disease |
| Alimentary (lag storage) | Transient peak | After gastrectomy, in hyperthyroidism — rapid absorption overwhelms the threshold briefly |
| Drug-induced | Normal or low | SGLT-2 inhibitors — deliberate therapeutic glycosuria |
CLINICAL PEARL
Glycosuria is not diabetes. A normal blood glucose with glycosuria means a low renal threshold, most often pregnancy. Conversely, the elderly and those with renal disease may have a raised threshold and show no glycosuria despite marked hyperglycaemia — which is why urine testing is unreliable for diagnosis.
Detection Methods
| Method | Principle | Specificity |
|---|---|---|
| Glucose oxidase strip | Glucose oxidase → H2O2 → chromogen with peroxidase | Specific for glucose |
| Benedict test | Reduction of cupric to cuprous oxide in alkali | Detects any reducing sugar — glucose, galactose, fructose, lactose, pentose |
| Rothera test | Nitroprusside | For ketones, not sugar |
- A positive Benedict with a negative glucose oxidase strip means a non-glucose reducing sugar — suspect galactosaemia in an infant, or essential fructosuria, or lactosuria in late pregnancy. A classical examination question
- False negatives on strips — large doses of vitamin C, or old strips
- False positives on Benedict — ascorbic acid, salicylates, some antibiotics, homogentisic acid
Applied Aspects
- Urine glucose is no longer used to diagnose or monitor diabetes — blood testing has replaced it entirely, because the renal threshold varies so widely between individuals
- Glycosuria in pregnancy is common and usually physiological, from increased GFR and reduced tubular reabsorption; it still warrants a glucose tolerance test to exclude gestational diabetes
- SGLT-2 inhibitors deliberately induce glycosuria of 50–80 g/day, lowering glucose independently of insulin; the cost is an increased risk of genital fungal infection and, rarely, euglycaemic ketoacidosis
Definition
Galactosaemia = an autosomal recessive disorder of galactose metabolism, classically due to deficiency of galactose-1-phosphate uridyl transferase (GALT).
Types
| Type | Enzyme deficient | Accumulates | Severity |
|---|---|---|---|
| Classical (type I) | GALT | Galactose-1-phosphate and galactitol | Severe — liver, brain, kidney, lens |
| Type II | Galactokinase | Galactitol only | Mild — cataract only |
| Type III | UDP-galactose-4-epimerase | UDP-galactose | Benign or severe forms |
Biochemical Basis of the Damage
GALT deficient → Galactose-1-phosphate accumulates → Traps inorganic phosphate → ATP depletion → Inhibits phosphoglucomutase → glycogenolysis blocked → hypoglycaemia → Direct toxicity to liver, kidney tubule and brain
Excess galactose → aldose reductase (NADPH used) → galactitol — cannot leave the lens → Osmotic water entry → fibre swelling and opacity → cataract
- Galactitol explains the cataract; galactose-1-phosphate explains everything else. That single distinction accounts for why galactokinase deficiency causes cataract alone
Clinical Features
- Appear within days of starting milk feeds
- Vomiting, diarrhoea, refusal of feeds, failure to thrive
- Jaundice and hepatomegaly, progressing to liver failure and cirrhosis
- Cataract — may be present within weeks
- Mental retardation if untreated
- Renal tubular acidosis with aminoaciduria
- Overwhelming escherichia coli sepsis — characteristic, and a frequent cause of death; galactose-1-phosphate impairs neutrophil function
Diagnosis
- Urine gives a positive Benedict test with a negative glucose oxidase strip — the classical screening finding
- Confirmed by assay of GALT in red blood cells
- Newborn screening by tandem mass spectrometry where available
- Do not rely on a galactose tolerance test — it is dangerous and contraindicated
Treatment and Applied Aspects
- Lifelong exclusion of galactose and lactose — stop breast and cow milk; use soya-based formula
- Early treatment reverses the acute illness and the cataract and prevents liver damage
- Long-term outcome is imperfect despite good control — learning difficulties, speech delay and premature ovarian failure in girls occur even in well-treated patients, probably from endogenous galactose production
- Galactose is not an essential nutrient — the epimerase reaction makes UDP-galactose from glucose, so a galactose-free diet is nutritionally safe
- Suspect it in any neonate with jaundice, hepatomegaly and sepsis, and stop milk immediately while awaiting results
Definition
Glycosaminoglycans (GAGs, mucopolysaccharides) = long unbranched polysaccharides of repeating disaccharide units, each containing an amino sugar and a uronic acid, usually sulphated.
- They are strongly negatively charged, so they bind large amounts of water and cations
- Bound to a core protein they form proteoglycans — the ground substance of connective tissue
The Important Glycosaminoglycans
| Gag | Site | Special feature |
|---|---|---|
| Hyaluronic acid | Synovial fluid, vitreous humour, loose connective tissue | The only one that is not sulphated and not protein-bound; a lubricant and shock absorber |
| Chondroitin sulphate | Cartilage, bone, cornea | The most abundant in the body |
| Keratan sulphate | Cornea, cartilage, intervertebral disc | Contains galactose instead of uronic acid |
| Dermatan sulphate | Skin, blood vessels, heart valves | Gives skin its pliability |
| Heparin | Mast cell granules | Anticoagulant — the most highly charged molecule in the body |
| Heparan sulphate | Basement membranes, cell surfaces | Charge barrier of the glomerulus |
Functions
- Structural — ground substance of connective tissue, cartilage and bone
- Lubrication and shock absorption — hyaluronic acid in synovial fluid
- Charge-selective filtration — heparan sulphate in the glomerular basement membrane repels albumin
- Anticoagulation — heparin activates antithrombin III
- Corneal transparency — regular arrangement of keratan sulphate with collagen
- Cell signalling and adhesion; binding of growth factors
- Clearing of chylomicrons — heparin releases lipoprotein lipase
Mucopolysaccharidoses
Inherited lysosomal storage disorders in which GAGs cannot be degraded and accumulate in tissues, with excess excretion in urine.
| Disease | Enzyme deficient | Inheritance | Features |
|---|---|---|---|
| Hurler (MPS I) | α-L-iduronidase | Autosomal recessive | Coarse facies (gargoylism), corneal clouding, mental retardation, hepatosplenomegaly, dwarfism; death in childhood |
| Hunter (MPS II) | Iduronate sulphatase | X-linked | Milder; NO corneal clouding — the key distinction from Hurler |
| Sanfilippo (MPS III) | Heparan sulphate degradation | Autosomal recessive | Severe neurological disease with mild somatic features |
| Morquio (MPS IV) | Galactose-6-sulphatase | Autosomal recessive | Skeletal deformity with normal intelligence |
- Diagnosis — urinary gag screening, then enzyme assay and genetic testing
- Treatment — enzyme replacement therapy for several types; haematopoietic stem cell transplantation in Hurler if done early
Applied Aspects
- Heparin is used clinically as an anticoagulant; unfractionated heparin is monitored by APTT, low molecular weight heparin usually needs no monitoring
- Loss of glomerular heparan sulphate is one mechanism of the proteinuria of diabetic nephropathy and minimal change disease
- Hyaluronic acid injections are used in osteoarthritis of the knee and in ophthalmic surgery
- Osteoarthritis involves loss of cartilage proteoglycan, reducing its capacity to hold water and resist compression
Definition
Uronic acid pathway (glucuronic acid pathway) = a minor route of glucose metabolism, small in bulk but important in function, producing glucuronic acid, pentoses and, in most animals, ascorbic acid.
- Site — cytosol of the liver
- Produces no ATP; it is a synthetic rather than an energy-yielding pathway
The Pathway
Glucose-6-phosphate → Glucose-1-phosphate → UDP-glucose → UDP-glucose dehydrogenase (NAD+) → UDP-glucuronic acid — the active donor → L-Gulonate → In most animals → ascorbic acid → In man → L-xylulose → xylitol → D-xylulose → HMP shunt
CLINICAL PEARL
Man, other primates and the guinea pig lack L-gulonolactone oxidase, so the pathway stops short of ascorbic acid. This single missing enzyme is why vitamin C is a vitamin for us but not for a dog or a rat.
Functions
- Conjugation and detoxification — UDP-glucuronic acid is the donor in glucuronidation, the commonest phase II reaction
- Bilirubin conjugation — by UDP-glucuronyl transferase, converting insoluble unconjugated bilirubin to the water-soluble diglucuronide
- Drug and hormone conjugation — morphine, paracetamol, chloramphenicol, steroids, thyroxine
- Synthesis of glycosaminoglycans — glucuronic acid is a component of hyaluronic acid, heparin and chondroitin sulphate
- Ascorbic acid synthesis in species that possess the final enzyme
Disorders
| Disorder | Defect | Features |
|---|---|---|
| Essential pentosuria | Xylitol dehydrogenase (L-xylulose reductase) | L-xylulose in urine; benign — but gives a positive Benedict test and may be mistaken for diabetes |
| Crigler–Najjar type I | Complete absence of UDP-glucuronyl transferase | Severe unconjugated hyperbilirubinaemia, kernicterus; fatal without transplantation |
| Crigler–Najjar type II | Partial deficiency | Milder; responds to phenobarbitone (enzyme induction) |
| Gilbert syndrome | Reduced enzyme activity (about 30%) | Mild intermittent jaundice on fasting, stress or illness; entirely benign; affects 5–10% of people |
| Neonatal physiological jaundice | Immature enzyme | Transient; matures within 1–2 weeks |
Applied Aspects
- Phenobarbitone induces UDP-glucuronyl transferase and was formerly used to treat neonatal jaundice and Crigler–Najjar type II
- Chloramphenicol in neonates causes grey baby syndrome — the immature glucuronyl transferase cannot conjugate it, so the drug accumulates
- Gilbert syndrome must be recognised as harmless — it is a common cause of unexplained mild jaundice in young adults and needs no treatment, only reassurance
- Essential pentosuria illustrates why urine sugar tests must be specific — a benign condition mistaken for diabetes on a Benedict test
- Irinotecan toxicity is greater in people with the Gilbert genotype, since the drug is cleared by the same enzyme — genotyping is used before treatment
Definition
β-Oxidation = the stepwise oxidative degradation of fatty acids, in which two carbons are removed at a time as acetyl-CoA from the carboxyl end.
- Site — mitochondrial matrix
- Named because oxidation occurs at the β-carbon (C-3)
- Occurs in most tissues, especially liver, heart, skeletal muscle and kidney
- Does not occur in the brain (fatty acids cross the blood–brain barrier poorly) or in RBC (no mitochondria)
Activation of Fatty Acid — in the Cytosol
Fatty acid + CoA-SH + ATP → Acyl-CoA synthetase (thiokinase), on the outer mitochondrial membrane → Fatty acyl-CoA + amp + PPi
- 2 high-energy bonds are consumed, because ATP goes to amp, and the pyrophosphate is then hydrolysed
- This is the only step requiring energy — the rest yields it
Carnitine Shuttle — Transport Into the Mitochondrion
Fatty acyl-CoA (cytosol) → CPT-I (carnitine palmitoyl transferase I) on the outer membrane — rate-limiting → Acyl-carnitine → Carried across by translocase → CPT-II on the inner membrane regenerates acyl-CoA → Fatty acyl-CoA in the matrix
- CPT-I is inhibited by malonyl-CoA — the first intermediate of fatty acid synthesis. This single control prevents synthesis and oxidation running at the same time
- Short and medium chain fatty acids (< 12 C) do not need carnitine — they diffuse in directly. Hence MCT oil is useful in carnitine deficiency and fat malabsorption
- Carnitine is synthesised in liver and kidney from lysine and methionine, requiring vitamin C
The Four Repeating Reactions
| Step | Enzyme | Change | Product |
|---|---|---|---|
| 1. Oxidation | Acyl-CoA dehydrogenase | Forms a double bond | FADH2 |
| 2. Hydration | Enoyl-CoA hydratase | Adds water | — |
| 3. Oxidation | β-hydroxyacyl-CoA dehydrogenase | Forms a keto group | NADH |
| 4. Thiolysis | Thiolase | Cleaves off 2 carbons | Acetyl-CoA + shortened acyl-CoA |
- The shortened acyl-CoA re-enters the cycle; the sequence repeats until only acetyl-CoA remains
- Mnemonic for the sequence — Oxidation, Hydration, Oxidation, Thiolysis; it mirrors the succinate → oxaloacetate span of the TCA cycle
Energetics — Palmitate (C16)
| Item | Calculation | ATP |
|---|---|---|
| Number of cycles | (16 ÷ 2) − 1 = 7 | — |
| Acetyl-CoA produced | 8 | 8 × 10 = 80 |
| FADH2 | 7 | 7 × 1.5 = 10.5 |
| NADH | 7 | 7 × 2.5 = 17.5 |
| Gross total | — | 108 |
| Less activation | — | −2 |
| Net | — | 106 ATP |
CLINICAL PEARL
Note: older texts using NADH = 3 and FADH2 = 2 give 129 ATP. Quote 106 with the modern P/O ratios, and mention 129.
- Compare: one glucose yields only 32 ATP. Weight for weight, fat yields more than twice the energy of carbohydrate — 9 kcal/g against 4
Oxidation of Odd-chain and Unsaturated Fatty Acids
- Odd-chain → the final three carbons form propionyl-CoA → methylmalonyl-CoA → succinyl-CoA. Requires biotin and vitamin B12
- This is the only part of a fatty acid that is glucogenic
- Unsaturated fatty acids need two extra enzymes — an isomerase and a reductase; they yield slightly less ATP
- α-oxidation occurs in peroxisomes for branched-chain fatty acids such as phytanic acid; ω-oxidation in the endoplasmic reticulum
Regulation
- CPT-I is the rate-limiting enzyme, inhibited by malonyl-CoA
- Fed state — insulin → ↑ malonyl-CoA → β-oxidation off, lipogenesis on
- Fasting — glucagon → ↓ malonyl-CoA → β-oxidation ON
- Availability of free fatty acids, released by hormone-sensitive lipase in adipose tissue, is the other determinant
Peroxisomal Β-oxidation
- Handles very long chain fatty acids (> C20), which mitochondria cannot
- The first dehydrogenation uses an oxidase and yields H2O2, not FADH2 → the energy is lost as heat
- Removed by catalase
- Shortens the chain to about C8, which is then passed to the mitochondrion
- Also handles branched-chain fatty acids and bile acid intermediates
Applied Aspects
- MCAD deficiency (medium-chain acyl-CoA dehydrogenase) — the commonest inherited defect of β-oxidation; presents as hypoketotic hypoglycaemia during fasting or illness, and may cause sudden infant death. Detected on newborn screening
- Carnitine deficiency — muscle weakness, cardiomyopathy, hypoketotic hypoglycaemia; primary or secondary to dialysis and valproate
- Refsum disease — defective α-oxidation → phytanic acid accumulates → retinitis pigmentosa, neuropathy, ataxia. Treated by dietary restriction
- Zellweger syndrome — absent peroxisomes → very long chain fatty acids accumulate
- Jamaican vomiting sickness — hypoglycin from unripe ackee fruit inhibits acyl-CoA dehydrogenase
Definition
Ketone bodies = acetoacetate, β-hydroxybutyrate and acetone — water-soluble fuels synthesised in the liver from acetyl-CoA and used by extrahepatic tissues.
- β-hydroxybutyrate is the most abundant of the three, though chemically it is not a ketone at all
- Acetone is formed by spontaneous decarboxylation, is not metabolised, and is excreted by the lungs — the fruity breath
- Normal blood level < 1 mg/dL; rises to 90 mg/dL in ketoacidosis
Ketogenesis — Site and Steps
- Site — mitochondria of liver cells only
2 Acetyl-CoA → Thiolase → Acetoacetyl-CoA → + acetyl-CoA, by HMG-CoA synthase — rate-limiting → HMG-CoA → HMG-CoA lyase → acetoacetate → Reduced (NADH) → β-hydroxybutyrate; or spontaneous → acetone
CLINICAL PEARL
Mitochondrial HMG-CoA goes to ketone bodies; cytosolic HMG-CoA goes to cholesterol. Same intermediate, different compartment, entirely different fate.
WHY the Liver Cannot Use Them
- Utilisation requires thiophorase (succinyl-CoA acetoacetate CoA transferase)
- The liver lacks thiophorase — so it makes ketone bodies but cannot oxidise them
- This is a deliberate arrangement: the liver exports them for other tissues
Ketolysis — Utilisation
β-hydroxybutyrate → acetoacetate (NADH produced) → thiophorase — CoA donated by succinyl-CoA → Acetoacetyl-CoA → Thiolase → 2 Acetyl-CoA → TCA cycle
| Tissue | Uses ketone bodies? |
|---|---|
| Heart, skeletal muscle, renal cortex | Yes — readily, even preferentially |
| Brain | Yes, but only after adaptation over several days of starvation |
| Liver | NO — lacks thiophorase |
| RBC | NO — no mitochondria |
Physiological Significance
- Water-soluble fuel — unlike fatty acids they need no albumin carrier and can cross the blood–brain barrier
- In prolonged starvation ketone bodies supply 60–75% of the brain's energy
- This spares glucose and therefore spares muscle protein — the single most important consequence, and the reason humans survive prolonged fasting
- Ketogenesis is a normal adaptive response, not inherently pathological
Causes of Ketosis
| Cause | Mechanism |
|---|---|
| Starvation and prolonged fasting | ↓ Insulin, ↑ glucagon → ↑ lipolysis |
| Uncontrolled diabetes mellitus (type 1) | Absolute insulin lack → unrestrained lipolysis; the most severe form |
| High fat, low carbohydrate diet | Ketogenic diet |
| Pregnancy, lactation | Increased demand |
| Severe vomiting, alcoholism | Starvation plus altered redox state |
| Von Gierke disease | Fasting hypoglycaemia |
Why ketosis occurs — the common mechanism
↓ Insulin : glucagon ratio → ↑ Lipolysis → ↑ free fatty acids → ↑ β-oxidation → ↑↑ Acetyl-CoA → Meanwhile oxaloacetate is diverted to gluconeogenesis → Acetyl-CoA cannot enter the TCA cycle → Diverted to ketone bodies
- Hence the saying "fat burns in the flame of carbohydrate"
Diabetic Ketoacidosis
- Acetoacetate and β-hydroxybutyrate are moderately strong acids → consume bicarbonate → high anion gap metabolic acidosis
- Features — Kussmaul breathing, fruity breath, vomiting, abdominal pain, dehydration from osmotic diuresis, altered consciousness
- Biochemistry — hyperglycaemia, ketonaemia, low pH and bicarbonate, raised anion gap, and total body potassium depletion despite a normal or high serum potassium
- Treatment — fluids, insulin, potassium, and treating the precipitating cause
Ketosis in Starvation — the Time Course
| Phase | Blood ketones | Brain fuel |
|---|---|---|
| Fed | Negligible | Glucose 100% |
| Overnight fast | Slight rise | Glucose |
| 2–3 days | Rising | Glucose, with ketones starting |
| 1 week | High | Ketones about 50% |
| 3–5 weeks | Plateau (5–7 mmol/L) | Ketones 60–75% |
- The switch to ketones cuts the brain's glucose requirement from 120 g to about 40 g a day
- This halves the rate of muscle protein breakdown and roughly doubles survival time in starvation
Applied Aspects
- Urine nitroprusside (Rothera) test detects acetoacetate and acetone but not β-hydroxybutyrate — so it may underestimate severity, and may appear to worsen during treatment as β-hydroxybutyrate converts back to acetoacetate. Blood β-hydroxybutyrate is the better measure
- Ketogenic diet is an established treatment for refractory epilepsy in children, and for GLUT-1 deficiency and PDH deficiency
- Alcoholic ketoacidosis — starvation plus a high NADH:NAD ratio; blood glucose may be normal or low, unlike DKA
- Distinguish ketosis from ketoacidosis — the first is a normal adaptation with intact buffering; the second is a decompensated emergency
- Type 2 diabetics rarely develop DKA — residual insulin is enough to restrain lipolysis; they present instead with a hyperosmolar state
Definition and Site
De novo lipogenesis = synthesis of fatty acids from acetyl-CoA, yielding palmitate (C16) as the primary product.
| Feature | Detail |
|---|---|
| Site (cell) | Cytosol |
| Site (tissue) | Liver (chief), adipose tissue, lactating mammary gland, kidney |
| When | Fed state, carbohydrate excess |
| Reducing agent | NADPH |
| Product | Palmitate |
Transport of Acetyl-coa — the Citrate Shuttle
- Acetyl-CoA is made in the mitochondrion but needed in the cytosol, and cannot cross the inner membrane
Acetyl-CoA + oxaloacetate → citrate (citrate synthase) → Citrate crosses via the tricarboxylate carrier → In cytosol: ATP-citrate lyase → Acetyl-CoA + oxaloacetate → OAA → malate → malic enzyme → pyruvate + NADPH → Pyruvate returns to the mitochondrion
- The shuttle also generates NADPH through the malic enzyme — a second purpose
- Citrate accumulates only when the cell has plenty of energy, so it is a natural signal that lipogenesis is appropriate
The Committed Step — Acetyl-coa Carboxylase
Acetyl-CoA + CO2 + ATP → malonyl-CoAEnzyme: acetyl-CoA carboxylase; coenzyme: biotin
| Regulation | Effect |
|---|---|
| Citrate | Activates (allosteric; polymerises the enzyme) |
| Palmitoyl-CoA | Inhibits (feedback) |
| Insulin | Activates (dephosphorylation); also induces the enzyme |
| Glucagon, adrenaline | Inhibit (phosphorylation via AMPK) |
- This is the rate-limiting and committed step of fatty acid synthesis
- Malonyl-CoA inhibits CPT-I, shutting down β-oxidation at the same time — reciprocal control from a single molecule
Fatty Acid Synthase Complex
- A dimer, each monomer carrying seven enzyme activities plus acyl carrier protein (ACP)
- ACP contains phosphopantetheine, derived from pantothenic acid (B5)
- The growing chain remains bound throughout — no free intermediates escape
The repeating sequence
Condensation — acetyl + malonyl, CO2 released → Reduction — NADPH → Dehydration → Reduction — NADPH → Chain now 2 carbons longer; repeat 7 times
- After 7 cycles, thioesterase releases palmitate
- The CO2 fixed by carboxylase is released again at condensation — it is catalytic, driving the reaction forward
Stoichiometry and Sources of Nadph
8 Acetyl-CoA + 7 ATP + 14 NADPH → Palmitate
| Source of NADPH | Contribution |
|---|---|
| HMP (pentose phosphate) shunt | The chief source |
| Malic enzyme | Within the citrate shuttle |
| Cytosolic isocitrate dehydrogenase | Minor |
Comparison with Β-oxidation
| Feature | Synthesis | β-Oxidation |
|---|---|---|
| Site | Cytosol | Mitochondrial matrix |
| Carrier | ACP | Coenzyme A |
| Coenzyme | NADPH | NAD+ and FAD |
| 2-carbon unit | Malonyl-CoA | Acetyl-CoA |
| Bicarbonate / biotin | Required | Not required |
| Regulated by | Acetyl-CoA carboxylase | CPT-I |
| Hormone | Insulin | Glucagon |
| Energy | Consumes | Yields |
Elongation and Desaturation
- Elongation occurs in the endoplasmic reticulum (malonyl-CoA, NADPH) and in mitochondria (acetyl-CoA)
- Desaturation by Δ9, Δ6 and Δ5 desaturases in the ER
- Man cannot introduce a double bond beyond carbon 9 — which is why linoleic and α-linolenic acids are essential and must come from the diet
Applied Aspects
- Excess carbohydrate is converted to fat — the biochemical basis of obesity from a high-carbohydrate diet
- Non-alcoholic fatty liver disease — excess hepatic lipogenesis, driven by insulin resistance and fructose, is central to its pathogenesis
- Biotin deficiency impairs acetyl-CoA carboxylase and therefore lipogenesis
- Metformin activates AMPK → inhibits acetyl-CoA carboxylase → ↓ lipogenesis and ↑ fat oxidation
- Fatty acid synthase is over-expressed in many tumours and is being explored as a drug target
Introduction
Cholesterol = a 27-carbon steroid alcohol, present only in animal tissue, and an essential component of every cell membrane.
| Source | Amount per day |
|---|---|
| Endogenous synthesis | About 1 g — chiefly liver (50%), intestine, adrenal cortex, gonads, skin |
| Diet | 300–500 mg |
| Normal plasma level | < 200 mg/dL desirable |
Functions
- Membrane structure — modulates fluidity; a major constituent of myelin
- Precursor of bile acids — the largest single use
- Precursor of steroid hormones — cortisol, aldosterone, testosterone, oestrogen
- Precursor of vitamin D, via 7-dehydrocholesterol in skin
- Forms lipid rafts for cell signalling
Biosynthesis
- Site — cytosol and endoplasmic reticulum; requires NADPH and ATP
- All 27 carbons come from acetyl-CoA
2 Acetyl-CoA → Acetoacetyl-CoA → + Acetyl-CoA → HMG-CoA (HMG-CoA synthase, cytosolic) → HMG-CoA reductase — needs 2 NADPH; rate-limiting → mevalonate → Isopentenyl pyrophosphate (5C) → Squalene (30C) → Lanosterol → cholesterol (27C)
CLINICAL PEARL
HMG-CoA reductase is the key enzyme of the whole pathway and the target of the statins. Note again that cytosolic HMG-CoA makes cholesterol, while mitochondrial HMG-CoA makes ketone bodies.
Regulation of Hmg-coa Reductase
| Mechanism | Effect |
|---|---|
| Feedback inhibition | Cholesterol inhibits the enzyme and suppresses its gene (via SREBP-2) |
| Covalent modification | Phosphorylation by AMPK inactivates it (low energy state) |
| Hormonal | Insulin and thyroxine activate; glucagon and cortisol inhibit |
| Drugs | Statins competitively inhibit it |
| Diurnal rhythm | Synthesis is maximal at midnight — hence statins are traditionally given at night |
Transport and Fate
- Carried in plasma as lipoproteins; about 70% is esterified with fatty acid
- LCAT esterifies cholesterol in plasma (on HDL); ACAT does so within cells
- Excretion is only through bile — as bile acids or as free cholesterol. Cholesterol cannot be degraded for energy — its ring structure cannot be broken down by human enzymes
Cholesterol → 7α-hydroxylase — rate-limiting for bile acids → Primary bile acids — cholic and chenodeoxycholic → Conjugated with glycine or taurine → Secreted in bile → 95% reabsorbed in terminal ileum (enterohepatic circulation)
Factors Affecting Plasma Cholesterol
| ↑ Cholesterol | ↓ Cholesterol |
|---|---|
| Saturated and trans fats | Polyunsaturated fats, omega-3 |
| Hypothyroidism | Hyperthyroidism |
| Nephrotic syndrome, obstructive jaundice | Dietary fibre, plant sterols |
| Diabetes, obesity, smoking | Exercise, oestrogen |
| Familial hypercholesterolaemia | Statins, ezetimibe, bile acid sequestrants |
Cholesterol Balance in the Body
| Input | Mg/day | Output | Mg/day |
|---|---|---|---|
| Synthesis | ~1000 | Bile acids in faeces | ~500 |
| Diet | 300–500 | Neutral sterols in faeces | ~500 |
| — | — | Skin, steroid hormones | ~100 |
- Synthesis falls when dietary intake rises — feedback inhibition of HMG-CoA reductase. This is why dietary cholesterol alone has a modest effect on plasma levels, and why saturated fat matters more than dietary cholesterol
- Bile acid sequestrants (cholestyramine) break the enterohepatic circulation → the liver must make more bile acids from cholesterol → LDL receptors are up-regulated
Applied Aspects
- Atherosclerosis — LDL is oxidised in the intimal wall, taken up by macrophages through scavenger receptors to form foam cells, and the plaque grows. Oxidised LDL is the key step
- Familial hypercholesterolaemia — defective LDL receptor; autosomal dominant; tendon xanthomas, corneal arcus, and premature coronary disease. Homozygotes may have infarction in childhood
- Statins lower LDL both by inhibiting synthesis and by up-regulating LDL receptors — the second effect matters more
- Gallstones form when bile is supersaturated with cholesterol relative to bile salts and lecithin
- Smith–Lemli–Opitz syndrome — a defect in the final step of cholesterol synthesis, causing severe malformations; it shows that cholesterol is essential for normal development
- Statin myopathy — from reduced coenzyme Q synthesis, which shares the mevalonate pathway; ranges from myalgia to rhabdomyolysis
- Cholesterol is not an energy source — unlike fatty acids it yields no ATP, which is why excess can only be excreted or deposited
- Xanthelasma and corneal arcus before the age of 45 should prompt a lipid profile
- Plant sterols compete with cholesterol for intestinal absorption and lower LDL by about 10%
- Cholesterol synthesis needs 18 acetyl-CoA, 36 ATP and 16 NADPH per molecule — a costly pathway
- Nephrotic syndrome raises cholesterol because hypoalbuminaemia stimulates hepatic lipoprotein synthesis
- Hypothyroidism raises LDL by reducing LDL receptor expression — always check thyroid function in unexplained hypercholesterolaemia
Definition and Structure
Lipoproteins = spherical macromolecular complexes that transport water-insoluble lipids in plasma.
- Core — non-polar lipids: triglyceride and cholesteryl ester
- Surface — amphipathic: phospholipid, free cholesterol and apolipoproteins
- Density is inversely related to lipid content — the more triglyceride, the lower the density
Classification
| Class | Chief lipid | Source | Function | Electrophoresis |
|---|---|---|---|---|
| Chylomicron | Dietary triglyceride (85%) | Intestine | Carries dietary fat to tissues | Origin |
| VLDL | Endogenous triglyceride | Liver | Carries hepatic triglyceride to tissues | Pre-β |
| IDL | TG and cholesterol | From VLDL | Transient | Broad β |
| LDL | Cholesterol (50%) | From VLDL | Delivers cholesterol TO tissues — "bad" | β |
| HDL | Protein (50%) | Liver, intestine | Reverse cholesterol transport — "good" | α |
Important Apolipoproteins
| Apo | Found on | Function |
|---|---|---|
| Apo A-I | HDL | Activates LCAT |
| Apo B-100 | VLDL, IDL, LDL | Ligand for the LDL receptor |
| Apo B-48 | Chylomicron | Chylomicron assembly |
| Apo C-II | Chylomicron, VLDL, HDL | Activates lipoprotein lipase |
| Apo E | Chylomicron remnant, VLDL, IDL | Remnant uptake by the liver |
Metabolism
A. Exogenous pathway (dietary fat)
Dietary fat → chylomicron (intestine) → Lymph → blood; acquires apo C-II and E from HDL → Lipoprotein lipase on capillary endothelium hydrolyses TG → Free fatty acids to adipose and muscle → Chylomicron remnant → taken up by liver via apo E
B. Endogenous pathway
Liver → VLDL → Lipoprotein lipase removes TG → IDL → Further TG removal by hepatic lipase → LDL → Taken up by LDL (apo B-100) receptors in liver and tissues
C. Reverse cholesterol transport
Nascent HDL from liver and intestine → Picks up free cholesterol from tissues via ABCA1 → LCAT (activated by apo A-I) esterifies it → Mature HDL → Delivers cholesterol to liver (SR-B1) or transfers to VLDL/LDL via CETP → Excreted in bile
- This is why HDL is protective — it is the only route by which peripheral cholesterol returns to the liver for excretion
Lipoprotein Lipase
- Located on the capillary endothelium of adipose tissue, muscle and lactating breast
- Activated by apo C-II; induced by insulin
- Released into plasma by heparin — "clearing factor"
- The adipose enzyme has a high Km (works after a meal); the muscle enzyme a low Km (works when fat is scarce)
Fredrickson Classification of Hyperlipoproteinaemias
| Type | Raised | Defect |
|---|---|---|
| I | Chylomicrons | Lipoprotein lipase or apo C-II deficiency |
| IIa | LDL | LDL receptor defect — familial hypercholesterolaemia |
| IIb | LDL and VLDL | Combined hyperlipidaemia |
| III | IDL | Apo E2/E2 — broad beta disease |
| IV | VLDL | Over-production; the commonest |
| V | VLDL and chylomicrons | Mixed |
LDL Receptor Pathway (brown and Goldstein)
LDL binds the LDL receptor via apo B-100 → Internalised in clathrin-coated pits → Endosome → lysosome → Cholesteryl ester hydrolysed → free cholesterol → Three consequences
- Inhibits HMG-CoA reductase → less synthesis
- Down-regulates the LDL receptor → less uptake
- Activates ACAT → excess is esterified and stored
- This feedback is absent on the macrophage scavenger receptor, which is why foam cells form
Applied Aspects
- Lipid profile — total cholesterol, triglyceride, HDL, and LDL by the Friedewald formula: LDL = Total − HDL − (TG ÷ 5). Invalid if triglyceride exceeds 400 mg/dL
- Abetalipoproteinaemia — no apo B → no chylomicrons or VLDL → fat malabsorption, acanthocytosis, retinitis pigmentosa, neurological damage from vitamin E deficiency
- Tangier disease — ABCA1 defect → almost no HDL → orange tonsils and neuropathy
- Very high triglyceride (> 1000 mg/dL) causes acute pancreatitis — a medical emergency independent of cardiovascular risk
- Lp(a) resembles plasminogen and is an independent risk factor for thrombosis and atherosclerosis
- Fasting is no longer required for a routine lipid profile in most guidelines, except when triglyceride is very high
- Familial combined hyperlipidaemia (type IIb) is the commonest genetic dyslipidaemia and a frequent finding in premature coronary disease
- Secondary causes must be excluded first — hypothyroidism, nephrotic syndrome, diabetes, alcohol, and drugs such as thiazides and steroids
Definition
Carnitine shuttle = the transport system that carries long-chain fatty acyl groups from the cytosol into the mitochondrial matrix for β-oxidation.
- Necessary because the inner mitochondrial membrane is impermeable to acyl-CoA
- Carnitine (β-hydroxy-γ-trimethylammonium butyrate) is synthesised in liver and kidney from lysine and methionine, requiring vitamin C, niacin, B6 and iron
- Richest dietary source — red meat
The Steps
Fatty acyl-CoA in cytosol → CPT-I on the outer mitochondrial membrane — rate-limiting → Acyl-carnitine → Carnitine–acylcarnitine translocase carries it in, carnitine out → CPT-II on the inner membrane → Fatty acyl-CoA in the matrix → β-oxidation
Regulation
- CPT-I is inhibited by malonyl-CoA, the first committed intermediate of fatty acid synthesis
- Fed state — insulin → ↑ malonyl-CoA → CPT-I blocked → oxidation off
- Fasting — glucagon → ↓ malonyl-CoA → oxidation ON
- This prevents a futile cycle of simultaneous synthesis and breakdown
Fatty Acids That Bypass It
- Short (< 6 C) and medium chain (6–12 C) fatty acids diffuse directly into the mitochondrion and are activated there
- Hence MCT oil is valuable in carnitine deficiency, CPT deficiency, and in fat malabsorption from any cause
Functions of Carnitine Beyond Transport
- Removes accumulated acyl groups from the mitochondrion as acylcarnitines, freeing coenzyme A
- Maintains the free CoA : acyl-CoA ratio, which many mitochondrial enzymes depend on
- Acylcarnitine profiling of a dried blood spot is the basis of newborn screening for fatty acid oxidation disorders — each defect gives a characteristic pattern
Applied Aspects
- Primary carnitine deficiency — defective OCTN2 transporter; cardiomyopathy, muscle weakness, hypoketotic hypoglycaemia; responds to oral carnitine
- Secondary carnitine deficiency — haemodialysis, valproate therapy, prematurity, severe malnutrition
- CPT-II deficiency — the commonest inherited disorder of lipid metabolism in muscle; exercise-induced rhabdomyolysis and myoglobinuria
- Carnitine supplements are widely sold to athletes on the claim that they increase fat burning; controlled trials have not supported this in people with normal carnitine stores
- Vegetarians have lower carnitine intake but synthesise enough; deficiency from diet alone is not seen in health
Definition
Fatty liver (hepatic steatosis) = abnormal accumulation of triglyceride in hepatocytes, exceeding 5% of liver weight.
Mechanism — the Balance
Fat arriving at the liver — free fatty acids from adipose tissue, dietary chylomicron remnants, de novo lipogenesis → vs → Fat leaving the liver — β-oxidation, and export as VLDL → Imbalance → triglyceride accumulates
Causes Grouped BY Mechanism
| Mechanism | Causes |
|---|---|
| ↑ Supply of fatty acids | Obesity, diabetes, starvation, high-fat diet, corticosteroids |
| ↑ De novo lipogenesis | High carbohydrate and fructose intake, insulin resistance |
| ↓ β-oxidation | Alcohol (↑ NADH), carnitine deficiency, tetracycline |
| ↓ VLDL export | Choline or protein deficiency (kwashiorkor), carbon tetrachloride, puromycin (block apoprotein synthesis), abetalipoproteinaemia |
Alcohol — WHY It Is So Potent
- Alcohol oxidation generates a large excess of NADH
- The high NADH:NAD+ ratio inhibits β-oxidation and the TCA cycle
- It also favours triglyceride synthesis from the accumulating glycerol-3-phosphate
- Acetaldehyde damages the microtubules needed for VLDL secretion
- The result is the earliest and most reversible stage of alcoholic liver disease
Lipotropic Factors
Lipotropic factors = substances that prevent or reverse fatty liver, chiefly by promoting phospholipid synthesis and hence VLDL export.
| Factor | Role |
|---|---|
| Choline | Directly needed for phosphatidylcholine (lecithin), the chief phospholipid of the VLDL surface |
| Methionine | Provides methyl groups via SAM to make choline |
| Betaine, folate, vitamin B12 | Support methyl group transfer |
| Essential fatty acids | Phospholipid synthesis |
| Vitamin E and selenium | Antioxidant protection |
Applied Aspects
- Non-alcoholic fatty liver disease (NAFLD) is now the commonest liver disease worldwide and the hepatic manifestation of the metabolic syndrome
- It may progress: steatosis → steatohepatitis (NASH) → fibrosis → cirrhosis → hepatocellular carcinoma
- Simple steatosis is reversible — weight loss, exercise, control of diabetes and stopping alcohol are the mainstay; no drug is firmly established
- Reye syndrome — acute microvesicular fatty liver with encephalopathy in children given aspirin during a viral illness
Definition
Essential fatty acids = polyunsaturated fatty acids that cannot be synthesised by man and must be supplied in the diet.
- Man lacks desaturases beyond carbon 9, so a double bond cannot be introduced at position ω-3 or ω-6
The Essential Fatty Acids
| Fatty acid | Carbons : double bonds | Family | Source |
|---|---|---|---|
| Linoleic acid | 18 : 2 | ω-6 | Sunflower, safflower, corn, soybean oil |
| α-Linolenic acid | 18 : 3 | ω-3 | Flaxseed, mustard, walnut, soybean oil |
| Arachidonic acid | 20 : 4 | ω-6 | Semi-essential — made from linoleic acid |
| EPA and DHA | 20:5 and 22:6 | ω-3 | Fish oil; made poorly from α-linolenic acid |
Functions
- Precursors of eicosanoids — prostaglandins, thromboxanes and leukotrienes, all derived from arachidonic acid
- Membrane structure and fluidity; phospholipid components
- DHA is a major structural lipid of the retina and brain — critical in fetal and infant development
- Lower plasma cholesterol and LDL; ω-3 lowers triglyceride and has antithrombotic and anti-inflammatory effects
- Maintain the integrity of skin and the epidermal water barrier
- Needed for normal reproduction and growth
Deficiency
- Scaly dermatitis and increased transepidermal water loss
- Poor wound healing, hair loss
- Growth retardation in children; thrombocytopenia
- Fatty liver
- Rare on a normal diet; seen in prolonged fat-free parenteral nutrition and severe fat malabsorption
The Ω-6 : Ω-3 Ratio
- Both families compete for the same desaturase and elongase enzymes
- ω-6 derived eicosanoids are broadly pro-inflammatory and pro-aggregatory; ω-3 derived ones are less so
- A ratio of about 5:1 to 10:1 is recommended; the modern diet is often 15–20:1 because of the heavy use of ω-6 rich seed oils
Applied Aspects
- Fish oil (ω-3) reduces plasma triglyceride substantially and is used in severe hypertriglyceridaemia
- Infant formula is fortified with DHA, since breast milk supplies it and it is needed for retinal and neural development
- Trans fats, produced by partial hydrogenation of vegetable oils, raise LDL and lower HDL — the worst combination; now restricted by law in many countries including India
- Prolonged parenteral nutrition requires intravenous lipid emulsion to prevent essential fatty acid deficiency, which can appear within 2–4 weeks
Definition
Eicosanoids = biologically active 20-carbon compounds derived from arachidonic acid and related fatty acids. They include prostaglandins, thromboxanes, prostacyclin and leukotrienes.
- They act as local hormones (autacoids) — produced on demand, acting near their site of formation, and rapidly destroyed
- They are not stored
Synthesis
Membrane phospholipid → phospholipase A2 — inhibited by corticosteroids → arachidonic acid → Two routes
| Pathway | Enzyme | Products | Inhibited by |
|---|---|---|---|
| Cyclo-oxygenase | COX-1 and COX-2 | Prostaglandins, thromboxane, prostacyclin | Aspirin, NSAIDs |
| Lipoxygenase | 5-lipoxygenase | Leukotrienes | Zileuton; receptors blocked by montelukast |
Chief Actions
| Eicosanoid | Source | Chief actions |
|---|---|---|
| PGE2 | Most tissues | Vasodilatation, pain, fever; protects gastric mucosa; contracts uterus |
| PGF2α | Uterus | Uterine contraction; bronchoconstriction; luteolysis |
| PGI2 (prostacyclin) | Vascular endothelium | Vasodilatation; inhibits platelet aggregation |
| TXA2 (thromboxane) | Platelets | Vasoconstriction; promotes platelet aggregation |
| Leukotrienes (LTC4, D4, E4) | Leucocytes, mast cells | Bronchoconstriction (1000× histamine), ↑ vascular permeability — the slow reacting substance of anaphylaxis |
| LTB4 | Neutrophils | Powerful chemotaxis |
CLINICAL PEARL
Prostacyclin and thromboxane are physiological opposites — the balance between endothelial PGI2 and platelet TXA2 determines whether blood clots on a vessel wall.
WHY Low-dose Aspirin Works
Low-dose aspirin irreversibly acetylates COX → Platelets have NO nucleus → cannot make new COX → Effect lasts the platelet's whole 8–12 day lifespan → Endothelial cells can resynthesise COX and recover → Net result: TXA2 suppressed, PGI2 preserved → antithrombotic
Applied Aspects
- NSAIDs relieve pain, fever and inflammation by blocking COX; the gastric ulceration is caused by loss of protective PGE2, not by local acidity
- Selective COX-2 inhibitors spare the stomach but shift the balance toward thromboxane → increased cardiovascular risk
- Corticosteroids inhibit phospholipase A2 (through lipocortin) → block both pathways — hence more powerful than NSAIDs
- Montelukast blocks leukotriene receptors in asthma
- Therapeutic prostaglandins — misoprostol (ulcer prevention), dinoprostone (labour induction), latanoprost (glaucoma), alprostadil (to keep the ductus arteriosus open)
Definition
Lipoprotein lipase (LPL) = the enzyme on the luminal surface of capillary endothelium that hydrolyses triglyceride in chylomicrons and VLDL, releasing free fatty acids for uptake by tissues.
Site and Properties
| Feature | Detail |
|---|---|
| Location | Anchored by heparan sulphate to capillary endothelium |
| Tissues | Adipose tissue, skeletal and cardiac muscle, lactating mammary gland |
| Activator | Apo C-II — essential |
| Inhibitor | Apo C-III |
| Released by | Heparin — hence the old name "clearing factor lipase" |
| Induced by | Insulin (adipose tissue) |
Tissue-specific KM — How One Enzyme Does Two Jobs
| Tissue | Km | Consequence |
|---|---|---|
| Adipose tissue | High | Active only when triglyceride is plentiful, as after a meal → fat is stored |
| Cardiac and skeletal muscle | Low | Active even when triglyceride is scarce, as in fasting → fat is used for energy |
- The same enzyme therefore directs fat to storage after a meal and to oxidation during fasting, purely through its kinetic properties
- No hormone is needed to make the switch — the Km difference does it automatically
Related Lipases
| Enzyme | Site | Substrate | Regulation |
|---|---|---|---|
| Lipoprotein lipase | Capillary endothelium | Chylomicron and VLDL triglyceride | Insulin ↑; apo C-II |
| Hormone-sensitive lipase | Inside the adipocyte | Stored triglyceride | Glucagon and adrenaline ↑ (phosphorylation); insulin ↓ |
| Hepatic lipase | Liver sinusoids | IDL and HDL triglyceride | — |
| Pancreatic lipase | Intestinal lumen | Dietary triglyceride | Needs colipase and bile salts |
CLINICAL PEARL
Do not confuse the two adipose enzymes: lipoprotein lipase brings fat IN to the fat cell and is stimulated by insulin; hormone-sensitive lipase sends fat out and is inhibited by insulin.
Applied Aspects
- Type I hyperlipoproteinaemia — deficiency of lipoprotein lipase or apo C-II → massive chylomicronaemia, eruptive xanthomas, lipaemia retinalis and recurrent acute pancreatitis
- Post-heparin lipolytic activity is measured to diagnose LPL deficiency
- In uncontrolled diabetes low insulin means low LPL activity → chylomicrons and VLDL are cleared poorly → hypertriglyceridaemia
- Fibrates lower triglyceride partly by inducing lipoprotein lipase through PPAR-α
Definition
Phospholipids = complex lipids containing phosphoric acid, in which one hydroxyl of glycerol (or sphingosine) is esterified to phosphate and a nitrogenous base.
- They are amphipathic — a hydrophilic head and hydrophobic tails — which is why they form bilayers
Classification
| Type | Example | Note |
|---|---|---|
| Glycerophospholipids | Lecithin (phosphatidylcholine) | The most abundant in membranes and in bile |
| — | Cephalin (phosphatidylethanolamine) | Membranes; clotting |
| — | Phosphatidylserine | Normally on the inner leaflet; its appearance outside signals apoptosis and triggers coagulation |
| — | Phosphatidylinositol | Source of IP3 and DAG second messengers |
| — | Cardiolipin | Only in the inner mitochondrial membrane; the antigen in the VDRL test |
| Sphingophospholipid | Sphingomyelin | Rich in myelin; accumulates in Niemann–Pick disease |
Functions
- Structural — the basic framework of all biological membranes
- Lung surfactant — dipalmitoyl phosphatidylcholine is the chief surface-active agent
- Lipoprotein structure — forms the amphipathic surface coat
- Signal transduction — phosphatidylinositol yields IP3 and DAG
- Source of arachidonic acid for eicosanoids
- Bile — lecithin keeps cholesterol in solution, preventing gallstones
- Lipotropic action — needed for VLDL export from the liver
- Blood coagulation — platelet phospholipid (factor 3) provides the surface for the clotting cascade
Lung Surfactant
- Secreted by type II pneumocytes from about the 24th–28th week of gestation; adequate by 35 weeks
- Composition — 90% lipid (chiefly dipalmitoyl phosphatidylcholine), 10% protein (SP-A, B, C, D)
- Reduces alveolar surface tension → prevents collapse, increases compliance, keeps alveoli dry
- Lecithin : sphingomyelin ratio > 2 in amniotic fluid indicates lung maturity
Applied Aspects
- Respiratory distress syndrome of the newborn — surfactant deficiency in prematurity; treated with exogenous surfactant and prevented by antenatal corticosteroids, which accelerate its synthesis
- Niemann–Pick disease — sphingomyelinase deficiency → sphingomyelin accumulates → hepatosplenomegaly and a cherry-red spot
- Antiphospholipid syndrome — antibodies against phospholipid-binding proteins → paradoxical thrombosis with a prolonged APTT; recurrent fetal loss
- Cardiolipin antibodies account for the biological false positive VDRL in SLE
Definition
Atherosclerosis = a chronic inflammatory disease of large and medium-sized arteries, in which lipid, inflammatory cells and fibrous tissue accumulate in the intima to form a plaque.
Biochemical Pathogenesis
Endothelial injury — hypertension, smoking, hyperglycaemia, turbulent flow → LDL enters the intima and is retained by proteoglycans → oxidation of LDL — the key step → Oxidised LDL taken up by macrophages via scavenger receptors → Scavenger receptors are not down-regulated by cholesterol → foam cells → fatty streak → Smooth muscle migration, collagen → fibrous plaque → Plaque rupture → thrombosis → infarction
- The crucial point is that the scavenger receptor has no feedback control — the macrophage keeps engulfing oxidised LDL until it becomes a foam cell
Lipid Risk Factors
| Marker | Desirable | Risk |
|---|---|---|
| Total cholesterol | < 200 mg/dL | > 240 high |
| LDL cholesterol | < 100 mg/dL | > 160 high; < 70 in established disease |
| HDL cholesterol | > 40 (men), > 50 (women) | < 40 is an independent risk factor |
| Triglyceride | < 150 mg/dL | > 200 high |
| Lp(a) | < 30 mg/dL | Independent risk factor |
| Total : HDL ratio | < 4.5 | Higher is worse |
Non-lipid Contributors
- Homocysteine — damages endothelium; raised in folate, B6 and B12 deficiency
- Diabetes — glycation of LDL makes it more atherogenic and less well cleared
- Smoking — oxidative stress, endothelial injury, ↓ HDL
- Hypertension — mechanical injury and increased LDL entry
- Inflammation — hs-CRP is a marker of risk
- Small dense LDL is far more atherogenic than large buoyant LDL
WHY HDL Is Protective
- Reverse cholesterol transport — the only route by which peripheral cholesterol reaches the liver for excretion
- Antioxidant — carries paraoxonase, which prevents LDL oxidation
- Anti-inflammatory and antithrombotic
- Raised by exercise, moderate alcohol, oestrogen and stopping smoking
Applied Aspects
- Statins are the mainstay — they lower LDL and also stabilise the plaque, an effect partly independent of cholesterol lowering
- Ezetimibe blocks intestinal absorption; PCSK9 inhibitors prevent degradation of the LDL receptor, giving very large reductions
- Antioxidant vitamins have failed in trials despite the oxidation hypothesis — a reminder that a plausible mechanism does not guarantee benefit
- Indians develop coronary disease a decade earlier and at lower LDL levels than Western populations, with a characteristic pattern of low HDL, high triglyceride and raised Lp(a)
Definition
Electron transport chain (respiratory chain) = a series of carriers in the inner mitochondrial membrane that transfer electrons from NADH and FADH2 to oxygen, releasing energy used to pump protons.
| Feature | Detail |
|---|---|
| Site | Inner mitochondrial membrane |
| Purpose | Reoxidise NADH and FADH2 and create the proton gradient |
| Final acceptor | Molecular oxygen → water |
| Absent in | RBC (no mitochondria) |
| Accounts for | About 90% of all ATP produced |
- The inner membrane is impermeable to ions and rich in cardiolipin — both essential for holding the gradient
- Its cristae greatly increase the surface area
The Four Complexes
| Complex | Name | Prosthetic groups | Protons pumped |
|---|---|---|---|
| I | NADH–CoQ reductase | FMN, Fe–S centres | 4 H+ |
| II | Succinate–CoQ reductase | FAD, Fe–S | None |
| III | CoQ–cytochrome c reductase | Cytochromes b and c1, Fe–S | 4 H+ |
| IV | Cytochrome oxidase | Cytochromes a and a3, 2 copper centres | 2 H+ |
| V | ATP synthase | F0 and F1 subunits | Uses the gradient to make ATP |
The two mobile carriers
- Coenzyme Q (ubiquinone) — lipid-soluble, moves freely within the membrane; the only non-protein carrier; collects electrons from both complex I and complex II
- Cytochrome c — a small water-soluble protein on the outer face of the inner membrane; carries one electron at a time
Sequence of Electron Flow
NADH → Complex I → Succinate (FADH2) → Complex II → Both feed into coenzyme Q → Complex III → cytochrome c → Complex IV → ½ O2 + 2H+ → H2O
- Electrons flow down a redox gradient, from NAD+/NADH (−0.32 V) to O2/H2O (+0.82 V)
- The total drop of 1.14 V releases about 52 kcal/mol — enough for roughly 3 ATP, of which about 40% is captured
- FADH2 enters after complex I, bypassing one proton-pumping site — which is exactly why it yields 1.5 ATP against 2.5 for NADH
Other Substrates Entering at Coq
- Glycerol-3-phosphate dehydrogenase — the glycerophosphate shuttle
- Acyl-CoA dehydrogenase of β-oxidation, via ETF
- Choline dehydrogenase
- All are FAD-linked and therefore yield 1.5 ATP
Inhibitors
| Site blocked | Inhibitor | Note |
|---|---|---|
| Complex I | Rotenone, amytal, piericidin, MPTP | Rotenone is an insecticide and fish poison; MPTP causes parkinsonism |
| Complex II | Malonate, carboxin | Competitive with succinate |
| Complex III | Antimycin A, BAL | — |
| Complex IV | Cyanide, carbon monoxide, azide, H2S | The most rapidly lethal |
| ATP synthase | Oligomycin | Blocks the F0 proton channel |
| ADP/ATP translocase | Atractyloside | Prevents ADP entering the matrix |
CLINICAL PEARL
The consequence of any block is the same: electron flow stops, NADH accumulates, the proton gradient collapses and ATP synthesis ceases. Cells then depend entirely on glycolysis, producing lactic acidosis. Tissues with the highest demand — brain and heart — fail first.
Cyanide and Carbon Monoxide Poisoning
- Cyanide binds the ferric iron of cytochrome a3 with very high affinity → histotoxic hypoxia: oxygen is delivered but cannot be used
- Features — headache, confusion, seizures, bitter almond odour, and characteristically bright red venous blood with a high venous oxygen saturation, since the tissues extract none
- Treatment — sodium nitrite to form methaemoglobin, which competes for cyanide; sodium thiosulphate to form thiocyanate; hydroxocobalamin to form cyanocobalamin; 100% oxygen
- Carbon monoxide binds both haemoglobin and cytochrome oxidase; treated with 100% or hyperbaric oxygen
Iron–sulphur Proteins
- Non-haem iron proteins in which iron is bound to cysteine sulphur and inorganic sulphide
- Present in complexes I, II and III, and in aconitase
- One-electron carriers, cycling between Fe3+ and Fe2+
- Configurations — Fe2S2 and Fe4S4
- Iron deficiency therefore impairs the chain before anaemia appears, contributing to fatigue and poor exercise tolerance
Applied Aspects
- Mitochondrial diseases are maternally inherited and affect high-energy tissues — brain, heart, skeletal muscle, retina. Examples: melas, MERRF, Leber hereditary optic neuropathy, Leigh syndrome
- Heteroplasmy — a cell contains both normal and mutant mitochondrial DNA; disease appears only above a threshold, which explains the variable severity
- Ragged red fibres on muscle biopsy are the classical finding
- Coenzyme Q10 deficiency is one of the few treatable mitochondrial disorders; statins may lower CoQ10 and contribute to myopathy
- Reperfusion injury — restoring oxygen to ischaemic tissue floods a damaged chain with electrons, generating free radicals
Definition
Oxidative phosphorylation = the synthesis of ATP from ADP and inorganic phosphate, driven by the energy released as electrons pass down the respiratory chain to oxygen.
- Site — inner mitochondrial membrane
- Accounts for about 90% of the ATP made by an aerobic cell
- Distinguished from substrate-level phosphorylation, which needs no oxygen and no membrane
The Chemiosmotic Theory
Proposed by Peter Mitchell (1961; Nobel Prize 1978). The energy of electron transport is conserved not as a chemical intermediate but as an electrochemical proton gradient across the inner membrane.
Electrons pass along the chain → Complexes I, III and IV pump H+ from matrix to intermembrane space → Creates a proton motive force → Two components: a pH gradient and a membrane potential → Protons flow back through the F0 channel of ATP synthase → ATP is synthesised
- The membrane potential is about −150 to −180 mV, matrix side negative
- The membrane must be intact and impermeable to protons — this is why the theory predicts that anything making it leaky will uncouple the process
Evidence supporting the theory
- An intact membrane is essential — disrupted mitochondria oxidise substrate but make no ATP
- Electron transport generates a measurable pH and voltage gradient
- Uncouplers, which carry protons across, abolish ATP synthesis without blocking electron flow
- An artificial pH gradient alone can drive ATP synthesis in the absence of any substrate
ATP Synthase (complex V)
| Part | Location | Function |
|---|---|---|
| F0 | Spans the membrane | Proton channel; the c-ring rotates as protons pass. Blocked by oligomycin |
| F1 | Projects into the matrix | Catalytic head, α3β3γδε; the three β subunits make ATP |
- Binding change mechanism (Boyer and Walker, Nobel Prize 1997) — rotation of the γ subunit drives each β subunit through three states: Loose (binds ADP + Pi), Tight (forms ATP), Open (releases ATP)
- The energy is used to release the ATP, not to form the bond — a counter-intuitive point worth stating
- About 4 protons are needed per ATP, including one for transporting phosphate
- It is a rotary molecular motor, and can run in reverse as an ATPase
P:o Ratio
P:O ratio = molecules of ATP formed per atom of oxygen reduced.
| Substrate | Entry point | H+ pumped | ATP yield |
|---|---|---|---|
| NADH | Complex I | 10 | 2.5 (older texts 3) |
| FADH2 | Complex II or CoQ | 6 | 1.5 (older texts 2) |
| Ascorbate | Cytochrome c | 2 | 0.5 |
- The modern values are non-integral because the proton requirement per ATP is not a whole number
Regulation — Respiratory Control
- ADP availability is the chief regulator — oxidation and phosphorylation are tightly coupled
- A rise in ADP (that is, energy use) immediately accelerates respiration; this is acceptor control
- Respiratory control ratio = rate with ADP ÷ rate without; a measure of mitochondrial integrity
- The ATP:ADP ratio is therefore the master signal linking demand to fuel oxidation
- Thyroid hormone increases the number of mitochondria and respiratory chain components, raising basal metabolic rate
Transport Systems of the Inner Membrane
| Transporter | Carries | Significance |
|---|---|---|
| Adenine nucleotide translocase | ADP in, ATP out | Inhibited by atractyloside |
| Phosphate carrier | Pi with H+ | Supplies phosphate for ATP synthesis |
| Dicarboxylate and tricarboxylate carriers | Malate, citrate | Link cytosolic and mitochondrial metabolism |
| Carnitine shuttle | Fatty acyl groups | β-oxidation |
| Pyruvate carrier | Pyruvate | Feeds the PDH complex |
Coupling and its Loss
| State | Electron transport | ATP synthesis | Example |
|---|---|---|---|
| Coupled (normal) | Proceeds when ADP available | Proceeds | Healthy mitochondria |
| Uncoupled | ↑↑ Maximal | Abolished | 2,4-DNP, thermogenin |
| Inhibited chain | Stops | Stops | Cyanide, antimycin |
| Inhibited synthase | Stops secondarily | Stops | Oligomycin |
| Resting (state 4) | Slow | Slow | ADP limiting |
Applied Aspects
- Uncouplers dissipate the gradient → energy appears as heat. 2,4-dinitrophenol was sold as a slimming drug in the 1930s and caused fatal hyperthermia; it is still bought illicitly and still kills
- Brown adipose tissue uncouples physiologically through thermogenin (UCP-1) to generate heat in the newborn
- Thyrotoxicosis — excess thyroxine partially uncouples and increases chain components, producing heat intolerance, weight loss and a raised metabolic rate
- Aspirin overdose uncouples oxidative phosphorylation, causing hyperthermia and metabolic acidosis alongside the respiratory alkalosis
- Oligomycin blocks ATP synthesis but not electron transport initially — the gradient builds up and then halts the chain, which distinguishes it from an uncoupler
Bioenergetics and Free Energy
Bioenergetics = the study of energy transformations in living systems.
| Term | Meaning |
|---|---|
| ΔG (free energy change) | The energy available to do useful work |
| Exergonic | ΔG negative — energy released; spontaneous |
| Endergonic | ΔG positive — energy required; not spontaneous |
| ΔG = 0 | The reaction is at equilibrium |
| ΔG°′ | Standard free energy change at pH 7.0, 25 °C, 1 M |
- ΔG depends on the actual concentrations, not only on ΔG°′ — which is why reactions with a positive ΔG°′ still proceed in the cell when the product is removed
- Endergonic reactions are driven by coupling to an exergonic one, usually ATP hydrolysis, through a shared intermediate
Definition of a High-energy Compound
High-energy compounds = compounds whose hydrolysis releases a large amount of free energy, conventionally ΔG°′ more negative than −7 kcal/mol (−30 kJ/mol).
- The bond is written ~ (a squiggle), though it is not a special kind of chemical bond — the energy comes from the greater stability of the products, through resonance and relief of charge repulsion
Classification with Values
| Compound | ΔG°′ (kcal/mol) | Type |
|---|---|---|
| Phosphoenolpyruvate | −14.8 | Enol phosphate — the highest |
| Carbamoyl phosphate | −12.3 | Acyl phosphate |
| 1,3-Bisphosphoglycerate | −11.8 | Acyl phosphate |
| Creatine phosphate | −10.3 | Phosphagen (guanidino phosphate) |
| Acetyl-CoA | −7.5 | Thioester |
| ATP → ADP + Pi | −7.3 | Pyrophosphate |
| Glucose-1-phosphate | −5.0 | Low energy |
| Glucose-6-phosphate | −3.3 | Low energy |
| Glycerol-3-phosphate | −2.2 | Low energy — the lowest |
CLINICAL PEARL
ATP sits deliberately in the middle of the range. That is the whole point. It can be formed by compounds above it and can donate phosphate to those below it — making it a universal intermediate rather than a dead end. A molecule at either extreme could not serve as currency.
ATP — the Energy Currency
- Structure — adenine + ribose + three phosphates; the β and γ phosphates carry high-energy bonds
- Turnover is enormous — a resting adult makes and uses about 40–70 kg of ATP a day, while the body contains only about 50 g at any moment
- Total cellular concentration is only 2–5 mM; it is a transmitter of energy, not a store
- ATP → amp + PPi releases about 10 kcal, since the pyrophosphate is then hydrolysed — used to drive reactions that must not reverse, such as fatty acid activation and aminoacyl-tRNA formation
Uses of ATP
- Chemical work — biosynthesis
- Mechanical work — muscle contraction, cilia, chromosome movement
- Transport work — Na+/K+-ATPase and other pumps
- Electrical work — maintaining membrane potential
- Heat production
- Precursor of cAMP, and a component of NAD, FAD and coenzyme A
Creatine Phosphate — the Immediate Buffer
Rest: ATP + creatine → creatine phosphate + ADP → Exercise: creatine phosphate + ADP → ATP + creatine → Enzyme: creatine kinase, freely reversible
- Present at 4–5 times the concentration of ATP in muscle
- Supplies energy for the first 5–8 seconds of maximal effort, before glycolysis takes over
- Because it is higher on the scale than ATP, it can regenerate ATP directly — a phosphagen
Sources of High-energy Phosphate
| Source | Mechanism | Contribution |
|---|---|---|
| Oxidative phosphorylation | Proton gradient | About 90% |
| Glycolysis | Substrate-level (2 steps) | Small but oxygen-independent |
| TCA cycle | Substrate-level (succinate thiokinase → GTP) | 1 per turn |
| Creatine phosphate | Creatine kinase | Immediate buffer |
| Adenylate kinase | 2 ADP ↔ ATP + amp | Salvages energy; generates the amp that signals depletion |
Applied Aspects
- Cyanide, carbon monoxide and any block of the respiratory chain stop ATP production, and death follows within minutes — the brain has almost no reserve
- Rigor mortis occurs because ATP is required to release the actin–myosin cross-bridge; without it the muscle stays contracted
- Creatine supplements raise the muscle phosphocreatine pool and improve performance in short bursts of high-intensity exercise
- Creatine kinase measurement — CK-MB in myocardial infarction, CK-MM in muscular dystrophy and rhabdomyolysis
- Ischaemia depletes ATP within seconds, and the amp formed is degraded to urate — which is why serum urate rises after a myocardial infarction or seizure
- The Na+/K+-ATPase alone consumes 20–30% of resting ATP, and far more in the kidney and brain
- Hypothermia during cardiac surgery lowers ATP demand and protects the brain — the practical use of the temperature dependence of metabolism
Definition
Free radical = any atom or molecule containing one or more unpaired electrons in its outer orbital, making it highly reactive and short-lived.
- They react by stealing an electron from a neighbouring molecule, which itself becomes a radical — a self-propagating chain reaction
Reactive Oxygen Species
| Species | Formula | Origin | Reactivity |
|---|---|---|---|
| Superoxide anion | O2•− | Leak from complexes I and III; NADPH oxidase; xanthine oxidase | Moderate |
| Hydrogen peroxide | H2O2 | From superoxide, by SOD | Not a radical, but crosses membranes freely and is the precursor of the worst one |
| Hydroxyl radical | OH• | Fenton and Haber–Weiss reactions | The most damaging — reacts with almost anything it meets |
| Singlet oxygen | 1O2 | Photosensitisation | High |
| Peroxynitrite | ONOO− | Superoxide + nitric oxide | Very high |
| Hypochlorous acid | HOCl | Myeloperoxidase in neutrophils | High — bactericidal |
The Fenton reaction
Fe2+ + H2O2 → Fe3+ + OH• + OH−
- This is why free iron and copper are dangerous, and why the body binds them so carefully to transferrin, ferritin and caeruloplasmin
Sources
| Endogenous | Exogenous |
|---|---|
| Respiratory chain leak — 1–3% of oxygen used | Ionising and ultraviolet radiation |
| NADPH oxidase — the respiratory burst of phagocytes | Cigarette smoke, air pollution |
| Xanthine oxidase — especially on reperfusion | Drugs — paracetamol, doxorubicin, bleomycin, paraquat |
| Cytochrome P450 | Heavy metals, pesticides |
| Peroxisomal oxidases; autoxidation of haemoglobin | Hyperoxia — oxygen therapy |
Mechanisms of Damage
| Target | Damage | Marker |
|---|---|---|
| Lipids | Lipid peroxidation of membrane polyunsaturated fatty acids → loss of fluidity and integrity | Malondialdehyde (MDA); 4-hydroxynonenal |
| Proteins | Oxidation of –SH groups, fragmentation, cross-linking → loss of enzyme activity | Protein carbonyls |
| DNA | Base modification, strand breaks → mutation and carcinogenesis | 8-hydroxydeoxyguanosine |
| Carbohydrates | Depolymerisation of hyaluronic acid | Loss of joint lubrication |
- Lipid peroxidation is a chain reaction — one radical can destroy many fatty acid molecules until an antioxidant terminates it
Antioxidant Defences
A. Enzymatic
| Enzyme | Reaction | Cofactor |
|---|---|---|
| Superoxide dismutase (SOD) | 2 O2•− → H2O2 + O2 | Cu and Zn (cytosol); Mn (mitochondria) |
| Catalase | 2 H2O2 → 2 H2O + O2 | Haem; in peroxisomes |
| Glutathione peroxidase | H2O2 + 2 GSH → 2 H2O + GSSG | Selenium |
| Glutathione reductase | GSSG → 2 GSH | NADPH from the HMP shunt |
B. Non-enzymatic
- Vitamin E — the chief lipid-phase antioxidant; breaks the lipid peroxidation chain
- Vitamin C — the chief aqueous-phase antioxidant; regenerates vitamin E
- Glutathione — the most abundant intracellular thiol
- β-Carotene — quenches singlet oxygen
- Uric acid — a major plasma antioxidant, which is one argument for not lowering it excessively
- Bilirubin — an effective antioxidant, possibly explaining a benefit of mild unconjugated hyperbilirubinaemia
- Trace elements — selenium, zinc, copper, manganese as enzyme cofactors
- Metal-binding proteins — transferrin, ferritin, caeruloplasmin, albumin; they prevent the Fenton reaction
Free Radicals in Disease
| Condition | Role of free radicals |
|---|---|
| Atherosclerosis | Oxidation of LDL → foam cell formation — the key step |
| Cancer | DNA damage and mutation |
| Ageing | Cumulative oxidative damage — the free radical theory |
| Reperfusion injury | Xanthine oxidase burst when oxygen returns to ischaemic tissue |
| Neurodegeneration | Parkinson and Alzheimer disease; SOD1 mutation causes familial ALS |
| Retinopathy of prematurity, bronchopulmonary dysplasia | Oxygen therapy in an infant with immature defences |
| Rheumatoid arthritis | Neutrophil-derived radicals in the joint |
| Cataract | Lens protein oxidation and cross-linking |
| Paracetamol and CCl4 toxicity | Reactive metabolites deplete glutathione |
Applied Aspects
- N-acetylcysteine replenishes glutathione — the antidote in paracetamol poisoning; the clearest therapeutic success of antioxidant reasoning
- Large trials of antioxidant vitamin supplements have been disappointing, and β-carotene increased lung cancer in smokers. A convincing mechanism does not guarantee that supplementation helps
- Dietary antioxidants from whole foods behave differently from isolated supplements — the practical advice remains fruit and vegetables, not pills
- Free radicals are not simply harmful — the respiratory burst kills bacteria, and nitric oxide is a signalling molecule. Its absence causes chronic granulomatous disease
Definition
Biological oxidation = the enzymatic removal of hydrogen or electrons from a substrate in living cells, releasing energy in controlled steps.
- Unlike combustion, it proceeds at body temperature, in small steps, with much of the energy conserved as ATP
Classification of Oxidoreductases
| Class | Action | Examples |
|---|---|---|
| Oxidases | Transfer electrons to O2, forming water | Cytochrome oxidase |
| — | Form H2O2 instead | Xanthine oxidase, D-amino acid oxidase, monoamine oxidase |
| Dehydrogenases | Remove hydrogen; the acceptor is not oxygen | NAD-linked (lactate, malate DH); FAD-linked (succinate DH) |
| Hydroperoxidases | Use H2O2 as substrate | Catalase, peroxidases |
| Oxygenases | Incorporate oxygen into the substrate | See below |
Oxygenases
| Type | Oxygen atoms incorporated | Examples |
|---|---|---|
| Dioxygenase | Both into the substrate | Homogentisate oxidase, tryptophan pyrrolase |
| Monooxygenase (mixed function oxidase) | One into the substrate, one into water | Cytochrome P450, phenylalanine hydroxylase, dopamine β-hydroxylase |
Monooxygenase reaction: RH + O2 + NADPH + H+ → ROH + H2O + NADP+
Cytochrome P450
- A haem-containing superfamily, named because the reduced form binds carbon monoxide and absorbs maximally at 450 nm
- Located chiefly in the smooth endoplasmic reticulum (microsomes) of liver; also mitochondria of adrenal cortex, gonads, kidney
- Requires NADPH and molecular oxygen; works with NADPH-cytochrome P450 reductase
- Over 50 functional isoforms in man; CYP3A4 handles about half of all drugs
Functions
- Drug and xenobiotic metabolism — the largest role
- Steroid hormone synthesis — side-chain cleavage, and the 11-, 17- and 21-hydroxylases
- Vitamin D activation — 25-hydroxylase in liver, 1α-hydroxylase in kidney
- Bile acid synthesis — 7α-hydroxylase
- Fatty acid ω-oxidation; prostaglandin metabolism; cholesterol degradation
Biotransformation of Drugs
| Phase | Reactions | Effect | Enzymes |
|---|---|---|---|
| Phase I | Oxidation, reduction, hydrolysis | Introduces or exposes a functional group; product may be more or less toxic | Cytochrome P450, esterases |
| Phase II | Conjugation — with glucuronate, sulphate, glutathione, glycine, acetate, methyl | Makes the compound water-soluble and excretable; almost always detoxifying | UDP-glucuronyl transferase, sulphotransferase, GST, NAT |
CLINICAL PEARL
Phase I does not necessarily detoxify. It often creates a more reactive metabolite — paracetamol to NAPQI, benzpyrene to its epoxide. Toxicity arises when phase I outpaces phase II, which is exactly what happens in paracetamol overdose and in the induced liver of a chronic alcoholic.
Induction and Inhibition
| Inducers (↑ metabolism, ↓ drug level) | Inhibitors (↓ metabolism, ↑ drug level) |
|---|---|
| Rifampicin | Cimetidine |
| Phenytoin, carbamazepine, phenobarbitone | Erythromycin, clarithromycin |
| Chronic alcohol | Ketoconazole, fluconazole |
| Cigarette smoke (CYP1A2) | Grapefruit juice (CYP3A4) |
| St John's wort | Ritonavir, ciprofloxacin |
| Griseofulvin, glucocorticoids | Acute alcohol, valproate |
- Induction takes days to weeks, since new protein must be made; inhibition is immediate — a practical difference in predicting interactions
- Note that alcohol induces chronically but inhibits acutely
Non-microsomal Oxidation Systems
| Enzyme | Location | Substrate | Clinical relevance |
|---|---|---|---|
| Alcohol dehydrogenase | Cytosol | Ethanol, methanol | Ethanol as antidote in methanol poisoning |
| Aldehyde dehydrogenase | Mitochondria | Acetaldehyde | Disulfiram inhibits it; a common East Asian variant causes flushing |
| Monoamine oxidase | Mitochondrial outer membrane | Catecholamines, serotonin, tyramine | MAO inhibitors and the cheese reaction |
| Xanthine oxidase | Cytosol | Hypoxanthine, xanthine | Allopurinol inhibits it |
| Catalase, peroxidases | Peroxisomes | H2O2 | Antioxidant defence |
Applied Aspects
- Rifampicin causes oral contraceptive failure and destabilises warfarin — the classic examination example of enzyme induction
- Paracetamol overdose — conjugation is saturated, P450 makes NAPQI, glutathione is exhausted and hepatocytes die. Alcoholics and the malnourished are at far greater risk, having induced P450 and low glutathione. Treated with N-acetylcysteine
- Pharmacogenetics — CYP2D6 shows poor and ultrarapid metaboliser phenotypes; codeine is useless in poor metabolisers, who cannot convert it to morphine, and dangerous in ultrarapid ones
- Slow acetylators (NAT2) are prone to isoniazid-induced neuropathy and hepatitis, and to hydralazine-induced lupus — a phase II polymorphism common in India
- Neonates conjugate poorly — immature UDP-glucuronyl transferase explains physiological jaundice and grey baby syndrome with chloramphenicol
- Grapefruit juice inhibits intestinal CYP3A4 → raised levels of statins, calcium channel blockers and ciclosporin; the effect lasts up to 24 hours
- Induction is the reason antitubercular therapy destabilises so many drugs — rifampicin affects contraceptives, warfarin, antiretrovirals and steroids
Definition
Uncouplers = substances that dissociate oxidation from phosphorylation, so electron transport and oxygen consumption continue but ATP is not synthesised; the energy appears as heat.
Mechanism
Uncoupler is a lipid-soluble weak acid → Picks up H+ in the intermembrane space → Carries it across the inner membrane → Releases H+ in the matrix → proton gradient dissipated → ATP synthase has no gradient to use → Energy released as heat
- The membrane is effectively made leaky to protons
- This is strong evidence for the chemiosmotic theory — it predicts exactly this behaviour
Effects
| Parameter | Change |
|---|---|
| Oxygen consumption | Increased (respiration runs unrestrained) |
| Electron transport | Continues, even accelerates |
| ATP synthesis | Decreased or abolished |
| Heat production | Increased — hyperthermia |
| P:O ratio | Falls |
| Respiratory control | Lost |
Chemical and Physiological Uncouplers
| Type | Examples |
|---|---|
| Chemical | 2,4-dinitrophenol (DNP), dinitrocresol, CCCP, FCCP, pentachlorophenol |
| Physiological | Thermogenin (UCP-1) of brown adipose tissue |
| Drugs and metabolites | Salicylates in overdose, thyroxine in excess, unconjugated bilirubin, free fatty acids, valinomycin (ionophore) |
Distinguishing Uncouplers from Inhibitors
| Feature | Uncoupler | Etc inhibitor | ATP synthase inhibitor |
|---|---|---|---|
| Example | 2,4-DNP | Cyanide | Oligomycin |
| Electron transport | ↑ | Stops | Stops secondarily |
| O2 consumption | ↑↑ | ↓↓ | ↓ |
| ATP | ↓ | ↓ | ↓ |
| Heat | ↑↑ | Normal or low | Normal |
| Reversed by uncoupler | — | No | Yes — adding DNP restores electron flow |
CLINICAL PEARL
The last row is the classical discriminating test. Adding an uncoupler restores respiration blocked by oligomycin (the gradient is relieved) but does nothing when the chain itself is blocked by cyanide.
Applied Aspects
- 2,4-dinitrophenol was sold as a slimming drug in the 1930s. It does cause rapid weight loss, but the therapeutic and lethal doses are dangerously close; it caused fatal hyperthermia and cataracts and was banned. It is still bought online and still kills
- Salicylate poisoning — uncoupling produces hyperthermia and metabolic acidosis, on top of the respiratory alkalosis from direct stimulation of the respiratory centre
- Thyrotoxicosis — heat intolerance, sweating, weight loss despite a good appetite, and a raised basal metabolic rate
- Kernicterus — unconjugated bilirubin uncouples brain mitochondria, contributing to the neurological damage
- Malignant hyperthermia is a different mechanism — uncontrolled calcium release and ATP consumption, not uncoupling — but the clinical picture of extreme hyperthermia is similar
Definition
Shuttle systems = mechanisms that transfer the reducing equivalents of cytosolic NADH into the mitochondrion, since the inner membrane is impermeable to NADH itself.
- Necessary because glycolysis generates NADH in the cytosol but the respiratory chain is inside the mitochondrion
- Without them, cytosolic NAD+ could not be regenerated and glycolysis would stop
Malate–aspartate Shuttle
Cytosol: Oxaloacetate + NADH → malate (malate dehydrogenase) → Malate enters via the malate–α-ketoglutarate carrier → Matrix: malate → oxaloacetate + NADH → OAA cannot leave — transaminated to aspartate (ast) → Aspartate returns to the cytosol and is reconverted to OAA
| Feature | Detail |
|---|---|
| Tissues | Liver, kidney, heart |
| Yield | NADH in the matrix → 2.5 ATP |
| Reversible | Yes |
| Enzymes | Malate dehydrogenase and ast, in both compartments |
Glycerophosphate Shuttle
Cytosol: DHAP + NADH → glycerol-3-phosphate → Glycerol-3-phosphate meets mitochondrial glycerol-3-phosphate dehydrogenase (on the outer face of the inner membrane) → This enzyme is FAD-linked → FADH2 → passes electrons directly to coenzyme Q → DHAP returns to the cytosol
| Feature | Detail |
|---|---|
| Tissues | Skeletal muscle, brain, brown adipose tissue, insect flight muscle |
| Yield | FADH2 → 1.5 ATP |
| Reversible | NO — irreversible |
| Advantage | Faster; works even when the matrix NADH:NAD ratio is high |
Comparison
| Feature | Malate–aspartate | Glycerophosphate |
|---|---|---|
| Carrier into mitochondrion | Malate | Glycerol-3-phosphate |
| Product in matrix | NADH | FADH2 |
| ATP yield per NADH | 2.5 | 1.5 |
| ATP per glucose (total) | 32 | 30 |
| Speed | Slower | Faster |
| Reversibility | Reversible | Irreversible |
| Chief tissue | Liver, heart, kidney | Muscle, brain |
CLINICAL PEARL
This is why the ATP yield of glucose is quoted as 30 or 32. The difference is not an inconsistency in the textbooks but a genuine tissue difference: liver uses the more efficient shuttle, muscle the faster one.
Other Transport Systems of the Inner Membrane
- Citrate shuttle — carries acetyl-CoA out for fatty acid synthesis; also generates cytosolic NADPH
- Carnitine shuttle — carries fatty acyl groups in for β-oxidation
- Adenine nucleotide translocase — ADP in, ATP out
- Pyruvate carrier, phosphate carrier, dicarboxylate carrier
Applied Aspects
- The shuttles explain why the same glucose molecule yields different ATP in different tissues — a favourite examination point
- Brown adipose tissue uses the glycerophosphate shuttle heavily, which suits its role in heat production rather than efficient ATP capture
- In alcoholism the cytosolic NADH:NAD+ ratio rises sharply, overwhelming the shuttles and driving pyruvate to lactate and oxaloacetate to malate — hence hypoglycaemia and lactic acidosis
Definition
Brown adipose tissue (bat) = a specialised fat tissue whose function is non-shivering thermogenesis — producing heat rather than storing energy.
Structure and Distinguishing Features
| Feature | Brown adipose tissue | White adipose tissue |
|---|---|---|
| Colour due to | Many mitochondria (cytochromes) and rich blood supply | Little pigment |
| Lipid droplets | MULTIlocular (many small) | UNIlocular (one large) |
| Mitochondria | Numerous, large cristae | Few |
| Nucleus | Central | Peripheral, flattened |
| Innervation | Rich sympathetic supply | Sparse |
| Function | Heat production | Energy storage |
| Sites | Interscapular, nape of neck, around kidneys, aorta and great vessels | Subcutaneous, visceral |
- Abundant in the newborn (about 5% of body weight) and in hibernating animals; largely regresses in adults, though active depots persist and can be detected on pet scanning
Mechanism — Thermogenin (ucp-1)
Cold → hypothalamus → sympathetic discharge → Noradrenaline on β3 receptors → ↑ cAMP → hormone-sensitive lipase → Free fatty acids released — both fuel and activator → Activate thermogenin (UCP-1) in the inner mitochondrial membrane → Protons bypass ATP synthase and re-enter the matrix → Gradient dissipated → energy released as heat
- Thermogenin is a physiological uncoupler — it does the same thing as 2,4-dinitrophenol, but under precise control
- Respiration runs at maximal rate with almost no ATP produced
- Thyroid hormone is permissive, inducing UCP-1 and the type II deiodinase
Physiological Importance
- The newborn cannot shiver effectively and has a large surface area to volume ratio — bat is its chief defence against cold
- Prevents neonatal hypothermia, which would otherwise cause hypoglycaemia, acidosis and increased oxygen consumption
- Arousal from hibernation in animals
- Contributes to diet-induced thermogenesis and to overall energy balance
Applied Aspects
- Preterm infants have little brown fat and are highly prone to hypothermia — the reason for warmers, skin-to-skin care and delivery-room temperature control
- Bat is being explored as a target in obesity; β3 agonists and cold exposure can activate it, but no useful drug has emerged
- Brown fat causes false positive FDG uptake on pet scans, particularly in the neck and supraclavicular region of young thin patients in cold weather — a well-recognised pitfall that may be mistaken for lymph node metastases
- Phaeochromocytoma can activate brown fat through catecholamine excess, contributing to weight loss and heat intolerance
Definition
Superoxide dismutase (SOD) = the enzyme that converts the superoxide anion to hydrogen peroxide and oxygen — the first line of defence against reactive oxygen species.
2 O2•− + 2H+ → H2O2 + O2
Isoforms
| Isoform | Metal | Location | Gene |
|---|---|---|---|
| SOD1 | Cu–Zn | Cytosol, nucleus | Mutated in familial ALS |
| SOD2 | Manganese | Mitochondrial matrix | Induced by oxidative stress |
| SOD3 | Cu–Zn | Extracellular fluid | — |
- Copper, zinc and manganese are all essential for SOD activity — one reason these trace elements are described as antioxidant nutrients
- SOD2 is the most critical, since the mitochondrion is where most superoxide is generated
The Antioxidant Enzyme Cascade
O2•− (superoxide) → superoxide dismutase → H2O2 → Two routes:catalase (peroxisomes) → H2O + O2glutathione peroxidase (selenium) → H2O, using 2 GSH → safe products
- SOD alone is not enough — it produces H2O2, which must be removed, or it will generate the far worse hydroxyl radical by the Fenton reaction
- Glutathione peroxidase depends on NADPH from the HMP shunt to regenerate GSH — which is the link explaining G6PD deficiency
- Catalase has a very high Km and handles large amounts; glutathione peroxidase has a low Km and handles the everyday low concentrations
Other Antioxidant Enzymes
| Enzyme | Function | Cofactor |
|---|---|---|
| Catalase | Destroys H2O2 | Haem (iron) |
| Glutathione peroxidase | Destroys H2O2 and lipid peroxides | Selenium |
| Glutathione reductase | Regenerates GSH | NADPH, FAD (riboflavin) |
| Glutathione S-transferase | Conjugates electrophiles | — |
| Peroxiredoxins, thioredoxin reductase | Reduce peroxides | Selenium |
Applied Aspects
- SOD1 mutations cause about 20% of familial amyotrophic lateral sclerosis — through a toxic gain of function rather than loss of antioxidant activity, which is why simply supplying antioxidants does not help
- Selenium deficiency impairs glutathione peroxidase → Keshan disease (cardiomyopathy) and Kashin–Beck disease
- Acatalasaemia — catalase deficiency; usually mild, with oral ulceration and gangrene
- Chronic granulomatous disease is the mirror image — there the problem is failure to produce superoxide, so bacteria are not killed. Reactive oxygen species are not simply harmful
- Recombinant SOD has been tried therapeutically in reperfusion injury and bronchopulmonary dysplasia, with limited success — it is a large molecule that penetrates cells poorly
Definition
Redox potential (E°′, oxidation–reduction potential) = a measure of the tendency of a substance to donate or accept electrons, expressed in volts relative to the standard hydrogen electrode at pH 7.0.
- More negative E°′ → greater tendency to donate electrons — a stronger reducing agent
- More positive E°′ → greater tendency to accept electrons — a stronger oxidising agent
- Electrons flow spontaneously from negative to positive
Values Along the Respiratory Chain
| Redox couple | E°′ (volts) |
|---|---|
| NAD+ / NADH | −0.32 |
| FAD / FADH2 (complex II) | −0.22 to 0.0 |
| Coenzyme Q | +0.10 |
| Cytochrome b | +0.077 |
| Cytochrome c1 | +0.22 |
| Cytochrome c | +0.25 |
| Cytochrome a | +0.29 |
| Cytochrome a3 | +0.55 |
| ½ O2 / H2O | +0.82 — the highest |
- The carriers are arranged in order of increasing redox potential — this is the organising principle of the chain
- Total drop from NADH to oxygen = 1.14 V
Relation to Free Energy
ΔG°′ = −nFΔE°′where n = number of electrons transferred, F = Faraday constant (23.06 kcal/volt/mol)
- For NADH to oxygen: ΔG°′ = −2 × 23.06 × 1.14 = about −52.6 kcal/mol
- Since ATP synthesis needs about 7.3 kcal/mol, this could in principle make 7 ATP; in practice 2.5 are made — an efficiency of roughly 35–40%, the rest appearing as heat
- A positive ΔE°′ gives a negative ΔG°′, that is, a spontaneous reaction
The Three Coupling Sites
| Site | Between | ΔE°′ | Sufficient for ATP? |
|---|---|---|---|
| Site 1 | NADH → CoQ | 0.42 V | Yes |
| Site 2 | Cytochrome b → cytochrome c1 | 0.21 V | Yes |
| Site 3 | Cytochrome a → O2 | 0.53 V | Yes |
- FADH2 enters after site 1, which is precisely why it yields less ATP
- The "sites" are a historical description; the modern chemiosmotic account describes them as the three proton-pumping complexes (I, III and IV)
Applied Aspects
- Redox potential explains the order of the chain — each carrier must be more positive than the one before, or electrons would not flow
- The NADH:NAD+ ratio determines the direction of many reactions — in alcoholism the rise in NADH drives pyruvate to lactate and oxaloacetate to malate, producing hypoglycaemia, lactic acidosis and fatty liver
- Redox-active drugs — methylene blue, used in methaemoglobinaemia, works by shuttling electrons; paraquat poisons by redox cycling and generating superoxide in the lung
- Ascorbate–dehydroascorbate and GSH–GSSG couples set the redox environment of the cell, which influences enzyme activity and gene expression
Definition
Cytochromes = haem-containing proteins that transfer electrons by reversible change of their iron between Fe3+ and Fe2+.
- They are one-electron carriers, unlike NAD and FAD which carry two
- The name means "cellular pigment" — they have characteristic absorption spectra, which is how they were discovered
Classification
| Type | Haem | Members | Location |
|---|---|---|---|
| Cytochrome a | Haem A | A, a3 | Complex IV (cytochrome oxidase) |
| Cytochrome b | Haem B (protoporphyrin IX) | B562, b566 | Complex II and complex III |
| Cytochrome c | Haem C — covalently bound | C, c1 | C is mobile; c1 in complex III |
| Cytochrome P450 | Haem | Many isoforms | Endoplasmic reticulum; not in the respiratory chain |
Cytochrome C — Special Features
- Small (104 amino acids) and water-soluble
- Loosely attached to the outer surface of the inner membrane, so it shuttles between complexes III and IV
- Highly conserved through evolution — widely used in phylogenetic studies
- Release into the cytosol triggers apoptosis by activating Apaf-1 and caspase-9 — a second, entirely separate function
Cytochrome Oxidase (complex IV)
- Contains cytochromes a and a3 plus two copper centres (CuA and CuB)
- The only cytochrome that reacts directly with oxygen
- Catalyses: 4 cyt c (Fe2+) + O2 + 4H+ → 4 cyt c (Fe3+) + 2H2O
- Reduces oxygen completely to water in one step, holding the intermediates bound so no free radicals escape — a critical safety feature
- Inhibited by cyanide, carbon monoxide, azide and hydrogen sulphide, all binding cytochrome a3
- Copper deficiency impairs it — part of the anaemia and neurological features of Menkes disease
Comparison of Electron Carriers
| Carrier | Electrons carried | Nature | Mobile? |
|---|---|---|---|
| NAD+ | 2 (as hydride) | Niacin-derived coenzyme | Yes — freely diffusible |
| FAD / FMN | 2 | Riboflavin-derived | Bound (prosthetic group) |
| Coenzyme Q | 2 | Lipid, non-protein | Yes — within the membrane |
| Cytochromes | 1 | Haem protein (iron) | Only cytochrome c |
| Iron–sulphur proteins | 1 | Non-haem iron | No |
Applied Aspects
- Cyanide poisoning — binds cytochrome a3; histotoxic hypoxia with bright red venous blood and a high venous oxygen saturation, since tissues cannot extract oxygen
- Cytochrome c release is a central event in apoptosis, and is exploited by many anticancer drugs
- Cytochrome P450 polymorphisms determine individual responses to drugs — codeine, warfarin, clopidogrel
- Iron deficiency reduces cytochrome synthesis, contributing to the fatigue and reduced exercise capacity that precede anaemia
- Mitochondrial DNA encodes several cytochrome subunits, which is why mitochondrial mutations impair the chain and are maternally inherited
Definition
Biotransformation (drug metabolism, detoxification) = the enzymatic conversion of lipid-soluble foreign compounds into water-soluble derivatives that can be excreted.
- Xenobiotic = any compound foreign to the body — drugs, pollutants, food additives, plant toxins
- The chief site is the liver; also intestine, lung, kidney and skin
- Lipid-soluble compounds cannot be excreted by the kidney — they are reabsorbed. Increasing polarity is therefore the whole purpose
Phase I Reactions
| Reaction | Enzyme | Example |
|---|---|---|
| Oxidation — the commonest | Cytochrome P450 (microsomal) | Hydroxylation, dealkylation, deamination |
| — | Non-microsomal — alcohol dehydrogenase, monoamine oxidase, xanthine oxidase | Ethanol, catecholamines |
| Reduction | Nitroreductase, azoreductase | Chloramphenicol, prontosil |
| Hydrolysis | Esterases, amidases | Aspirin, procaine, suxamethonium |
- Phase I introduces or exposes a functional group — –OH, –NH2, –SH, –COOH
- The product may be more toxic than the parent — this is bioactivation
Phase II Reactions — Conjugation
| Conjugation | Donor | Enzyme | Example |
|---|---|---|---|
| Glucuronidation — the commonest | UDP-glucuronic acid | UDP-glucuronyl transferase | Bilirubin, paracetamol, morphine, steroids |
| Sulphation | PAPS | Sulphotransferase | Steroids, paracetamol |
| Glutathione conjugation | Glutathione | Glutathione S-transferase | NAPQI, epoxides → mercapturic acid |
| Acetylation | Acetyl-CoA | N-acetyl transferase (NAT2) | Isoniazid, sulphonamides, hydralazine |
| Methylation | SAM | COMT, TPMT | Catecholamines, 6-mercaptopurine |
| Glycine conjugation | Glycine | Acyl-CoA glycine transferase | Benzoate → hippurate; bile acids |
- Phase II almost always detoxifies and always increases water solubility
- Conjugation requires energy and a donor molecule, both of which can be depleted
CLINICAL PEARL
Toxicity arises when phase I outpaces phase II. In paracetamol overdose, conjugation is saturated, P450 keeps producing NAPQI, and once glutathione is exhausted the reactive metabolite attacks the hepatocyte. This is why an induced P450 and low glutathione — the alcoholic, the malnourished — make a standard overdose far more dangerous.
Factors Affecting Biotransformation
- Age — neonates conjugate poorly (physiological jaundice, grey baby syndrome); the elderly metabolise more slowly
- Genetics — slow and fast acetylators (NAT2); CYP2D6 and CYP2C19 polymorphisms; TPMT deficiency and azathioprine toxicity
- Liver disease — reduced capacity; doses must be lowered
- Nutrition — protein and glutathione depletion impair conjugation
- Enzyme induction and inhibition by other drugs
- Sex and pregnancy; disease states such as hypothyroidism
Applied Aspects
- Prodrugs deliberately exploit phase I — codeine to morphine (CYP2D6), enalapril to enalaprilat, levodopa to dopamine. A poor metaboliser gets no analgesia from codeine
- Slow acetylators are prone to isoniazid neuropathy and hepatitis, and to drug-induced lupus with hydralazine and procainamide — a common phenotype in India
- Crigler–Najjar and Gilbert syndromes are inherited deficiencies of UDP-glucuronyl transferase, causing unconjugated hyperbilirubinaemia
- First-pass metabolism in liver and gut wall determines oral bioavailability — the reason glyceryl trinitrate is given sublingually
- Benzoate and phenylacetate are used therapeutically in urea cycle disorders, conjugating with glycine and glutamine to provide alternative routes of nitrogen excretion
Definition and Purpose
Urea cycle (ornithine cycle, Krebs–Henseleit cycle) = the pathway by which toxic ammonia is converted to non-toxic, water-soluble urea for excretion.
| Feature | Detail |
|---|---|
| Site (organ) | Liver only (a partial cycle exists in kidney and brain) |
| Site (cell) | First 2 steps in mitochondria, last 3 in cytosol |
| Discovered by | Krebs and Henseleit, 1932 — the first metabolic cycle described |
| Urea excreted | 25–30 g/day |
| Blood urea | 20–40 mg/dL |
| Nitrogen | Urea accounts for 80–90% of urinary nitrogen |
The Five Steps
- NH3 + CO2 + 2 ATP → 1.
- Carbamoyl phosphate synthetase I (mitochondria) — rate-limiting → Carbamoyl phosphate → 2.
- Ornithine transcarbamoylase (OTC) + ornithine (mitochondria) → citrulline → leaves the mitochondrion → 3.
- Argininosuccinate synthetase + aspartate + ATP (cytosol) → Argininosuccinate → 4.
- Argininosuccinate lyase → arginine + fumarate → 5.
- Arginase → urea + ornithine (ornithine re-enters)
Key Points on Each Step
| Enzyme | Point to remember |
|---|---|
| CPS-I | Mitochondrial; needs N-acetylglutamate as an obligatory allosteric activator; uses free ammonia. (CPS-II is cytosolic, uses glutamine, and makes pyrimidines) |
| OTC | Deficiency is the commonest urea cycle defect; X-linked |
| Argininosuccinate synthetase | Uses ATP → amp, so 2 high-energy bonds |
| Arginase | Present only in the liver — the reason only the liver makes urea |
Sources of the Two Nitrogens
- First nitrogen — free ammonia, mostly from oxidative deamination of glutamate
- Second nitrogen — from aspartate
- The carbon of urea comes from CO2 (as bicarbonate)
Energetics
2 NH3 + CO2 + 3 ATP → Urea + 2 ADP + amp + 2 Pi + PPi
- 3 ATP are used but 4 high-energy bonds are consumed, because the third ATP goes to amp
- Partly recovered — the fumarate released rejoins the TCA cycle and yields NADH through malate dehydrogenase
Link with the TCA Cycle — the "krebs Bicycle"
Argininosuccinate lyase releases fumarate → Fumarate → malate → oxaloacetate (TCA cycle) → OAA + glutamate → aspartate (transamination by ast) → Aspartate re-enters the urea cycle
- The two cycles are therefore interlocked, sharing fumarate and aspartate
Regulation
| Mechanism | Detail |
|---|---|
| Allosteric | N-acetylglutamate activates CPS-I. It is synthesised from glutamate and acetyl-CoA, stimulated by arginine |
| Substrate availability | A high-protein diet or tissue breakdown → more ammonia → more urea |
| Enzyme induction | All five enzymes are induced by a high-protein diet and by starvation; takes days |
| Hormonal | Glucocorticoids and glucagon induce the enzymes |
Properties and Fate of Urea
- A small, neutral, highly water-soluble molecule; non-toxic even at high concentration
- Contains 2 nitrogen atoms — an efficient carrier
- Freely filtered at the glomerulus; about 40–50% is reabsorbed passively, more when urine flow is low
- Contributes to the medullary osmotic gradient through urea recycling
- A small amount diffuses into the gut, where bacterial urease releases ammonia
| Blood urea | Interpretation |
|---|---|
| ↑ Prerenal | Dehydration, shock, GI bleeding, high-protein diet, catabolic states |
| ↑ Renal | Acute and chronic kidney disease |
| ↑ Postrenal | Obstruction |
| ↓ low | Liver failure, low-protein diet, pregnancy, overhydration |
- A urea : creatinine ratio above 20:1 suggests a prerenal cause
Applied Aspects
- Urea cycle disorders present in the newborn with vomiting, lethargy, seizures and coma, with hyperammonaemia and respiratory alkalosis (ammonia stimulates the respiratory centre) — a useful clue distinguishing them from organic acidaemias, which cause acidosis
- OTC deficiency — commonest; X-linked; carbamoyl phosphate accumulates and spills into pyrimidine synthesis → orotic aciduria without megaloblastic anaemia
- Citrullinaemia (argininosuccinate synthetase) and argininosuccinic aciduria (lyase) are the next commonest
- Treatment — low-protein diet, sodium benzoate and sodium phenylacetate to provide alternative routes of nitrogen excretion, arginine supplementation, and dialysis in crisis
- Hepatic failure → the urea cycle fails → hyperammonaemia and hepatic encephalopathy; blood urea is low, not high
- N-acetylglutamate synthase deficiency mimics CPS-I deficiency and responds to carglumic acid
- Arginase deficiency (argininaemia) is the rarest and presents later, with spastic diplegia rather than neonatal coma
- Liver transplantation is curative in severe urea cycle defects
Introduction
Amino acids are not stored. Their nitrogen must be removed before the carbon skeleton can be oxidised or converted to glucose or fat. The nitrogen appears as ammonia, which is toxic and must be disposed of.
- Normal blood ammonia 10–80 µg/dL
Transamination
Transamination = reversible transfer of an amino group from an amino acid to an α-keto acid, forming a new amino acid and a new keto acid.
- Enzyme — aminotransferase (transaminase)
- Coenzyme — pyridoxal phosphate (vitamin B6), for every transaminase
- No net loss of nitrogen — it only funnels nitrogen into glutamate
- All amino acids undergo transamination except lysine, threonine, proline and hydroxyproline
| Enzyme | Reaction | Clinical use |
|---|---|---|
| ALT (SGPT) | Alanine + α-KG ↔ Pyruvate + glutamate | More specific for liver |
| Ast (SGOT) | Aspartate + α-KG ↔ Oxaloacetate + glutamate | Liver, heart, muscle |
Deamination
A. Oxidative deamination — the chief route
Glutamate + NAD(P)+ + H2O → glutamate dehydrogenase (mitochondria of liver and kidney) → α-Ketoglutarate + NH3 + NAD(P)H
- The only enzyme that can use both NAD+ and NADP+
- Reversible — it can also fix ammonia into glutamate
- Activated by ADP and GDP; inhibited by ATP and GTP
- Transdeamination = transamination followed by oxidative deamination of glutamate. This is how most amino acid nitrogen is finally released
B. Non-oxidative and other routes
- Serine and threonine dehydratase — needs PLP
- D-amino acid oxidase and L-amino acid oxidase — FAD-linked, minor
- Glutaminase — releases ammonia from glutamine, chiefly in kidney
Sources of Ammonia
- Deamination of amino acids in the liver — the largest source
- Intestinal bacteria acting on dietary protein and urea — absorbed into the portal blood
- Glutaminase in the kidney — for acid excretion
- Deamination of purines, pyrimidines and biogenic amines
- Muscle — purine nucleotide cycle during exercise
Transport of Ammonia in Blood
| Carrier | Formed by | Chief role |
|---|---|---|
| Glutamine | Glutamine synthetase (glutamate + NH3 + ATP) | The chief non-toxic carrier; carries ammonia from brain and muscle to liver and kidney |
| Alanine | Transamination of pyruvate in muscle | Glucose–alanine cycle — carries nitrogen and carbon to the liver |
- Glutamine is the most abundant free amino acid in blood — it carries two nitrogens per molecule and is completely non-toxic
Disposal of Ammonia
| Route | Site | Product |
|---|---|---|
| Urea cycle | Liver | Urea — the major route (80–90%) |
| Glutamine formation | Brain, muscle, liver | Glutamine |
| Renal ammoniagenesis | Kidney | NH4+ in urine — for acid excretion |
| Reductive amination | All tissues | Glutamate (glutamate dehydrogenase, reverse) |
Fate of the Carbon Skeletons
| Class | Converted to | Examples |
|---|---|---|
| Purely glucogenic | Pyruvate, α-KG, succinyl-CoA, fumarate, oxaloacetate | Alanine, glycine, serine, glutamate, aspartate, methionine, valine, histidine |
| Purely ketogenic | Acetyl-CoA or acetoacetyl-CoA | Leucine and lysine only |
| Both | Yield glucogenic and ketogenic fragments | Phenylalanine, tyrosine, tryptophan, isoleucine, threonine |
- Mnemonic for the purely ketogenic pair — "Leucine and Lysine, the two L's"
- The seven that are both are worth memorising — PITTT: Phenylalanine, Isoleucine, Threonine, Tryptophan, Tyrosine
Applied Aspects
- Hepatic encephalopathy — the liver cannot make urea, so ammonia accumulates. Treated with lactulose (acidifies the colon, trapping NH4+) and rifaximin (reduces ammonia-producing gut bacteria)
- Why ammonia damages the brain — it is fixed into glutamate and glutamine, draining α-ketoglutarate from the TCA cycle; glutamine accumulation also causes astrocyte swelling
- Transaminases in diagnosis — ALT is more liver-specific; an ast:ALT ratio above 2 suggests alcoholic liver disease
- Vitamin B6 deficiency impairs all transaminations — isoniazid antagonises pyridoxine, hence prophylactic pyridoxine with antitubercular therapy
- Renal ammoniagenesis increases up to ten-fold in chronic acidosis — the most important adaptive mechanism for acid excretion
- Glutamine is the preferred fuel of the enterocyte and of rapidly dividing cells, which is why it is added to parenteral nutrition
- Blood ammonia rises artefactually if the sample is delayed or the tourniquet is tight — send on ice and analyse at once
Introduction
Phenylalanine is an essential aromatic amino acid. Tyrosine is semi-essential — it can be made from phenylalanine, but becomes essential if that conversion fails.
- Both are glucogenic and ketogenic
The Central Reaction
Phenylalanine → Phenylalanine hydroxylase — needs tetrahydrobiopterin (BH4) and O2 → tyrosine
- Irreversible — tyrosine cannot make phenylalanine
- BH4 is regenerated by dihydropteridine reductase
- The same cofactor is needed by tyrosine hydroxylase and tryptophan hydroxylase — which is why BH4 defects are so damaging
Fates of Tyrosine
| Product | Pathway | Site |
|---|---|---|
| Catecholamines | Tyrosine → dopa → dopamine → noradrenaline → adrenaline | Adrenal medulla, sympathetic neurones, brain |
| Melanin | Tyrosine → dopa → dopaquinone → melanin (tyrosinase) | Melanocytes |
| Thyroid hormones | Iodination of tyrosine on thyroglobulin | Thyroid |
| Complete degradation | Tyrosine → homogentisate → fumarate + acetoacetate | Liver |
Degradation Pathway
Tyrosine → Tyrosine transaminase → p-Hydroxyphenylpyruvate → p-Hydroxyphenylpyruvate dioxygenase → homogentisate → homogentisate oxidase → Maleylacetoacetate → Fumarylacetoacetate → fumarate (glucogenic) + acetoacetate (ketogenic)
Disorders — Where Each Block Lies
| Disorder | Enzyme deficient | Accumulates | Key features |
|---|---|---|---|
| Phenylketonuria | Phenylalanine hydroxylase | Phenylalanine, phenylpyruvate | Mental retardation, mousy odour, fair skin, eczema, seizures |
| Tyrosinaemia type I | Fumarylacetoacetate hydrolase | Succinylacetone | Liver failure, renal tubular defect, cabbage-like odour |
| Tyrosinaemia type II | Tyrosine transaminase | Tyrosine | Corneal ulcers, palmar keratosis |
| Alkaptonuria | Homogentisate oxidase | Homogentisic acid | Urine darkens on standing, ochronosis, arthritis |
| Albinism | Tyrosinase | — (melanin not formed) | White skin and hair, photophobia, nystagmus, skin cancer risk |
CLINICAL PEARL
The pattern is worth learning as a sequence: a block early in the pathway (PKU) causes the substrate to spill into abnormal routes; a block late (alkaptonuria) causes accumulation of a pigmented intermediate; a block in a branch (albinism) causes loss of the product only.
Phenylketonuria in Detail
Phenylalanine hydroxylase deficient → Phenylalanine accumulates (> 20 mg/dL; normal 1–2) → Diverted to transamination → Phenylpyruvate, phenyllactate, phenylacetate → Excreted in urine — phenylacetate gives the mousy odour → Phenylalanine competes for the amino acid transporter at the blood–brain barrier → Impaired brain development → mental retardation
- Fair skin and hair — excess phenylalanine inhibits tyrosinase, so melanin falls
- Incidence about 1 in 10,000; autosomal recessive
- Guthrie bacterial inhibition test or tandem mass spectrometry on a heel prick, taken after 48–72 hours of milk feeding
- Treatment — a low phenylalanine diet started within the first weeks of life, continued at least through childhood
- Aspartame must be avoided — it is a phenylalanine-containing dipeptide
- Malignant PKU — defect in BH4 synthesis or in dihydropteridine reductase; diet alone does not help because catecholamine and serotonin synthesis also fail. Needs BH4, L-dopa and 5-hydroxytryptophan
Catecholamine Synthesis and Degradation
Tyrosine → Tyrosine hydroxylase (BH4) — rate-limiting → dopa → dopa decarboxylase (PLP) → dopamine → Dopamine β-hydroxylase (vitamin C, copper) → noradrenaline → PNMT (SAM; induced by cortisol) → adrenaline
- Degraded by MAO and COMT → excreted as VMA and metanephrines
- Dopamine in the brain is degraded to homovanillic acid (HVA)
- Urinary VMA is the screening test for phaeochromocytoma; HVA and VMA for neuroblastoma
Melanin and Thyroid Hormone
- Melanin — tyrosine → dopa → dopaquinone → eumelanin (brown-black) or phaeomelanin (red-yellow, requires cysteine). Enzyme: tyrosinase, a copper enzyme
- Thyroid hormone — tyrosine residues on thyroglobulin are iodinated to MIT and DIT, then coupled to T3 and T4
Applied Aspects
- Maternal PKU — a treated woman who abandons the diet in pregnancy exposes the fetus to high phenylalanine → microcephaly, congenital heart disease and retardation even in a genetically normal baby. Strict dietary control must resume before conception
- Alkaptonuria is usually harmless in childhood; the ochronotic arthritis of the spine and large joints appears after 30. Urine darkens on standing or on adding alkali
- Albinism — the lack of melanin means no protection from ultraviolet light; skin cancer and visual defects are the real dangers
- Newborn screening for PKU is one of the great successes of preventive medicine — a cheap test that prevents irreversible retardation
- Tyrosinaemia type I — treated with nitisinone, which blocks the pathway higher up and prevents the toxic intermediate; a rare example of treating a metabolic block by creating another
- Parkinson disease — loss of nigral dopamine; treated with L-dopa, which crosses the blood–brain barrier whereas dopamine does not
- Carbidopa inhibits peripheral dopa decarboxylase, so more L-dopa reaches the brain and nausea is reduced
- α-Methyldopa produces a false neurotransmitter and was widely used as an antihypertensive in pregnancy
- Vitiligo — acquired autoimmune destruction of melanocytes; distinct from albinism, which is congenital and enzymatic
- Copper deficiency impairs tyrosinase and gives hypopigmented hair, as in Menkes disease
- Maple syrup urine disease — branched-chain α-keto acid dehydrogenase deficiency; sweet-smelling urine, ketoacidosis and neurological damage. It uses the same five coenzymes as the PDH complex
- Hartnup disease — defective tryptophan transport → a pellagra-like rash, since tryptophan is a precursor of niacin
- Carcinoid syndrome — the tumour diverts tryptophan to serotonin → may cause pellagra as well as flushing and diarrhoea
- Tandem mass spectrometry detects more than thirty inborn errors from a single dried blood spot — the modern basis of newborn screening
- Levodopa-induced dyskinesia limits long-term treatment of Parkinson disease and reflects pulsatile rather than continuous dopamine stimulation
The Sulphur-containing Amino Acids
| Amino acid | Essential? | Note |
|---|---|---|
| Methionine | Essential | The chief methyl donor of the body, via SAM |
| Cysteine | Semi-essential | Made from methionine; contains the reactive –SH group |
| Cystine | — | Two cysteines joined by a disulphide bond |
Activation of Methionine — Sam
Methionine + ATP → Methionine adenosyltransferase → S-adenosylmethionine (SAM) — the "active methionine" → Donates its methyl group → S-adenosylhomocysteine (SAH) → homocysteine + adenosine
- All three phosphates of ATP are lost — an unusual reaction
- SAM is the universal methyl donor in over 40 reactions
Transmethylation reactions using SAM
| Product | From | Significance |
|---|---|---|
| Adrenaline | Noradrenaline | By PNMT in adrenal medulla |
| Creatine | Guanidoacetate | Muscle energy store |
| Phosphatidylcholine | Phosphatidylethanolamine | Lipotropic — needed for VLDL export |
| Melatonin | N-acetylserotonin | Pineal hormone |
| Methylated DNA, RNA, histones | — | Epigenetic regulation of gene expression |
| Methylated drugs | — | Detoxification (COMT) |
Fate of Homocysteine — Two Routes
A. Remethylation — back to methionine
Homocysteine → Methionine synthase — needs vitamin B12 (methylcobalamin) → Methyl group from N5-methyl-THF (folate) → methionine
- A second, folate-independent route uses betaine (from choline)
- This step links folate and B12 metabolism
B. Transsulphuration — to cysteine
Homocysteine + Serine → cystathionine β-synthase — needs vitamin B6 (PLP) → Cystathionine → Cystathionase (also PLP) → cysteine + α-ketobutyrate
- The sulphur comes from methionine; the carbon skeleton from serine
- This is why cysteine is not essential provided methionine is adequate
- α-Ketobutyrate → propionyl-CoA → succinyl-CoA — hence methionine is glucogenic
The Methyl Trap Hypothesis
Vitamin B12 deficiency → Methionine synthase cannot function → N5-methyl-THF cannot give up its methyl group → Folate is trapped as methyl-THF → Other THF forms become unavailable → DNA synthesis fails → megaloblastic anaemia
- This explains why B12 deficiency produces a megaloblastic anaemia identical to that of folate deficiency
- Folic acid corrects the anaemia but not the neurological damage — which continues and may become irreversible. This is why B12 must be excluded before giving folate
Functions of Cysteine
- Disulphide bonds — stabilise protein tertiary structure (insulin, immunoglobulins, keratin)
- Glutathione — cysteine supplies the essential –SH group
- Taurine — for bile salt conjugation
- Coenzyme A — the reactive thiol comes from cysteine
- Source of sulphate for conjugation reactions and for glycosaminoglycans
Other Products of Cysteine and Methionine
| Product | From | Function |
|---|---|---|
| Taurine | Cysteine | Bile salt conjugation; neuromodulator; retinal function |
| Glutathione | Cysteine + glutamate + glycine | Antioxidant and detoxification |
| Coenzyme A | Cysteine + pantothenate | The reactive –SH group |
| PAPS | Cysteine sulphate + ATP | Active sulphate for conjugation and glycosaminoglycans |
| Creatine | Methionine (methyl group) | Muscle energy store |
| Carnitine | Methionine + lysine | Fatty acid transport |
- Sulphate from cysteine is used to conjugate steroids, drugs and bilirubin, and to sulphate the glycosaminoglycans of cartilage
Applied Aspects
- Homocystinuria — usually cystathionine β-synthase deficiency; marfanoid habitus, downward lens dislocation, mental retardation, osteoporosis and thromboembolism. About half respond to large doses of pyridoxine
- Distinguish from Marfan syndrome — there the lens dislocates upward, intelligence is normal, and there is no thrombotic tendency
- Raised homocysteine is an independent risk factor for atherosclerosis and thrombosis; caused by deficiency of folate, B6 or B12. Lowering it with vitamins has not, however, reduced cardiovascular events in trials
- Cystinuria — a transport defect, not a metabolic one; the dibasic amino acids cola (cystine, ornithine, lysine, arginine) are not reabsorbed → cystine renal stones, which are radio-opaque and hexagonal on microscopy
- N-acetylcysteine replenishes glutathione — the antidote in paracetamol poisoning, and a mucolytic
- Nitrous oxide inactivates vitamin B12 irreversibly → can precipitate megaloblastic anaemia and neuropathy after repeated anaesthesia
- SAM is sold as a supplement for depression and osteoarthritis; the evidence is modest
- Methionine load test unmasks mild cystathionine β-synthase deficiency
Protein Turnover
Protein turnover = the continuous synthesis and degradation of body protein.
- About 300–400 g of protein is turned over daily, against a dietary intake of only 60–100 g
- Most amino acids released are reused; only about 20% are oxidised
- Half-lives vary widely — ornithine decarboxylase 11 minutes, albumin 20 days, collagen years
Pathways of degradation
| System | Location | Handles |
|---|---|---|
| Ubiquitin–proteasome | Cytosol; ATP-dependent | Short-lived and abnormal proteins; the selective route |
| Lysosomal | Lysosome; ATP-independent | Long-lived and extracellular proteins; non-selective |
- Proteins destined for the proteasome are tagged with ubiquitin; the N-terminal residue (the N-end rule) and pest sequences determine the rate
Nitrogen Balance
Nitrogen balance = the difference between nitrogen intake and nitrogen excretion.Protein is about 16% nitrogen, so 1 g nitrogen = 6.25 g protein.
| State | Meaning | Occurs in |
|---|---|---|
| Nitrogen equilibrium | Intake = output | Normal healthy adult |
| Positive balance | Intake > output — tissue being built | Growth, pregnancy, lactation, convalescence, athletic training |
| Negative balance | Output > intake — tissue being lost | Starvation, trauma, burns, sepsis, fever, immobilisation, uncontrolled diabetes, deficiency of any single essential amino acid |
CLINICAL PEARL
A negative balance can be caused by the lack of one essential amino acid, even when total protein intake is generous. Protein synthesis is all-or-none: the limiting amino acid halts the whole process, and the remainder are deaminated.
Protein Quality
- Biological value — the proportion of absorbed nitrogen retained. Egg 100, milk 85, meat 75, rice 65, wheat 50
- Limiting amino acid — lysine in cereals, methionine in pulses
- Mutual supplementation — cereals with pulses (dal–chawal) gives a combined value approaching that of animal protein. The traditional Indian diet is well designed in this respect
- Daily requirement 0.8–1 g/kg in adults; up to 2 g/kg in infancy
Protein Energy Malnutrition
| Feature | Kwashiorkor | Marasmus |
|---|---|---|
| Deficiency | Protein, with adequate calories | Total calories including protein |
| Age | 1–3 years (after weaning) | Under 1 year |
| Oedema | Present — the defining feature | Absent |
| Weight for age | 60–80% (masked by oedema) | Below 60% |
| Muscle wasting | Present but hidden | Severe and obvious |
| Subcutaneous fat | Preserved | Lost — "old man" face |
| Serum albumin | Markedly low | Normal or slightly low |
| Fatty liver | Present | Absent |
| Skin and hair | Flaky paint dermatosis; flag sign; sparse pale hair | Relatively normal |
| Appetite | Poor | Good (voracious) |
| Mood | Apathetic, irritable | Alert but miserable |
Why kwashiorkor causes oedema and fatty liver
- Oedema — ↓ albumin → ↓ plasma oncotic pressure → fluid moves into the interstitium
- Fatty liver — no apoprotein can be made, so VLDL cannot be exported and triglyceride accumulates
- Free radical damage and aflatoxin exposure are also implicated
Management of Severe Malnutrition
- Treat life-threatening problems first — hypoglycaemia, hypothermia, dehydration, electrolyte imbalance, infection
- Feed cautiously at first
- Refeeding syndrome — rapid feeding drives phosphate, potassium and magnesium into cells → arrhythmia, cardiac failure and death. The commonest cause of death in the first days of treatment
- Then catch-up growth with high-energy feeds, micronutrients and sensory stimulation
Applied Aspects
- Marasmic kwashiorkor — features of both; the commonest severe form seen in Indian hospitals
- Nutritional oedema — bilateral, pitting and starting in the feet; the cardiac, renal and hepatic causes have their own signs
- Hypoglycaemia and hypothermia are the two commonest causes of death in the first 48 hours and must be looked for actively
- Vitamin and mineral deficiencies coexist — zinc, potassium, magnesium, vitamin A and iron must all be corrected
- Iron is withheld in the first week of treatment — free iron promotes bacterial growth and oxidative damage
- Recovery is judged by weight gain of 10–15 g/kg/day during the catch-up phase
- Prevention — exclusive breast feeding for 6 months, timely complementary feeding, immunisation and growth monitoring
- Serum albumin is a poor marker of acute nutrition — its half-life is 20 days. Prealbumin (2 days) and retinol-binding protein (12 hours) respond faster
- Negative nitrogen balance after major surgery or burns is driven by cortisol and cytokines and cannot be fully reversed by feeding alone
- India carries a very large burden of childhood undernutrition; the commonest picture is marasmic kwashiorkor, with features of both
- Anthropometry — weight for height detects acute wasting, height for age detects chronic stunting; mid-upper arm circumference is the simplest field measure
Definition
Transamination = the reversible transfer of an α-amino group from an amino acid to an α-keto acid, forming a new amino acid and a new keto acid.
Amino acid1 + Keto acid2 ↔ Keto acid1 + Amino acid2
Features
- Enzyme — aminotransferase (transaminase)
- Coenzyme — pyridoxal phosphate (vitamin B6) for every transaminase
- Freely reversible; ΔG is near zero
- No free ammonia is released and no nitrogen is lost — it is a redistribution, not an excretion
- α-Ketoglutarate is the usual acceptor, so nitrogen is funnelled into glutamate
- Occurs in cytosol and mitochondria of most tissues, especially liver and muscle
Amino Acids That Do Not Transaminate
- Lysine, threonine, proline and hydroxyproline
- All others do, including the essential ones — which is why their keto acid analogues can substitute for them in the diet
Mechanism — Ping Pong Bi Bi
PLP + amino acid → Schiff base (aldimine) → Tautomerisation → ketimine → Hydrolysis → Keto acid1 released; enzyme now carries pyridoxamine phosphate → Second keto acid binds → Reverse sequence → Amino acid2 released; PLP regenerated
Clinically Important Transaminases
| Enzyme | Reaction | Normal | Raised in |
|---|---|---|---|
| ALT (SGPT) | Alanine + α-KG ↔ pyruvate + glutamate | 7–40 U/L | Liver disease — more specific; very high in viral hepatitis |
| Ast (SGOT) | Aspartate + α-KG ↔ oxaloacetate + glutamate | 10–40 U/L | Liver, myocardial infarction, muscle disease, haemolysis |
CLINICAL PEARL
Ast : ALT ratio — above 2 suggests alcoholic liver disease (ast is also released from mitochondria and ALT synthesis needs B6, which alcoholics lack); below 1 suggests viral hepatitis or fatty liver.
Significance and Applied Aspects
- Collects nitrogen from all amino acids into glutamate, the single substrate for oxidative deamination — the funnel principle
- Allows synthesis of non-essential amino acids from available keto acids
- Links amino acid metabolism to the TCA cycle through pyruvate, oxaloacetate and α-ketoglutarate
- Diagnostic — the transaminases are among the most widely used enzymes in clinical medicine
- Vitamin B6 deficiency impairs all transaminations; a transaminase assay with and without added PLP is used to assess B6 status
Definition
Hyperammonaemia = a raised blood ammonia level, above the normal of 10–80 µg/dL (11–47 µmol/L).
Classification of Causes
| Type | Causes |
|---|---|
| Acquired (secondary) | Hepatic failure and cirrhosis — the commonest; portosystemic shunting; Reye syndrome; valproate; severe sepsis |
| Inherited (primary) | Urea cycle enzyme defects — OTC deficiency is the commonest; also organic acidaemias and fatty acid oxidation defects |
WHY Ammonia Is Toxic to the Brain
↑ Blood NH3 crosses the blood–brain barrier → Fixed by glutamate dehydrogenase → glutamate → Then by glutamine synthetase → glutamine → Two consequences → 1. α-Ketoglutarate is drained from the TCA cycle → ATP production falls → 2. Glutamine accumulates in astrocytes → osmotic swelling → cerebral oedema
- Glutamate is also depleted, disturbing neurotransmission; and false neurotransmitters accumulate
Clinical Features
- Neonate — poor feeding, vomiting, lethargy, hypotonia, seizures, coma; often mistaken for sepsis
- Adult — the four grades of hepatic encephalopathy: altered sleep rhythm → confusion → drowsiness → coma
- Flapping tremor (asterixis), constructional apraxia, fetor hepaticus
- Respiratory alkalosis — ammonia stimulates the respiratory centre. A valuable clue: urea cycle defects cause alkalosis, organic acidaemias cause acidosis
Management
| Measure | Rationale |
|---|---|
| Stop protein intake temporarily | Removes the nitrogen load |
| Lactulose | Acidifies the colon → traps ammonia as NH4+; also a laxative |
| Rifaximin, neomycin | Reduce ammonia-producing gut flora |
| Sodium benzoate and phenylacetate | Provide alternative routes of nitrogen excretion — conjugate with glycine and glutamine |
| L-Arginine | Replenishes urea cycle intermediates |
| Haemodialysis | For severe acute hyperammonaemia |
| Treat precipitants | GI bleeding, infection, constipation, sedatives, electrolyte disturbance |
Applied Aspects
- Gastrointestinal bleeding is a classic precipitant — blood in the gut is a large protein load
- Blood ammonia must be sent on ice and analysed promptly, or it rises artefactually
- Blood urea is low in liver failure — the opposite of what students often expect
- Valproate can cause hyperammonaemia even with normal liver function, by depleting carnitine and inhibiting CPS-I
Definition
Phenylketonuria (PKU) = an autosomal recessive inborn error caused by deficiency of phenylalanine hydroxylase, leading to accumulation of phenylalanine and its abnormal metabolites.
- Incidence about 1 in 10,000; the commonest inborn error of amino acid metabolism
Biochemical Basis
Phenylalanine hydroxylase deficient (needs BH4) → Phenylalanine cannot become tyrosine → Blood phenylalanine > 20 mg/dL (normal 1–2) → Diverted to minor pathways by transamination → Phenylpyruvate → phenyllactate → phenylacetate → Excreted in urine
Clinical Features and Their Basis
| Feature | Explanation |
|---|---|
| Mental retardation | Phenylalanine competes for the neutral amino acid transporter at the blood–brain barrier → deprives the brain of tyrosine and tryptophan; also impairs myelination |
| Mousy or musty odour | Phenylacetate in urine and sweat |
| Fair skin, blue eyes, blond hair | Excess phenylalanine inhibits tyrosinase → less melanin |
| Eczema | Common; mechanism uncertain |
| Seizures, hypertonia, tremor | Neurotoxicity |
| Microcephaly | Impaired brain growth |
- The infant is normal at birth, protected in utero by the maternal circulation. Damage begins only after milk feeding starts — which is precisely why screening works
Diagnosis
- Guthrie bacterial inhibition test or tandem mass spectrometry on a heel-prick blood spot
- Taken after 48–72 hours of milk feeding — too early and phenylalanine has not yet risen
- Ferric chloride test on urine — transient green colour; now obsolete
- Confirm with quantitative plasma phenylalanine and tyrosine; measure BH4 and pterins to exclude the malignant variant
Variants
| Type | Defect | Response to diet |
|---|---|---|
| Classical PKU | Phenylalanine hydroxylase | Good |
| Malignant (atypical) PKU | BH4 synthesis or dihydropteridine reductase | Poor — catecholamine and serotonin synthesis also fail. Needs BH4, L-dopa and 5-hydroxytryptophan |
| Benign hyperphenylalaninaemia | Partial enzyme deficiency | May need no treatment |
Treatment and Applied Aspects
- Low phenylalanine diet begun within the first weeks of life — special formula, restricted natural protein, with tyrosine supplementation
- Phenylalanine cannot be eliminated entirely — it is essential; the aim is to keep blood levels in a target range
- Diet for life is now recommended; relaxing it in adolescence causes cognitive and psychiatric problems
- Aspartame must be avoided — it releases phenylalanine; hence the warning on diet drinks
- Maternal PKU — strict control must resume before conception, or the fetus suffers microcephaly and congenital heart disease even though genetically normal
Alkaptonuria
Alkaptonuria = an autosomal recessive defect of homogentisate oxidase, in the degradation pathway of tyrosine.
Tyrosine → p-Hydroxyphenylpyruvate → homogentisate → homogentisate oxidase — blocked → Homogentisic acid accumulates → Excreted in urine; oxidises and polymerises on standing → urine darkens TO black
Clinical features
- Urine darkens on standing or on adding alkali — often first noticed as black staining of nappies. Present from birth
- Ochronosis — blue-black pigment deposited in cartilage, sclera, ear cartilage and skin; appears after 20–30 years
- Ochronotic arthritis — degenerative arthritis of the spine and large joints; the chief disability
- Pigmented and calcified intervertebral discs on X-ray; valve calcification
- The first disease shown to follow Mendelian recessive inheritance (Garrod, 1902) — the origin of the concept of an "inborn error of metabolism"
- Treatment is largely symptomatic; nitisinone reduces homogentisic acid; vitamin C may slow pigment deposition
Albinism
Albinism = a group of inherited disorders in which melanin synthesis fails, most often through deficiency of tyrosinase.
Tyrosine → tyrosinase (copper-containing) — deficient → dopa → dopaquinone → melanin not formed
| Type | Defect | Features |
|---|---|---|
| Oculocutaneous type 1 | Tyrosinase | Complete absence of pigment in skin, hair and eyes |
| Oculocutaneous type 2 | P gene | Some pigment develops with age |
| Ocular albinism | X-linked | Eyes only |
| Partial (piebaldism) | C-kit | Patchy depigmentation |
Clinical features
- White skin and hair, pink or blue irides
- Photophobia, nystagmus, reduced visual acuity — melanin is needed for normal development of the fovea and the optic pathways
- Very high risk of sunburn and skin cancer, since melanin is the natural ultraviolet shield
Comparison of the Tyrosine Disorders
| Disorder | Enzyme | Consequence |
|---|---|---|
| PKU | Phenylalanine hydroxylase | Substrate accumulates → toxicity |
| Alkaptonuria | Homogentisate oxidase | Intermediate accumulates → pigment deposition |
| Albinism | Tyrosinase | Product not formed → loss of function |
| Tyrosinaemia I | Fumarylacetoacetate hydrolase | Toxic intermediate → liver and renal damage |
Applied Aspects
- Alkaptonuria is benign in childhood but disabling in later life; it illustrates that an inborn error need not present in infancy
- Albinism requires lifelong sun protection — clothing, sunscreen and regular skin examination; and low-vision aids
- Social stigma is a serious problem for people with albinism in many countries and should be addressed alongside the medical management
Structure
Glutathione (GSH) = a tripeptide of glutamate, cysteine and glycine — γ-glutamyl-cysteinyl-glycine.
- The glutamate is joined by an unusual γ-peptide bond, which makes it resistant to ordinary peptidases
- The –SH group of cysteine is the functional part
- The most abundant intracellular thiol, at about 5 mmol/L
- Exists as reduced GSH and oxidised GSSG; the normal GSH:GSSG ratio exceeds 100:1
Synthesis and Regeneration
Glutamate + cysteine → γ-glutamylcysteine (ATP) → + Glycine → glutathione (ATP) → Used as reductant → GSSG → Glutathione reductase — needs NADPH from the HMP shunt → Back to 2 GSH
- The HMP shunt is therefore essential to glutathione function — the link that explains G6PD deficiency
Functions
- Antioxidant — glutathione peroxidase (a selenium enzyme) destroys H2O2 and lipid peroxides
- Keeps protein –SH groups reduced, including haemoglobin and enzymes
- Detoxification — glutathione S-transferase conjugates drugs, carcinogens and heavy metals; the basis of mercapturic acid formation
- Amino acid transport — the γ-glutamyl cycle (Meister cycle), using GGT
- Maintains RBC membrane integrity — prevents haemolysis
- Coenzyme for some enzymes; store and transport form of cysteine
- Regenerates vitamins C and E from their oxidised forms
Clinical Correlations
| Condition | Mechanism |
|---|---|
| G6PD deficiency | ↓ NADPH → GSH cannot be regenerated → oxidative haemolysis with Heinz bodies after oxidant drugs, fava beans or infection |
| Paracetamol poisoning | NAPQI depletes hepatic glutathione → hepatocyte necrosis |
| Selenium deficiency | Glutathione peroxidase fails → oxidative damage (Keshan disease) |
| Cataract | ↓ Lens glutathione → protein cross-linking |
| Cancer chemoresistance | Tumour cells over-express glutathione S-transferase and inactivate the drug |
Paracetamol Poisoning — the Key Example
Paracetamol, normal dose → 95% conjugated safely → Overdose → conjugation saturated → Cytochrome P450 makes NAPQI (toxic) → Normally detoxified by glutathione → Glutathione stores exhausted → NAPQI binds hepatocyte proteins → necrosis
- N-acetylcysteine is the antidote — it supplies cysteine and replenishes glutathione. Most effective within 8–10 hours
- Risk is greater in alcoholics and the malnourished, who have induced P450 and depleted glutathione
Applied Aspects
- Gamma-glutamyl transferase (GGT), an enzyme of the γ-glutamyl cycle, is the most sensitive marker of alcohol intake
- Oral glutathione supplements are of doubtful value — it is hydrolysed in the gut; supplying cysteine is the effective route
- Newborns have low glutathione and are more vulnerable to oxidative injury
Definition
Homocystinuria = an autosomal recessive disorder of methionine metabolism, most often due to deficiency of cystathionine β-synthase (CBS), causing accumulation of homocysteine.
Biochemical Basis
Methionine → SAM → SAH → homocysteine → cystathionine β-synthase — blocked (needs vitamin B6) → Homocysteine and methionine accumulate → Cysteine becomes essential (cannot be made) → Homocysteine excreted in urine
| Cause | Enzyme or vitamin | Methionine level |
|---|---|---|
| Classical (CBS deficiency) | Cystathionine β-synthase | High |
| Remethylation defect | Methionine synthase, or B12 | Low or normal |
| MTHFR deficiency | Methylene-THF reductase | Low |
| Nutritional | Folate, B6 or B12 deficiency | Variable |
Clinical Features
- Skeletal — marfanoid habitus: tall, long limbs, arachnodactyly, pectus deformity, osteoporosis, scoliosis
- Ocular — downward dislocation of the lens (ectopia lentis), myopia, glaucoma
- Neurological — mental retardation in 50%, seizures, psychiatric disturbance
- Vascular — thromboembolism: the chief cause of death; arterial and venous, from endothelial damage and platelet activation
- Fair complexion, malar flush, livedo reticularis
Homocystinuria VS Marfan Syndrome
| Feature | Homocystinuria | Marfan syndrome |
|---|---|---|
| Inheritance | Autosomal recessive | Autosomal dominant |
| Defect | Cystathionine β-synthase | Fibrillin-1 |
| Lens dislocation | Downward | Upward |
| Intelligence | Often reduced | Normal |
| Thrombosis | Characteristic | Absent |
| Cardiac | Coronary and vascular thrombosis | Aortic dilatation and dissection |
| Osteoporosis | Present | Absent |
Diagnosis and Treatment
- Urinary cyanide–nitroprusside test screens for disulphides; plasma homocysteine and methionine confirm
- Newborn screening by tandem mass spectrometry in many countries
- About half are pyridoxine-responsive — large doses of vitamin B6 (up to 500 mg/day) restore enzyme activity
- Non-responders — low methionine diet with cysteine supplementation
- Betaine provides an alternative remethylation route, lowering homocysteine
- Folate and B12 supplementation; antiplatelet therapy
Applied Aspects
- Mild hyperhomocysteinaemia is common and is an independent risk factor for atherosclerosis, stroke and venous thrombosis
- Usually caused by deficiency of folate, B6 or B12, or by the common MTHFR C677T variant
- Vitamin supplementation lowers homocysteine but has not reduced cardiovascular events in randomised trials — a caution against assuming that correcting a marker corrects the risk
- Anaesthesia carries a high thrombotic risk in these patients; nitrous oxide is avoided because it inactivates B12
Creatine — Synthesis
Creatine = a nitrogenous compound that stores high-energy phosphate in muscle as creatine phosphate.
Glycine + Arginine (in the kidney) → Transamidinase → Guanidoacetate → Transported to the liver → Methylation by SAM → creatine → Carried to muscle and brain
- Three amino acids contribute — glycine, arginine and methionine
- Synthesis occurs in two organs: begins in the kidney, completed in the liver
- About 1–2 g is synthesised daily; diet (meat, fish) supplies more
- 95% of body creatine is in skeletal muscle; total pool about 120 g
Creatine Phosphate
Creatine + ATP → creatine kinase → Creatine phosphate + ADP
- A high-energy phosphate reservoir, present at 4–5 times the concentration of ATP
- The immediate energy buffer of muscle — supplies ATP for the first 5–8 seconds of maximal effort, before glycolysis takes over
- The reaction is freely reversible, so it both stores and releases energy
Creatinine — Formation and Excretion
Creatine phosphate → Spontaneous, non-enzymatic, irreversible cyclisation → creatinine → Freely filtered at the glomerulus → Excreted in urine
| Feature | Value |
|---|---|
| Daily excretion | 1–2 g/day; remarkably constant for an individual |
| Serum creatinine | 0.6–1.2 mg/dL (lower in women and children) |
| Creatinine coefficient | Mg creatinine per kg body weight per day — 20–26 (male), 14–22 (female); an index of muscle mass |
| Clearance | 120–130 mL/min |
- Excretion is proportional to muscle mass, not to diet or urine flow — which is what makes it so useful
Clinical Importance
- Serum creatinine is the standard index of renal function
- Creatinine clearance estimates GFR; it slightly overestimates it, since a little creatinine is secreted by the tubule
- It is insensitive early — serum creatinine stays normal until GFR has fallen by about 50% (the "creatinine blind range")
- Used to check the completeness of a 24-hour urine collection
- Creatine kinase is a key diagnostic enzyme — CK-MB in myocardial infarction, CK-MM in muscular dystrophy and rhabdomyolysis
Creatinuria
- Physiological — in children, pregnancy and after delivery
- Pathological — muscular dystrophy, myositis, starvation, hyperthyroidism, uncontrolled diabetes, fever
- The common mechanism is that muscle cannot retain creatine, so it spills into urine
Applied Aspects
- Creatine supplements are widely used by athletes to increase the muscle phosphocreatine pool; they do improve performance in short bursts of high-intensity exercise, though with water retention and weight gain
- Serum creatinine varies with muscle mass — a frail elderly patient may have significant renal impairment with a "normal" value; hence eGFR formulas correct for age and sex
- Cystatin C is an alternative marker independent of muscle mass
- Cooked meat raises serum creatinine transiently, which is why a fasting sample is preferred for accurate assessment
Introduction
Purines = adenine and guanine, the double-ringed nitrogenous bases of nucleic acids.
- Synthesised de novo in the cytosol, chiefly in the liver
- The ring is built up step by step ON the ribose-5-phosphate — the opposite of pyrimidine synthesis
Sources of the Ring Atoms
| Atom | Comes from |
|---|---|
| N1 | Aspartate |
| C2 and C8 | Formate (N10-formyl THF) |
| N3 and N9 | Glutamine (amide nitrogen) |
| C4, C5 and N7 | Glycine (all three, intact) |
| C6 | CO2 |
- Glycine is incorporated whole — the only amino acid to contribute more than one atom
- The pathway therefore needs glutamine, glycine, aspartate, CO2 and tetrahydrofolate
De Novo Synthesis
Ribose-5-phosphate (from the HMP shunt) → PRPP synthetase → PRPP → PRPP glutamyl amidotransferase — rate-limiting, committed step → 5-Phosphoribosylamine → 9 more steps → inosine monophosphate (IMP) → Branch point
| Branch | Requires | Product |
|---|---|---|
| IMP → amp | GTP (and aspartate) | Adenylosuccinate → amp |
| IMP → GMP | ATP (and glutamine) | Xanthosine monophosphate → GMP |
CLINICAL PEARL
Cross-regulation: amp synthesis needs GTP and GMP synthesis needs ATP. If one nucleotide runs low, the other drives its production — keeping the two in balance.
Regulation
- PRPP glutamyl amidotransferase is inhibited by the end products amp, GMP and IMP — feedback inhibition at the committed step
- PRPP synthetase is inhibited by ADP and GDP
- PRPP availability is itself a major determinant — excess PRPP drives synthesis
- The pathway is energetically expensive, consuming about 6 ATP per IMP
Salvage Pathway
Salvage = re-use of preformed purine bases, released from nucleic acid breakdown, rather than making them afresh.
| Enzyme | Salvages | Product |
|---|---|---|
| HGPRT (hypoxanthine-guanine phosphoribosyl transferase) | Hypoxanthine and guanine | IMP and GMP |
| APRT (adenine phosphoribosyl transferase) | Adenine | Amp |
| Adenosine kinase | Adenosine | Amp |
- Both transferases use PRPP as the ribose-phosphate donor
- Salvage is energetically far cheaper than de novo synthesis
- Brain, RBC and leucocytes depend almost entirely on salvage — they cannot carry out de novo synthesis
- Salvage also consumes PRPP, so it indirectly restrains the de novo pathway
Degradation
Amp → adenosine → inosine → Nucleoside phosphorylase → hypoxanthine → xanthine oxidase → xanthine → xanthine oxidase → uric acid
- GMP → guanosine → guanine → xanthine, joining the same route
- Uric acid is the end product of purine catabolism in man — we lack uricase, which other mammals use to convert it to soluble allantoin
- Uric acid is poorly soluble — this single fact explains gout and urate stones
- Normal serum urate 3–7 mg/dL (male), 2.5–6 mg/dL (female)
- About 75% is excreted by the kidney, the rest in the gut
Sources and Handling of Uric Acid
| Point | Detail |
|---|---|
| Daily production | About 700 mg |
| Endogenous | Cell turnover and de novo synthesis — two-thirds |
| Dietary | Purine-rich foods — red meat, organ meat, shellfish, pulses, beer |
| Renal handling | Freely filtered, then 98% reabsorbed in the PCT, then secreted, then partly reabsorbed again |
| Net excretion | Only 6–10% of the filtered load |
| Gut | About 25%, degraded by colonic bacteria |
- Because reabsorption is so extensive, small changes in tubular transport cause large changes in serum urate — which is why drugs and organic acids matter so much
- Lactate and ketone bodies compete for the same transporter → alcohol, starvation and diabetic ketoacidosis all raise urate
Applied Aspects
- Gout — hyperuricaemia with deposition of monosodium urate crystals in joints; see the separate note
- Lesch–Nyhan syndrome — complete HGPRT deficiency; X-linked; PRPP accumulates → de novo synthesis runs unchecked → severe hyperuricaemia with self-mutilation, choreoathetosis and retardation
- Adenosine deaminase (ADA) deficiency — dATP accumulates and inhibits ribonucleotide reductase → severe combined immunodeficiency; the first disease treated by gene therapy
- Allopurinol inhibits xanthine oxidase — both competitively and as a suicide inhibitor; the more soluble hypoxanthine and xanthine are excreted instead
- Methotrexate and 6-mercaptopurine block purine synthesis and are used in leukaemia
Introduction
Pyrimidines = cytosine, uracil and thymine — the single-ringed nitrogenous bases.
- Synthesised in the cytosol, chiefly in the liver
- The ring is built first and then attached to ribose-5-phosphate — the reverse of purine synthesis. This is the single most examined contrast
Sources of the Ring Atoms
| Atom | Comes from |
|---|---|
| N1, C4, C5, C6 | Aspartate |
| N3 | Glutamine (amide nitrogen) |
| C2 | CO2 |
- Far simpler than the purine ring — only three sources
De Novo Synthesis
Glutamine + CO2 + 2 ATP → carbamoyl phosphate synthetase II (cytosol) — rate-limiting in man → Carbamoyl phosphate → + Aspartate, by aspartate transcarbamoylase (ATCase) → Carbamoyl aspartate → Dihydroorotate → orotic acid → + PRPP (orotate phosphoribosyl transferase) → OMP → OMP decarboxylase → UMP → UDP → UTP → CTP (needs glutamine)
CLINICAL PEARL
Distinguish the two carbamoyl phosphate synthetases: CPS-I is mitochondrial, uses free ammonia, needs N-acetylglutamate, and serves the urea cycle. CPS-II is cytosolic, uses glutamine, needs no activator, and serves pyrimidine synthesis. This distinction is asked repeatedly.
Formation of Deoxyribonucleotides and Thymidylate
- Ribonucleotide reductase converts NDP → dNDP; it acts at the diphosphate level and needs thioredoxin and NADPH
- DUMP → dTMP by thymidylate synthase, using N5,N10-methylene THF as the methyl donor
- This reaction oxidises THF to dihydrofolate, which must be regenerated by dihydrofolate reductase
- The only reaction in which folate is oxidised — hence its unique vulnerability to methotrexate
Regulation
| Enzyme | Activated by | Inhibited by |
|---|---|---|
| CPS-II (man) | PRPP, ATP | UTP (feedback) |
| ATCase (bacteria) | ATP | CTP — the classic allosteric enzyme |
| Ribonucleotide reductase | ATP | DATP |
| OMP decarboxylase | — | UMP, CMP |
Degradation
Cytosine → uracil → Dihydrouracil → β-alanine + NH3 + CO2 → Thymine → β-aminoisobutyrate
| Feature | Purine degradation | Pyrimidine degradation |
|---|---|---|
| End product | Uric acid | β-alanine, β-aminoisobutyrate, NH3, CO2 |
| Solubility | Poor | High |
| Ring | Not opened | Opened |
| Clinical problem | Gout, urate stones | None — no disease of excess |
| Excretion | Urine as uric acid | Enters general metabolism; β-alanine → acetyl-CoA |
- This is why there is no "pyrimidine gout" — the products are freely soluble and simply enter ordinary metabolism
Comparison of Purine and Pyrimidine Synthesis
| Feature | Purine | Pyrimidine |
|---|---|---|
| Ring assembly | Built ON the ribose-5-phosphate | Ring built first, then attached to PRPP |
| First committed enzyme | PRPP glutamyl amidotransferase | CPS-II (in man) |
| Nitrogen donors | Glutamine, glycine, aspartate | Glutamine, aspartate |
| Folate needed | Yes — for C2 and C8 | Yes — but only for dTMP |
| First nucleotide formed | IMP | UMP |
| Energy cost | High — about 6 ATP | Lower |
| End product of catabolism | Uric acid (insoluble) | β-alanine (soluble) |
| Disease of catabolism | Gout | None |
- Both pathways require PRPP, so PRPP availability governs the output of both
- Both are inhibited by their end products at the first committed step
Applied Aspects
- Orotic aciduria — deficiency of UMP synthase; megaloblastic anaemia unresponsive to B12 and folate, growth retardation, orotic acid crystals in urine. Treated with oral uridine, which bypasses the block and also restores feedback inhibition
- Distinguish from OTC deficiency, which also causes orotic aciduria — but there it is accompanied by hyperammonaemia and NO megaloblastic anaemia
- 5-Fluorouracil — a suicide inhibitor of thymidylate synthase; used in colorectal, breast and gastric cancer
- Methotrexate — inhibits dihydrofolate reductase → THF cannot be regenerated → thymidylate synthesis fails. Rescued with folinic acid (leucovorin)
- Hydroxyurea inhibits ribonucleotide reductase; used in chronic myeloid leukaemia and sickle cell disease
- Cytarabine and gemcitabine are pyrimidine analogues that terminate DNA chain elongation
- Dihydropyrimidine dehydrogenase deficiency — patients cannot degrade 5-fluorouracil and suffer severe, sometimes fatal toxicity from a standard dose; testing before treatment is now recommended
- β-Aminoisobutyrate excretion rises after chemotherapy or radiation, reflecting the breakdown of nucleic acid
- Leflunomide inhibits dihydroorotate dehydrogenase — used in rheumatoid arthritis
- Trimethoprim inhibits bacterial dihydrofolate reductase selectively, which is why it is antibacterial rather than cytotoxic
Definition and Principles
DNA replication = the process by which a DNA molecule produces two identical copies of itself before cell division.
| Principle | Meaning |
|---|---|
| Semiconservative | Each daughter molecule has one parent and one new strand — proved by Meselson and Stahl |
| Bidirectional | Proceeds both ways from each origin |
| Semidiscontinuous | One strand made continuously, the other in fragments |
| 5′ → 3′ only | All DNA polymerases add nucleotides only to a free 3′-OH |
| Needs a primer | DNA polymerase cannot start a chain from nothing |
- Occurs in the S phase of the cell cycle
- Rate — about 50 nucleotides/second in man, 1000/second in bacteria
Enzymes and Proteins
| Protein | Function |
|---|---|
| DNA helicase | Unwinds the double helix at the fork |
| Topoisomerase (DNA gyrase) | Relieves the supercoiling ahead of the fork |
| Single-strand binding protein | Keeps the separated strands apart and protects them |
| Primase | Lays down a short RNA primer |
| DNA polymerase III (prokaryote) | Chief replicating enzyme |
| DNA polymerase δ and ε (eukaryote) | Lagging and leading strand synthesis |
| DNA polymerase I (prokaryote) | Removes the RNA primer and fills the gap |
| DNA ligase | Seals the nicks between fragments; needs ATP |
| Telomerase | Extends the ends of linear chromosomes |
The Replication Fork
Origin of replication — AT-rich, easier to melt → Helicase unwinds; topoisomerase relieves strain → Primase lays an RNA primer → leading strand — synthesised continuously toward the fork → lagging strand — synthesised discontinuously, away from the fork → okazaki fragments (100–200 nucleotides in man) → Primers removed, gaps filled, nicks sealed by ligase
- The lagging strand must be discontinuous because polymerase works only 5′→3′ while the fork opens in the opposite direction
- Eukaryotes have many origins per chromosome; bacteria have one
Proofreading and Fidelity
- DNA polymerase has 3′→5′ exonuclease activity — it removes a mismatched nucleotide immediately
- Error rate falls from 1 in 105 to about 1 in 109 after proofreading and mismatch repair
- DNA polymerase I also has 5′→3′ exonuclease activity, used to remove the RNA primer
Telomeres and Telomerase
- Telomeres are repetitive sequences (TTAGGG in man) capping the chromosome ends
- The end-replication problem — removal of the final RNA primer leaves a gap that cannot be filled, so the chromosome shortens with each division
- Telomerase is a reverse transcriptase carrying its own RNA template; it extends the 3′ end
- Active in germ cells, stem cells and most cancer cells; absent in most somatic cells
- Progressive shortening acts as a mitotic clock and underlies the Hayflick limit and cellular senescence
Inhibitors
| Agent | Target | Use |
|---|---|---|
| Quinolones (ciprofloxacin) | Bacterial DNA gyrase | Antibacterial |
| Etoposide | Topoisomerase II | Anticancer |
| Doxorubicin | Topoisomerase II; intercalates | Anticancer |
| Cytarabine | DNA polymerase | Leukaemia |
| Zidovudine | Reverse transcriptase (chain terminator) | HIV |
| Actinomycin D | Intercalates into DNA | Anticancer |
Differences Between Prokaryotic and Eukaryotic Replication
| Feature | Prokaryote | Eukaryote |
|---|---|---|
| Origins | One | Many per chromosome |
| Chief polymerase | DNA pol III | DNA pol δ and ε |
| Primer removal | DNA pol I | RNase H and FEN1 |
| Okazaki fragment | 1000–2000 nucleotides | 100–200 |
| Rate | 1000 nucleotides/second | 50/second |
| Telomerase | Not needed (circular DNA) | Required for linear chromosomes |
| Histones | Absent | Must be synthesised and assembled in parallel |
Applied Aspects
- Xeroderma pigmentosum — defective nucleotide excision repair of ultraviolet damage → extreme photosensitivity and skin cancers in childhood
- Hereditary non-polyposis colorectal cancer (Lynch syndrome) — defective mismatch repair → microsatellite instability
- Telomerase is a target in cancer therapy, since its reactivation is one of the steps by which cells become immortal
- Rapidly dividing cells are the most vulnerable to replication inhibitors — which explains both the action of anticancer drugs and their toxicity to marrow, gut and hair follicles
Definition
Transcription = synthesis of an RNA molecule using one strand of DNA as template.
| Term | Meaning |
|---|---|
| Template (antisense) strand | The strand actually read, 3′ → 5′ |
| Coding (sense) strand | The other strand; identical in sequence to the mRNA, with T for U |
| Promoter | The DNA sequence where RNA polymerase binds |
| Transcription unit | Promoter + coding region + terminator |
- RNA is synthesised 5′ → 3′, like DNA
- NO primer is required — a key difference from replication
- Only one strand of a given gene is transcribed; but different genes may use different strands
- Uses ribonucleoside triphosphates; uracil replaces thymine
RNA Polymerases
| Enzyme | Product | Inhibited by |
|---|---|---|
| RNA polymerase I | RRNA (nucleolus) | — |
| RNA polymerase II | MRNA and most snRNA | α-Amanitin (death cap mushroom) |
| RNA polymerase III | TRNA and 5S rRNA | High-dose α-amanitin |
| Bacterial RNA polymerase | All bacterial RNA | Rifampicin |
- Bacterial RNA polymerase has a σ (sigma) factor that recognises the promoter and then dissociates
- Bacterial promoter has the −10 (Pribnow, TATAAT) and −35 consensus sequences; eukaryotic promoters have the TATA box at −25 and a CAAT box
Stages
Initiation — polymerase + transcription factors bind the promoter; DNA melts → elongation — RNA synthesised 5′→3′; the DNA rewinds behind → termination — rho-dependent or rho-independent (hairpin) in bacteria; poly-A signal in eukaryotes
Post-transcriptional Processing of Mrna
| Modification | Detail | Purpose |
|---|---|---|
| 5′ Capping | 7-methylguanosine joined by an unusual 5′–5′ triphosphate bond | Protects from exonuclease; needed for ribosome binding |
| 3′ Polyadenylation | Poly-A tail of 100–250 adenines, after the AAUAAA signal | Stability and export from the nucleus |
| Splicing | Introns removed, exons joined by the spliceosome (snRNP); GU at the donor, AG at the acceptor site | Produces the mature coding sequence |
| RNA editing | Base changed after transcription | Apo B-48 vs B-100 arise from the same gene this way |
- Alternative splicing lets one gene produce several proteins — a major reason 20,000 human genes yield far more proteins
- Prokaryotes do none of this: they have no introns, no cap and no poly-A tail, and transcription and translation are coupled
Comparison — Replication VS Transcription
| Feature | Replication | Transcription |
|---|---|---|
| Product | DNA | RNA |
| Template | Both strands | One strand only |
| Primer | Required | Not required |
| Enzyme | DNA polymerase | RNA polymerase |
| Proofreading | Yes | Little or none |
| Extent | Entire genome | Selected genes only |
| Ligase needed | Yes | No |
Regulation of Gene Expression
- Operon model (Jacob and Monod) in bacteria — the lac operon is inducible, the trp operon repressible
- In eukaryotes — enhancers and silencers, transcription factors, hormone response elements
- Epigenetic control — DNA methylation at CpG islands silences genes; histone acetylation activates them
- Steroid hormones act by binding intracellular receptors that become transcription factors — hence their slow onset and prolonged action
Types of RNA
| RNA | Share | Function |
|---|---|---|
| RRNA | 80% | Structural and catalytic core of the ribosome; peptidyl transferase is a ribozyme |
| TRNA | 15% | Adaptor; clover-leaf secondary structure with anticodon and CCA end |
| MRNA | 5% | Carries the coding message; the most heterogeneous and shortest-lived |
| SnRNA | Small | Splicing (spliceosome) |
| MiRNA and siRNA | Small | Gene silencing — degrade or block mRNA |
Applied Aspects
- Rifampicin inhibits bacterial RNA polymerase selectively — the basis of its use in tuberculosis and leprosy; it colours urine and secretions orange
- α-Amanitin from Amanita phalloides blocks RNA polymerase II → fatal hepatic necrosis
- β-Thalassaemia is often caused by a splice-site mutation, so the β-globin mRNA is processed abnormally
- Systemic lupus erythematosus — anti-Sm antibodies are directed against snRNP splicing proteins
- Antisense oligonucleotides and siRNA silence specific mRNAs; several are now licensed drugs
Definition
Translation = synthesis of a polypeptide on the ribosome, in which the nucleotide sequence of mRNA is decoded into an amino acid sequence.
- Site — cytoplasmic ribosomes, free or bound to rough endoplasmic reticulum
- The polypeptide grows from its N-terminal to its C-terminal end
- MRNA is read 5′ → 3′
The Genetic Code
| Property | Meaning |
|---|---|
| Triplet | 3 bases = 1 codon; 43 = 64 codons |
| Degenerate (redundant) | Most amino acids have more than one codon; only methionine and tryptophan have a single codon |
| Non-overlapping | Each base belongs to one codon only |
| Comma-less | Read continuously with no punctuation |
| Unambiguous | Each codon specifies one amino acid |
| Universal | Nearly the same in all organisms — mitochondria are the exception |
- Start codon — AUG (methionine; formyl-methionine in bacteria)
- Stop codons — UAA, UAG, UGA; they code for no amino acid
- Mnemonic for stops: U Are Away, U Are Gone, U Go Away
- Wobble hypothesis — the third base of a codon pairs loosely, so one tRNA can read several codons. This explains degeneracy and limits the number of tRNAs needed
Requirements
- MRNA — the template
- TRNA — the adaptor; carries the anticodon and the amino acid on its CCA 3′ end
- Ribosome — 80S (60S + 40S) in eukaryotes, 70S (50S + 30S) in prokaryotes; has A, P and E sites
- Aminoacyl-tRNA synthetases — one for each amino acid; they provide the second genetic code and proofread
- Energy — 4 high-energy bonds per peptide bond (2 for charging the tRNA, 2 GTP in elongation)
- Initiation, elongation and release factors
Stages
A. Initiation
Small subunit + initiation factors + Met-tRNA → Binds mRNA at the cap (eukaryote) or Shine–Dalgarno sequence (bacteria) → Scans to the AUG start codon → Large subunit joins → initiation complex; Met-tRNA sits in the P site
B. Elongation
Aminoacyl-tRNA enters the A site (EF-1, GTP) → peptidyl transferase forms the peptide bond — it is a ribozyme, part of the large subunit rRNA → translocation — ribosome moves one codon (EF-2, GTP) → Empty tRNA leaves via the E site; cycle repeats
C. Termination
- A stop codon enters the A site
- Release factors bind (no tRNA recognises a stop codon)
- Peptidyl transferase hydrolyses the bond → polypeptide released; ribosome dissociates
- Polysome (polyribosome) — several ribosomes translating one mRNA simultaneously, greatly increasing output
Post-translational Modification
- Folding — assisted by chaperones
- Proteolytic cleavage — proinsulin → insulin; zymogen activation
- Glycosylation — in the endoplasmic reticulum and Golgi
- Hydroxylation — of proline and lysine in collagen; needs vitamin C
- γ-Carboxylation — of glutamate in clotting factors; needs vitamin K
- Phosphorylation, acetylation, ubiquitination, lipidation
Inhibitors of Protein Synthesis
| Agent | Target | Action |
|---|---|---|
| Streptomycin | 30S | Causes misreading; blocks initiation |
| Tetracycline | 30S | Blocks aminoacyl-tRNA binding to the A site |
| Chloramphenicol | 50S | Inhibits peptidyl transferase |
| Erythromycin | 50S | Blocks translocation |
| Puromycin | Both | Analogue of aminoacyl-tRNA; premature release |
| Cycloheximide | 60S (eukaryote) | Peptidyl transferase; laboratory use only |
| Diphtheria toxin | EEF-2 | ADP-ribosylates it → blocks translocation |
| Ricin | 60S rRNA | Depurinates it; extremely toxic |
- Antibacterial selectivity depends on the 70S vs 80S difference — which is also why chloramphenicol harms human mitochondrial ribosomes (70S-like), causing aplastic anaemia and grey baby syndrome
Applied Aspects
- Sickle cell disease — a single missense mutation, gag → GTG, replaces glutamate with valine at position 6 of the β chain
- β-Thalassaemia — often a nonsense or splice mutation, giving a truncated or absent chain
- Cystic fibrosis — ΔF508 is a deletion of three bases, removing one phenylalanine without shifting the frame
- Frameshift mutations (insertion or deletion of a number not divisible by three) are the most damaging, altering every codon downstream
- Diphtheria kills by halting protein synthesis in heart and nerve; the toxin is enzymatically active, so a single molecule can kill a cell
Definition
Gout = a disorder of purine metabolism characterised by hyperuricaemia and deposition of monosodium urate crystals in joints and soft tissues.
- Hyperuricaemia — serum urate above 7 mg/dL in men, 6 mg/dL in women
- Most people with hyperuricaemia never develop gout; it is necessary but not sufficient
Classification and Causes
| Type | Mechanism | Causes |
|---|---|---|
| Primary — overproduction (10%) | ↑ De novo purine synthesis | PRPP synthetase over-activity; partial HGPRT deficiency; glucose-6-phosphatase deficiency |
| Primary — underexcretion (90%) | ↓ Renal urate clearance | Idiopathic; genetic transporter variants |
| Secondary — overproduction | Excess cell turnover | Leukaemia, lymphoma, psoriasis, haemolysis, tumour lysis syndrome |
| Secondary — underexcretion | Competition or renal disease | Thiazides, low-dose aspirin, alcohol, lactic acidosis, ketosis, chronic kidney disease, lead |
WHY Crystals Form and Where
- Urate is least soluble at low temperature and low pH
- Hence the classical first attack in the first metatarsophalangeal joint (podagra) — the coolest, most peripheral joint
- Crystals are needle-shaped and negatively birefringent under polarised light — the diagnostic finding
- They are phagocytosed by neutrophils → inflammasome activation → IL-1β → acute inflammation
Clinical Features
- Acute gouty arthritis — sudden, exquisitely painful, red, swollen joint, often at night
- Intercritical period — symptom-free between attacks
- Chronic tophaceous gout — tophi in the ear cartilage, olecranon bursa and tendons; joint destruction
- Renal — uric acid stones (radiolucent), urate nephropathy
- Associated with the metabolic syndrome, hypertension and cardiovascular disease
Treatment
| Phase | Drug | Mechanism |
|---|---|---|
| Acute attack | NSAIDs, colchicine, steroids | Colchicine binds tubulin → blocks neutrophil migration |
| Long term — underexcretors | Probenecid (uricosuric) | ↑ Renal urate excretion |
| Long term — overproducers | Allopurinol, febuxostat | Inhibit xanthine oxidase |
| Refractory | Rasburicase (recombinant uricase) | Converts urate to soluble allantoin |
Applied Aspects
- Never start or stop allopurinol during an acute attack — any sudden change in urate level can precipitate or prolong it
- Allopurinol with azathioprine or 6-mercaptopurine is dangerous — xanthine oxidase normally inactivates them, so the dose must be cut drastically
- Tumour lysis syndrome — massive cell breakdown after chemotherapy → hyperuricaemia, hyperkalaemia, hyperphosphataemia and renal failure. Prevented by hydration and allopurinol or rasburicase
- Low-dose aspirin raises urate (it competes for the tubular transporter) while high doses are uricosuric
Definition
Salvage pathway = the route by which preformed purine and pyrimidine bases and nucleosides, released from nucleic acid turnover or diet, are re-converted to nucleotides instead of being degraded.
The Enzymes
| Enzyme | Substrate | Product | Co-substrate |
|---|---|---|---|
| HGPRT | Hypoxanthine, guanine | IMP, GMP | PRPP |
| APRT | Adenine | Amp | PRPP |
| Adenosine kinase | Adenosine | Amp | ATP |
| Thymidine kinase | Thymidine | DTMP | ATP |
Importance
- Energetically far cheaper — de novo synthesis of one purine costs about 6 ATP; salvage costs one
- Brain, RBC, leucocytes and bone marrow depend on salvage, being unable to carry out de novo synthesis
- Consumes PRPP, which restrains de novo synthesis indirectly
- Reduces the load of uric acid that would otherwise be produced
Lesch–nyhan Syndrome
Complete deficiency of HGPRT; X-linked recessive; affects boys.
HGPRT absent → Hypoxanthine and guanine cannot be salvaged → Diverted to xanthine oxidase → ↑↑ uric acid → Meanwhile PRPP accumulates (not consumed by salvage) → PRPP drives de novo synthesis → more purines → more urate → Double mechanism of hyperuricaemia
Clinical features
- Severe hyperuricaemia — gout, urate stones, "orange sand" in the nappy
- Choreoathetosis, spasticity and dystonia
- Mental retardation
- Compulsive self-mutilation — biting of lips and fingers; the characteristic and distressing feature
- The neurological features are not caused by urate and are not improved by allopurinol — they relate to defective dopamine pathways in the basal ganglia
Comparison of HGPRT Defects
| Degree | Condition | Features |
|---|---|---|
| Complete deficiency | Lesch–Nyhan | Hyperuricaemia plus neurological and behavioural disease |
| Partial deficiency | Kelley–Seegmiller | Gout and stones only, with normal intellect |
Applied Aspects
- Allopurinol controls the urate but not the neurological disease — a clear illustration that a metabolite and a phenotype need not be causally linked
- Physical restraints and dental extraction are sometimes needed to prevent self-injury
- Prenatal diagnosis and carrier detection are possible by enzyme assay or DNA analysis
- Salvage enzymes are exploited in chemotherapy — 6-mercaptopurine must be activated by HGPRT, so tumours lacking it become resistant
Definition
Polymerase chain reaction (PCR) = a technique for producing millions of copies of a specific DNA sequence in vitro, devised by Kary Mullis (Nobel Prize 1993).
Requirements
| Component | Purpose |
|---|---|
| Template DNA | The sequence to be amplified |
| Two primers | Short oligonucleotides flanking the target; define what is amplified |
| Taq polymerase | Heat-stable DNA polymerase from Thermus aquaticus |
| DNTPs | The four deoxynucleotides |
| Mg2+ and buffer | Cofactor and optimal pH |
| Thermal cycler | Automates the temperature changes |
The Three Steps of a Cycle
| Step | Temperature | What happens |
|---|---|---|
| 1. Denaturation | 94–95 °C | Strands separate |
| 2. Annealing | 50–65 °C | Primers bind their complementary sequences |
| 3. Extension | 72 °C | Taq polymerase synthesises the new strand |
- Each cycle takes 2–5 minutes and doubles the target
- 25–35 cycles give about 106 to 109 copies — 2n amplification
- Taq polymerase is essential — an ordinary polymerase would be destroyed at 95 °C and would have to be replaced each cycle
Variants
| Type | Feature | Use |
|---|---|---|
| RT-PCR | RNA is first copied to cDNA by reverse transcriptase | RNA viruses (HIV, hepatitis C, SARS-CoV-2); gene expression |
| Real-time (quantitative) PCR | Product measured during amplification by fluorescence | Viral load; quantitation |
| Nested PCR | Two successive primer pairs | Greater sensitivity and specificity |
| Multiplex PCR | Several primer pairs together | Multiple targets at once |
| Allele-specific PCR | Primers match a single base change | Point mutation detection |
Applications
- Infection — diagnosis of tuberculosis, HIV, hepatitis, COVID-19; detection of organisms that cannot be cultured
- Genetic disease — sickle cell, thalassaemia, cystic fibrosis, Duchenne dystrophy; prenatal and carrier diagnosis
- Oncology — detection of translocations (BCR-ABL), minimal residual disease, tumour mutations guiding targeted therapy
- Forensic medicine — DNA fingerprinting from minute samples of blood, semen or hair
- Paternity and identity testing
- Research — cloning, sequencing, site-directed mutagenesis
Applied Aspects
- Extreme sensitivity is also its weakness — a single contaminating molecule gives a false positive. Strict separation of pre- and post-PCR areas is essential
- A positive PCR does not prove active infection — it detects nucleic acid, which may come from dead organisms; this caused much confusion during the COVID-19 pandemic
- Inhibitors in the sample (heparin, haemoglobin, bile) can cause false negatives; an internal control should always be run
Definition
Mutation = a permanent, heritable change in the nucleotide sequence of DNA.
Classification BY Extent
| Type | Meaning |
|---|---|
| Point (gene) mutation | A single base changed, added or lost |
| Chromosomal | Deletion, duplication, inversion, translocation |
| Genomic | Change in chromosome number — aneuploidy, polyploidy |
Point Mutations
| Type | Change | Consequence | Example |
|---|---|---|---|
| Silent | Base changed but the same amino acid is coded | No effect — because the code is degenerate | — |
| Missense | A different amino acid | Altered protein, may be mild or severe | Sickle cell disease (Glu → Val) |
| Nonsense | Codon becomes a stop | Truncated, usually non-functional protein | β-Thalassaemia |
| Frameshift | Insertion or deletion not a multiple of three | Every codon downstream altered — usually the most damaging | Duchenne muscular dystrophy |
| In-frame deletion | Loss of a multiple of three bases | One or more amino acids missing; frame preserved | Cystic fibrosis ΔF508 |
| Triplet repeat expansion | A trinucleotide repeated excessively | Anticipation — earlier and more severe in each generation | Huntington disease, fragile X |
Transition and transversion
- Transition — purine to purine, or pyrimidine to pyrimidine; the commoner
- Transversion — purine to pyrimidine or the reverse
Mutagens
| Type | Examples | Effect |
|---|---|---|
| Physical | Ultraviolet light | Thymine dimers |
| — | X-rays, gamma rays | Strand breaks, free radicals |
| Chemical — base analogues | 5-Bromouracil, 2-aminopurine | Mispairing |
| Chemical — deaminating | Nitrous acid | Cytosine → uracil |
| Chemical — alkylating | Nitrogen mustard, ethyl methanesulphonate | Adds alkyl groups |
| Chemical — intercalating | Acridine dyes, ethidium bromide | Frameshift |
| Biological | Viruses, transposons | Insertional mutagenesis |
DNA Repair
| Mechanism | Repairs | Defect causes |
|---|---|---|
| Mismatch repair | Replication errors | Lynch syndrome (HNPCC) |
| Nucleotide excision repair | Thymine dimers, bulky adducts | Xeroderma pigmentosum |
| Base excision repair | Single altered bases (glycosylase) | — |
| Double-strand break repair | Breaks, by homologous recombination | BRCA1/2 mutations → breast and ovarian cancer; ataxia telangiectasia |
| Direct repair | Photolyase (not in man) | — |
Applied Aspects
- Mutation is the raw material of both evolution and disease — most are silent or harmful, a few advantageous
Definition
Recombinant DNA technology (genetic engineering) = the set of techniques by which DNA from different sources is joined and introduced into a host cell, where it can be replicated and expressed.
The Tools
| Tool | Function |
|---|---|
| Restriction endonucleases | "Molecular scissors" — cut DNA at specific palindromic sequences, leaving sticky or blunt ends. Example: EcoRI |
| DNA ligase | "Molecular glue" — joins the fragments |
| Vectors | Carry the insert into the host — plasmids, bacteriophage, cosmids, BAC, YAC |
| Host cell | E. Coli, yeast, mammalian cells |
| Reverse transcriptase | Makes cDNA from mRNA |
| Probes | Labelled DNA used to identify a sequence |
The Basic Steps
Isolate the DNA of interest → Cut both insert and vector with the same restriction enzyme → Ligate to form recombinant DNA → Transform into the host cell → Select the successful clones (antibiotic resistance, blue–white screening) → Express and harvest the product
Blotting Techniques
| Technique | Detects | Probe | Use |
|---|---|---|---|
| Southern blot | DNA | Labelled DNA | Gene deletions, RFLP, DNA fingerprinting |
| Northern blot | RNA | Labelled DNA or RNA | Gene expression |
| Western blot | Protein | Antibody | Confirmatory test for HIV |
CLINICAL PEARL
Mnemonic — Southern for DNA, Northern for RNA, Western for Protein: "SNoW DRoP".
Medical Applications
- Therapeutic proteins — human insulin (the first, 1982), growth hormone, erythropoietin, clotting factor VIII, interferons, tPA
- Vaccines — recombinant hepatitis B vaccine; HPV vaccine; mRNA vaccines
- Monoclonal antibodies — rituximab, trastuzumab, infliximab
- Diagnosis — gene probes, PCR, prenatal and carrier detection
- Gene therapy — ADA-SCID was the first success; now used in haemophilia, spinal muscular atrophy and some retinal disease
- CRISPR-Cas9 gene editing — precise correction of mutations; already licensed for sickle cell disease and β-thalassaemia
Applied Aspects
- Recombinant human insulin removed the risk of allergy to animal insulin and the dependence on pancreas supply — the clearest early benefit of the technology
- Recombinant factor VIII eliminated the transmission of HIV and hepatitis C that devastated the haemophilia population in the 1980s
- Ethical concerns — germline editing is heritable and remains widely prohibited; questions of consent, equity of access and genetic privacy are unresolved
- Gene therapy remains limited by delivery, immune responses to vectors, durability and cost
Definition
Genetic code = the set of rules by which the sequence of bases in mRNA is translated into the sequence of amino acids in a protein.
Properties
| Property | Meaning | Consequence |
|---|---|---|
| Triplet | 3 bases = 1 codon | 43 = 64 codons for 20 amino acids |
| Degenerate | Several codons per amino acid | A silent mutation may have no effect |
| Unambiguous | One codon → one amino acid only | No confusion in reading |
| Non-overlapping | Each base used once | A single deletion shifts the whole frame |
| Comma-less | Read continuously | The reading frame is critical |
| Universal | Same in nearly all species | Human genes can be expressed in bacteria — the basis of recombinant insulin |
| Has punctuation | Start and stop codons | Defines the boundaries of the message |
Special Codons
| Codon | Meaning |
|---|---|
| AUG | Start and methionine (formyl-methionine in bacteria) |
| UAA, UAG, UGA | Stop — ochre, amber and opal |
| UGG | Tryptophan — only one codon |
| AUG | Methionine — only one codon |
| Leucine, serine, arginine | Six codons each — the most |
The Wobble Hypothesis
- Proposed by Crick
- The third base of the codon pairs loosely with the first base of the anticodon
- Therefore one tRNA can read more than one codon
- Explains why only about 30–40 tRNAs are needed rather than 61
- Inosine in the anticodon can pair with U, C or A — the widest wobble
- Explains why the third base is the most tolerant of mutation
Exceptions to Universality
- Mitochondria use a slightly different code — UGA codes tryptophan instead of stop, and AUA codes methionine
- Mitochondria also need fewer tRNAs (22) because of extended wobble
- Some organisms use selenocysteine (UGA in context), called the 21st amino acid
Applied Aspects
- Degeneracy is protective — many random base changes produce no change in protein
- Frameshift mutations are the most damaging precisely because the code is comma-less and non-overlapping
- Universality made genetic engineering possible — a human gene placed in E. Coli is read correctly, which is how recombinant insulin is made
- Nonsense mutations may be overcome by read-through drugs (ataluren) or suppressor tRNAs — an active area of therapy in cystic fibrosis and muscular dystrophy
Structure of DNA
- A polymer of deoxyribonucleotides, each consisting of a nitrogenous base, deoxyribose and a phosphate group, joined by 3′–5′ phosphodiester bonds
- Bases — the purines adenine and guanine (double-ringed) and the pyrimidines cytosine and thymine (single-ringed)
- WATSON and CRICK double helix — two antiparallel strands (one running 5′ to 3′, the other 3′ to 5′) wound into a right-handed helix about a common axis
- The sugar-phosphate backbone lies outside, hydrophilic and negatively charged, with the bases stacked inside
- Chargaff rules — A = T and G = C, so purines equal pyrimidines; the ratio (A+T)/(G+C) varies between species
- Base pairing by hydrogen bonds — A pairs with T by two bonds; G pairs with C by three
- Dimensions of B-DNA — one complete turn every 3.4 nm containing 10 base pairs, so adjacent bases are 0.34 nm apart; diameter 2 nm. major and minor grooves allow proteins to read the sequence without unwinding it
- Forms — B (the physiological right-handed form), A (right-handed, dehydrated) and Z (left-handed, with a zigzag backbone)
CLINICAL PEARL
G–C pairs have three hydrogen bonds and A–T only two, and almost everything about DNA stability follows from that. A GC-rich sequence is held together more firmly, so it has a higher melting temperature, resists denaturation, and is harder to unwind. Conversely, AT-rich regions are where replication origins and promoters sit — the cell puts the places it must open frequently where opening is cheapest.
Denaturation and Melting Temperature
Heating, extremes of pH, urea or formamide break the hydrogen bonds between the strands → The phosphodiester backbone is not broken — denaturation is a separation, not a degradation → The two strands separate — denaturation or melting → The stacked bases are exposed, and absorbance at 260 nm increases by up to 40% — the hyperchromic effect → Tm (melting temperature) is the temperature at which half the DNA has become single-stranded → On slow cooling the complementary strands re-form — renaturation or annealing, with a corresponding hypochromic effect
- Tm rises with GC content, because of the third hydrogen bond, and also with increasing salt concentration and length of the molecule
- Tm falls with extremes of pH, urea, formamide and low ionic strength
- Hybridisation — single strands from different sources anneal if their sequences are complementary, which is the principle underlying Southern and Northern blotting, DNA probes, microarrays and PCR
Higher Order Structure
- DNA is wound around histone octamers (two each of H2A, H2B, H3 and H4) with about 146 base pairs per nucleosome, giving the "beads on a string" appearance; H1 is the linker histone
- Nucleosomes coil into a 30 nm fibre, then into loops and finally the condensed chromosome — a packing ratio of about 10,000-fold, which is what allows two metres of DNA to fit in a nucleus
- Histones are strongly basic (rich in lysine and arginine), so they bind the acidic phosphate backbone electrostatically
- Euchromatin is loosely packed and transcriptionally active; heterochromatin is condensed and inactive
- Supercoiling is managed by topoisomerases, which are the targets of quinolone antibiotics and of etoposide and irinotecan
Applied Aspects
- PCR depends directly on denaturation and annealing — heating to separate the strands, cooling to let primers anneal, and extension by a thermostable polymerase; the annealing temperature is chosen from the primer Tm
- Absorbance at 260 nm measures nucleic acid concentration, and the 260/280 ratio assesses protein contamination — about 1.8 for pure DNA and 2.0 for RNA
- Quinolones and several anticancer drugs act on topoisomerases, exploiting the fact that DNA must be transiently cut and resealed to be replicated
- Histone modification and DNA methylation regulate gene expression without altering the sequence — the basis of epigenetics, and the target of several newer anticancer drugs
- Ultraviolet light causes thymine dimers, repaired by nucleotide excision repair; its failure causes xeroderma pigmentosum, with extreme photosensitivity and early skin cancer
Chemistry and Forms
Vitamin A = a group of fat-soluble retinoids, existing in three active forms.
| Form | Function |
|---|---|
| Retinol | Transport and storage form; reproduction |
| Retinal (retinaldehyde) | Vision — combines with opsin |
| Retinoic acid | Growth, differentiation and gene expression; cannot support vision or reproduction |
| β-Carotene | Provitamin from plants; cleaved in intestinal mucosa to 2 retinal |
- Interconversion: retinol ↔ retinal → retinoic acid. The last step is irreversible — which is why retinoic acid alone cannot cure night blindness
Sources and Requirement
| Preformed (animal) | Provitamin carotene (plant) |
|---|---|
| Fish liver oil (richest) | Carrot, green leafy vegetables |
| Liver, egg yolk | Mango, papaya, pumpkin |
| Milk, butter, ghee, cheese | Tomato, red palm oil |
- Requirement 600 µg retinol equivalents/day in adults; 950 in lactation
- 1 RE = 1 µg retinol = 6 µg β-carotene (absorption of carotene is poor)
Absorption, Transport and Storage
Dietary retinyl ester → Hydrolysed; absorbed with fat and bile salts → Re-esterified in mucosa → chylomicrons → liver — stored in stellate (Ito) cells, 90% of body stores → Released as retinol bound to retinol-binding protein + prealbumin → Delivered to tissues
- Liver stores last 6–12 months — deficiency takes months to appear
- Zinc is needed to synthesise retinol-binding protein — hence zinc deficiency causes a functional vitamin A deficiency that does not respond to vitamin A alone
- Absorption fails in fat malabsorption, obstructive jaundice and cystic fibrosis
Functions
A. Vision — the Wald visual cycle
11-cis retinal + opsin → rhodopsin → Light → 11-cis retinal → all-trans retinal (isomerisation) → Rhodopsin → metarhodopsin II → Transducin → phosphodiesterase → ↓ cGMP → Na+ channels close → hyperpolarisation → nerve impulse → All-trans retinal re-isomerised — some is lost and must be replaced from the diet
B. Other functions
- Epithelial integrity — maintains normal differentiation of epithelium; deficiency causes keratinising metaplasia
- Gene expression — retinoic acid binds nuclear RAR and RXR receptors, acting like a steroid hormone
- Growth and bone remodelling
- Reproduction — spermatogenesis and placental development (needs retinol, not retinoic acid)
- Immunity — "the anti-infective vitamin"; deficiency raises mortality from measles and diarrhoea
- Antioxidant — β-carotene quenches singlet oxygen
- Glycoprotein synthesis — retinol phosphate is a sugar carrier
Deficiency — Ocular Features (WHO Classification)
| Grade | Sign | Reversible? |
|---|---|---|
| XN | Night blindness (nyctalopia) — the earliest symptom | Yes |
| X1A | Conjunctival xerosis | Yes |
| X1B | Bitot spots — foamy triangular patches of keratin | Yes |
| X2 | Corneal xerosis | Yes, with treatment |
| X3A | Corneal ulceration < one-third | Partly |
| X3B | Keratomalacia — corneal melting | NO — permanent blindness |
| XS / XF | Corneal scar; xerophthalmic fundus | No |
Extra-ocular features
- Follicular hyperkeratosis (phrynoderma) — "toad skin" on the extensor surfaces
- Dry, rough skin; keratinising metaplasia of respiratory, urinary and genital epithelium
- Recurrent infections, particularly respiratory and diarrhoeal
- Growth retardation; anaemia; urinary and renal stones
Hypervitaminosis a
| Type | Features |
|---|---|
| Acute | Headache, vomiting, drowsiness, raised intracranial pressure; skin peeling |
| Chronic | Bone and joint pain, hyperostosis, hepatomegaly and cirrhosis, alopecia, dry cracked lips |
| Teratogenic | Craniofacial, cardiac and CNS malformations — retinoids are absolutely contraindicated in pregnancy |
- Carotene does not cause toxicity — excess gives only harmless yellow skin (carotenaemia), sparing the sclera. This distinguishes it from jaundice
Applied Aspects
- India's prophylaxis programme — 1 lakh IU at 9 months with measles vaccine, then 2 lakh IU every 6 months up to 5 years
- Vitamin A in measles reduces mortality substantially and is recommended by WHO for every severe case
- Isotretinoin for acne and tretinoin for acute promyelocytic leukaemia, where it induces differentiation of the malignant cells
- Golden rice is genetically engineered to make β-carotene, aimed at deficiency in rice-eating populations
Nature and Forms
Vitamin D = a fat-soluble prohormone, since it is synthesised in the body, transported in blood, and acts on distant tissues through a nuclear receptor.
| Form | Origin |
|---|---|
| Vitamin D3 (cholecalciferol) | Skin, from 7-dehydrocholesterol; also animal foods |
| Vitamin D2 (ergocalciferol) | Plants and yeast, from ergosterol |
| 25(OH)D3 (calcidiol) | Liver — the storage and circulating form; the one measured |
| 1,25(OH)2D3 (calcitriol) | Kidney — the active hormone |
Synthesis and Activation
7-Dehydrocholesterol in skin → UV-B light (290–315 nm) → Cholecalciferol (D3) → liver — 25-hydroxylase → 25(OH)D3 — half-life 2–3 weeks → kidney — 1α-hydroxylase (rate-limiting, in the PCT) → calcitriol — 1,25(OH)2D3
- Sunlight is the chief source — 15–30 minutes of exposure to face and arms several times a week suffices
- 25(OH)D is measured, not calcitriol, because it has the longest half-life and reflects total stores
- Transported bound to vitamin D binding protein
Regulation of 1α-hydroxylase
| Stimulated by | Inhibited by |
|---|---|
| Parathyroid hormone — the chief regulator | Calcitriol itself (feedback) |
| Low serum calcium | High calcium |
| Low serum phosphate | FGF-23 |
| Prolactin, oestrogen, growth hormone | High phosphate |
- The alternative enzyme 24-hydroxylase makes the inactive 24,25(OH)2D, diverting the pathway when calcium is plentiful
Actions
| Target | Action | Mechanism |
|---|---|---|
| Intestine (chief target) | ↑ Absorption of calcium and phosphate | Induces calbindin and the TRPV6 channel |
| Bone | Permits normal mineralisation; with PTH, mobilises calcium | Stimulates osteoblasts and, indirectly, osteoclasts via RANKL |
| Kidney | ↑ Reabsorption of calcium and phosphate | Direct |
| Parathyroid | ↓ PTH synthesis | Negative feedback |
| Other | Immune modulation, cell differentiation, insulin secretion, muscle function | VDR is present in most tissues |
CLINICAL PEARL
Contrast with PTH: both raise calcium, but vitamin D raises phosphate while PTH lowers it. Vitamin D acts chiefly on the gut; PTH on bone and kidney. This is the commonest discriminating question on calcium metabolism.
Deficiency — Rickets and Osteomalacia
| Feature | Rickets (child) | Osteomalacia (adult) |
|---|---|---|
| Defect | Failure of mineralisation at the growing epiphyseal plate | Failure of mineralisation of newly formed osteoid |
| Head | Craniotabes, delayed fontanelle closure, frontal bossing | — |
| Chest | Rachitic rosary, Harrison sulcus, pigeon chest | — |
| Limbs | Widened wrists, bowing of legs, knock knees | Bone pain and tenderness |
| Other | Delayed dentition, pot belly, hypotonia, delayed walking | Proximal myopathy — waddling gait, pseudofractures (Looser zones) |
| X-ray | Cupping, splaying and fraying of metaphyses | Pseudofractures, reduced density |
Biochemical findings
| Test | Result |
|---|---|
| Serum calcium | Low or normal (kept up by PTH) |
| Serum phosphate | Low |
| Alkaline phosphatase | Markedly raised — the most useful screening test |
| PTH | Raised (secondary hyperparathyroidism) |
| 25(OH)D | Low — the diagnostic test |
Causes of Deficiency and Resistance
- Inadequate sunlight — dark skin, veiling, urban living, air pollution, prolonged indoor life
- Dietary lack — exclusive breast feeding without supplements
- Malabsorption — coeliac disease, cystic fibrosis, cholestasis
- Chronic kidney disease — 1α-hydroxylase fails → renal osteodystrophy; needs calcitriol, not cholecalciferol
- Liver disease — impaired 25-hydroxylation
- Anticonvulsants (phenytoin, phenobarbitone) induce P450 and accelerate degradation
- Vitamin D dependent rickets — type I (1α-hydroxylase defect, responds to calcitriol); type II (receptor defect, resistant)
- Vitamin D resistant rickets — X-linked hypophosphataemia; a renal phosphate leak with high FGF-23
Applied Aspects
- Vitamin D deficiency is extremely common in India despite abundant sunshine — skin pigmentation, clothing, pollution and indoor working all contribute
- Hypervitaminosis D — hypercalcaemia, nephrocalcinosis, metastatic calcification, polyuria. The most toxic of all vitamins in overdose
- Sarcoidosis and tuberculosis — macrophages express 1α-hydroxylase independently of PTH → hypercalcaemia
- Prevention — 400 IU daily in infancy; supplementation in pregnancy, the elderly and the housebound
Thiamine (vitamin B₁)
Coenzyme form — thiamine pyrophosphate (TPP).
| Function | Enzyme | Consequence of deficiency |
|---|---|---|
| Oxidative decarboxylation | Pyruvate dehydrogenase | Pyruvate and lactate accumulate → lactic acidosis |
| — | α-Ketoglutarate dehydrogenase | TCA cycle impaired |
| — | Branched-chain α-keto acid dehydrogenase | BCAA accumulate |
| Transketolase | HMP shunt | ↓ NADPH and ribose; the basis of the diagnostic test |
| Nerve conduction | Membrane function | Peripheral neuropathy |
- Sources — whole grains, pulses, pork, yeast, nuts; destroyed by polishing rice, cooking and thiaminases in raw fish and betel nut
- Requirement 0.5 mg per 1000 kcal; needs rise with carbohydrate intake
- Body stores last only 2–3 weeks — deficiency appears quickly
Deficiency
| Form | Features |
|---|---|
| Dry beri-beri | Peripheral neuropathy — symmetrical, sensory and motor, wrist and foot drop; wasting |
| Wet beri-beri | High-output cardiac failure, oedema, dyspnoea, warm extremities |
| Infantile beri-beri | 2–3 months; aphonia (hoarse cry), cardiac failure, convulsions |
| Wernicke encephalopathy | Confusion, ophthalmoplegia, ataxia — the classical triad; alcoholics |
| Korsakoff psychosis | Anterograde amnesia with confabulation; often irreversible |
- Assessment — erythrocyte transketolase activity with the TPP effect; a rise over 25% on adding TPP indicates deficiency
- Always give thiamine before glucose in an alcoholic or malnourished patient — a glucose load consumes the last thiamine and can precipitate Wernicke encephalopathy
Riboflavin (vitamin B₂)
- Coenzymes — FMN and FAD; carry 2 hydrogen atoms
- Enzymes — succinate dehydrogenase, acyl-CoA dehydrogenase, xanthine oxidase, glutathione reductase, and complexes I and II of the respiratory chain
- Sources — milk, egg, liver, green leafy vegetables; destroyed by light, which is why milk should not stand in sunlight
- Requirement 1.2–1.6 mg/day
Deficiency (ariboflavinosis)
- Angular stomatitis and cheilosis — cracks at the angles of the mouth and on the lips
- Glossitis — magenta-coloured tongue
- Seborrhoeic dermatitis around the nose and scrotum
- Corneal vascularisation and photophobia
- Normocytic anaemia
- Assessed by erythrocyte glutathione reductase activity coefficient
Niacin (vitamin B₃)
- Coenzymes — NAD+ and NADP+; carry 2 electrons and 1 H+
- NAD+ is used in catabolic (oxidative) reactions; NADPH in anabolic (reductive) ones
- Involved in over 200 dehydrogenases
Synthesis from tryptophan
Tryptophan → Kynurenine pathway → Needs vitamin B6, B2 and iron → niacin
- 60 mg tryptophan = 1 mg niacin
- Requirement 16–18 mg niacin equivalents/day
- Sources — liver, meat, fish, groundnut, whole grains. Maize niacin is bound (niacytin) and unavailable unless treated with alkali — as in the traditional Mexican preparation of tortillas
Pellagra — the three Ds
- Dermatitis — symmetrical, on sun-exposed areas; Casal's necklace around the neck; glove and boot distribution
- Diarrhoea — with glossitis and stomatitis
- Dementia — irritability, depression, confusion, psychosis
- A fourth D — death if untreated
- Secondary pellagra — Hartnup disease (tryptophan malabsorption), carcinoid syndrome (tryptophan diverted to serotonin), isoniazid (antagonises B6), alcoholism
- Maize-eating populations are at particular risk — maize is low in both available niacin and tryptophan, and high in leucine, which inhibits the conversion
Applied Aspects
- Nicotinic acid in pharmacological doses (1–3 g) lowers LDL and triglyceride and raises HDL more than any other drug; limited by cutaneous flushing, which aspirin reduces
- Nicotinamide does not cause flushing and has NO lipid effect — the two forms are not interchangeable therapeutically
- Beri-beri and pellagra are diseases of monotonous staple diets — polished rice and maize respectively; both are prevented by dietary diversity
- Thiamine deficiency should be suspected in any alcoholic with confusion, and treated empirically — the cost of treating is trivial, the cost of missing it is permanent amnesia
- Refeeding syndrome — thiamine demand rises sharply when carbohydrate feeding restarts; it must be given before and during refeeding
- Riboflavin colours urine bright yellow, which is harmless but alarms patients who have not been warned
Vitamin B₁₂ — Chemistry and Sources
Vitamin B12 (cobalamin) = a cobalt-containing corrinoid, the only vitamin containing a metal and the only one synthesised exclusively by microorganisms.
- Sources — animal foods only: liver, meat, fish, egg, milk. Absent from plants
- Requirement 1–2 µg/day; body stores 2–5 mg, mostly in liver
- Stores last 3–5 years — deficiency takes years to appear
- Active coenzymes — methylcobalamin and deoxyadenosylcobalamin
Absorption
Dietary B12 bound to protein → Released by gastric acid and pepsin → Binds haptocorrin (R-binder) from saliva → Pancreatic proteases release it in the duodenum → Binds intrinsic factor (from gastric parietal cells) → IF–B12 complex absorbed in the terminal ileum (cubilin receptor) → Transported in blood on transcobalamin II
- A defect at any of these steps causes deficiency — which is why the causes are so varied
- There is an enterohepatic circulation of B12, which is why malabsorption causes deficiency faster than dietary lack
The Two B₁₂-dependent Reactions
| Reaction | Coenzyme | Consequence of block |
|---|---|---|
| Homocysteine → Methionine(methionine synthase) | Methylcobalamin | Methyl trap → folate trapped as methyl-THF → megaloblastic anaemia; homocysteine rises |
| Methylmalonyl-CoA → Succinyl-CoA(mutase) | Deoxyadenosylcobalamin | Methylmalonic acid accumulates → abnormal branched-chain fatty acids in myelin → neurological damage |
CLINICAL PEARL
This is the crux of the whole topic. The first reaction is shared with folate, so folate can correct the anaemia. The second is unique to B12, so folate does nothing for the neurological disease — which progresses silently while the blood count looks better.
Folic Acid
- Structure — pteridine + PABA + glutamate
- Active form — tetrahydrofolate (THF), formed by dihydrofolate reductase
- Function — one-carbon transfer at various oxidation levels
- Sources — green leafy vegetables (Latin folium, leaf), liver, pulses, citrus. Destroyed by prolonged cooking
- Requirement 200 µg/day; 400–500 µg in pregnancy
- Stores last only 3–4 months
One-carbon reactions requiring folate
- Thymidylate synthesis (dUMP → dTMP) — the rate-limiting step of DNA synthesis
- Purine synthesis — carbons 2 and 8
- Methionine regeneration from homocysteine
- Glycine ↔ serine interconversion; histidine catabolism
Megaloblastic Anaemia — WHY It Occurs
↓ B12 or folate → ↓ Thymidylate synthesis → DNA synthesis impaired, but RNA and protein synthesis continue → Nuclear–cytoplasmic asynchrony — the nucleus lags behind → Large cells with immature nuclei → Ineffective erythropoiesis → intramedullary haemolysis
| Finding | Detail |
|---|---|
| Peripheral smear | Macro-ovalocytes; hypersegmented neutrophils (> 5 lobes) — the earliest sign |
| MCV | > 100 fL |
| Bone marrow | Megaloblasts; giant metamyelocytes |
| Reticulocytes | Low |
| LDH and bilirubin | Raised (ineffective erythropoiesis) |
| Pancytopenia | In severe cases |
Distinguishing B₁₂ from Folate Deficiency
| Feature | Vitamin B12 | Folate |
|---|---|---|
| Neurological signs | Present — subacute combined degeneration, neuropathy, dementia | Absent |
| Serum methylmalonic acid | Raised | Normal |
| Serum homocysteine | Raised | Raised |
| Time to develop | Years | Months |
| Commonest cause | Malabsorption — pernicious anaemia, gastrectomy, ileal disease | Dietary lack, pregnancy, alcohol, methotrexate |
| Effect of folate alone | Anaemia improves, nerves worsen | Corrects everything |
- Serum methylmalonic acid is the discriminating test — it is raised only in B12 deficiency
Applied Aspects
- Pernicious anaemia — autoimmune destruction of parietal cells; anti-IF and anti-parietal cell antibodies; needs parenteral B12 for life, since oral is useless without intrinsic factor
- Subacute combined degeneration — posterior column and corticospinal tract damage → loss of vibration and joint sense with brisk reflexes and extensor plantars; may be irreversible if treatment is delayed
- Never give folate alone in an unexplained megaloblastic anaemia — always exclude B12 first
- Periconceptional folic acid prevents neural tube defects — 400 µg daily started before conception, since the neural tube closes by day 28, often before pregnancy is recognised
- Strict vegans and their breast-fed infants need B12 supplementation — an important issue in India
- Metformin, proton pump inhibitors and nitrous oxide all impair B12 status
- Folic acid fortification of flour has reduced neural tube defects substantially where introduced, though it may mask B12 deficiency
- Tropical sprue and coeliac disease cause deficiency of both, since folate is absorbed in the jejunum and B12 in the ileum
- Fish tapeworm (Diphyllobothrium latum) competes for B12 and is a classical cause of deficiency
- The Schilling test is now largely obsolete, replaced by antibody testing and serum methylmalonic acid
Chemistry and Sources
Vitamin C (ascorbic acid) = a water-soluble vitamin and powerful reducing agent, functioning chiefly as an antioxidant and a cofactor for hydroxylation reactions.
- Man, other primates and the guinea pig cannot synthesise it — they lack L-gulonolactone oxidase. Most other animals make their own
- Sources — amla (Indian gooseberry) is the richest; guava, citrus, tomato, capsicum, green leafy vegetables, sprouted pulses
- Destroyed by heat, alkali, storage and copper — cooking losses are large
- Requirement 40–60 mg/day; more in smokers, pregnancy and stress
Functions
A. Collagen synthesis — the most important
Procollagen with proline and lysine residues → prolyl and lysyl hydroxylase → Require vitamin C to keep the enzyme iron in the Fe2+ state → Hydroxyproline and hydroxylysine → Allow cross-linking and triple helix formation → stable collagen
- Without hydroxylation the collagen triple helix is unstable and degraded — this single defect explains almost every feature of scurvy
B. Other functions
| Function | Detail |
|---|---|
| Iron absorption | Reduces Fe3+ → Fe2+ — the absorbable form; the most effective dietary enhancer of non-haem iron |
| Antioxidant | Scavenges free radicals; regenerates vitamin E |
| Carnitine synthesis | Two hydroxylation steps |
| Catecholamine synthesis | Cofactor for dopamine β-hydroxylase |
| Bile acid synthesis | Cofactor for 7α-hydroxylase |
| Folate metabolism | Maintains folate in the reduced form |
| Tyrosine metabolism | P-Hydroxyphenylpyruvate dioxygenase |
| Immunity and wound healing | Neutrophil function; collagen deposition |
| Prevents nitrosamine formation | Possible anticarcinogenic role |
Deficiency — Scurvy
| System | Features | Basis |
|---|---|---|
| Gums | Swollen, spongy, bleeding gums; loose teeth | Defective collagen of periodontal ligament |
| Skin | Perifollicular haemorrhage; corkscrew hairs; petechiae, ecchymoses | Fragile capillaries |
| Bone (infants) | Subperiosteal haemorrhage — exquisitely painful, pseudoparalysis; costochondral beading (scorbutic rosary) | Defective osteoid |
| Wounds | Poor healing; old scars break down | No new collagen |
| Blood | Anaemia — from bleeding, poor iron absorption and folate deficiency | — |
| General | Fatigue, irritability, arthralgia, low-grade fever | — |
- Infantile scurvy (Barlow disease) — between 6 and 12 months, in infants fed boiled milk without supplements
- Distinguish the rosary of scurvy from that of rickets — the scorbutic rosary is sharp and angular, the rachitic rosary rounded and smooth
- X-ray shows ground-glass osteopenia, the white line of Frankel, Wimberger ring and Pelkan spurs
Comparison of Scurvy and Rickets
| Feature | Scurvy | Rickets |
|---|---|---|
| Deficiency | Vitamin C | Vitamin D |
| Defect | Collagen (osteoid matrix) | Mineralisation of osteoid |
| Bleeding | Marked | Absent |
| Rosary | Sharp, angular | Rounded, smooth |
| Alkaline phosphatase | Normal or low | Markedly raised |
| Serum calcium | Normal | Low or normal |
Toxicity of Excess
- Generally safe, since it is water-soluble and excreted; but megadoses (> 2 g/day) may cause:
- Oxalate renal stones — ascorbate is metabolised to oxalate
- Osmotic diarrhoea and abdominal cramps
- Rebound scurvy on sudden withdrawal after prolonged megadoses
- Interferes with laboratory tests — falsely alters glucose and occult blood results
- May precipitate haemolysis in G6PD deficiency; dangerous in haemochromatosis by increasing iron absorption
Applied Aspects
- Vitamin C with iron — taking iron tablets with citrus juice substantially improves absorption; tea and coffee do the opposite
- Scurvy still occurs in the elderly living alone, in alcoholics, in severely restricted diets and in institutionalised patients — it is not merely a historical disease
- Response to treatment is dramatic — symptoms improve within days, which is itself diagnostic
- Claims for high-dose vitamin C in the common cold and in cancer have not been supported by controlled trials, despite persistent popular belief
- Smokers need about 35 mg more per day because of increased oxidative turnover
- Vitamin C is the reason citrus fruit prevented scurvy at sea — James Lind's 1747 trial is regarded as the first controlled clinical trial
- Ascorbate is used in methaemoglobinaemia as a second-line reducing agent when methylene blue is contraindicated, as in G6PD deficiency
Nature and Sources
Vitamin K = a fat-soluble vitamin essential for the γ-carboxylation of glutamate residues in certain proteins.
| Form | Source |
|---|---|
| K1 (phylloquinone) | Green leafy vegetables — the dietary form |
| K2 (menaquinone) | Synthesised by intestinal bacteria |
| K3 (menadione) | Synthetic, water-soluble; can cause haemolysis in neonates |
- Requirement 50–100 µg/day; largely met by gut flora
- Absorption needs bile salts — hence deficiency in obstructive jaundice
Function — Γ-carboxylation
Glutamate residue in the precursor protein → γ-Glutamyl carboxylase, requiring vitamin K and CO2 → γ-Carboxyglutamate (Gla) → Gla residues chelate Ca2+ → Protein binds to phospholipid membrane → Biologically active
| Vitamin K-dependent protein | Role |
|---|---|
| Factors II, VII, IX, X | Coagulation (mnemonic — 1972) |
| Protein C and Protein S | Anticoagulant |
| Osteocalcin | Bone mineralisation |
| Matrix Gla protein | Prevents vascular calcification |
Deficiency
- Bleeding tendency — easy bruising, mucosal bleeding, haematuria
- Prolonged prothrombin time with a normal platelet count and bleeding time
- Causes — newborn (sterile gut, poor placental transfer, low milk content); obstructive jaundice and fat malabsorption; prolonged broad-spectrum antibiotics; liver disease; warfarin
- Haemorrhagic disease of the newborn — bleeding on days 2–5; prevented by 1 mg vitamin K intramuscularly at birth
Warfarin and its Antagonism
Warfarin inhibits vitamin K epoxide reductase → Vitamin K cannot be regenerated from its epoxide → γ-Carboxylation fails → Inactive (des-carboxy) clotting factors — PIVKA → Anticoagulation
- Onset takes 2–3 days, until existing factors are cleared — factor VII has the shortest half-life (6 h) so PT rises first
- Protein C also falls early, which can cause a transient prothrombotic state and warfarin-induced skin necrosis; heparin cover prevents it
- Reversed by vitamin K (slow) or fresh frozen plasma / prothrombin complex concentrate (immediate)
Applied Aspects
- Monitored by prothrombin time expressed as INR; target 2–3 for most indications
- Dietary consistency matters more than avoidance — patients on warfarin should keep their green vegetable intake steady rather than eliminate it
- Vitamin K is contraindicated in pregnancy only as warfarin is — warfarin itself is teratogenic and is replaced by heparin
- Rodenticides (superwarfarins) cause prolonged bleeding requiring weeks of vitamin K treatment
Nature and Sources
Vitamin E = a group of eight tocopherols and tocotrienols; α-tocopherol is the most active.
- Sources — vegetable oils (wheat germ, sunflower, safflower), nuts, seeds, green leafy vegetables
- Requirement 8–10 mg/day; needs rise with polyunsaturated fat intake
- Transported in lipoproteins; stored in adipose tissue and liver
Functions
- The chief lipid-soluble antioxidant of the body — it sits in the membrane and terminates lipid peroxidation chain reactions
- Protects polyunsaturated fatty acids of membranes and lipoproteins from free radical damage
- Protects the RBC membrane — deficiency causes haemolysis
- Regenerated by vitamin C after it is oxidised — the two work as a team
- Spares selenium; works with glutathione peroxidase
- Inhibits platelet aggregation; may protect LDL from oxidation
Deficiency
- Rare from dietary lack alone in adults, because stores are large
- Haemolytic anaemia of the newborn, especially in prematurity
- Spinocerebellar ataxia and peripheral neuropathy — loss of proprioception, areflexia, ophthalmoplegia
- Retinitis pigmentosa and myopathy
- Causes — abetalipoproteinaemia, cystic fibrosis, chronic cholestasis, short bowel, and a rare defect of the α-tocopherol transfer protein
Relationship with Other Nutrients
| Nutrient | Relationship |
|---|---|
| Vitamin C | Regenerates oxidised vitamin E |
| Selenium | Glutathione peroxidase; the two are mutually sparing |
| Polyunsaturated fat | Increases the requirement — more substrate to protect |
| Vitamin K | Large doses of E antagonise K → bleeding risk on warfarin |
| Iron | Excess iron promotes the oxidation that E prevents |
Applied Aspects
- Given routinely to preterm infants to prevent haemolysis and retinopathy of prematurity
- Large trials of vitamin E supplements for cardiovascular disease and cancer have been negative, and some suggested harm at high doses — another example of a sound mechanism failing to translate into benefit
- High doses (> 400 IU/day) may increase all-cause mortality and bleeding risk
- Used in abetalipoproteinaemia, where large doses prevent the neurological deterioration
Nature
Vitamin B6 exists as pyridoxine, pyridoxal and pyridoxamine; the active coenzyme is pyridoxal phosphate (PLP).
- Sources — whole grains, meat, fish, liver, nuts, pulses, banana
- Requirement 2 mg/day; needs rise with protein intake
Reactions Requiring PLP
| Reaction type | Example | Product |
|---|---|---|
| Transamination | All transaminases (ALT, ast) | Amino acid interconversion |
| Decarboxylation | Glutamate decarboxylase | GABA |
| — | Dopa decarboxylase | Dopamine |
| — | 5-Hydroxytryptophan decarboxylase | Serotonin |
| — | Histidine decarboxylase | Histamine |
| Haem synthesis | Ala synthase | δ-Aminolaevulinic acid |
| Transsulphuration | Cystathionine β-synthase | Cysteine from homocysteine |
| Glycogenolysis | Glycogen phosphorylase | The largest store of B6 in the body |
| Niacin synthesis | Kynureninase | Niacin from tryptophan |
- PLP is the most versatile coenzyme in amino acid metabolism — over 100 enzymes require it
Deficiency
- Peripheral neuropathy — the commonest feature
- Convulsions in infants — from reduced GABA synthesis
- Sideroblastic (microcytic) anaemia — ala synthase fails, so iron accumulates in mitochondria → ring sideroblasts
- Seborrhoeic dermatitis, glossitis, cheilosis — resembling riboflavin deficiency
- Depression, confusion; raised homocysteine
- Xanthurenic aciduria after a tryptophan load — the classical diagnostic test
Drug-induced Deficiency
| Drug | Mechanism | Consequence |
|---|---|---|
| Isoniazid | Forms a hydrazone with PLP | Peripheral neuropathy — prevented by giving pyridoxine 10 mg daily |
| Penicillamine | Chelates PLP | Neuropathy |
| Hydralazine, cycloserine | Similar | Neuropathy |
| Oral contraceptives | Increased requirement | Mild depletion |
Toxicity and Applied Aspects
- Vitamin B6 is the one water-soluble vitamin with clear toxicity — doses above 200 mg/day for long periods cause a severe sensory neuropathy. The same vitamin that treats neuropathy causes it in excess
- Pyridoxine-responsive conditions — homocystinuria (about half of cases), sideroblastic anaemia, primary hyperoxaluria, infantile convulsions
- Given prophylactically with isoniazid in every antitubercular regimen
- Used in the vomiting of pregnancy and in premenstrual syndrome, with modest evidence
Definition
Xerophthalmia = the spectrum of ocular changes caused by vitamin A deficiency, ranging from reversible night blindness to irreversible corneal destruction.
- The commonest preventable cause of childhood blindness in developing countries
Night Blindness — the Biochemical Basis
↓ Vitamin A → ↓ 11-cis retinal available → ↓ Rhodopsin in rods → Rods cannot respond to dim light → Delayed dark adaptation → night blindness
- Rods are affected before cones, because rhodopsin turnover is faster and rods are far more numerous
- The earliest and most sensitive symptom; fully reversible
- Historically detected by asking mothers whether the child stumbles at dusk — still a useful field question
WHO Classification and Sequence
| Stage | Sign | Nature |
|---|---|---|
| XN | Night blindness | Functional, reversible |
| X1A | Conjunctival xerosis — dry, wrinkled, unwettable | Reversible |
| X1B | Bitot spots — foamy, triangular, silvery-white patches of keratin, usually temporal | Reversible |
| X2 | Corneal xerosis — hazy, dry cornea | Urgent |
| X3A | Corneal ulceration involving < one-third | Partial scarring |
| X3B | Keratomalacia — liquefactive necrosis of the cornea | Irreversible blindness |
| XS | Corneal scar | Permanent |
| XF | Xerophthalmic fundus | Permanent |
CLINICAL PEARL
The progression can be alarmingly rapid — a child with measles or severe diarrhoea can pass from xerosis to keratomalacia within days. Any child with corneal signs is a medical emergency.
Risk Factors
- Preschool children, 1–5 years — the peak age
- Measles — depletes stores rapidly and damages epithelium
- Severe diarrhoea and protein energy malnutrition
- Poverty; a diet lacking green leafy vegetables, milk and yellow fruit
- Early weaning without supplementation
Treatment and Prevention
| Situation | Dose of vitamin A |
|---|---|
| Treatment of xerophthalmia | 2 lakh IU orally on day 1, day 2 and day 14 (half the dose under 1 year) |
| Prophylaxis in India | 1 lakh IU at 9 months with measles vaccine, then 2 lakh IU every 6 months to 5 years |
| Measles | Vitamin A for every severe case, whatever the eye signs |
| Long term | Dietary diversification, food fortification, horticulture, health education |
Applied Aspects
- Vitamin A supplementation reduces all-cause child mortality by about 23% in deficient populations — one of the most cost-effective public health measures known
- It works through immunity, not just vision — deaths prevented are chiefly from measles and diarrhoea
- Zinc deficiency must be corrected too, since retinol-binding protein cannot be made without it
- Bitot spots may persist after treatment in older children; their presence alone does not mean current deficiency
Definition
Pellagra = the deficiency disease of niacin (vitamin B3) or of its precursor tryptophan, characterised by the three Ds.
- The name is from Italian pelle agra — "rough skin"
The Three (and Fourth) DS
| Feature | Description |
|---|---|
| Dermatitis | Symmetrical, on sun-exposed areas; erythema then pigmentation, thickening and scaling. Casal's necklace around the neck; "glove and boot" on limbs; butterfly on the face |
| Diarrhoea | With glossitis, stomatitis, angular cheilitis; a raw beefy red tongue; achlorhydria |
| Dementia | Irritability, insomnia, depression, memory loss, confusion, hallucinations, frank psychosis |
| Death | If untreated |
- The dermatitis is photosensitive because niacin deficiency impairs the repair of ultraviolet damage — this is why it spares covered skin
Biochemical Basis
- Niacin forms NAD+ and NADP+, required by over 200 dehydrogenases
- Deficiency impairs energy metabolism, the HMP shunt and DNA repair (NAD is the substrate for PARP)
- Rapidly dividing and high-energy tissues suffer first — skin, gut mucosa and brain, which is precisely the pattern of the three Ds
- 60 mg tryptophan yields 1 mg niacin; the conversion needs vitamin B6, B2 and iron
Causes
| Type | Cause |
|---|---|
| Primary (dietary) | Maize-based diets — maize niacin is bound as niacytin and unavailable; maize is also low in tryptophan and high in leucine, which inhibits the conversion |
| — | Sorghum (jowar) diets — high leucine |
| Secondary — malabsorption | Hartnup disease — defective neutral amino acid transport, so tryptophan is lost |
| Secondary — diversion | Carcinoid syndrome — tryptophan diverted to serotonin |
| Secondary — drugs | Isoniazid (antagonises B6), 5-fluorouracil, phenytoin |
| Secondary — other | Alcoholism, chronic diarrhoea, prolonged parenteral nutrition |
- Alkali treatment of maize releases the bound niacin — the traditional Mexican preparation of tortillas with lime is why pellagra was rare there despite a maize diet
Diagnosis and Treatment
- Largely clinical; the distribution of the rash is characteristic
- Urinary N-methylnicotinamide is reduced — the biochemical test
- Treatment — nicotinamide 100 mg three times daily, with a high-protein diet and other B vitamins
- Nicotinamide is preferred to nicotinic acid because it does not cause flushing
- Response is rapid — the mental changes improve within days
Applied Aspects
- Pellagra is a disease of monotonous staple diets, historically in maize and jowar eating regions of India, Africa and the southern United States
- Goldberger proved it was nutritional, not infectious, in a series of experiments in the early twentieth century — a landmark in epidemiology
- Suspect it in any alcoholic with a photosensitive rash and confusion
- Prevention — dietary diversification with pulses and groundnut, both rich in tryptophan
Definition
Antivitamins = substances that oppose or destroy the action of a vitamin, producing a deficiency state even when the dietary intake is adequate.
Classification BY Mechanism
| Mechanism | Example | Vitamin affected |
|---|---|---|
| Structural analogue (competitive) | Methotrexate, aminopterin | Folic acid |
| — | Dicoumarol, warfarin | Vitamin K |
| — | Sulphonamides (vs PABA) | Bacterial folate |
| — | Pyrithiamine, oxythiamine | Thiamine |
| — | Isoniazid | Pyridoxine |
| Destroying enzyme | Thiaminase in raw fish, betel nut, some ferns | Thiamine |
| — | Ascorbic acid oxidase in cucumber | Vitamin C |
| Binding protein | Avidin in raw egg white | Biotin |
| Increasing requirement | Leucine (excess, as in jowar) | Niacin |
| Inactivation | Nitrous oxide | Vitamin B12 |
Therapeutically Useful Antivitamins
- Methotrexate — inhibits dihydrofolate reductase; used in cancer, rheumatoid arthritis, psoriasis. Rescued with folinic acid
- Trimethoprim — selective for bacterial dihydrofolate reductase, which is why it is antibacterial and not cytotoxic to man
- Sulphonamides — compete with PABA, so bacteria cannot make folate. Man absorbs preformed folate and is unaffected — the basis of selective toxicity
- Warfarin — blocks vitamin K epoxide reductase; the standard oral anticoagulant
Clinically Harmful Antivitamins
- Isoniazid forms a hydrazone with pyridoxal phosphate → peripheral neuropathy; prevented by routine pyridoxine
- Avidin in raw egg white binds biotin irreversibly → dermatitis, alopecia and neurological signs in those who eat many raw eggs. Cooking denatures avidin
- Thiaminase in raw fish and betel nut chewing contributes to beri-beri in some populations
- Nitrous oxide irreversibly oxidises the cobalt of B12 → megaloblastic anaemia and neuropathy after repeated or prolonged anaesthesia
- Phenytoin and phenobarbitone induce hepatic enzymes → accelerated breakdown of vitamin D and folate
Applied Aspects
- The concept underlies much of chemotherapy and antibiotic action — exploiting a pathway that the pathogen or tumour needs more than the host does
- Selective toxicity is the key — sulphonamides and trimethoprim work because bacteria must synthesise folate while man absorbs it
- Prophylactic vitamin supplementation is standard practice where an antivitamin drug is unavoidable — pyridoxine with isoniazid, folinic acid with methotrexate
- A vitamin deficiency in the presence of a normal diet should always prompt a search for an antivitamin, a malabsorption state, or an increased requirement
Biotin
Biotin (vitamin B7) = a sulphur-containing vitamin that acts as the coenzyme for carboxylation reactions, bound covalently to the enzyme as biocytin.
| Enzyme | Reaction | Pathway |
|---|---|---|
| Pyruvate carboxylase | Pyruvate → oxaloacetate | Gluconeogenesis; anaplerotic |
| Acetyl-CoA carboxylase | Acetyl-CoA → malonyl-CoA | Fatty acid synthesis |
| Propionyl-CoA carboxylase | Propionyl-CoA → methylmalonyl-CoA | Odd-chain fatty acid oxidation |
| β-Methylcrotonyl-CoA carboxylase | — | Leucine catabolism |
- All four require ATP and CO2 (as bicarbonate)
- Sources — liver, egg yolk, nuts, pulses; also synthesised by intestinal bacteria
- Deficiency is rare, and occurs with raw egg white (avidin), prolonged antibiotics, or total parenteral nutrition
- Features — dermatitis, alopecia, glossitis, depression, hypotonia, and in infants a characteristic periorificial rash
- Multiple carboxylase deficiency (holocarboxylase synthetase or biotinidase deficiency) responds dramatically to large doses of biotin — and is screened for in the newborn
Pantothenic Acid
Pantothenic acid (vitamin B5) = the precursor of coenzyme A and of the acyl carrier protein (ACP) of fatty acid synthase.
- The name is from Greek pantothen, "from everywhere" — it is ubiquitous in food, so deficiency is very rare
- Coenzyme A carries acyl groups in over 100 reactions — the TCA cycle, β-oxidation, ketogenesis, cholesterol and haem synthesis, acetylcholine formation, drug acetylation
- The reactive part is the –SH group of the phosphopantetheine arm, which comes from cysteine
- Deficiency, produced experimentally, causes "burning feet syndrome", fatigue, and impaired adrenal function
Comparison of the Two
| Feature | Biotin | Pantothenic acid |
|---|---|---|
| Coenzyme | Biocytin | Coenzyme A, ACP |
| Reaction type | Carboxylation (adds CO2) | Acyl group transfer |
| Binding | Covalent (prosthetic group) | Freely diffusible |
| Antivitamin | Avidin | None known |
| Deficiency | Rare; raw egg white, inborn errors | Very rare; burning feet |
Applied Aspects
- Biotinidase deficiency is treatable and is included in newborn screening — untreated it causes deafness, optic atrophy and developmental delay; treated it is entirely preventable
- High-dose biotin supplements interfere with immunoassays that use the biotin–streptavidin system — giving falsely abnormal thyroid function and falsely low troponin, which has led to missed myocardial infarction. Patients should stop biotin before blood tests
- "Burning feet syndrome" was described in prisoners of war and is attributed to pantothenate deficiency, though other B vitamins were also lacking
- Both vitamins are synthesised by gut flora, which is why prolonged broad-spectrum antibiotics can contribute to deficiency
Distribution and Normal Values
| Parameter | Value |
|---|---|
| Total body calcium | 1–1.5 kg; 99% in bone and teeth as hydroxyapatite |
| Serum calcium | 9–11 mg/dL |
| — Ionised (free) | 4.5–5.5 mg/dL (50%) — the physiologically active fraction |
| — Protein bound | 40% — chiefly to albumin |
| — Complexed | 10% — with citrate, phosphate, bicarbonate |
| Serum phosphorus | 2.5–4.5 mg/dL (higher in children) |
| Requirement | 600 mg/day adult; 1200 mg in pregnancy, lactation and adolescence |
- Corrected calcium — add 0.8 mg/dL for every 1 g/dL that albumin falls below 4 g/dL. Essential in hypoalbuminaemia, or true hypocalcaemia will be over-diagnosed
- Alkalosis lowers ionised calcium by increasing protein binding — the reason hyperventilation causes tetany with a normal total calcium
Absorption
| Promotes absorption | Inhibits absorption |
|---|---|
| Vitamin D (calcitriol) — induces calbindin | Phytate (cereals, bran) |
| Parathyroid hormone (indirectly) | Oxalate (spinach, tea) |
| Acidity — low pH keeps calcium soluble | Alkali, antacids |
| Lactose and dietary protein | Excess dietary fibre and fat (forms soaps) |
| Growth, pregnancy, lactation, low intake | Excess phosphate; malabsorption; steroids |
- Absorbed chiefly in the duodenum and jejunum, by an active vitamin D-dependent route and by passive diffusion at high intake
- Only about 20–40% of dietary calcium is absorbed
Hormonal Regulation
| Hormone | Bone | Kidney | Gut | Serum Ca | Serum PO4 |
|---|---|---|---|---|---|
| PTH | ↑ Resorption | ↑ Ca reabsorption; ↓ PO4; ↑ 1α-hydroxylase | ↑ (via vitamin D) | ↑ | ↓ |
| Calcitriol | ↑ Mineralisation and resorption | ↑ Reabsorption of both | ↑↑ (chief action) | ↑ | ↑ |
| Calcitonin | ↓ Resorption | ↑ Excretion of both | — | ↓ | ↓ |
CLINICAL PEARL
The discriminating point: PTH and calcitriol both raise calcium, but PTH lowers phosphate while calcitriol raises it. PTH acts chiefly on bone and kidney; calcitriol on the gut. This single contrast answers most questions on calcium homeostasis.
↓ Serum ionised calcium → Detected by the calcium-sensing receptor of the parathyroid → ↑ PTH secretion → Bone resorption + renal reabsorption + ↑ calcitriol → ↑ gut absorption → Serum calcium restored
Functions
- Bone and teeth — as hydroxyapatite, Ca10(PO4)6(OH)2
- Blood coagulation — factor IV; needed by the vitamin K-dependent factors to bind phospholipid
- Muscle contraction — binds troponin C; excitation–contraction coupling
- Nerve conduction and neurotransmitter release
- Second messenger — with calmodulin; the IP3 pathway
- Enzyme activation — phosphorylase kinase, PDH phosphatase, lipase
- Secretion of hormones, and cell adhesion and division
Phosphorus
- 85% in bone; the rest intracellular
- Functions — ATP and all high-energy compounds, nucleic acids, phospholipids, 2,3-BPG, phosphorylation of proteins, and the urinary buffer
- Absorbed readily; excretion is controlled by PTH and FGF-23
- Hypophosphataemia — refeeding syndrome, alcoholism, DKA treatment; causes muscle weakness, haemolysis and respiratory failure
Disorders of Calcium
| Hypocalcaemia | Hypercalcaemia |
|---|---|
| Causes — hypoparathyroidism, vitamin D deficiency, chronic kidney disease, hypomagnesaemia, acute pancreatitis, massive transfusion | Causes — primary hyperparathyroidism, malignancy, vitamin D excess, sarcoidosis, immobilisation, thiazides |
| Features — tetany, carpopedal spasm, laryngospasm, perioral numbness, seizures, prolonged QT | Features — "stones, bones, abdominal groans and psychic moans"; polyuria, constipation, short QT |
| Signs — Trousseau (carpal spasm on inflating a cuff), Chvostek (facial twitch on tapping) | Nephrocalcinosis, peptic ulcer, pancreatitis |
Excretion and Balance
- Urinary calcium 100–300 mg/day; the kidney reabsorbs about 98% of the filtered load
- PTH increases renal calcium reabsorption in the distal tubule, while increasing phosphate excretion in the proximal tubule
- Thiazides reduce urinary calcium (used in hypercalciuric stone formers); loop diuretics increase it (used in hypercalcaemia)
- Faecal calcium exceeds urinary, since most dietary calcium is never absorbed
- Bone acts as the buffer — it releases calcium when intake fails, which is why serum calcium stays normal long after the diet has become inadequate
Applied Aspects
- Rickets and osteomalacia — defective mineralisation from vitamin D deficiency; alkaline phosphatase is markedly raised
- Osteoporosis — loss of both mineral and matrix, with normal biochemistry; diagnosed by bone density, not by blood tests
- Renal osteodystrophy — failure of 1α-hydroxylation with phosphate retention → secondary hyperparathyroidism. Needs calcitriol, not plain vitamin D
- Tetany after thyroidectomy follows inadvertent removal of the parathyroids — check calcium in the first 24–48 hours
- Hypocalcaemia resistant to calcium is usually due to hypomagnesaemia, which impairs both PTH release and its action; correct the magnesium first
Distribution and Requirement
| Compartment | Amount | Share |
|---|---|---|
| Haemoglobin | 2.5 g | 65–70% |
| Ferritin and haemosiderin | 1 g | 25% |
| Myoglobin | 130 mg | 3–4% |
| Enzymes (cytochromes, catalase, peroxidase) | 8 mg | < 1% |
| Transferrin-bound (transport) | 3 mg | 0.1% |
- Total body iron 3–4 g
- Daily requirement — 17 mg (adult male), 21 mg (adult female) by Indian recommendations, allowing for poor absorption from a cereal-based diet
- Daily loss is only about 1 mg, shed in desquamated cells; man has NO mechanism for excreting excess iron
Absorption
Dietary iron — haem and non-haem → Gastric HCl and vitamin C reduce Fe3+ → Fe2+ → duodenum and upper jejunum → Enters enterocyte via DMT-1 (haem iron by its own receptor) → Either stored as ferritin and lost when the cell is shed, → or exported to blood by ferroportin → Oxidised by hephaestin and bound to transferrin
| Enhances absorption | Inhibits absorption |
|---|---|
| Vitamin C (ascorbate) — the most effective | Phytate (cereals, bran) |
| Gastric acid | Tannin (tea and coffee) |
| Haem iron (meat, fish) — absorbed 2–3× better | Oxalate, phosphate |
| Amino acids, fructose, "meat factor" | Antacids and proton pump inhibitors |
| Iron deficiency and pregnancy (up-regulate DMT-1) | Calcium; excess zinc, copper or manganese |
- Only 5–10% of dietary iron is absorbed, rising to 20–30% in deficiency
- The Indian vegetarian diet is high in phytate and low in haem iron — a major reason for the prevalence of iron deficiency
Regulation — Hepcidin
Hepcidin made by the liver → Binds ferroportin on enterocytes and macrophages → Causes it to be internalised and degraded → Iron is trapped inside the cell and cannot enter plasma → ↓ Absorption and ↓ release from stores
| Hepcidin raised by | Hepcidin lowered by |
|---|---|
| Iron overload | Iron deficiency |
| Inflammation (IL-6) | Hypoxia, anaemia |
| — | Increased erythropoiesis (erythroferrone) |
CLINICAL PEARL
Hepcidin explains the anaemia of chronic disease. Inflammation raises it, so iron is locked inside macrophages: serum iron is low but ferritin is normal or high. Giving oral iron does not help, because absorption is blocked at the same step.
Transport and Storage
| Protein | Role | Clinical note |
|---|---|---|
| Transferrin | Transports iron in plasma; binds 2 Fe3+ per molecule | Raised in iron deficiency; measured as TIBC |
| Ferritin | Soluble storage form; up to 4500 iron atoms | Serum ferritin reflects body stores — the best single test; but it is an acute phase reactant |
| Haemosiderin | Insoluble aggregated storage form | Seen in overload; stains with Prussian blue |
| Ferroportin | The only iron exporter | Target of hepcidin |
Iron Deficiency Anaemia
| Test | Result |
|---|---|
| Peripheral smear | Microcytic hypochromic; anisocytosis, poikilocytosis, pencil cells |
| MCV, MCH, MCHC | All low |
| Serum ferritin | Low — the earliest and most specific change |
| Serum iron | Low |
| TIBC | High |
| Transferrin saturation | < 16% |
| Red cell distribution width | Raised early |
| Soluble transferrin receptor | Raised — unaffected by inflammation, so useful when ferritin is unreliable |
Iron Overload
- Hereditary haemochromatosis — usually an HFE mutation → inappropriately low hepcidin → excessive absorption
- Features — "bronze diabetes": skin pigmentation, cirrhosis, diabetes, cardiomyopathy, arthropathy, hypogonadism
- Transfusional overload — in thalassaemia major; each unit carries 200–250 mg of iron
- Ferritin and transferrin saturation are both high; treated by venesection (or chelation with desferrioxamine or deferasirox when anaemic)
Applied Aspects
- Iron deficiency is the commonest nutritional disorder in India, particularly in women and children; the national programme provides iron and folic acid supplementation
- Take iron on an empty stomach with citrus juice, and avoid tea with meals — simple advice that substantially improves absorption
- Always find the cause in an adult — iron deficiency in a man or a postmenopausal woman means gastrointestinal blood loss until proved otherwise
- Acute iron poisoning in children is a genuine emergency — tablets look like sweets; treated with desferrioxamine
- Ferritin is falsely normal in inflammation; in a patient with infection or malignancy, use transferrin saturation or soluble transferrin receptor instead
- Parenteral iron is reserved for intolerance, malabsorption or renal disease on erythropoietin; modern preparations are far safer than the older iron dextran
- Iron is withheld in the first week of treating severe malnutrition — free iron promotes bacterial growth and oxidative injury
- Anaemia of chronic disease does not respond to oral iron, because hepcidin blocks the same transporter it must cross
Balanced Diet
A balanced diet contains all nutrients in the correct proportions and adequate amounts to meet the requirements of the body, with a small reserve for periods of stress.
| Nutrient | Share of total calories | Energy yield |
|---|---|---|
| Carbohydrate | 55–70% | 4 kcal/g |
| Fat | 20–30% | 9 kcal/g |
| Protein | 10–15% | 4 kcal/g |
| Alcohol | — | 7 kcal/g — "empty calories", no nutrients |
- Must also supply vitamins, minerals, essential amino acids, essential fatty acids, fibre and water
- The Indian diet is typically cereal-based, so it needs pulses for protein complementation, and is often low in iron, calcium and vitamin A
Basal Metabolic Rate
BMR = the energy expended by the body at complete physical and mental rest, in a thermoneutral environment, 12–18 hours after the last meal, while awake.
- About 24 kcal/kg body weight/day, or 1 kcal/kg/hour
- Adult male 1600–1800 kcal/day; female 1300–1500
- It accounts for 60–70% of total daily energy expenditure
- Measured by indirect calorimetry (oxygen consumption) or the Benedict–Roth apparatus
| BMR increased by | BMR decreased by |
|---|---|
| Hyperthyroidism (up to +100%) | Hypothyroidism (−30 to −40%) |
| Fever — about +13% per °C | Starvation and undernutrition (adaptive fall) |
| Male sex (greater muscle mass) | Female sex; ageing |
| Larger body surface area | Sleep |
| Cold exposure; pregnancy and lactation | Hot climate |
| Adrenaline, growth hormone; infection, burns, trauma | — |
- BMR correlates best with body surface area, and with lean body mass — adipose tissue is metabolically inactive
Specific Dynamic Action
Specific dynamic action (thermic effect of food) = the increase in metabolic rate that follows ingestion of food, above the basal level.
| Nutrient | SDA |
|---|---|
| Protein | 20–30% — the highest |
| Carbohydrate | 5–6% |
| Fat | 2–3% — the lowest |
| Mixed diet | About 10% |
- Due to the energy cost of digestion, absorption, transport and metabolic processing — deamination and urea synthesis make protein the most expensive
- Extra calories must be allowed for SDA when calculating requirements; the high SDA of protein is one reason high-protein diets aid weight control
Respiratory Quotient
RQ = volume of CO2 produced ÷ volume of O2 consumed
| Substrate | RQ | Reason |
|---|---|---|
| Carbohydrate | 1.0 | Fully oxygenated — CO2 equals O2 |
| Protein | 0.8 | — |
| Fat | 0.7 | Highly reduced — needs more oxygen |
| Mixed diet | 0.85 | Usual value |
| Lipogenesis | > 1.0 | Carbohydrate converted to fat releases CO2 |
| Ketosis, starvation, diabetes | < 0.7 | Fat is the sole fuel |
- RQ indicates which fuel is being oxidised — a practical use in metabolic studies and in ventilated patients
- Overfeeding carbohydrate raises CO2 production and can make weaning from a ventilator difficult
Energy Requirement
| Activity level | Male (kcal/day) | Female (kcal/day) |
|---|---|---|
| Sedentary | 2320 | 1900 |
| Moderate | 2730 | 2230 |
| Heavy | 3490 | 2850 |
| Pregnancy | — | +350 |
| Lactation (0–6 months) | — | +600 |
- Total expenditure = BMR + physical activity + SDA + growth
- Body mass index = weight (kg) ÷ height (m)2; normal 18.5–24.9. Asian cut-offs are lower — overweight above 23, obese above 25
Applied Aspects
- BMR was historically used to assess thyroid function; it has been replaced by serum TSH and free T4, which are far more specific
- Fever raises requirements by about 13% per degree — important in feeding the septic or burned patient
- Obesity results from sustained positive energy balance; a surplus of only 100 kcal a day adds about 5 kg in a year
- India carries a double burden — undernutrition and stunting alongside rising obesity and type 2 diabetes, often within the same community
- The "thin fat Indian" phenotype — a normal BMI with high body fat and central obesity, which is why lower Asian cut-offs are used
Definition and Classification
Trace elements = minerals required in amounts of less than 100 mg per day, forming less than 0.01% of body weight.
| Group | Elements |
|---|---|
| Essential | Iron, zinc, copper, iodine, selenium, manganese, molybdenum, chromium, cobalt, fluoride |
| Possibly essential | Nickel, silicon, vanadium, tin |
| Toxic | Lead, mercury, cadmium, arsenic |
Zinc
- Cofactor for over 300 enzymes — carbonic anhydrase, alkaline phosphatase, alcohol dehydrogenase, carboxypeptidase, RNA and DNA polymerase, superoxide dismutase
- Zinc finger motifs in transcription factors and steroid receptors
- Needed for insulin storage in the β cell, and for retinol-binding protein synthesis
- Wound healing, immunity, taste, spermatogenesis, growth
Zinc deficiency
- Growth retardation and hypogonadism — the classical picture described in Iran and Egypt
- Poor wound healing; dermatitis; alopecia
- Impaired taste (hypogeusia) and smell
- Impaired immunity; diarrhoea
- Night blindness unresponsive to vitamin A — because retinol-binding protein cannot be made
- Acrodermatitis enteropathica — an inherited defect of zinc absorption; periorificial and acral dermatitis, diarrhoea and alopecia, responding dramatically to zinc
Copper
| Enzyme | Function | Consequence of deficiency |
|---|---|---|
| Caeruloplasmin (ferroxidase) | Oxidises Fe2+ for transferrin binding | Anaemia unresponsive to iron |
| Cytochrome oxidase | Complex IV of the respiratory chain | Impaired energy production |
| Lysyl oxidase | Collagen and elastin cross-linking | Vascular fragility, bone abnormality |
| Tyrosinase | Melanin synthesis | Hypopigmentation |
| Superoxide dismutase | Antioxidant | Oxidative damage |
| Dopamine β-hydroxylase | Noradrenaline synthesis | Neurological features |
| Wilson disease | Menkes disease |
|---|---|
| Copper accumulation | Copper deficiency |
| ATP7B defect — failure of biliary excretion | ATP7A defect — failure of absorption |
| Autosomal recessive | X-linked |
| Kayser–Fleischer rings, cirrhosis, basal ganglia degeneration, psychiatric change | Kinky (steely) hair, arterial tortuosity, neurodegeneration, hypothermia |
| Serum caeruloplasmin low; urinary copper high | Serum copper and caeruloplasmin both low |
| Penicillamine, trientine, zinc | Copper histidine injections; largely ineffective |
Iodine, Selenium and Fluoride
| Element | Function | Deficiency | Excess |
|---|---|---|---|
| Iodine | Thyroid hormone synthesis; requirement 150 µg/day | Goitre, cretinism, hypothyroidism, stillbirth | Iodine-induced hyperthyroidism (Jod-Basedow) |
| Selenium | Glutathione peroxidase; deiodinase | Keshan disease (cardiomyopathy), Kashin–Beck disease | Selenosis — hair and nail loss, garlic breath |
| Fluoride | Forms fluoroapatite — resists acid; prevents caries | Dental caries | Dental and skeletal fluorosis |
- Iodine deficiency is the commonest preventable cause of mental retardation worldwide; prevented by universal salt iodisation
- Fluorosis is endemic in parts of Rajasthan, Andhra Pradesh, Gujarat and Punjab, from high fluoride in groundwater; the optimum level in drinking water is 0.5–1 ppm
Other Trace Elements
| Element | Role | Note |
|---|---|---|
| Manganese | Mitochondrial SOD, arginase, pyruvate carboxylase | Deficiency rare; toxicity causes a parkinsonian syndrome in welders |
| Molybdenum | Xanthine oxidase, sulphite oxidase | Deficiency causes neurological damage |
| Chromium | Glucose tolerance factor — potentiates insulin | Deficiency impairs glucose tolerance |
| Cobalt | Constituent of vitamin B12 | Useful only as B12 |
| Magnesium | Cofactor for all ATP-requiring enzymes; over 300 enzymes | Deficiency causes tetany and refractory hypocalcaemia |
Applied Aspects
- Zinc supplementation reduces the duration and severity of childhood diarrhoea and is recommended by WHO alongside ORS — one of the best-established uses of a trace element
- Wilson disease must be excluded in any young person with unexplained liver disease or a movement disorder; it is treatable, and fatal if missed
- Trace element deficiency occurs in prolonged parenteral nutrition unless deliberately supplied
- Zinc treats Wilson disease by inducing intestinal metallothionein, which traps copper in the enterocyte, so it is shed with the cell — one metal used against another
- Copper deficiency should be suspected in anaemia that does not respond to iron, particularly after bariatric surgery or with excessive zinc supplementation
- Excessive supplementation is harmful — zinc impairs copper absorption, iron impairs zinc absorption, and selenium is toxic in modest excess
- Chromium as glucose tolerance factor is widely marketed for diabetes; benefit is confined to genuine deficiency, which is rare
Composition of Bone
| Component | Share | Constituents |
|---|---|---|
| Inorganic (mineral) | 65–70% | Hydroxyapatite — Ca10(PO4)6(OH)2; also carbonate, magnesium, fluoride, citrate |
| Organic (matrix, osteoid) | 25–30% | Type I collagen (90%); osteocalcin, osteonectin, osteopontin, proteoglycans |
| Water | 5–10% | — |
- Mineral gives compressive strength; collagen gives tensile strength
- Loss of mineral → osteomalacia; loss of both → osteoporosis; abnormal collagen → osteogenesis imperfecta
Cells of Bone
| Cell | Origin | Function | Marker |
|---|---|---|---|
| Osteoblast | Mesenchymal | Forms matrix and mineralises it | Alkaline phosphatase, osteocalcin |
| Osteocyte | Trapped osteoblast | Mechanosensing; secretes FGF-23 and sclerostin | — |
| Osteoclast | Monocyte–macrophage lineage | Bone resorption — secretes acid and cathepsin K | Tartrate-resistant acid phosphatase |
Osteoblast expresses RANKL → Binds rank on the osteoclast precursor → Osteoclast differentiation and activation → resorption → Osteoblast also secretes osteoprotegerin (OPG) → OPG is a decoy receptor that mops up RANKL → The RANKL : OPG ratio determines net bone turnover
- PTH and cytokines raise RANKL; oestrogen raises OPG — which is exactly why bone is lost after the menopause
- Denosumab is a monoclonal antibody against RANKL, a treatment derived directly from this pathway
Biochemical Markers of Bone Turnover
| Formation markers | Resorption markers |
|---|---|
| Alkaline phosphatase (bone isoenzyme) | Urinary hydroxyproline |
| Osteocalcin (bone Gla protein; vitamin K dependent) | Deoxypyridinoline and pyridinoline cross-links |
| Procollagen type I propeptides (P1NP) | C-telopeptide (CTX) and N-telopeptide (NTX) |
| — | Tartrate-resistant acid phosphatase |
Biochemistry of Common Bone Disorders
| Disorder | Ca | PO4 | ALP | PTH | Key feature |
|---|---|---|---|---|---|
| Osteoporosis | N | N | N | N | All biochemistry normal — diagnosed by bone density |
| Osteomalacia / rickets | ↓ or N | ↓ | ↑↑ | ↑ | Low 25(OH)D |
| Primary hyperparathyroidism | ↑ | ↓ | ↑ | ↑ | Stones, bones, groans |
| Renal osteodystrophy | ↓ | ↑ | ↑ | ↑↑ | Failed 1α-hydroxylation |
| Paget disease | N | N | ↑↑↑ | N | Very high ALP with normal calcium |
| Bone metastases | ↑ or N | N | ↑ | ↓ | Raised ALP and hydroxyproline |
CLINICAL PEARL
Two patterns worth memorising: osteoporosis has entirely normal biochemistry, so a normal calcium and phosphate never excludes it. Paget disease has a strikingly raised alkaline phosphatase with normal calcium and phosphate — a combination almost unique to it.
Connective Tissue Matrix
- Collagen — tensile strength; type I in bone and skin, II in cartilage, III in reticulin, IV in basement membrane
- Elastin — recoil; cross-linked by desmosine; not hydroxylated and not glycosylated, unlike collagen
- Proteoglycans — hydrated gel resisting compression; aggrecan in cartilage
- Fibronectin and laminin — adhesion glycoproteins linking cells to matrix
- Matrix metalloproteinases degrade the matrix in remodelling, and in tumour invasion; opposed by TIMPs
Mineralisation and its Control
Osteoblast secretes osteoid (type I collagen + non-collagenous proteins) → Matrix vesicles bud from the osteoblast membrane → Concentrate Ca2+ and PO43− → alkaline phosphatase raises local phosphate by hydrolysing pyrophosphate → Pyrophosphate is a natural inhibitor of mineralisation — removing it permits crystal growth → Hydroxyapatite crystals nucleate and grow along the collagen fibrils
- This is why alkaline phosphatase rises whenever bone formation increases — in growing children, in rickets, in Paget disease and around healing fractures
- Bisphosphonates are stable analogues of pyrophosphate, which is exactly why they inhibit resorption and bind so avidly to bone
- Requires adequate calcium, phosphate, vitamin D, vitamin C and vitamin K
Applied Aspects
- Bisphosphonates bind hydroxyapatite and are taken up by osteoclasts, inhibiting them — first-line in osteoporosis and Paget disease
- Osteocalcin is vitamin K dependent, which is one reason warfarin and vitamin K deficiency affect bone
- Fluoride forms fluoroapatite, which is more acid-resistant — the basis of caries prevention; in excess it causes brittle, mottled bone and teeth
- Alkaline phosphatase is the single most useful screening test in bone disease, but it also rises in liver disease — check GGT to distinguish
- Bone turnover markers guide treatment response long before bone density changes, since density takes a year or more to shift measurably
- Cathepsin K, the osteoclast protease that degrades collagen, has been a drug target; its deficiency causes pycnodysostosis, with dense but brittle bone
- Fluoride stimulates osteoblasts and increases bone density, but the bone formed is of poor quality — which is why it failed as an osteoporosis treatment
- Bone is a metabolically active reservoir, not an inert scaffold: about 10% of the adult skeleton is remodelled each year
- Osteoporosis after the menopause follows loss of oestrogen, which normally raises osteoprotegerin and restrains osteoclasts
- Glucocorticoids cause osteoporosis by inhibiting osteoblasts, reducing calcium absorption and increasing urinary loss — the commonest drug-induced cause
- Immobilisation causes rapid bone loss, since mechanical loading sensed by osteocytes is the stimulus for formation
- Hydroxyproline and pyridinoline in urine come almost entirely from collagen breakdown, and rise in Paget disease and bone metastases
- Vitamin C deficiency affects bone as well as skin — the osteoid cannot be laid down, giving the subperiosteal haemorrhages of infantile scurvy
- Denosumab and teriparatide are derived directly from this biology — one blocks RANKL, the other is recombinant PTH given intermittently, which paradoxically stimulates formation
Definition
Iron deficiency anaemia = anaemia resulting from depletion of body iron stores, characterised by a microcytic hypochromic blood picture.
- The commonest nutritional deficiency in the world and in India, affecting over half of Indian women and children
Causes
| Mechanism | Causes |
|---|---|
| Inadequate intake | Cereal-based vegetarian diet, poverty, faddism |
| Increased demand | Infancy, adolescence, pregnancy, lactation |
| Impaired absorption | Achlorhydria, proton pump inhibitors, coeliac disease, gastrectomy, phytate and tannin |
| Chronic blood loss | Menorrhagia; hookworm; peptic ulcer, piles, carcinoma colon; NSAIDs |
- Hookworm infestation is a major cause in rural India and should be treated alongside iron
Stages of Depletion
1. Iron depletion — ferritin falls; haemoglobin normal → 2. Iron-deficient erythropoiesis — serum iron ↓, TIBC ↑, saturation < 16% → 3. Iron deficiency anaemia — haemoglobin falls; cells microcytic and hypochromic
- Serum ferritin is the earliest and most specific index — it falls before any change in haemoglobin
Clinical Features
- Pallor, fatigue, dyspnoea on exertion, palpitations
- Koilonychia (spoon-shaped nails), brittle nails and hair
- Angular stomatitis, glossitis
- Pica — craving for earth, ice or chalk
- Plummer–Vinson syndrome — anaemia with post-cricoid web and dysphagia; premalignant
- In children — impaired cognitive development and school performance, which may not be fully reversible
Investigations
| Test | Iron deficiency | Anaemia of chronic disease | Thalassaemia trait |
|---|---|---|---|
| MCV | ↓ | N or slightly ↓ | ↓↓ |
| Serum ferritin | Low | Normal or high | Normal |
| Serum iron | ↓ | ↓ | Normal |
| TIBC | ↑ | ↓ | Normal |
| RDW | ↑ | N | Normal |
| HbA2 | N or ↓ | N | ↑ (> 3.5%) |
Treatment and Applied Aspects
- Oral ferrous sulphate is the standard; 100–200 mg elemental iron daily, best taken on an empty stomach with vitamin C
- Continue for 3 months after the haemoglobin normalises, to replenish stores
- Reticulocytosis appears in 5–10 days — the earliest sign of response and a useful check of compliance
- Always identify the cause in an adult; in a man or postmenopausal woman it means gastrointestinal blood loss until proved otherwise
- Failure to respond usually means poor compliance, continuing blood loss, a wrong diagnosis, or malabsorption
- Prevention in India — iron and folic acid supplementation, food fortification, deworming, and dietary advice to avoid tea with meals
Definition
Wilson disease (hepatolenticular degeneration) = an autosomal recessive disorder of copper metabolism in which copper accumulates in the liver, brain, cornea and kidney.
- Defect in the ATP7B gene on chromosome 13, encoding a copper-transporting ATPase
- Incidence about 1 in 30,000
Biochemical Basis
- ATP7B defective → Two consequences → 1.
- Copper cannot be incorporated into caeruloplasmin → serum caeruloplasmin low → 2.
- Copper cannot be excreted into bile — the only route of elimination → Copper accumulates in the liver → Hepatocytes are damaged and release free copper into blood → Deposited in brain, cornea, kidney
- Free (non-caeruloplasmin-bound) copper is the toxic species — it generates free radicals by the Fenton reaction
Clinical Features
| System | Features |
|---|---|
| Hepatic (younger patients) | Fatty liver, acute or chronic hepatitis, cirrhosis, fulminant hepatic failure with haemolysis |
| Neurological (older patients) | Tremor, dysarthria, dystonia, parkinsonism, chorea; ataxia |
| Psychiatric | Personality change, depression, psychosis, declining school performance |
| Ocular | KAYSER–fleischer rings — golden-brown copper deposits in Descemet membrane, seen on slit lamp; sunflower cataract |
| Renal | Fanconi syndrome, aminoaciduria, renal tubular acidosis, stones |
| Haematological | Coombs-negative haemolytic anaemia |
Diagnosis
| Test | Finding |
|---|---|
| Serum caeruloplasmin | Low (< 20 mg/dL) — the screening test |
| Serum total copper | Low (most is carried on caeruloplasmin) |
| Free serum copper | High |
| 24-hour urinary copper | High (> 100 µg/day) |
| Liver copper on biopsy | > 250 µg/g dry weight — the gold standard |
| Slit lamp examination | Kayser–Fleischer rings |
| Genetic testing | ATP7B mutation; used for family screening |
CLINICAL PEARL
Note the apparent paradox: serum total copper is low in a disease of copper overload. The explanation is that most circulating copper is normally bound to caeruloplasmin, which is deficient. The free copper and the urinary copper are both high.
Treatment
- D-Penicillamine — chelates copper and promotes urinary excretion; give pyridoxine with it, since it antagonises B6
- Trientine — an alternative chelator, better tolerated
- Zinc — induces intestinal metallothionein, which traps copper in the enterocyte so it is lost when the cell is shed; used for maintenance
- Avoid copper-rich foods — liver, shellfish, nuts, chocolate, mushrooms
- Liver transplantation for fulminant failure or decompensated cirrhosis; it is curative, since the defect is hepatic
- Treatment is lifelong
Applied Aspects
- Wilson disease must be excluded in any young person with unexplained liver disease, a movement disorder, or new psychiatric illness — it is one of the few treatable causes, and untreated it is fatal
- Siblings must be screened, since presymptomatic treatment prevents all organ damage
- Contrast with Menkes disease — also a copper transport defect (ATP7A), but X-linked and causing deficiency, with kinky hair and neurodegeneration
- Kayser–Fleischer rings are present in almost all patients with neurological disease, but may be absent in purely hepatic presentations
Definition
Iodine deficiency disorders (IDD) = the whole spectrum of consequences of iodine deficiency in a population, of which goitre is only the most visible.
- Requirement 150 µg/day; 250 µg in pregnancy and lactation
- Total body iodine 15–20 mg, most of it in the thyroid
Role of Iodine
Dietary iodide absorbed → Trapped by the thyroid sodium–iodide symporter — concentrated 30× → Oxidised by thyroid peroxidase → Organification — iodinates tyrosine residues on thyroglobulin → MIT and DIT → Coupling: DIT + DIT → T4; MIT + DIT → T3
- T4 is the chief secretory product; T3 is the active hormone, formed mostly by peripheral deiodination (a selenium-dependent enzyme)
The Spectrum of Disorders
| Age group | Consequences |
|---|---|
| Fetus | Abortion, stillbirth, congenital anomaly, increased perinatal mortality |
| Neonate | Neonatal hypothyroidism (cretinism) — irreversible mental retardation, deaf-mutism, spasticity, short stature |
| Child and adolescent | Goitre, impaired mental function, poor school performance, growth retardation |
| Adult | Goitre, hypothyroidism, impaired mental function, reduced work capacity |
- Iodine deficiency is the commonest preventable cause of mental retardation worldwide — the single most important fact about it
- Damage to the developing brain is irreversible, which is why prevention must reach women before and during pregnancy
Goitre
↓ Iodine → ↓ T3 and T4 → Loss of negative feedback → ↑ TSH → Thyroid hyperplasia and hypertrophy → goitre
- Goitrogens aggravate deficiency — cabbage, cauliflower, tapioca, mustard, soybean, bajra; also thiocyanate from smoking
- Tapioca contains cyanogenic glycosides converted to thiocyanate, which competes with iodide uptake
Assessment and Control
| Indicator | Significance |
|---|---|
| Urinary iodine excretion | The best population indicator; adequate if median > 100 µg/L |
| Goitre prevalence | Endemic if > 5% in schoolchildren |
| Neonatal TSH | Deficiency if > 3% of newborns have TSH above 5 mIU/L |
| Serum thyroglobulin | Reflects longer-term status |
- Universal salt iodisation is the strategy of choice — 15 ppm at consumer level in India
- Iodised oil injections or capsules are used where salt distribution is impractical
- National Iodine Deficiency Disorders Control Programme in India
Applied Aspects
- Iodised salt must be stored dry and added after cooking, since iodine is lost with heat, moisture and light
- Jod–Basedow phenomenon — iodine-induced thyrotoxicosis when iodine is given suddenly to a chronically deficient population with nodular goitre
- Wolff–Chaikoff effect — a large iodide load transiently inhibits thyroid hormone synthesis; exploited in thyroid storm
- Congenital hypothyroidism screening by neonatal TSH is now routine in many Indian centres; treatment within the first two weeks prevents retardation entirely
- Selenium deficiency worsens iodine deficiency, because deiodinase requires selenium
Definition
Basal metabolic rate (BMR) = the minimum energy required to maintain the vital functions of the body at complete physical and mental rest, measured in a thermoneutral environment, 12–18 hours after the last meal, while the subject is awake.
Normal Values and Measurement
- Approximately 24 kcal/kg body weight/day, or 1 kcal/kg/hour
- Adult male 1600–1800 kcal/day; adult female 1300–1500 kcal/day
- Expressed per unit body surface area: about 40 kcal/m2/hour in men, 37 in women
- Accounts for 60–70% of total daily energy expenditure
- Measured by indirect calorimetry — oxygen consumption, using the Benedict–Roth apparatus or a modern metabolic cart. Direct calorimetry measures heat output but is impractical
Conditions for Measurement
- Complete physical and mental rest, lying down, awake
- Post-absorptive — 12 to 18 hours after the last meal, so no SDA
- Thermoneutral environment, about 20–25 °C
- No exercise for at least 1 hour; no emotional stress
- Usually measured in the early morning
Factors Affecting BMR
| Factor | Effect | Explanation |
|---|---|---|
| Body surface area | Directly proportional | Heat loss is from the surface — the best single correlate |
| Lean body mass | ↑ | Muscle is metabolically active; fat is not |
| Sex | Male > female by 5–10% | Greater muscle mass, less fat |
| Age | Highest in infancy, falls with age | Growth and higher surface-to-volume ratio in the young |
| Thyroid hormone | ↑↑ in hyperthyroidism (up to +100%); ↓ in hypothyroidism | The most powerful hormonal influence |
| Fever | +13% per °C rise | Increased enzyme activity |
| Climate | Higher in cold, lower in tropics | Heat production requirement |
| Pregnancy and lactation | ↑ 5–20% | Fetal and mammary metabolism |
| Starvation and undernutrition | ↓ up to 30% | Adaptive conservation — the reason weight loss plateaus |
| Sleep | ↓ about 10% | Reduced muscle tone |
| Adrenaline, growth hormone, cortisol | ↑ | Catabolic effect |
| Infection, burns, trauma, surgery | ↑ markedly | Hypermetabolic response |
Applied Aspects
- BMR was once the standard test of thyroid function — long superseded by serum TSH and free T4, which are specific and far simpler
- The adaptive fall in starvation explains why weight loss slows on a restricted diet, and why regain is so common
- Estimating energy requirements in the critically ill uses BMR-based formulas such as Harris–Benedict with stress factors, though indirect calorimetry is more accurate
- Fever, sepsis and burns raise requirements substantially, and underfeeding these patients delays recovery
- Obesity is not usually due to a low BMR — a heavier person has a higher absolute BMR; the imbalance is in intake and activity
Definition
Magnesium = the second most abundant intracellular cation after potassium, and an essential cofactor for over 300 enzymes.
| Parameter | Value |
|---|---|
| Total body | 25 g; 60% in bone, 39% intracellular, 1% extracellular |
| Serum | 1.8–2.4 mg/dL (0.75–1.0 mmol/L) |
| Requirement | 350–400 mg/day |
| Sources | Green leafy vegetables (chlorophyll), nuts, whole grains, pulses |
- Serum magnesium reflects body stores poorly, since only 1% is extracellular — deficiency may exist with a normal level
Functions
- Cofactor for all reactions involving ATP — the true substrate of kinases is the Mg-ATP complex
- Over 300 enzymes — hexokinase, phosphofructokinase, adenylate cyclase, Na+/K+-ATPase, DNA and RNA polymerase
- Neuromuscular excitability — it is a physiological calcium antagonist, blocking calcium channels and stabilising membranes
- Bone structure
- Required for PTH secretion and for PTH action on target tissues
- Ribosome and nucleic acid stability; muscle relaxation
Hypomagnesaemia
| Causes | Features |
|---|---|
| Chronic alcoholism — the commonest | Tetany, tremor, weakness |
| Malabsorption, chronic diarrhoea | Trousseau and Chvostek signs |
| Diuretics (loop and thiazide), aminoglycosides, cisplatin | Arrhythmias — torsades de pointes, prolonged QT |
| Diabetic ketoacidosis, refeeding syndrome | Seizures, confusion, apathy |
| Prolonged parenteral nutrition; hyperaldosteronism | Refractory hypocalcaemia and hypokalaemia |
CLINICAL PEARL
The clinically vital point: hypomagnesaemia causes hypocalcaemia and hypokalaemia that will not correct until the magnesium is replaced. It impairs both PTH secretion and PTH action, and promotes renal potassium wasting. Always check magnesium in refractory electrolyte disturbance.
Hypermagnesaemia
- Almost always from renal failure, or from magnesium-containing antacids and purgatives, or treatment of eclampsia
- Features are progressive with level — loss of deep tendon reflexes (earliest sign), then hypotension, respiratory depression, bradycardia and cardiac arrest
- Treated with intravenous calcium gluconate, which antagonises it directly
Therapeutic Uses of Magnesium
| Indication | Rationale |
|---|---|
| Eclampsia and pre-eclampsia | Magnesium sulphate is the drug of choice for preventing and treating seizures |
| Torsades de pointes | Stabilises the myocardium |
| Severe asthma | Bronchodilatation through calcium antagonism |
| Constipation | Magnesium salts as osmotic laxatives |
| Antacid | Magnesium hydroxide |
Applied Aspects
- Deep tendon reflexes are monitored during magnesium therapy in eclampsia — their loss is the earliest warning of toxicity, and calcium gluconate must be kept at the bedside
- Suspect magnesium deficiency in any alcoholic, and in refractory hypocalcaemia or hypokalaemia
Definition
Fluorosis = the toxic effects of chronic excessive fluoride ingestion, affecting chiefly teeth and bone.
- Optimum fluoride in drinking water is 0.5–1.0 ppm
- Above 1.5 ppm dental fluorosis appears; above 3–4 ppm skeletal fluorosis follows
Normal Role of Fluoride
Fluoride replaces the hydroxyl group of hydroxyapatite → fluoroapatite formed → More resistant to acid dissolution → Prevents dental caries
- Also inhibits bacterial enolase, reducing acid production by plaque organisms
- Fluoride is not strictly essential, but is beneficial at optimum intake
Dental Fluorosis
- Occurs when excess fluoride is taken during tooth development, before the age of 8; once teeth have erupted they are unaffected
- Earliest — chalky white opaque patches on the enamel
- Then yellow to brown mottling and staining
- Severe — pitting, chipping and loss of enamel
- Cosmetic rather than functional in mild forms, but socially distressing
Skeletal Fluorosis
| Stage | Features |
|---|---|
| Early | Vague joint and back pain, stiffness, easily mistaken for arthritis |
| Established | Osteosclerosis, calcification of ligaments and interosseous membranes, exostoses |
| Crippling | Kyphosis, rigid spine ("poker back"), genu valgum or varum, restricted movement |
| Neurological | Cord compression from vertebral changes → paraplegia |
| Non-skeletal | Gastrointestinal upset, muscle weakness, fatigue; may precede bone changes |
- X-ray shows increased bone density with a ground-glass appearance and calcified ligaments
- Fluoride also chelates calcium, causing secondary hyperparathyroidism, and inhibits several enzymes including enolase and cholinesterase
Epidemiology in India
- Endemic in Rajasthan, Andhra Pradesh, Telangana, Gujarat, Punjab, Haryana, Tamil Nadu and Karnataka
- Source is groundwater from deep bore wells in fluoride-rich rock
- Aggravated by poor nutrition, low calcium and vitamin C intake, and high water consumption in hot climates
- Other sources — fluoride-rich foods, black rock salt, some toothpastes, industrial exposure, and rarely long-term drug use
Prevention and Applied Aspects
- Provide an alternative safe water source — the only fully effective measure
- Defluoridation — the Nalgonda technique using alum and lime, activated alumina, or reverse osmosis
- Improve nutrition — adequate calcium, vitamin C and vitamin D reduce fluoride absorption and its effects
- The changes are largely irreversible once established, so prevention is everything; early skeletal disease may improve after removal of the source
- National Programme for Prevention and Control of Fluorosis operates in endemic districts
- Children under 6 should use only a smear of toothpaste and be supervised, since swallowing it adds substantially to intake
Definition
Sodium and potassium are the chief cations of the extracellular and intracellular compartments respectively, and their gradient across the cell membrane underlies excitability, transport and cell volume.
| Ion | Chief location | Serum level | Total body |
|---|---|---|---|
| Sodium | Extracellular | 135–145 mEq/L | 4000 mEq |
| Potassium | Intracellular (98%) | 3.5–5.0 mEq/L | 3500 mEq |
- The gradient is created by the Na+/K+-ATPase, pumping 3 Na+ out for 2 K+ in
- Requirement — sodium about 5 g of salt per day; potassium 3–4 g
Functions
- Sodium — determines extracellular volume and osmolality; nerve and muscle excitability; acid–base balance; drives secondary active transport of glucose and amino acids
- Potassium — sets the resting membrane potential; essential for cardiac conduction, muscle contraction, protein and glycogen synthesis, and enzyme activity
Regulation
| Hormone | Action |
|---|---|
| Aldosterone | ↑ Na+ reabsorption and ↑ K+ excretion in the distal tubule |
| ADH (vasopressin) | Water reabsorption — controls sodium concentration, not total sodium |
| Atrial natriuretic peptide | ↑ Sodium and water excretion |
| Insulin and β-agonists | Drive K+ into cells |
| Acidosis | Drives K+ out of cells → raises serum potassium |
Disorders of Sodium
| Hyponatraemia (< 135) | Hypernatraemia (> 145) |
|---|---|
| Causes — SIADH, diuretics, vomiting, diarrhoea, cardiac and hepatic failure, adrenal insufficiency, excess water | Causes — dehydration, diabetes insipidus, osmotic diuresis, inadequate water intake |
| Features — nausea, headache, confusion, seizures, coma (cerebral oedema) | Features — thirst, lethargy, irritability, weakness, seizures |
| Correct slowly — too rapid causes osmotic demyelination | Correct slowly — too rapid causes cerebral oedema |
Disorders of Potassium
| Hypokalaemia (< 3.5) | Hyperkalaemia (> 5.0) |
|---|---|
| Causes — vomiting, diarrhoea, diuretics, hyperaldosteronism, insulin therapy, alkalosis, refeeding | Causes — renal failure, potassium-sparing diuretics, ACE inhibitors, acidosis, haemolysis, rhabdomyolysis, Addison disease |
| Features — muscle weakness, cramps, ileus, arrhythmia, polyuria | Features — weakness, paraesthesiae, cardiac arrest |
| ECG — flattened T, prominent U wave, ST depression | ECG — tall peaked T, wide QRS, absent P, sine wave |
| Treatment — oral or intravenous potassium; correct magnesium | Treatment — calcium gluconate (protects the heart), insulin with glucose, salbutamol, bicarbonate, resins, dialysis |
CLINICAL PEARL
Hyperkalaemia is the most immediately lethal electrolyte disturbance. Calcium gluconate is given first — it does not lower potassium at all, but stabilises the myocardium while the other measures take effect. Insulin with glucose acts within minutes by driving potassium into cells.
Applied Aspects
- Pseudohyperkalaemia — from a haemolysed sample, a tight tourniquet, clenching the fist, or delay in analysis; always repeat before treating a surprising result
- Refractory hypokalaemia is usually due to hypomagnesaemia — correct the magnesium first
- Hyponatraemia in hyperglycaemia is dilutional — glucose draws water out of cells; correct the sodium by about 1.6 mEq/L for every 100 mg/dL of glucose above normal
- Oral rehydration solution contains sodium, potassium, glucose and citrate — the glucose is essential, since SGLT-1 couples its absorption to sodium
- In diabetic ketoacidosis, total body potassium is depleted despite a normal or high serum level; it falls sharply once insulin is started, and failure to replace it is a classic fatal error
Functions of the Liver
- Metabolic — the hub of carbohydrate, lipid and protein metabolism; glycogen storage, gluconeogenesis, ketogenesis, lipogenesis
- Synthetic — albumin, clotting factors, most plasma proteins, urea, cholesterol, bile acids
- Excretory — bilirubin, bile salts, cholesterol, drugs
- Detoxification — ammonia to urea; cytochrome P450 biotransformation
- Storage — glycogen, vitamins A, D, B12, iron, copper
- Immunological — Kupffer cells
Classification of Liver Function Tests
| Group | Tests | What they reflect |
|---|---|---|
| Excretory | Serum bilirubin (total, direct, indirect); urine bile pigments | Uptake, conjugation and excretion |
| Hepatocellular damage | ALT (SGPT), ast (SGOT) | Leakage from damaged hepatocytes |
| Cholestasis | Alkaline phosphatase, GGT, 5′-nucleotidase | Obstruction to bile flow |
| Synthetic function | Serum albumin, prothrombin time / INR | The true measure of liver function |
| Detoxification | Blood ammonia, blood urea | Urea cycle capacity |
CLINICAL PEARL
The transaminases measure damage, not function. A patient with end-stage cirrhosis may have near-normal ALT because little viable liver remains. Albumin and prothrombin time are the tests that measure what the liver can still do, and prothrombin time is the more sensitive, since clotting factors have a half-life of hours against albumin's 20 days.
Individual Tests
| Test | Normal | Interpretation |
|---|---|---|
| Total bilirubin | 0.2–1.0 mg/dL | Jaundice becomes visible above 2–2.5 mg/dL |
| Direct (conjugated) | < 0.3 mg/dL | Raised in hepatocellular and obstructive jaundice |
| ALT | 7–40 U/L | More liver-specific; > 10× suggests viral hepatitis |
| Ast | 10–40 U/L | Also from heart and muscle; ast:ALT > 2 suggests alcohol |
| Alkaline phosphatase | 40–130 U/L | > 3× suggests obstruction; also bone origin |
| GGT | 10–50 U/L | Most sensitive marker of alcohol intake; confirms a raised ALP is hepatic |
| Albumin | 3.5–5.0 g/dL | Falls in chronic disease; half-life 20 days |
| Prothrombin time / INR | 11–14 s / 0.9–1.2 | The most sensitive index of acute synthetic failure |
Patterns in the Three Types of Jaundice
| Feature | Pre-hepatic (haemolytic) | Hepatic | Post-hepatic (obstructive) |
|---|---|---|---|
| Total bilirubin | ↑ | ↑↑ | ↑↑↑ |
| Type predominating | Unconjugated | Both | Conjugated |
| Urine bilirubin | Absent (unconjugated is protein-bound, not filtered) | Present | Present (dark urine) |
| Urine urobilinogen | Increased | Variable | Absent |
| Stool | Dark | Normal or pale | Clay-coloured |
| ALT / ast | Normal | ↑↑↑ | Mildly ↑ |
| Alkaline phosphatase | Normal | ↑ | ↑↑↑ |
| Prothrombin time | Normal | Prolonged, not corrected by vitamin K | Prolonged, corrected by vitamin K |
- The vitamin K response distinguishes hepatocellular from obstructive jaundice — in obstruction the liver is capable but the vitamin is not absorbed; in hepatocellular disease the liver cannot use it
- Absent urine urobilinogen with dark urine is characteristic of complete biliary obstruction
Specific Patterns
| Condition | Characteristic finding |
|---|---|
| Acute viral hepatitis | ALT and ast > 10×, ALT > ast |
| Alcoholic hepatitis | Ast : ALT > 2, both usually < 300; GGT high |
| Obstructive jaundice | ALP > 3× with GGT raised; modest transaminase rise |
| Cirrhosis | Low albumin, prolonged INR, reversed A:G ratio; transaminases may be normal |
| Paracetamol overdose | Very high transaminases with rapidly rising INR |
| Gilbert syndrome | Isolated unconjugated hyperbilirubinaemia with all else normal, worse on fasting |
Other Tests
- Serum protein electrophoresis — cirrhosis shows low albumin with a diffuse rise in γ and β–γ bridging
- Blood ammonia — raised in hepatic encephalopathy; must be sent on ice
- α-Fetoprotein — screening for hepatocellular carcinoma
- Autoantibodies, viral serology, caeruloplasmin, ferritin, α1-antitrypsin to establish the cause
Applied Aspects
- A "liver function test" panel mostly measures damage; the term is a misnomer that misleads students and clinicians alike
- Blood urea is low in liver failure, not high — the urea cycle has failed. This surprises most students
- Isolated raised ALP — check GGT: if normal, the source is bone, placenta or intestine, not liver
- Prothrombin time is the single best prognostic marker in acute liver failure and forms part of the King's College transplant criteria
- Normal liver tests do not exclude significant liver disease — up to a third of patients with cirrhosis have normal transaminases
Functions of the Kidney
- Excretory — urea, creatinine, uric acid, drugs
- Regulatory — water, electrolytes, acid–base balance
- Endocrine — erythropoietin, renin, 1α-hydroxylase (calcitriol)
- Metabolic — gluconeogenesis, ammoniagenesis, peptide degradation
Classification of Tests
| Group | Tests |
|---|---|
| Glomerular function | Blood urea, serum creatinine, creatinine clearance, eGFR, cystatin C, inulin clearance |
| Tubular function | Urine concentration and dilution, urine specific gravity and osmolality, urinary acidification, PAH clearance |
| Glomerular integrity | Proteinuria, microalbuminuria, urine microscopy for casts |
| Others | Electrolytes, acid–base, calcium and phosphate |
Glomerular Filtration Rate
GFR = the volume of plasma filtered by the glomeruli per minute. Normal 120–130 mL/min/1.73 m2.
| Marker | Merit | Limitation |
|---|---|---|
| Inulin clearance | Gold standard — freely filtered, neither secreted nor reabsorbed | Needs infusion; impractical |
| Creatinine clearance | Endogenous; no infusion needed | Overestimates GFR by 10–20% because some is secreted; needs a complete 24-hour collection |
| Serum creatinine | Simple, cheap, universal | Insensitive — stays normal until GFR has fallen by about 50%; varies with muscle mass |
| EGFR (CKD-EPI, MDRD) | Corrects for age, sex and race; no collection needed | Unreliable at extremes of muscle mass, in pregnancy and in acute illness |
| Cystatin C | Independent of muscle mass; detects early loss | Costlier; affected by steroids and thyroid disease |
Creatinine clearance = (U × V) ÷ PU = urine creatinine, V = urine flow (mL/min), P = plasma creatinine
CLINICAL PEARL
The "creatinine blind range" matters clinically. Serum creatinine can remain within the reference interval while half the renal function has already been lost, because of the reciprocal relationship between creatinine and GFR. A rise from 0.8 to 1.6 mg/dL — both "normal-looking" — represents a halving of GFR.
Blood Urea and Creatinine
| Feature | Blood urea | Serum creatinine |
|---|---|---|
| Normal | 20–40 mg/dL | 0.6–1.2 mg/dL |
| Source | Protein catabolism, urea cycle | Creatine phosphate, non-enzymatically |
| Affected by diet | Yes — high protein raises it | Little |
| Reabsorbed | 40–50% | Negligible |
| Better index of GFR | No | Yes |
| Raised in GI bleed | Yes | No |
- Urea : creatinine ratio above 20:1 suggests a prerenal cause — dehydration, shock, gastrointestinal bleeding, or a high protein load
- Blood urea is low in liver failure, pregnancy and a low-protein diet
Tubular Function Tests
- Urine concentration test — after overnight fluid deprivation, specific gravity should exceed 1.022 and osmolality 800 mOsm/kg. Loss of concentrating ability is the earliest sign of tubular damage
- Urine dilution test — specific gravity should fall below 1.003 after a water load
- Urinary acidification (ammonium chloride loading) — urine pH should fall below 5.3; failure indicates renal tubular acidosis
- PAH clearance measures effective renal plasma flow (about 600 mL/min), since PAH is completely cleared in one pass
- Fractional excretion of sodium — below 1% in prerenal failure, above 2% in acute tubular necrosis
Proteinuria and Albuminuria
| Category | Albumin excretion | Significance |
|---|---|---|
| Normal | < 30 mg/day | — |
| Microalbuminuria | 30–300 mg/day | Earliest sign of diabetic nephropathy — and reversible |
| Overt proteinuria | > 300 mg/day | Established nephropathy |
| Nephrotic range | > 3.5 g/day | With hypoalbuminaemia, oedema and hyperlipidaemia |
- Ordinary dipsticks detect albumin but miss Bence Jones protein — a critical limitation in suspected myeloma
- Albumin : creatinine ratio on a spot sample has largely replaced timed collections
Biochemical Findings in Renal Failure
| Parameter | Change | Reason |
|---|---|---|
| Urea and creatinine | ↑↑ | Failure of excretion |
| Potassium | ↑ | Failure of excretion; acidosis shifts it out of cells |
| Bicarbonate, pH | ↓ | Failure of acid excretion and bicarbonate regeneration |
| Calcium | ↓ | Failed 1α-hydroxylation of vitamin D |
| Phosphate | ↑ | Failure of excretion |
| PTH | ↑↑ | Secondary hyperparathyroidism → renal osteodystrophy |
| Haemoglobin | ↓ | Erythropoietin deficiency |
Applied Aspects
- Annual microalbuminuria screening in diabetes is worthwhile precisely because that stage is reversible with ACE inhibitors and good glycaemic control
- Serum creatinine must be interpreted against muscle mass — a frail elderly woman may have marked impairment with a "normal" value, which is why eGFR is reported
- Drug dosing must be adjusted to eGFR for renally excreted drugs; metformin, digoxin and aminoglycosides are common pitfalls
- Cooked meat transiently raises creatinine, so a fasting sample is preferred
- Uraemia is a clinical syndrome, not a number — nausea, pruritus, pericarditis, encephalopathy and bleeding from platelet dysfunction
Introduction
Haem = a porphyrin ring (protoporphyrin IX) chelating ferrous iron; the prosthetic group of haemoglobin, myoglobin, cytochromes, catalase, peroxidase and cytochrome P450.
- Synthesised chiefly in the bone marrow (85%) and liver (15%)
- Begins and ends in the mitochondrion, with the middle steps in the cytosol
Pathway
Succinyl-CoA + Glycine (mitochondrion) → ala synthase — needs pyridoxal phosphate; rate-limiting → δ-Aminolaevulinic acid (ala) → moves to cytosol → ala dehydratase — inhibited by lead → Porphobilinogen → Uroporphyrinogen I synthase and III cosynthase → Uroporphyrinogen III → Coproporphyrinogen III → back to mitochondrion → Protoporphyrin IX → ferrochelatase — adds Fe2+; also inhibited by lead → haem
- All eight carbons and four nitrogens come from succinyl-CoA and glycine
- Haem inhibits ala synthase by feedback, and also represses its gene — the principal control
Regulation
| Ala synthase induced by | Ala synthase inhibited by |
|---|---|
| Drugs inducing cytochrome P450 — barbiturates, phenytoin, griseofulvin, sulphonamides, rifampicin | Haem (feedback) |
| Fasting and low carbohydrate intake | Glucose (the "glucose effect") |
| Alcohol | — |
| Steroid hormones — hence attacks around menstruation | — |
| Infection, stress, surgery | — |
CLINICAL PEARL
This regulation explains the whole clinical picture of acute porphyria. Anything that induces P450 consumes haem, releasing ala synthase from inhibition. The enzyme is up-regulated, precursors accumulate above the block, and an attack follows. It also explains the two treatments — glucose and haem arginate, both of which switch the enzyme off.
Classification of Porphyrias
| Type | Enzyme deficient | Site | Chief features |
|---|---|---|---|
| Acute intermittent porphyria | Porphobilinogen deaminase (uroporphyrinogen I synthase) | Hepatic | Abdominal pain, neuropsychiatric features; NO photosensitivity |
| Congenital erythropoietic porphyria | Uroporphyrinogen III cosynthase | Erythropoietic | Severe photosensitivity, red urine, red teeth, haemolysis |
| Porphyria cutanea tarda | Uroporphyrinogen decarboxylase | Hepatic | The commonest; photosensitivity, blistering; alcohol and hepatitis C |
| Hereditary coproporphyria | Coproporphyrinogen oxidase | Hepatic | Acute attacks and photosensitivity |
| Variegate porphyria | Protoporphyrinogen oxidase | Hepatic | Both; common in South Africa |
| Erythropoietic protoporphyria | Ferrochelatase | Erythropoietic | Burning photosensitivity without blisters |
- The rule is simple: a block early in the pathway accumulates ala and porphobilinogen, which are neurotoxic; a block later accumulates porphyrins, which are photosensitising
Acute Intermittent Porphyria
- Autosomal dominant; attacks usually after puberty, commoner in women
- The five Ps — Pain in the abdomen, Polyneuropathy, Psychological disturbance, Port-wine urine, Precipitated by drugs
- Severe colicky abdominal pain with NO peritoneal signs — many patients undergo needless laparotomy
- Tachycardia, hypertension, vomiting, constipation; hyponatraemia from SIADH
- Urine darkens to port-wine colour on standing in light, as porphobilinogen polymerises
- Diagnosis — raised urinary ala and porphobilinogen; the Watson–Schwartz test
- Treatment — withdraw the precipitant, intravenous glucose, haem arginate, analgesia, and propranolol for the autonomic features
Lead Poisoning
Lead inhibits ala dehydratase and ferrochelatase → Two consequences → ala accumulates → neurotoxicity → Protoporphyrin accumulates (iron cannot be inserted) → Zinc is inserted instead → ↑ zinc protoporphyrin → Microcytic anaemia with basophilic stippling
- Features — abdominal colic, peripheral neuropathy with wrist drop, encephalopathy in children, blue lead line on the gums, anaemia
- Raised blood lead, raised urinary ala, raised zinc protoporphyrin; porphobilinogen is normal, which distinguishes it from acute porphyria
- Treated with chelation — EDTA, dimercaprol, penicillamine, succimer
Catabolism of Haem
Haem from senescent red cells → Haem oxygenase — releases iron (reused) and CO → Biliverdin → biliverdin reductase → bilirubin → albumin-bound to liver → Conjugated with glucuronic acid → excreted in bile
- Iron and globin are conserved; only the porphyrin ring is degraded
- Carbon monoxide from haem breakdown is the only endogenous source, and is measurable in exhaled breath as an index of haemolysis
- 250–350 mg of bilirubin is produced daily
Applied Aspects
- Porphyria is a great mimic — consider it in unexplained abdominal pain with neuropsychiatric features, especially if attacks recur and investigations are normal
- A long list of drugs is unsafe — barbiturates, sulphonamides, phenytoin, oestrogens, griseofulvin; safe alternatives must be checked before prescribing
- Sideroblastic anaemia — from pyridoxine deficiency, isoniazid or lead, all interfering with haem synthesis; ring sideroblasts on marrow
- Porphyria cutanea tarda responds to venesection and to low-dose chloroquine, and is strongly associated with alcohol, hepatitis C and iron overload
- Photosensitivity arises because porphyrins absorb light at 400 nm (the Soret band) and generate free radicals in the skin
- Haem is also the prosthetic group of cytochrome P450, which is why drugs that induce P450 consume haem and precipitate attacks
- Ala synthase requires pyridoxal phosphate, so B6 deficiency and isoniazid cause sideroblastic anaemia
- Erythropoietic protoporphyria causes burning pain on sun exposure without blistering, and may progress to liver failure from protoporphyrin deposition
- Givosiran, a small interfering RNA that silences ala synthase, is a recent treatment for recurrent acute attacks — derived directly from the regulation described above
- Urine porphobilinogen must be measured during an attack; it may be normal between attacks, so a negative result in a well patient does not exclude the diagnosis
- Family screening is essential, since asymptomatic carriers can be warned about unsafe drugs before their first attack
- The porphyrias are often described as the "little imitator", and delayed diagnosis by years is common
Normal Values
| Parameter | Normal range |
|---|---|
| Arterial pH | 7.35–7.45 |
| PCO2 | 35–45 mmHg |
| HCO3− | 22–26 mEq/L |
| PO2 | 80–100 mmHg |
| Base excess | −2 to +2 mEq/L |
| Anion gap | 8–16 mEq/L |
Henderson–Hasselbalch: pH = 6.1 + log ([HCO3−] ÷ 0.03 × pCO2)The ratio of bicarbonate to carbonic acid is normally 20 : 1.
- The kidney controls the numerator (bicarbonate); the lung controls the denominator (pCO2). Every acid–base disorder is a disturbance of one, compensated by the other
The Four Primary Disorders
| Disorder | Primary change | PH | Compensation | Speed |
|---|---|---|---|---|
| Metabolic acidosis | ↓ HCO3 | ↓ | ↓ pCO2 (hyperventilation) | Minutes to hours |
| Metabolic alkalosis | ↑ HCO3 | ↑ | ↑ pCO2 (hypoventilation) | Hours; limited |
| Respiratory acidosis | ↑ pCO2 | ↓ | ↑ HCO3 (renal) | Days |
| Respiratory alkalosis | ↓ pCO2 | ↑ | ↓ HCO3 (renal) | Days |
- Compensation never fully corrects the pH — if the pH is normal with abnormal values, suspect a mixed disorder
- Respiratory compensation is fast; renal compensation is slow but far more powerful
Metabolic Acidosis and the Anion Gap
Anion gap = Na+ − (Cl− + HCO3−); normal 8–16 mEq/L. It represents the unmeasured anions, chiefly albumin.
| High anion gap (added acid) | Normal anion gap (bicarbonate lost) |
|---|---|
| Methanol | Diarrhoea — the commonest |
| Uraemia | Renal tubular acidosis |
| Diabetic ketoacidosis | Pancreatic or biliary fistula |
| Paraldehyde | Acetazolamide |
| Isoniazid, Iron | Ureteric diversion |
| Lactic acidosis | Excess saline (hyperchloraemic) |
| Ethylene glycol | — |
| Salicylates | — |
- Mnemonic mudpiles for the raised gap causes
- Normal anion gap acidosis is also called hyperchloraemic — chloride rises to replace the lost bicarbonate
- The gap must be corrected for albumin — add 2.5 mEq/L for every 1 g/dL that albumin falls below 4
Causes of the Other Disorders
| Disorder | Causes |
|---|---|
| Metabolic alkalosis | Vomiting, nasogastric suction, diuretics, hyperaldosteronism, excess alkali, hypokalaemia |
| Respiratory acidosis | COPD, respiratory depression (opioids, anaesthesia), neuromuscular disease, airway obstruction, severe asthma |
| Respiratory alkalosis | Anxiety and hyperventilation, high altitude, fever, sepsis, early salicylate poisoning, hepatic failure, pregnancy |
Approach to Interpretation
- 1. Look at the pH — acidaemia or alkalaemia? → 2.
- Which value explains it — HCO3 (metabolic) or pCO2 (respiratory)? → 3.
- Is compensation appropriate? Use the expected formulas → 4.
- If metabolic acidosis, calculate the anion gap → 5.
- If the gap is raised, check the delta ratio for a second disorder → 6.
- Interpret alongside the clinical picture
- Winter formula for metabolic acidosis: expected pCO2 = 1.5 × HCO3 + 8 ± 2. A higher value means a coexisting respiratory acidosis; a lower one, a respiratory alkalosis
Clinical Consequences
- Acidosis — Kussmaul breathing, reduced myocardial contractility, vasodilatation, arrhythmias, hyperkalaemia, insulin resistance, confusion
- Alkalosis — tetany (ionised calcium falls), paraesthesiae, confusion, hypokalaemia, arrhythmias; the oxygen dissociation curve shifts left
- Acidosis raises serum potassium by shifting it out of cells; alkalosis lowers it — a link that must be remembered when correcting either
Compensation Formulas
| Primary disorder | Expected compensation |
|---|---|
| Metabolic acidosis | PCO2 = 1.5 × HCO3 + 8 ± 2 (Winter) |
| Metabolic alkalosis | PCO2 rises 0.7 mmHg per 1 mEq/L rise in HCO3 |
| Acute respiratory acidosis | HCO3 rises 1 mEq/L per 10 mmHg rise in pCO2 |
| Chronic respiratory acidosis | HCO3 rises 3.5 mEq/L per 10 mmHg |
| Acute respiratory alkalosis | HCO3 falls 2 mEq/L per 10 mmHg fall |
| Chronic respiratory alkalosis | HCO3 falls 5 mEq/L per 10 mmHg fall |
Applied Aspects
- Salicylate poisoning gives a mixed picture — direct stimulation of the respiratory centre causes respiratory alkalosis, while uncoupling and lactate cause metabolic acidosis. A normal pH here is ominous
- Treat the cause, not the number — bicarbonate in lactic acidosis and DKA is reserved for severe acidaemia, and may worsen intracellular pH
- Correcting acidosis unmasks hypokalaemia and can precipitate arrhythmia; potassium must be replaced alongside
- In chronic COPD the bicarbonate is high from renal compensation; giving too much oxygen removes the hypoxic drive and worsens CO2 retention
- Venous blood gases suffice for pH and bicarbonate in most non-respiratory situations, sparing an arterial puncture
Formation
Senescent RBC (120 days) destroyed in the reticuloendothelial system → Haemoglobin → globin (reused) + haem → haem oxygenase — opens the ring; releases Fe2+ (reused) and CO → biliverdin (green) → Biliverdin reductase (NADPH) → bilirubin (yellow-orange)
- 250–350 mg of bilirubin is produced daily; 80–85% from senescent red cells, the rest from ineffective erythropoiesis and other haemoproteins
- Carbon monoxide is a by-product — the only endogenous source in the body, and it is measurable in breath
- 1 g of haemoglobin yields about 35 mg of bilirubin
Transport and Conjugation
Unconjugated bilirubin is water-insoluble → Transported bound to albumin → Taken up by the hepatocyte (ligandin) → UDP-glucuronyl transferase → Bilirubin diglucuronide — water-soluble → Actively secreted into bile (the rate-limiting step)
| Feature | Unconjugated (indirect) | Conjugated (direct) |
|---|---|---|
| Water solubility | Insoluble | Soluble |
| Albumin binding | Tight | Loose |
| Appears in urine | NO | Yes |
| Van den Bergh reaction | Indirect (needs alcohol) | Direct (immediate) |
| Crosses blood–brain barrier | Yes — causes kernicterus | No |
| Normal serum | < 0.8 mg/dL | < 0.3 mg/dL |
Intestinal Fate
Conjugated bilirubin enters the gut → Bacterial β-glucuronidase deconjugates it → Reduced to urobilinogen (colourless) → Most oxidised to stercobilin → brown colour of stool → About 20% reabsorbed — enterohepatic circulation → A small fraction reaches the kidney → urobilin in urine
- Absent stercobilin gives clay-coloured stools in biliary obstruction
- Absent urinary urobilinogen indicates complete obstruction; increased urobilinogen indicates haemolysis
Classification of Jaundice
| Type | Bilirubin raised | Mechanism | Examples |
|---|---|---|---|
| Pre-hepatic | Unconjugated | Excess production | Haemolysis, ineffective erythropoiesis, large haematoma |
| Hepatic | Both | Defective uptake, conjugation or excretion | Hepatitis, cirrhosis, drugs, Gilbert, Crigler–Najjar |
| Post-hepatic | Conjugated | Obstruction to bile flow | Gallstone, carcinoma head of pancreas, stricture |
Inherited Hyperbilirubinaemias
| Disorder | Defect | Bilirubin | Course |
|---|---|---|---|
| Gilbert syndrome | Reduced UDP-glucuronyl transferase (about 30% activity) | Unconjugated, < 3 mg/dL | Benign; worse on fasting, illness or stress; very common (5–8%) |
| Crigler–Najjar type I | Complete absence of the enzyme | Unconjugated, 20–45 mg/dL | Kernicterus; fatal without transplant; no response to phenobarbitone |
| Crigler–Najjar type II | Severe partial deficiency | Unconjugated, 6–20 mg/dL | Responds to phenobarbitone (enzyme induction) |
| Dubin–Johnson | Defective canalicular excretion (MRP2) | Conjugated | Benign; black liver on biopsy |
| Rotor syndrome | Defective storage | Conjugated | Benign; liver not pigmented |
Neonatal Jaundice
- Physiological jaundice — appears after 24 hours, peaks on days 3–5, resolves by day 10. Due to immature UDP-glucuronyl transferase, a shorter red cell lifespan, and increased enterohepatic circulation
- Pathological if it appears within 24 hours, exceeds 15 mg/dL, rises faster than 5 mg/dL/day, is conjugated, or persists beyond 2 weeks
- Kernicterus — unconjugated bilirubin crosses the immature blood–brain barrier and deposits in the basal ganglia, causing athetoid cerebral palsy, deafness and gaze palsy
- Risk is increased by prematurity, acidosis, hypoalbuminaemia, sepsis and drugs that displace bilirubin from albumin — sulphonamides, ceftriaxone, salicylates
- Treatment — phototherapy (450 nm light converts bilirubin to water-soluble lumirubin, excreted without conjugation) and exchange transfusion if severe
The Van Den Bergh Reaction
Serum + diazotised sulphanilic acid → Conjugated bilirubin reacts immediately (within 1 minute) → → direct positive → Unconjugated bilirubin needs alcohol or methanol to react → → indirect positive
| Reaction | Meaning | Seen in |
|---|---|---|
| Direct positive | Conjugated bilirubin raised | Obstructive jaundice, Dubin–Johnson |
| Indirect positive | Unconjugated bilirubin raised | Haemolysis, Gilbert, Crigler–Najjar |
| Biphasic | Both raised | Hepatocellular jaundice |
Applied Aspects
- Jaundice becomes clinically visible above 2–2.5 mg/dL, first in the sclera because of its high elastin content, which binds bilirubin
- Gilbert syndrome is often discovered incidentally and needs no treatment; recognising it prevents needless investigation. It also reduces the metabolism of irinotecan, increasing toxicity
- Bilirubin is a physiological antioxidant, and mild elevation may be mildly protective against cardiovascular disease
- Phototherapy works without conjugation, which is why it helps even in Crigler–Najjar disease
- Conjugated hyperbilirubinaemia in a neonate is always pathological and demands urgent exclusion of biliary atresia, where surgery before 8 weeks determines the outcome
- Breast milk jaundice — prolonged unconjugated hyperbilirubinaemia from a substance in milk inhibiting glucuronyl transferase; benign, and breast feeding should continue
- Physiological jaundice never appears in the first 24 hours; jaundice on day one is haemolytic or septic until proved otherwise
- Rh and ABO incompatibility are the commonest causes of severe neonatal haemolysis; prevented by anti-D immunoglobulin
- Phenobarbitone induces glucuronyl transferase and was formerly used in neonatal jaundice and in Crigler–Najjar type II
- Bilirubin encephalopathy is entirely preventable with timely phototherapy, which is why every jaundiced newborn needs a measured level rather than a visual estimate
- Transcutaneous bilirubinometry allows non-invasive screening, though high values must be confirmed on serum
- Jaundice is best examined in natural daylight, since artificial light masks mild elevation
Definition
Tumour markers = substances produced by tumour cells, or by the host in response to a tumour, that can be measured in blood, urine or tissue and used in diagnosis, prognosis and monitoring.
Classification
| Class | Examples |
|---|---|
| Oncofetal antigens | α-Fetoprotein (AFP), carcinoembryonic antigen (CEA) |
| Hormones | HCG, calcitonin, catecholamines, ACTH |
| Enzymes | Prostatic acid phosphatase, LDH, alkaline phosphatase, neurone-specific enolase |
| Glycoproteins (CA series) | CA-125, CA 19-9, CA 15-3 |
| Proteins | PSA, β2-microglobulin, thyroglobulin, immunoglobulins |
| Genetic markers | BRCA1/2, HER2, BCR-ABL, EGFR, KRAS |
Important Markers and Their Tumours
| Marker | Chief association | Other causes of elevation |
|---|---|---|
| AFP | Hepatocellular carcinoma; non-seminomatous germ cell tumour | Pregnancy (neural tube defects), hepatitis, cirrhosis |
| CEA | Colorectal carcinoma | Smoking, inflammatory bowel disease, pancreatitis, cirrhosis |
| PSA | Carcinoma prostate | Benign hypertrophy, prostatitis, after examination or catheterisation |
| CA-125 | Ovarian carcinoma | Endometriosis, menstruation, pregnancy, cirrhosis, any peritoneal irritation |
| CA 19-9 | Pancreatic carcinoma | Cholangitis, obstructive jaundice; absent in Lewis-negative individuals |
| HCG | Choriocarcinoma, hydatidiform mole, germ cell tumour | Pregnancy |
| Calcitonin | Medullary carcinoma thyroid | — |
| Thyroglobulin | Follicular and papillary thyroid carcinoma — follow-up | Thyroiditis |
Uses and Limitations
| Appropriate use | Inappropriate use |
|---|---|
| Monitoring response to treatment | Screening the general population — too many false positives |
| Detecting recurrence during follow-up | Making a diagnosis of cancer on the marker alone |
| Prognosis and staging | Excluding cancer when the level is normal |
| Guiding targeted therapy (HER2, EGFR) | — |
| Screening high-risk groups — AFP in cirrhosis, calcitonin in men-2 | — |
CLINICAL PEARL
No tumour marker is sufficiently sensitive or specific to diagnose cancer. Their value lies almost entirely in monitoring a known tumour — a rising level after treatment signals recurrence, often before imaging. Diagnosis still requires histology.
Applied Aspects
- PSA screening remains controversial — it detects many indolent cancers that would never have caused harm, leading to overtreatment. Free:total PSA ratio and PSA velocity improve specificity
- CA-125 is unreliable in premenopausal women, since so many benign gynaecological conditions raise it
- A marker is only useful in follow-up if it was raised at diagnosis
- Serial measurement in the same laboratory matters, since methods differ and results are not interchangeable
- β2-microglobulin is a prognostic marker in myeloma and lymphoma
Definition
Cerebrospinal fluid (CSF) = the clear fluid surrounding the brain and spinal cord, secreted chiefly by the choroid plexus.
- Volume 130–150 mL; produced at about 500 mL/day, so it is replaced three to four times daily
- Functions — mechanical protection (buoyancy), homeostasis of the neuronal environment, removal of metabolites, and a route for some signalling
Normal Composition
| Constituent | CSF | Compared with plasma |
|---|---|---|
| Appearance | Clear, "crystal clear" | — |
| Pressure | 60–150 mm H2O | — |
| Glucose | 45–80 mg/dL | About two-thirds of blood glucose |
| Protein | 15–45 mg/dL | Far lower — the blood–brain barrier excludes it |
| Chloride | 120–130 mEq/L | Higher than plasma |
| Cells | 0–5 lymphocytes/mm3 | No red cells or neutrophils |
| Sodium, osmolality | Similar to plasma | — |
| Calcium, potassium, urea | Lower | — |
- A simultaneous blood glucose must always be taken, since CSF glucose is meaningful only as a ratio
Changes in Meningitis
| Feature | Pyogenic | Tubercular | Viral | Fungal |
|---|---|---|---|---|
| Appearance | Turbid, purulent | Clear; cobweb clot | Clear | Clear or turbid |
| Cells | 1000–5000, neutrophils | 100–500, lymphocytes | 10–500, lymphocytes | 20–500, lymphocytes |
| Protein | ↑↑ (100–500) | ↑↑↑ (very high) | Normal or slightly ↑ | ↑ |
| Glucose | ↓↓ (very low) | ↓ | Normal | ↓ |
| Chloride | ↓ | ↓↓ (markedly low) | Normal | ↓ |
| Confirmation | Gram stain, culture, latex agglutination | ZN stain, GeneXpert, ADA | PCR | India ink, cryptococcal antigen |
CLINICAL PEARL
The two most useful discriminators are glucose and the cell type. Normal glucose with lymphocytes points to a viral cause; low glucose with lymphocytes and a very high protein to tuberculosis; low glucose with neutrophils to a pyogenic infection.
Other Abnormal Findings
- Xanthochromia — yellow supernatant after centrifugation, from bilirubin; indicates subarachnoid haemorrhage more than 12 hours old, and distinguishes it from a traumatic tap
- Froin syndrome — very high protein with xanthochromia and rapid clotting, in spinal block
- Albumino-cytological dissociation — raised protein with normal cell count; characteristic of Guillain–Barré syndrome
- Oligoclonal bands on CSF electrophoresis — multiple sclerosis
- Raised adenosine deaminase (ADA) supports tuberculous meningitis
Applied Aspects
- Lumbar puncture is contraindicated when intracranial pressure is raised with a focal lesion — the risk is coning; image the head first if there are focal signs, papilloedema or altered consciousness
- Antibiotics must not be delayed for the lumbar puncture in suspected bacterial meningitis
- Partially treated pyogenic meningitis can mimic the tubercular picture, with lymphocytes and a modestly low glucose — a common diagnostic trap
- CSF glucose falls in bacterial and tubercular meningitis because organisms and leucocytes consume it and transport is impaired
Definition
Thyroid function tests = the biochemical assessment of thyroid status, based chiefly on serum TSH with free thyroid hormone levels.
The Hormones
| Hormone | Normal range | Notes |
|---|---|---|
| TSH | 0.4–4.0 mIU/L | The single most sensitive test — changes logarithmically with small shifts in thyroid hormone |
| Free T4 | 0.8–1.8 ng/dL | The chief secretory product; a prohormone |
| Free T3 | 2.3–4.2 pg/mL | The active hormone; 80% made peripherally by deiodination |
| Total T4, T3 | — | Affected by binding proteins — less reliable |
- 99.97% of T4 is protein-bound, chiefly to thyroxine-binding globulin; only the free fraction is active
- TBG rises in pregnancy and with oestrogen, and falls in nephrotic syndrome and liver disease — which is why free hormone is measured
Interpretation
| TSH | Free T4 | Diagnosis |
|---|---|---|
| ↑ | ↓ | Primary hypothyroidism |
| ↑ | Normal | Subclinical hypothyroidism |
| ↓ | ↑ | Primary hyperthyroidism |
| ↓ | Normal | Subclinical hyperthyroidism; or T3 toxicosis (check free T3) |
| ↓ or normal | ↓ | Secondary (pituitary) hypothyroidism |
| ↑ | ↑ | TSH-secreting adenoma; thyroid hormone resistance; assay interference |
CLINICAL PEARL
TSH alone is the best screening test in a stable outpatient, because the pituitary responds to tiny changes in free hormone. But it is misleading in pituitary disease, in acute illness, and in the first weeks of treatment, when it lags behind by 6–8 weeks.
Other Tests
- Anti-TPO and anti-thyroglobulin antibodies — Hashimoto thyroiditis
- TSH receptor antibodies (TRAb) — Graves disease
- Thyroglobulin — a tumour marker in follow-up of differentiated thyroid carcinoma
- Radioiodine uptake scan — distinguishes Graves disease (high, diffuse) from thyroiditis (low uptake)
- Calcitonin — medullary carcinoma
Pitfalls
| Situation | Effect |
|---|---|
| Sick euthyroid syndrome | Low T3, normal or low TSH in any severe illness; do not test thyroid function in an acutely ill patient |
| Pregnancy | HCG stimulates the TSH receptor → low TSH in the first trimester; trimester-specific ranges are needed |
| Amiodarone | Can cause either hypo- or hyperthyroidism; contains large amounts of iodine |
| Biotin supplements | Interfere with immunoassays → falsely low TSH with high T4, mimicking thyrotoxicosis |
| Recent treatment change | TSH takes 6–8 weeks to equilibrate |
Applied Aspects
- Congenital hypothyroidism screening by neonatal TSH is among the most valuable of all screening programmes — treatment within the first two weeks prevents retardation entirely, while delay causes irreversible damage
- Hypothyroidism raises LDL cholesterol and creatine kinase, and should be excluded in unexplained dyslipidaemia or myopathy
- Subclinical hypothyroidism in pregnancy should be treated, since the fetus depends entirely on maternal thyroxine in the first trimester
- Iodine deficiency remains the commonest cause of hypothyroidism worldwide, though autoimmune thyroiditis predominates where salt is iodised
Definition
Quality control = the system of procedures that ensures laboratory results are reliable, reproducible and clinically usable.
| Term | Meaning |
|---|---|
| Accuracy | Closeness to the true value; affected by systematic error (bias) |
| Precision | Reproducibility on repeated measurement; affected by random error |
| Sensitivity | Ability to detect true positives; a sensitive test is good for ruling out |
| Specificity | Ability to identify true negatives; a specific test is good for ruling IN |
| Coefficient of variation | (SD ÷ mean) × 100 — the usual measure of precision |
- Mnemonic — SnNOut (a Sensitive test, if Negative, rules Out) and SpPIn (a Specific test, if Positive, rules In)
- A method can be precise but inaccurate — consistently wrong. Both are needed
Types of Quality Control
| Type | Description | Purpose |
|---|---|---|
| Internal (IQC) | Control sera of known value run with each batch, daily | Monitors precision day to day |
| External (EQAS) | Unknown samples sent by a central agency and compared between laboratories | Monitors accuracy against peers |
The Levey–jennings Chart
- Control values are plotted daily against the mean ± 1, 2 and 3 standard deviations
- 95% of results should fall within ± 2 SD
- Patterns are interpreted by the Westgard rules
| Westgard rule | Meaning | Suggests |
|---|---|---|
| 12s | One value beyond 2 SD | Warning only — expected in 1 of 20 runs |
| 13s | One value beyond 3 SD | Reject — random error |
| 22s | Two consecutive beyond the same 2 SD limit | Reject — systematic error |
| R4s | Two values differing by more than 4 SD | Random error |
| 10x | Ten consecutive on the same side of the mean | Shift — new reagent lot, recalibration |
| 7T | Seven consecutive rising or falling | Trend — deteriorating reagent, ageing lamp, electrode drift |
CLINICAL PEARL
A shift is abrupt; a trend is gradual. The distinction points to different causes — a shift usually follows a discrete event such as a new reagent lot or recalibration, while a trend suggests something deteriorating steadily.
Sources of Error
| Phase | Share of errors | Examples |
|---|---|---|
| Pre-analytical | 60–70% — the largest | Wrong patient or label, haemolysis, wrong tube, tourniquet too long, delay in transport, non-fasting sample |
| Analytical | 10–15% | Instrument fault, reagent deterioration, calibration error, interference |
| Post-analytical | 15–20% | Transcription error, delayed reporting, failure to communicate a critical value |
- Most laboratory error occurs before the sample reaches the analyser — which is why sample collection deserves as much attention as the assay
- Haemolysis falsely raises potassium, LDH, ast and phosphate — the commonest single interference
Applied Aspects
- Critical (panic) values must be telephoned immediately — potassium above 6.5, glucose below 40, calcium above 13, and a positive blood culture
- Always question a result that does not fit the patient; repeat before acting on a surprising value
- Reference ranges are population-specific, defined as the central 95%, which means 1 in 20 healthy people falls outside by definition — the reason a panel of 20 tests so often shows one "abnormal" result
Definition
Automation = the use of instruments to perform laboratory analyses with minimal manual intervention, from sample handling through to result reporting.
Types of Analyser
| Type | Principle | Feature |
|---|---|---|
| Continuous flow | Samples pass through the same tubing separated by air bubbles | Historic (AutoAnalyzer); carry-over is a problem |
| Discrete | Each sample in its own reaction vessel | The usual modern design; no carry-over |
| Centrifugal | Rotor spins samples into cuvettes | Fast; all read simultaneously |
| Dry chemistry | Reagents on a slide or strip; reflectance measured | Point-of-care; small sample volume |
| Random access | Any test on any sample in any order, with STAT priority | The standard in modern laboratories |
Common Analytical Principles
| Principle | Measures | Example |
|---|---|---|
| Photometry / colorimetry | Absorbance — Beer–Lambert law | Most enzymatic assays; NADH at 340 nm |
| Ion-selective electrode | Electrical potential | Sodium, potassium, chloride, ionised calcium |
| Immunoassay (ELISA, CLIA) | Antigen–antibody binding | Hormones, tumour markers, drugs |
| Nephelometry / turbidimetry | Light scattering | Specific proteins, CRP |
| Flame photometry | Emission | Sodium, potassium (largely obsolete) |
| Chromatography and mass spectrometry | Separation and mass | HbA1c, newborn screening, drug levels, toxicology |
Advantages and Limitations
| Advantages | Limitations |
|---|---|
| Speed and high throughput | High capital and maintenance cost |
| Better precision — removes manual variability | Needs trained staff and reliable power |
| Small sample volume — valuable in paediatrics | Breakdown halts all testing |
| Fewer transcription errors with bar coding and interfacing | Uneconomical for low workload |
| Biohazard exposure reduced | Cannot detect an unsuitable sample without safeguards |
| Multiple tests from one sample | May encourage unnecessary testing through panels |
Point-of-care Testing
- Performed near the patient — glucometers, blood gas analysers, urine dipsticks, pregnancy tests, rapid antigen tests, HbA1c devices
- Advantage — immediate result, so immediate action; valuable in emergency, intensive care, and remote settings
- Limitation — less precise, operator-dependent, and often outside formal quality control
- Must still be subject to quality control and periodic comparison with the laboratory
Applied Aspects
- Automation has not reduced pre-analytical error, which remains the largest source — a wrongly labelled sample is analysed perfectly and reported wrongly
- Bar-coded samples and bidirectional interfacing address post-analytical transcription error, the second largest source
- Delta checks — automatic comparison with the patient's previous result, flagging implausible changes; a useful safeguard against sample mix-up
- Reflex testing — an abnormal result automatically triggers a confirmatory test, such as free T4 after an abnormal TSH
- The clinician remains responsible for interpretation — an analyser reports a number, not a diagnosis
Definition
Xenobiotic detoxification in the liver and the assessment of drug levels form the basis of therapeutic drug monitoring (TDM) — measuring plasma concentrations to individualise dosage.
When Therapeutic Drug Monitoring Is Justified
- Narrow therapeutic index — the toxic level is close to the effective one
- Wide interindividual variation in metabolism
- No easily measured clinical endpoint
- Saturable (zero-order) kinetics — small dose changes cause large level changes
- Suspected toxicity or non-compliance
- Altered handling — renal or hepatic disease, pregnancy, extremes of age
Drugs Commonly Monitored
| Drug | Therapeutic range | Reason for monitoring |
|---|---|---|
| Digoxin | 0.5–2.0 ng/mL | Narrow index; toxicity worsened by hypokalaemia |
| Phenytoin | 10–20 µg/mL | Zero-order kinetics above therapeutic levels |
| Lithium | 0.6–1.2 mEq/L | Very narrow index; renal excretion |
| Theophylline | 10–20 µg/mL | Narrow index |
| Aminoglycosides | Peak and trough | Nephrotoxicity and ototoxicity |
| Vancomycin | Trough 10–20 µg/mL | Nephrotoxicity |
| Ciclosporin, tacrolimus | Trough | Rejection versus toxicity |
| Methotrexate | Level-guided rescue | Determines folinic acid rescue |
CLINICAL PEARL
Phenytoin is the classic example. Because its metabolism saturates within the therapeutic range, a small increase in dose can produce a disproportionately large rise in plasma level and sudden toxicity — ataxia, nystagmus and confusion. This is why it cannot be dosed by weight alone.
Principles of Sampling
- Take the sample at steady state — after about 5 half-lives
- Trough levels (immediately before the next dose) are usual; peaks are used for aminoglycosides
- Digoxin must be sampled at least 6–8 hours after a dose, or the distribution phase gives a falsely high result — a very common error
- Record the exact time of sampling and of the last dose, or the result is uninterpretable
Factors Altering Drug Levels
| Factor | Effect |
|---|---|
| Enzyme induction (rifampicin, phenytoin, carbamazepine, alcohol) | ↓ Level, ↓ effect |
| Enzyme inhibition (cimetidine, erythromycin, ketoconazole, grapefruit) | ↑ Level, toxicity |
| Hypoalbuminaemia | ↑ free fraction — toxicity at a normal total level (phenytoin, warfarin) |
| Renal impairment | Accumulation of renally excreted drugs — digoxin, lithium, aminoglycosides |
| Genetic polymorphism | CYP2D6, CYP2C19, NAT2, TPMT — poor and rapid metabolisers |
Applied Aspects
- Total phenytoin is misleading in hypoalbuminaemia — the free fraction may be toxic while the total looks therapeutic; measure free phenytoin or correct for albumin
- Lithium toxicity is precipitated by dehydration, diuretics, NSAIDs and ACE inhibitors, all reducing renal clearance
- TPMT testing before azathioprine prevents severe myelosuppression in poor metabolisers — pharmacogenetics in routine practice
- A level is interpreted alongside the patient: a "toxic" level in a well patient and a "therapeutic" level in a toxic one both demand clinical judgement rather than automatic dose change
Definition
Screening = the presumptive identification of unrecognised disease in apparently healthy individuals, by tests that can be applied rapidly and cheaply to large numbers.
Criteria for a Screening Programme (wilson and Jungner)
- The condition should be an important health problem
- Its natural history must be understood, with a recognisable latent or early symptomatic stage
- A suitable test must exist — simple, safe, acceptable, sensitive and specific
- An accepted treatment must be available, and early treatment must improve the outcome
- Facilities for diagnosis and treatment must be available
- The programme must be cost-effective and continuing, not a one-off
CLINICAL PEARL
The most important criterion is that early treatment changes the outcome. Detecting a disease earlier is worthless, and may be harmful, if nothing useful can be done sooner. This is the argument at the centre of the controversy over PSA screening.
Biochemical Screening in the Newborn
| Condition | Test | Why it matters |
|---|---|---|
| Congenital hypothyroidism | TSH on day 3–5 | Treatment within 2 weeks prevents retardation entirely |
| Phenylketonuria | Guthrie test or tandem MS, after 48–72 h of milk | Diet prevents irreversible mental retardation |
| Congenital adrenal hyperplasia | 17-hydroxyprogesterone | Prevents salt-wasting crisis and death |
| G6PD deficiency | Fluorescent spot test | Avoids drug-induced haemolysis and kernicterus |
| Galactosaemia | GALT assay | Diet prevents liver damage, cataract and sepsis |
| Sickle cell disease | Haemoglobin electrophoresis or HPLC | Penicillin prophylaxis reduces mortality |
| Biotinidase deficiency | Enzyme assay | Biotin prevents deafness and optic atrophy |
- Tandem mass spectrometry detects over 30 disorders from one dried blood spot — the modern basis of expanded newborn screening
- India screens for congenital hypothyroidism, CAH and G6PD deficiency in many centres, though coverage remains incomplete
Antenatal Biochemical Screening
| Test | Timing | Detects |
|---|---|---|
| Double marker — free β-hCG, PAPP-A | 11–13 weeks | Down syndrome, trisomy 18 |
| Triple marker — AFP, hCG, unconjugated oestriol | 15–20 weeks | Down syndrome, neural tube defects |
| Quadruple marker — adds inhibin A | 15–20 weeks | Better detection rate |
| Cell-free fetal DNA | From 10 weeks | Non-invasive; very high detection rate |
| Oral glucose tolerance test | 24–28 weeks | Gestational diabetes |
- Raised AFP suggests a neural tube defect; low AFP with low oestriol and high hCG suggests Down syndrome
- Screening tests give a risk, not a diagnosis — a positive result requires confirmation by amniocentesis or chorionic villus sampling
Screening in Adults
- Diabetes — fasting glucose or HbA1c in those over 30 or with risk factors; important given India's burden
- Dyslipidaemia — lipid profile for cardiovascular risk assessment
- Chronic kidney disease — urine albumin:creatinine ratio in diabetics and hypertensives
- Anaemia — haemoglobin in women and children
- Thyroid — TSH in pregnancy and in the elderly
Applied Aspects
One book of nineteen in the KAVACH series · mbbsadda.in